WorldWideScience

Sample records for b19 chlamydia pneumoniae

  1. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis

    DEFF Research Database (Denmark)

    Helweg-Larsen, J; Tarp, B; Obel, N;

    2002-01-01

    OBJECTIVES: Recent studies have suggested that infective agents may be involved in the pathogenesis of giant cell arteritis (GCA), in particular Chlamydia pneumoniae and parvovirus B19. We investigated temporal arteries from patients with GCA for these infections as well as human herpes viruses...... conditions. DNA was extracted from frozen biopsies and PCR was used to amplify genes from Chlamydia pneumoniae, parvovirus B19 and each of the eight human herpes viruses: herpes simplex viruses HSV-1 and 2, Epstein-Barr virus, cytomegalovirus, varicella zoster virus and human herpes viruses HHV-6, -7 and -8....... RESULTS: In all 30 biopsies, PCR was negative for DNAs of parvovirus B19, each of the eight human herpes viruses and C. pneumoniae. CONCLUSIONS: We found no evidence of DNA from parvovirus B19, human herpes virus or C. pneumoniae in any of the temporal arteries. These agents do not seem to play a unique...

  2. Molecular biology of the Chlamydia pneumoniae surface

    DEFF Research Database (Denmark)

    Christiansen, Gunna; Østergaard, Lars; Birkelund, Svend

    1997-01-01

    Chlamydia pneumoniaeis a fastidious microorganism with a characteristic biphasic lifecycle causing a variety of human respiratory tract infections. There is limited knowledge about the molecular biology of C. pneumoniae, and only a few genes have been sequenced. The structure of the chlamydial...

  3. Molecular characterization of Chlamydia pneumoniae in animals and humans from Argentina: Genetic characterization of Chlamydia pneumoniae.

    Science.gov (United States)

    Frutos, María C; Monetti, Marina S; Mosmann, Jessica; Kiguen, Ana X; Venezuela, Fernando R; Ré, Viviana E; Cuffini, Cecilia G

    2016-10-01

    In this study, genetic diversity of Chlamydia pneumoniae was investigated and the relationships between sequences amplified of different sources, clinical conditions and geographical regions of central Argentina were established. Samples amplified were similar to human C. pneumoniae patterns and show the high clonality of the population. PMID:27328126

  4. A family outbreak of Chlamydia pneumoniae infection.

    Science.gov (United States)

    Ghosh, K; Frew, C E; Carrington, D

    1992-07-01

    Chlamydia pneumoniae, a newly described Chlamydia species, has been shown to be a cause of acute respiratory tract infection in both adults and children, but its role in human infection is still under investigation. Here we present a family outbreak of C. pneumoniae infection where three members of a family presented with a 'flu-like illness' and acute upper respiratory tract infection which did not improve despite penicillin or septrin therapy. No history of exposure to birds, pets or animals was obtained. As C. pneumoniae isolation from respiratory secretions is not without difficulty, diagnosis usually relies currently on serum-based tests. In this study C. pneumoniae specific IgM determined by the micro-immunofluorescence test was detected in the three clinical cases. All three cases had an elevated complement-fixing antibody titre to Psittacosis-LGV antigen, which may have suggested psittacosis, if type-specific tests had not been performed. In addition, three other members of the family had C. pneumoniae-specific IgG antibody although specific IgM was absent. These three younger members of the family had been symptomatic in the month preceding symptoms in their older sibling and their parents. All the symptomatic members of the family made a complete recovery on tetracycline therapy. PMID:1522345

  5. Chlamydia pneumoniae and Atherosclerosis: The End?

    Directory of Open Access Journals (Sweden)

    LE Nicolle

    2005-01-01

    Full Text Available In this issue of the Journal, Patrick et al (pages 298-300 report on the results of a pilot study testing the hypothesis that seropositivity to Chlamydia pneumoniae together with a specific bacteriophage protein is associated with first-episode myocardial infarction or unstable angina. The study evolved from an earlier report suggesting that C pneumoniae with phage seropositivity was strongly associated with the presence of abdominal aortic aneurysm. The phage association suggested a potential explanation for some of the variability in previous studies exploring C pneumoniae as a cause for atherosclerosis (ie, only selected strains of C pneumoniae were pathogenic. Patrick et al found no significant association or trend, and the authors concluded that the negative findings in their pilot study did not support further studies to address this potential association.

  6. Chlamydia pneumoniae infection-associated erythema multiforme

    Directory of Open Access Journals (Sweden)

    Shinsaku Imashuku

    2013-06-01

    Full Text Available There is a well-known correlation between Herpes simplex (HSV infection and erythema multiforme (EM. More recently, in Japan, it was found that Chlamydia pneumoniae (Cp may promote the development of EM. All cases of Cp infection-associated EM that had been diagnosed in our clinic over the past two years (from 2011 to 2012 were analyzed. Cp infection was diagnosed on the basis of a significant increase (>2.00 in anti-Cp IgM titers, as measured by the HITAZYME-ELISA test. There were 7 cases of Cp-EM, one male and 6 females. Median age was 13 years (range 3-29 years. It is recommended that the possible involvement of Cp infection, besides HSV or Mycoplasma pneumoniae infections, should be considered in all cases of EM.

  7. Seropositivity for Chlamydia Pneumoniae and Mycoplasma Pneumoniae in Asthmatic Children

    Directory of Open Access Journals (Sweden)

    Murat Tutanc

    2014-03-01

    Full Text Available Acute respiratory tract infections may trigger acute asthma attacks and may be held responsible for etiopathogenesis in children with asthma. Although bacterial infections attract a limited amount of attention, recently Chlamydia pneumoniae (CP and Mycoplasma pneumoniae (MP, in particular, are reported to be the possible factors. IgM and IgG seroprevalence was investigated in 66 children patients with bronchial asthma (between the ages of 3 and 14 for CP and Mycoplasma pneumoniae. In a total of 66 cases, 18 (27.2% patients were detected with IgG positivity for CP whereas 27 of them (40.9% were detected with IgG positivity for MP. IgG positivity was determined in 6 patients (13.0% in the control group for CP, and in 6 patients (10.8% in the control group for MP. The rate of the asthma patients with IgG seropositivity for MP was 4 times higher than that of the control group. It was seen that IgG antibody seropositivity for CP was higher in those with more frequent attacks. No such difference was observed in terms of IgG antibody seropositivity for M. pneumoniae. There are many studies indicating that CP and MP infections take an importance place in the etiology of bronchial asthma and asthma attacks in children. The results obtained reveal the effect of both microorganisms on the etiopathogenesis of the bronchial asthma and the increased number of asthma attacks.

  8. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR)

    DEFF Research Database (Denmark)

    Lindholt, Jes Sanddal; Ostergård, L; Henneberg, E W;

    1998-01-01

    To investigate whether Chlamydia pneumoniae is present in symptomatic abdominal aortic aneurysms (AAA).......To investigate whether Chlamydia pneumoniae is present in symptomatic abdominal aortic aneurysms (AAA)....

  9. Chlamydia pneumoniae Promotes Dysfunction of Pancreatic Beta Cells

    Science.gov (United States)

    Rodriguez, Annette R.; Plascencia-Villa, Germán; Witt, Colleen M.; Yu, Jieh-Juen; José-Yacamán, Miguel; Chambers, James P.; Perry, George; Guentzel, M. Neal; Arulanandam, Bernard P.

    2015-01-01

    The human pathogen Chlamydia pneumoniae has been implicated in chronic inflammatory diseases including type 2 diabetes. Therefore, we designed a study to evaluate pancreatic beta cells and mast cells during chlamydial infection. Our study revealed that C. pneumoniae infected mast cells significantly (p< 0.005) decreased beta cell ATP and insulin production, in contrast to uninfected mast cells co-cultured with beta cells. Infected mast cells exhibited pyknotic nuclei and active caspase-3 and caspase-1 expression. Additionally, ex vivo analyses of tissues collected from C. pneumoniae infected mice showed increased interleukin-1β production in splenocytes and pancreatic tissues as was observed with in vitro mast cell-beta cell co-cultures during C. pneumoniae infection. Notably, infected mast cells promoted beta cell destruction. Our findings reveal the negative effect of C. pneumoniae on mast cells, and the consequential impact on pancreatic beta cell function and viability. PMID:25863744

  10. Relationship between Chlamydia pneumoniae infection and occurrence of bronchial asthma

    Institute of Scientific and Technical Information of China (English)

    SHI Yi; ZHENG Wen; XIA Xi-rong; ZHANG Xi-long; TONG Mao-rong; FENG Gen-bao; ZHAO Bei-lei; HU Lan-ping

    2002-01-01

    Objective: To study the relationship between Chlamydia pneumoniae (C. Pneumoniae) infection and asthma exacerbation. Methods: A prospective study of C. Pneumoniae infection was conducted in 75 patients with asthma and 63 patients with respiratory tract infection, and 100 blood donors served as controls.The presence of infection was convinced by the polymerase chain reaction and direct immunofluorescence assay for C. Pneumoniae DNA from throat swab specimens and micro-immunofluorescence testing for C. Pneumoniae-specific IgG, IgM and IgA antibodies. Results: Prevalence of specific IgG in asthma patients (81.3%) was higher than that of the blood donors (68. 0%, P<0. 05) and was not significantly different from respiratory tract infection patients (68. 0%, P>0. 05). The acute C. Pneumoniae infection rate of symptomatic asthma patients (59.4%) was markedly higher than that of respiratory tract infection patients (34.9%, P<0. 05). The average titer of C. Pneumoniae IgG instead of IgA in asthma patients (48. 38±6. 94)was significantly higher than respiratory tract infection patients (24. 70±8. 77, P<0. 05). Other pathogens were identified in 12 of 21 (57. 1%) asthma patients with C. Pneumoniae. The symptoms of 7 asthma patients with C. Pneumoniae infection were improved through antibiotic treatment. Conclusion: The findings suggest a possible role of C. Pneumoniae infection in asthma.

  11. Coproduction of KPC-2 and QnrB19 in Klebsiella pneumoniae ST340 isolate in Brazil.

    Science.gov (United States)

    Martins, Willames M B S; Almeida, Anna C S; Nicoletti, Adriana G; Cayô, Rodrigo; Gales, Ana C; Alves, Luiz C; Brayner, Fábio B; Vilela, Marinalda A; Morais, Márcia M C

    2015-12-01

    Few reports described the presence of bla(KPC) and qnr genes in the same isolate. This study reports the combination of bla(KPC-2) and qnrB19 genes in Klebsiella pneumoniae ST340 isolate in Brazil. These findings draw attention to this combination in ST340 isolate, which is part of the CC258, disseminated in Latin America. PMID:26458280

  12. Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain

    Directory of Open Access Journals (Sweden)

    Appelt Denah M

    2010-09-01

    Full Text Available Abstract Background Sporadic late-onset Alzheimer's disease (AD appears to evolve from an interplay between genetic and environmental factors. One environmental factor that continues to be of great interest is that of Chlamydia pneumoniae infection and its association with late-onset disease. Detection of this organism in clinical and autopsy samples has proved challenging using a variety of molecular and histological techniques. Our current investigation utilized immunohistochemistry with a battery of commercially available anti-C. pneumoniae antibodies to determine whether C. pneumoniae was present in areas typically associated with AD neuropathology from 5 AD and 5 non-AD control brains. Results Immunoreactivity for C. pneumoniae antigens was observed both intracellularly in neurons, neuroglia, endothelial cells, and peri-endothelial cells, and extracellularly in the frontal and temporal cortices of the AD brain with multiple C. pneumoniae-specific antibodies. This immunoreactivity was seen in regions of amyloid deposition as revealed by immunolabeling with two different anti-beta amyloid antibodies. Thioflavin S staining, overlaid with C. pneumoniae immunolabeling, demonstrated no direct co-localization of the organism and amyloid plaques. Further, the specificity of C. pneumoniae labeling of AD brain sections was demonstrated using C. pneumoniae antibodies pre-absorbed against amyloid β 1-40 and 1-42 peptides. Conclusions Anti-C. pneumoniae antibodies, obtained commercially, identified both typical intracellular and atypical extracellular C. pneumoniae antigens in frontal and temporal cortices of the AD brain. C. pneumoniae, amyloid deposits, and neurofibrillary tangles were present in the same regions of the brain in apposition to one another. Although additional studies are required to conclusively characterize the nature of Chlamydial immunoreactivity in the AD brain, these results further implicate C. pneumoniae infection with the

  13. Mycoplasma contamination of Chlamydia pneumoniae isolates

    DEFF Research Database (Denmark)

    Huniche, BS; Jensen, Lise Torp; Birkelund, Svend;

    1998-01-01

    We examined 6 C. pneumonia isolates from The American Type Culture Collection (ATCC) and 2 Finnish isolates for Mycoplasma contamination. Three of the ATCC isolates and both of the Finnish isolates were Mycoplasma-contaminated. The contaminants were characterized by means of growth in BEa and BEg...... media, immunoblotting, polymerase chain reaction and pulsed field gel electrophoresis. Two of the 6 ATCC isolates [ATCC VR1355 (TWAR strain 2043) and ATCC VR1356 (TWAR strain 2023)] were infected with Mycoplasma hominis and 1 isolate [ATCC VR2282 (TWAR strain TW183)] was contaminated with both...... Mycoplasma hominis and Mycoplasma orale, whereas 3 of the ATCC isolates [ATCC VR1310, ATCC VR1360 (TWAR strain CM-1) and ATCC 53592 (TWAR strain AR39)] were not contaminated. The Finnish C. pneumoniae isolates Kajaani 6 and Parola were found to be contaminated with M. hominis and M. orale, respectively...

  14. Coinfection with Mycoplasma Pneumoniae and Chlamydia Pneumoniae in ruptured plaques associated with acute myocardial infarction

    Directory of Open Access Journals (Sweden)

    Higuchi Maria de Lourdes

    2003-01-01

    Full Text Available OBJECTIVE: To study atheromas, Mycoplasma pneumoniae (M. pneumoniae, and Chlamydia pneumoniae (C. pneumoniae. METHODS: C. pneumoniae was studied with immunohistochemistry and M. pneumoniae with in situ hybridization (ISH, in segments of coronary arteries (SCA as follows: group A - thrombosed ruptured plaques (TRP of 23 patients who died due to acute myocardial infarction (AMI; group B - 23 nonruptured plaques (NRP of group A patients; group C - NRP of 11 coronary patients who did not die due to AMI; and group D - 11 SCA from patients with dilated cardiomyopathy or Chagas' disease without atherosclerosis. RESULTS: The mean number of C. pneumoniae+ cells/400x in groups A, B, C, and D was, respectively, 3.3±3.6; 1.0±1.3; 1.2±2.4; and 0.4±0.3; and the percentage of M. pneumoniae area was, respectively, 3.9±3.5; 1.5± 1.6; 0.9±0.9; and 0.4±0.2. More M. pneumoniae and C. pneumoniae were found in of group A than in group B (P<0.01. Good correlation was seen between the area of the vessel and the M. pneumoniae area in the plaque (r = 0.46; P=0.001 and between C. pneumoniae+ cells and CD4+ T lymphocytes (r = 0.42; P<0.01. The number of C. pneumoniae+ cells correlated with CD20+ B cells (r=0.48; P<0.01. CONCLUSION: M. pneumoniae and C. pneumoniae are more frequently found in TRP correlate with the intensity of the inflammation and diameter of the vessel (positive remodeling.

  15. Chlamydia pneumoniae Inhibits Activated Human T Lymphocyte Proliferation by the Induction of Apoptotic and Pyroptotic Pathways

    OpenAIRE

    Olivares-Zavaleta, Norma; Carmody, Aaron; Messer, Ronald; Whitmire, William M.; Caldwell, Harlan D.

    2011-01-01

    Chlamydia pneumoniae is an omnipresent obligate intracellular bacterial pathogen that infects numerous host species. C. pneumoniae infections of humans are a common cause of community acquired pneumonia but have also been linked to chronic diseases such as atherosclerosis, Alzheimer’s disease, and asthma. Persistent infection and immune avoidance are believed to play important roles in the pathophysiology of C. pneumoniae disease. We found that C. pneumoniae organisms inhibited activated but ...

  16. Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm

    DEFF Research Database (Denmark)

    Lindholt, J.S; Juul, Svend; Vammen, S;

    1999-01-01

    BACKGROUND: The aim of this study was to examine the possible association between the progression of small abdominal aortic aneurysm (AAA) and chronic infection with Chlamydia pneumoniae. METHODS: Patients from a hospital-based mass screening programme for AAA with annual follow-up (mean 2.7 years....... pneumoniae. Aneurysm progression correlated with evidence of chronic C. pneumoniae infection....

  17. Chlamydia pneumoniae and mycoplasma pneumoniae in children with acute respiratory infection in general practices in the Netherlands.

    NARCIS (Netherlands)

    Tjhie, J.H.T.; Dorigo-Zetsma, J.W.; Roosendaal, R.; Brule, A.J.C. van den; Bestebroer, T.M.; Bartelds, A.I.M.; Vandenbroucke-Grauls, C.M.J.E.

    2000-01-01

    In this retrospective study Chlamydia pneumoniae and Mycoplasma pneumoniae infections were detected by polymerase chain reaction (PCR) in samples (n=457) from children presenting with acute respiratory infection to general practitioners during 1992-97. Samples were collected in autumn and winter, an

  18. Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism

    DEFF Research Database (Denmark)

    Vandahl, Brian B S; Stensballe, Allan; Roepstorff, Peter;

    2005-01-01

    infected cells, whereas only the 65 kDa full-length Cpn0796 could be detected in purified Chlamydia. Confocal immunofluorescence microscopy demonstrated that Cpn0796 was localized in the Chlamydia membrane in young inclusions. However, at 36 h post infection and later Cpn0796 was detected in the cytoplasm...... of C. pneumoniae infected HEp-2 and BHK cells. Furthermore, Cpn0796 was detected in the cytoplasm of infected cells in the lungs of C. pneumoniae infected C57Bl mice. When cleavage was inhibited, Cpn0796 was retained in the chlamydiae. We propose that Cpn0796 is an autotransporter the N-terminal of...... which is translocated to the host cell cytoplasm. This is the first example of secretion of a Chlamydia autotransporter passenger domain into the host cell cytoplasm. Cpn0796 is specific for C. pneumoniae, where five homologous proteins are encoded by clustered genes. None of these five proteins were...

  19. Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection

    Institute of Scientific and Technical Information of China (English)

    Antonella Marangoni; Manuela Donati; Francesca Cavrini; Rita Aldini; Silvia Accardo; Vittorio Sambri; Marco Montagnani; Roberto Cevenini

    2006-01-01

    AIM: To develop an animal model of liver infection with Chlamydia pneumoniae (C.pneumoniae) in intraperitoneally infected mice for studying the presence of chlamydiae in Kupffer cells and hepatocytes.METHODS: A total of 80 BALB/c mice were inoculated intraperitoneally with C. pneumoniae and sacrificed at various time points after infection. Chlamydiae were looked for in liver homogenates as well as in Kupffer cells and hepatocytes separated by liver perfusion with collagenase. C. pneumoniae was detected by both isolation in LLC-MK2 cells and fluorescence in situ hybridization (FISH). The releasing of TNFA-α by C. pneumoniae in vitro stimulated Kupffer cells was studied by enzymelinked immunosorbent assay.RESULTS: C. pneumoniae isolation from liver homogenates reached a plateau on d 7 after infection when 6 of 10 animals were positive, then decreased, and became negative by d 20. C. pneumoniae isolation from separated Kupffer cells reached a plateau on d 7 when 5 of 10 animals were positive, and became negative by d 20.The detection of C. pneumoniae in separated Kupffer cells by FISH, confirmed the results obtained by culture.Isolated hepatocytes were always negative. Stimulation of Kupffer cells by alive C. pneumoniae elicited high TNF-α levels.CONCLUSION: A productive infection by C. pneumoniae may take place in Kupffer cells and C. pneumoniae induces a local pro-inflammatory activity. C. pneumoniae is therefore, able to act as antigenic stimulus when localized in the liver. One could speculate that C. pneumoniae infection, involving cells of the innate immunity such as Kupffer cells, could also trigger pathological immune reactions involving the liver, as observed in human patients with primary biliary cirrhosis.

  20. Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody

    OpenAIRE

    Bamford Kathleen B; Wyatt Dorothy E; O'Neill Hugh J; Duprex W; McCluggage W Glenn; Barros D'Sa Aires AB; Coyle Peter V; Ong Grace M; O'Loughlin Barney; McCaughey Conall

    2001-01-01

    Abstract Background The association of Chlamydia pneumoniae with atherosclerosis is controversial. We investigated the presence of C. pneumoniae and other Chlamydia spp. in atheromatous carotid artery tissue. Methods Forty elective carotid endarterectomy patients were recruited (27 males, mean age 65 and 13 females mean age 68), 4 had bilateral carotid endarterectomies (n= 44 endarterectomy specimens). Control specimens were taken from macroscopically normal carotid artery adjacent to the ath...

  1. Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices.

    NARCIS (Netherlands)

    Meijer, A.; Dagnelie, C.F.; Jong, J.C. de; Vries, A. de; Besteboer, T.M.; Loon, A.M. van; Bartelds, A.I.M.; Ossewaarde, J.M.

    2000-01-01

    Acute respiratory disease is one of the most common reasons to consult a general practitioner. A substantial part of these diseases cannot be explained by an infection with a virus or a common pathogenic bacterium. To study this diagnostic deficit, the prevalence of Chlamydia pneumoniae and Mycoplas

  2. Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis.

    Science.gov (United States)

    Hakala, Elina; Hanski, Leena; Uvell, Hanna; Yrjönen, Teijo; Vuorela, Heikki; Elofsson, Mikael; Vuorela, Pia Maarit

    2015-10-01

    Lignans from Schisandra chinensis berries show various pharmacological activities, of which their antioxidative and cytoprotective properties are among the most studied ones. Here, the first report on antibacterial properties of six dibenzocyclooctadiene lignans found in Schisandra spp. is presented. The activity was shown on two related intracellular Gram-negative bacteria Chlamydia pneumoniae and Chlamydia trachomatis upon their infection in human epithelial cells. All six lignans inhibited C. pneumoniae inclusion formation and infectious progeny production. Schisandrin B inhibited C. pneumoniae inclusion formation even when administered 8 h post infection, indicating a target that occurs relatively late within the infection cycle. Upon infection, lignan-pretreated C. pneumoniae elementary bodies had impaired inclusion formation capacity. The presence and substitution pattern of methylenedioxy, methoxy and hydroxyl groups of the lignans had a profound impact on the antichlamydial activity. In addition our data suggest that the antichlamydial activity is not caused only by the antioxidative properties of the lignans. None of the compounds showed inhibition on seven other bacteria, suggesting a degree of selectivity of the antibacterial effect. Taken together, the data presented support a role of the studied lignans as interesting antichlamydial lead compounds.

  3. Determination Of Frequency Rate Of Chlamydia Pneumonia Infection In Two Groups Of Patients With And Without AMI

    Directory of Open Access Journals (Sweden)

    Moghaddam M

    2004-06-01

    Full Text Available Background: ‏Today, coronary artery disease is a leading cause of death and morbidity in the world and recognition of all aspects of this problem appears to be necessary and important. In recent years in addition to traditional coronary risk factors, other new risk factors are presented that can affect coronary arteries and accelerate atherosclerosis process. One of the most important of these, are infections, specially with Chlamydia pneumonia. We aimed to study this possibility that is whether correlation between infection with Chlamydia pneumonia and Acute Myocardial Infarction. (AMI. Materials and Methods: This research is a descriptive case-control study which evaluates frequency of infection with Chlamydia pneumonia in the 100 patients with AMI and 105 patients without any history or evidence of CAD admitted in sections of CCU and surgery, in Dr. SHARIATI and SINA hospitals in 2001. For this purpose we took 5ml blood sample from all of the patients, and tested for specific anti Chlamydia pneumonia antibodies (IgG & IgM by ELISA method. Results: Our study showed that 38 percent of control group patients and 54 percent of patients with AMI had positive titer of anti Chlamydia pneumonia antibody and so they were infected with Chlamydia pneumonia {OR= 1.9 (95% CI: 1.34 to 2.46} (P< 0/001. Conclusion: This study demonstrates that, there is significant correlation between infection with Chlamydia pneumonia and occurrence of AMI so treatment of this infection could be of profit.

  4. Characterisation of Chlamydia pneumoniae and other novel chlamydial infections in captive snakes.

    Science.gov (United States)

    Taylor-Brown, Alyce; Rüegg, Simon; Polkinghorne, Adam; Borel, Nicole

    2015-07-01

    Chlamydiosis has been described in both free-ranging and captive reptiles. The infection usually manifests as granulomatous inflammation in inner organs such as spleen, heart, lung and liver but might also occur in asymptomatic reptiles. The aim of this study was to investigate and characterise Chlamydia pneumoniae and potential other novel chlamydial infections in the choana and cloaca samples of 137 clinically healthy captive snakes from six private collections. Forty eight samples from 29 animals were found to be positive by a Chlamydiaceae family-specific qPCR. By Chlamydia species-specific ArrayTube Microarray, 43 samples were positive, with 36 of these being identified as C. pneumoniae. The prevalence of Chlamydia ranged from 5 to 33%. PCR and sequencing of the Chlamydiales 16S rRNA signature sequence of 21 Chlamydia positive samples revealed the presence of seven novel 16S rRNA genotypes. BLAST-n and phylogenetic analysis of the near-full length 16S rRNA gene sequence of each of these novel 16S rRNA sequences revealed that five genotypes share closest sequence identity to 16S rRNA sequences from C. pneumoniae (98.6-99.2%), suggesting that these sequences are novel C. pneumoniae strains. One genotype is 96.9% similar to C. pneumoniae strains suggesting it may originate from a yet undescribed chlamydial species within the genus Chlamydia. This study further highlights the broad host range for C. pneumoniae and suggests that reptiles may still contain a significant and largely uncharacterised level of chlamydial genetic diversity that requires further investigation.

  5. Detection of Chlamydia pneumoniae in a collection of captive snakes and response to treatment with marbofloxacin.

    Science.gov (United States)

    Rüegg, S R; Regenscheit, N; Origgi, F C; Kaiser, C; Borel, N

    2015-09-01

    In a collection of 58 snakes comprising predominantly Eurasian vipers in Switzerland, five snakes died unexpectedly during hibernation from 2009 to 2012. In one snake, organisms resembling chlamydiae were detected by immunohistochemistry in multiple histiocytic granulomas. Real-time quantitative PCR and microarray analysis were used to determine the presence of Chlamydia pneumoniae in tissue samples and cloacal/choanal swabs from snakes in the collection; 8/53 (15.1%) of the remaining snakes were positive. Although one infected snake had suppurative periglossitis, infection with C. pneumoniae did not appear to be associated with specific clinical signs in snakes. Of seven snakes treated with 5 mg/kg marbofloxacin IM once daily, five became PCR negative for C. pneumoniae following treatment, whereas one animal remained positive and one snake was lost to follow-up.

  6. Proteolytic cleavage of the Chlamydia pneumoniae major outer membrane protein in the absence of Pmp10

    DEFF Research Database (Denmark)

    Juul, Nicolai Stefan; Timmerman, E; Gevaert, K;

    2007-01-01

    The genome of the obligate intracellular bacteria Chlamydia pneumoniae contains 21 genes encoding polymorphic membrane proteins (Pmp). While no function has yet been attributed to the Pmps, they may be involved in an antigenic variation of the Chlamydia surface. It has previously been demonstrated...... that Pmp10 is differentially expressed in the C. pneumoniae CWL029 isolate. To evaluate whether the absence of Pmp10 in the outer membrane causes further changes to the C. pneumoniae protein profile, we subcloned the CWL029 isolate and selected a clone with minimal Pmp10 expression. Subsequently, we...... compared the proteome of the CWL029 isolate with the proteome of the subcloned strain and identified a specific cleavage of the C-terminal part of the major outer membrane protein (MOMP), which occurred only in the absence of Pmp10. In contrast, when Pmp10 was expressed we predominantly observed full...

  7. Chlamydia

    Science.gov (United States)

    ... you may not notice them until several weeks after you get chlamydia. Signs and symptoms may include: Bleeding ... you may not notice them until several weeks after you get chlamydia. Signs and symptoms may include: Bleeding ...

  8. The inhibitory effect of disodium cromoglycate on the growth of Chlamydophila (Chlamydia) pneumoniae in vitro.

    Science.gov (United States)

    Yamazaki, Tsutomu; Yamaguchi, Tetsuya; Sasaki, Nozomu; Inoue, Miyuki; Sato, Kozue; Kishimoto, Toshio

    2006-04-01

    Chlamydophila (Chlamydia) pneumoniae is associated with asthma and several other respiratory illnesses. Disodium cromoglycate (DSCG) is known to inhibit both immediate and late asthmatic responses. In this study, the inhibitory effect of DSCG on the growth of C. pneumoniae was examined by minimum inhibitory concentration (MIC) and pre-inoculation minimal cidal concentration (MCC) assays using HL cells and C. pneumoniae AR-39. DSCG below the clinically relevant concentration inhibited the growth of C. pneumoniae in a dose-dependent manner in both the MCC and MIC assays. The inhibitory effect was also time-dependent in the MCC assay at 20 mg/ml of DSCG. These results warrant further clinical study on the connection between C. pneumoniae infections and use of DSCG. PMID:16595921

  9. The Lignan-containing Extract of Schisandra chinensis Berries Inhibits the Growth of Chlamydia pneumonia.

    Science.gov (United States)

    Hakala, Elina; Hanski, Leena L; Yrjönen, Teijo; Vuorela, Heikki J; Vuorela, Pia M

    2015-06-01

    The purpose of this study was to investigate the effect and selectivity of an extract of Schisandra chinensis berries against Chlamydia pneumoniae and C. trachomatis. Among the ethnopharmacological uses of the extract from Schisandrae fructus are cough and pneumonia. Therefore we focused on respiratory pathogens. The extract completely inhibited the growth of C. pneumoniae strain CV6 at 250 μg/mL concentration. The inhibition of C. pneumoniae and C. trachomatis growth was dose dependent and established with three different strains. The extract inhibited C. pneumoniae production of infectious progeny in a dose dependent manner. Chlamydia selectivity was elucidated with growth inhibition measurements of three other respiratory bacterial species. A pure compound found in Schisandra chinensis berries, schisandrin B at 20.0 μg/mL concentration inhibited the growth of both C. pneumoniae and C. trachomatis. The extract was found to be non-toxic to the human host cells. These findings highlight the potential of the extract from Schisandra chinensis berries as a source for antichlamydial compounds.

  10. Sudden psychotic episode probably due to meningoencephalitis and Chlamydia pneumoniae acute infection

    OpenAIRE

    Canas Nuno; Coromina Marta; Correa Bernardo; Xavier Miguel; Guimarães João

    2005-01-01

    Abstract Background Since 9% to 20% of all cases of acute psychosis presenting to an Emergency Department (ED) are due to a general medical condition, cautious medical workup should be mandatory in such patients. Differential diagnosis must consider conditions as diverse as renal failure or CNS infection. Acute Chlamydia pneumoniae infection usually causes a self-limited respiratory syndrome. Rarely, acute neurological complications occur, with acute meningoencephalitis most frequently report...

  11. The Infection of Chlamydia Pneumonia in Patients with Acute Myocardial Infarction

    Institute of Scientific and Technical Information of China (English)

    李涛; 许香广; 张国良; 方卫华

    2004-01-01

    Objectives To study the association between infection with chlamydia pneumonia and acute myocardial infarction (AMI). Methods Serology of chlamydia pneumoniae specific IgG、IgM antibodies were measured by microimmunofluorescence test in groups of acute myocardial infarction (AMI) and health control(HC). Results The total infection positive rates were 30.6% in HC group and 88.1% in AMI group, including the previous infection rates which were 30.6% and 71.4%, while the acute infection rates were 0% and 16.7%. The frequency of total infection, previous infection and acute infection was significantly higher in AMI group than in the HC group. Odds Ratio for the development of AMI were 16.82, 5.68, 14.2, respectively(95% CI 5.83 to 48.54,2.46 to 13.11, 1.68 to 119.97). Geometric mean IgG titre was significantly higher in patients with AMI compared with the HC group (P< 0.01). There is no IgM positive in HC group but there were two cases in AMI group. Conclusions The presence of high titers of immmunoglobulin G in AMI. Chlamydia pneumonia infection may be a risk factor for the AMI .

  12. Chlamydia pneumoniae Infection in Atherosclerotic Lesion Development through Oxidative Stress: A Brief Overview

    Directory of Open Access Journals (Sweden)

    Rosa Sessa

    2013-07-01

    Full Text Available Chlamydia pneumoniae, an obligate intracellular pathogen, is known as a leading cause of respiratory tract infections and, in the last two decades, has been widely associated with atherosclerosis by seroepidemiological studies, and direct detection of the microorganism within atheroma. C. pneumoniae is presumed to play a role in atherosclerosis for its ability to disseminate via peripheral blood mononuclear cells, to replicate and persist within vascular cells, and for its pro-inflammatory and angiogenic effects. Once inside the vascular tissue, C. pneumoniae infection has been shown to induce the production of reactive oxygen species in all the cells involved in atherosclerotic process such as macrophages, platelets, endothelial cells, and vascular smooth muscle cells, leading to oxidative stress. The aim of this review is to summarize the data linking C. pneumoniae-induced oxidative stress to atherosclerotic lesion development.

  13. Aspirin inhibits Chlamydia pneumoniae : Induced nuclear factor-kappa B activation, cytokine expression, and bacterial development in human endothelial cells

    NARCIS (Netherlands)

    Tiran, A; Gruber, HJ; Graier, WF; Wagner, AH; van Leeuwen, EBM; Tiran, B

    2002-01-01

    Objective-Chlamydia pneumoniae has been associated with atherosclerosis. Infection of vascular endothelial cells with C pneumoniae increases the expression of proatherogenic cytokines mediated by nuclear factor (NF)-kappaB, a transcription factor. The present study was designed to test the effect of

  14. The Study of Chlamydia Pneumoniae DNA in the Peripheral Blood Mononuclear Cell of Coronary Heart Disease

    Institute of Scientific and Technical Information of China (English)

    Li Tao; Xu Xiang Guang; Zhang Guo Liang; Fang Weihua

    2004-01-01

    Objectives To detection of chlamydia pneumoniae (Cpn) DNA in the circulating mononuclear cell fractions of coronary heart disease and to investigate the association between infection with chlamydia pneumoniae and coronary heart disease (CHD) and prospectively whether blood -based nested polymerase chain reaction ( nPCR ) is useful in identifying Cpn infection. Methods The peripheral blood mononuclear cell (PBMC) Cpn DNA was examined using nPCR technique and confirmed by electrophoresis in 150 patients with CHD. Select 55 patients with clinical suspected CHD but angiography result are normal as control group (CG). Then we conducted a prospective , randomized, double - blind, placebo -controlled study of 6 months of azithromycin and placebo treatment in CHD group. Patients with Cpn DNA positive were then randomized to receive azithromycin or placebo. After treatment blood sample were collected for repeated measurement . Results Chlamydia pneumoniae DNA was detected in 49(32.7% ) of 150persons with CHD and in 1 ( 1.8% ) of 55 persons with control group,odds ratio 26.2, 95% confidence interva13.52 - 194.98. The positivity rates of nPCR in CHD groups were higher than those in control group. 16 cases (29. 1% ) in latent coronary heart diseases(LCHD) group , 19 cases (39.6%) in unstable angina(UAP) group ,and 14 cases (29.9%) in acute myocardial infarction (AMI)group were Cpn positive by nPCR. There were no significant difference among in AMIUAP and LCHD group. There were significiant difference in Cpn DNA negative rates after the azithromycin and the placebo treatment. Conclusions Chlamydia pneumoniae is present in PBMC of a significant proportion of persons with CHD. The potential role of chlamydia pneumoniae in coronary atherosclerosis may therefore be more related to acceleration of disease or systemic effects by persistent infection than to sudden initiation of progressive coronary artery disease by acute infection. The detection of Cpn DNA in PBMC with nPCR may be

  15. Phylogenetic analysis of human Chlamydia pneumoniae strains reveals a distinct Australian indigenous clade that predates European exploration of the continent

    OpenAIRE

    Roulis, Eileen; Bachmann, Nathan; Humphrys, Michael; Myers, Garry; Huston, Wilhelmina; Polkinghorne, Adam; Timms, Peter

    2015-01-01

    Background The obligate intracellular bacterium Chlamydia pneumoniae is a common respiratory pathogen, which has been found in a range of hosts including humans, marsupials and amphibians. Whole genome comparisons of human C. pneumoniae have previously highlighted a highly conserved nucleotide sequence, with minor but key polymorphisms and additional coding capacity when human and animal strains are compared. Results In this study, we sequenced three Australian human C. pneumoniae strains, tw...

  16. Molecular cartography in acute Chlamydia pneumoniae infections--a non-targeted metabolomics approach.

    Science.gov (United States)

    Müller, Constanze; Dietz, Inga; Tziotis, Dimitrios; Moritz, Franco; Rupp, Jan; Schmitt-Kopplin, Philippe

    2013-06-01

    Infections with Chlamydia pneumoniae cause several respiratory diseases, such as community-acquired pneumonia, bronchitis or sinusitis. Here, we present an integrated non-targeted metabolomics analysis applying ultra-high-resolution mass spectrometry and ultra-performance liquid chromatography mass spectrometry to determine metabolite alterations in C. pneumoniae-infected HEp-2 cells. Most important permutations are elaborated using uni- and multivariate statistical analysis, logD retention time regression and mass defect-based network analysis. Classes of metabolites showing high variations upon infection are lipids, carbohydrates and amino acids. Moreover, we observed several non-annotated compounds as predominantly abundant after infection, which are promising biomarker candidates for drug-target and diagnostic research.

  17. Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months

    International Nuclear Information System (INIS)

    Background: The role of Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP) in lower respiratory tract infections (LRTI) is still little known in community settings. Methods: In all, 3207 adult cases of LRTI (871 with pneumonia, and 2336 with acute bronchitis) were prospectively included in the ETIIC1ETIIC : ETude de l'Incidence des Infections respiratoires basses d'origine Communautaire dues a Chlamydia pneumoniae et Mycoplasma pneumoniae (Incidence of CP and MP in LRTI in community settings)program by 303 general practitioners and 24 hospital physicians in France between September 1997 and February 2000. The polymerase chain reaction and immunoassays were used to detect CP or MP in 3198 pharyngeal specimens obtained by gargling. Results: Of these 3198 patients, 232 (7.3%), were PCR-positive for CP and/or MP. Immunoassays were far less sensitive than PCRs (Se = 2 and 13% for MP and CP). Among the 2336 patients with acute bronchitis, PCR was positive for CP in 95 (4.1%), and for MP, in 54 (2.3%). Among the 671 patients with radiologically confirmed pneumonia, PCR was positive for CP in 23 (3.4%), and for MP in 49 (7.3%). CP and MP displayed significant geographic heterogeneity. Independent clinical determinants of positive PCR for CP and/or MP were age below 45 years, previous antimicrobial therapy (especially betalactams). Clinical signs were not of practical use in distinguishing accurately between etiologic diagnoses. Conclusions: CP or MP diagnosed by PCR were found in more than 7% of patients with LRTI in community settings with a significant geographical heterogeneity and significant temporal trends in the incidence

  18. Chlamydia

    Science.gov (United States)

    ... with new or multiple sexual partners, particularly if protection with condoms is inconsistent. Re-infection of chlamydia happens easily if a sex partner is not treated. Signs and ... with oral antibiotics (usually azithromycin or doxycycline). All sexual partners ...

  19. Host cell Golgi anti-apoptotic protein (GAAP) and growth of Chlamydia pneumoniae.

    Science.gov (United States)

    Markkula, Eveliina; Hulkkonen, Jaakko; Penttilä, Tuula; Puolakkainen, Mirja

    2013-01-01

    Chlamydia pneumoniae protein CPn0809 is a type three secretion system substrate, the exact function of which in infection pathogenesis has remained unknown. In this study, we identified by yeast two-hybrid screening a potential host cell interaction partner of CPn0809, Golgi anti-apoptotic protein (GAAP), a conserved protein found in eukaryotic cells. GAAP gene is expressed at relatively constant levels and its expression remained stable also after C. pneumoniae infection. The interaction between GAAP and C. pneumoniae was suggested by transfection studies. GAAP knock-down by siRNA in infected A549 cells resulted in an increased number of C. pneumoniae genomes and growth of the bacteria as judged by quantitative PCR and inclusion counts, respectively. Silencing of GAAP did not make the A549 cells more susceptible to apoptosis per se, and infection with C. pneumoniae prevented staurosporin-induced apoptosis also in transfected cultures. Taken together, the proposed interaction between C. pneumoniae and GAAP modulates bacterial growth in A549 cells. PMID:23000903

  20. Prevalence of Chlamydia pneumoniae infection in squamous cell carcinoma of the head and neck.

    Science.gov (United States)

    Moutel, Karinne; Merol, Jean-Claude; Prevost, Alain; Eb, Francois; Lefebvre, Jean-Francois; Coninx, Paul; Liautaud-Roger, Francoise

    2004-01-01

    On the basis of epidemiological data, an association between Chlamydia pneumoniae (Cp) infection and head and neck cancer might be suggested. The aim of the present study was to detect Cp-DNA within tumour tissue specimens by a two-step polymerase chain reaction. Investigation was planned on the Fleming's procedure for early termination when initial results were extreme. So, after ten consecutive patients, only one tumour contained Cp-DNA. Hence the prevalence could be regarded as inferior to 60% (2a=b=0.08), the threshold under which a direct role of Cp in head and neck cancer development does not seem to be likely.

  1. Chlamydia pneumoniae in atherosclerotic carotid artery plaques: high prevalence among heavy smokers.

    Science.gov (United States)

    Dobrilovic, N; Vadlamani, L; Meyer, M; Wright, C B

    2001-06-01

    This study was designed to determine the prevalence of Chlamydia pneumoniae in carotid artery plaques. Although there have been numerous studies evaluating coronary plaques for this bacterium fewer studies have assessed noncoronary vasculature. In addition we wished to evaluate whether correlation exists between the presence of C. pneumoniae in carotid plaques and established risk factors for atherosclerosis. Sixty intact carotid artery plaques removed during surgery (carotid endarterectomy) were formalin-fixed and paraffin-embedded according to conventional techniques. These samples were evaluated by polymerase chain reaction analysis to detect presence of C. pneumoniae DNA. Results were tabulated and compared against established risk factors for atherosclerosis: diabetes, hypertension, hyperlipidemia, age, and smoking. Forty-two (70.0%) of the 60 plaques that were evaluated tested positive for the presence of C. pneumoniae DNA by polymerase chain reaction analysis. In the sample defined as being from heavy smokers (greater than 15-pack-year history) 33 (94.3%) of 35 plaques tested positive whereas two (5.7%) tested negative. This correlation demonstrated statistical significance (P = 1.36 x 10(-6), two-tailed Fisher exact test). Presence of C. pneumoniae in carotid plaques demonstrated no statistically significant correlation with diabetes, hypertension, or hyperlipidemia. Age as a risk factor was examined but not statistically evaluated because of the narrow range within our patient sample. Analysis of the data reveals that C. pneumoniae is present in large numbers of atheromatous plaques as is consistent with emerging data. What is interesting though is that 33 (94.3%) of the 35 smokers had plaques that tested positive for the bacterium as opposed to only nine (36.0%) of the 25 nonsmokers. Identification of specific populations exhibiting a high prevalence of C. pneumoniae may serve to focus future studies. Ongoing investigation will seek to determine whether C

  2. The novel chlamydial adhesin CPn0473 mediates the lipid raft-dependent uptake of Chlamydia pneumoniae.

    Science.gov (United States)

    Fechtner, Tim; Galle, Jan N; Hegemann, Johannes H

    2016-08-01

    Chlamydiae are Gram-negative, obligate intracellular pathogens that pose a serious threat to public health worldwide. Chlamydial surface molecules are essential for host cell invasion. The first interaction with the host cell is thereby accomplished by the Outer membrane complex protein B (OmcB) binding to heparan sulfate moieties on the host cell surface, followed by the interaction of the chlamydial polymorphic membrane proteins (Pmps) with host cell receptors. Specifically, the interaction of the Pmp21 adhesin and invasin with its human interaction partner, the epidermal growth factor receptor, results in receptor activation, down-stream signalling and finally internalization of the bacteria. Blocking both, the OmcB and Pmp21 adhesion pathways, did not completely abolish infection, suggesting the presence of additional factors relevant for host cell invasion. Here, we show that the novel surface protein CPn0473 of Chlamydia pneumoniae contributes to the binding and invasion of infectious chlamydial particles. CPn0473 is expressed late in the infection cycle and located on the infectious chlamydial cell surface. Soluble recombinant CPn0473 as well as rCPn0473-coupled fluorescent latex beads adhere to human epithelial HEp-2 cells. Interestingly, in classical infection blocking experiments pretreatment of HEp-2 cells with rCPn0473 does not attenuate adhesion but promotes dose-dependently internalization by C. pneumoniae suggesting an unusual mode of action for this adhesin. This CPn0473-dependent promotion of infection by C. pneumoniae depends on two different domains within the protein and requires intact lipid rafts. Thus, inhibition of the interaction of CPn0473 with the host cell could provide a way to reduce the virulence of C. pneumoniae.

  3. The novel chlamydial adhesin CPn0473 mediates the lipid raft‐dependent uptake of Chlamydia pneumoniae

    Science.gov (United States)

    Fechtner, Tim; Galle, Jan N.

    2016-01-01

    Summary Chlamydiae are Gram‐negative, obligate intracellular pathogens that pose a serious threat to public health worldwide. Chlamydial surface molecules are essential for host cell invasion. The first interaction with the host cell is thereby accomplished by the Outer membrane complex protein B (OmcB) binding to heparan sulfate moieties on the host cell surface, followed by the interaction of the chlamydial polymorphic membrane proteins (Pmps) with host cell receptors. Specifically, the interaction of the Pmp21 adhesin and invasin with its human interaction partner, the epidermal growth factor receptor, results in receptor activation, down‐stream signalling and finally internalization of the bacteria. Blocking both, the OmcB and Pmp21 adhesion pathways, did not completely abolish infection, suggesting the presence of additional factors relevant for host cell invasion. Here, we show that the novel surface protein CPn0473 of Chlamydia pneumoniae contributes to the binding and invasion of infectious chlamydial particles. CPn0473 is expressed late in the infection cycle and located on the infectious chlamydial cell surface. Soluble recombinant CPn0473 as well as rCPn0473‐coupled fluorescent latex beads adhere to human epithelial HEp‐2 cells. Interestingly, in classical infection blocking experiments pretreatment of HEp‐2 cells with rCPn0473 does not attenuate adhesion but promotes dose‐dependently internalization by C. pneumoniae suggesting an unusual mode of action for this adhesin. This CPn0473‐dependent promotion of infection by C. pneumoniae depends on two different domains within the protein and requires intact lipid rafts. Thus, inhibition of the interaction of CPn0473 with the host cell could provide a way to reduce the virulence of C. pneumoniae. PMID:26780295

  4. Koala Biovar of Chlamydia pneumoniae Infects Human and Koala Monocytes and Induces Increased Uptake of Lipids In Vitro

    OpenAIRE

    Coles, Katie A.; Timms, Peter; David W Smith

    2001-01-01

    We examined the ability of the koala biovar of Chlamydia pneumoniae to infect both Hep-2 cells and human monocytes and the effect of infection on the formation of foam cells. The koala biovar produced large inclusions in both human and koala monocytes and in Hep-2 cells. Koala C. pneumoniae induced foam cell formation with and without added low-density lipoprotein, in contrast to TW183, which produced increased foam cell formation only in the presence of low-density lipoprotein.

  5. Sudden psychotic episode probably due to meningoencephalitis and Chlamydia pneumoniae acute infection

    Directory of Open Access Journals (Sweden)

    Canas Nuno

    2005-09-01

    Full Text Available Abstract Background Since 9% to 20% of all cases of acute psychosis presenting to an Emergency Department (ED are due to a general medical condition, cautious medical workup should be mandatory in such patients. Differential diagnosis must consider conditions as diverse as renal failure or CNS infection. Acute Chlamydia pneumoniae infection usually causes a self-limited respiratory syndrome. Rarely, acute neurological complications occur, with acute meningoencephalitis most frequently reported. Diagnosis requires a high level of suspicion and is difficult to confirm. Case report We describe a 22 year-old female Caucasian who, three days after a mild pharingitis, developed an acute psychosis with exuberant symptoms interspersed with periods of lucidity, in a background of normal consciousness and orientation. Initial medical and imagiological workup were inconclusive. After 20 days of unsuccessful treatment with antipsychotics she developed a high fever and was re-evaluated medically. Lumbar puncture revealed an inflammatory cerebrospinal fluid. MRI showed irregular thickening and nodularity of the lateral ventricles' lining. An anti-Chlamydia pneumoniae IgM antibody titter of 85 IU/ml was detected. All symptoms cleared after treatment with antibiotics and corticosteroids. Conclusion This is, to our knowledge, the first reported case of acute CP-associated meningoencephalitis manifesting as an acute psychotic episode. It illustrates the principle that non-organic psychiatric syndromes must remain a diagnosis of exclusion in first-time acute psychosis.

  6. The association between Chlamydia pneumoniae DNA in atherosclerotic plaque and major risk factors in patients undergoing coronary artery bypass grafting

    NARCIS (Netherlands)

    Hedayat, Daryoosh Kamal; Jebeli, Mohammad; Mandegar, Mohammad Hossein; Bagheri, Jamshid; Nabavi, Seyed Abbas; Eghtesadi-Araghi, Payam; Mohammadzadeh, Robabeh; Darehzereshki, Ali; Chitsaz, Sam; Abbasi, Ali

    2009-01-01

    Background and aim: This study was conducted to investigate the prevalence of Chlamydia pneumoniae pathogen inside the atherosclerotic plaque of patients undergoing CABG by using PCR assay and to determine whether there is any association between the presence of bacteria in atherosclerotic lesions a

  7. Biophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment.

    Science.gov (United States)

    Evani, Shankar J; Dallo, Shatha F; Ramasubramanian, Anand K

    2016-01-01

    Multiple studies support the hypothesis that infectious agents may be involved in the pathogenesis of atherosclerosis. Chlamydia pneumoniae is strongly implicated in atherosclerosis, but the precise role has been underestimated and poorly understood due to the complexity of the disease process. In this work, we test the hypothesis that C. pneumoniae-infected macrophages lodged in the subendothelial matrix contribute to atherogenesis through pro-inflammatory factors and by cell-matrix interactions. To test this hypothesis, we used a 3D infection model with freshly isolated PBMC infected with live C. pneumoniae and chlamydial antigens encapsulated in a collagen matrix, and analyzed the inflammatory responses over 7 days. We observed that infection significantly upregulates the secretion of cytokines TNF-α, IL-1β, IL-8, MCP-1, MMP, oxidative stress, transendothelial permeability, and LDL uptake. We also observed that infected macrophages form clusters, and substantially modify the microstructure and mechanical properties of the extracellular matrix to an atherogenic phenotype. Together, our data demonstrates that C. pneumoniae-infection drives a low-grade, sustained inflammation that may predispose in the transformation to atherosclerotic foci. PMID:27582738

  8. Biophysical regulation of Chlamydia pneumoniae-infected monocyte recruitment to atherosclerotic foci

    Science.gov (United States)

    Evani, Shankar J.; Ramasubramanian, Anand K.

    2016-01-01

    Chlamydia pneumoniae infection is implicated in atherosclerosis although the contributory mechanisms are poorly understood. We hypothesize that C. pneumoniae infection favors the recruitment of monocytes to atherosclerotic foci by altering monocyte biophysics. Primary, fresh human monocytes were infected with C. pneumoniae for 8 h, and the interactions between monocytes and E-selectin or aortic endothelium under flow were characterized by video microscopy and image analysis. The distribution of membrane lipid rafts and adhesion receptors were analyzed by imaging flow cytometry. Infected cells rolled on E-selectin and endothelial surfaces, and this rolling was slower, steady and uniform compared to uninfected cells. Infection decreases cholesterol levels, increases membrane fluidity, disrupts lipid rafts, and redistributes CD44, which is the primary mediator of rolling interactions. Together, these changes translate to higher firm adhesion of infected monocytes on endothelium, which is enhanced in the presence of LDL. Uninfected monocytes treated with LDL or left untreated were used as baseline control. Our results demonstrate that the membrane biophysical changes due to infection and hyperlipidemia are one of the key mechanisms by which C. pneumoniae can exacerbate atherosclerotic pathology. These findings provide a framework to characterize the role of ‘infectious burden’ in the development and progression of atherosclerosis.

  9. Smoking, season, and detection of chlamydia pneumoniae DNA in clinically stable COPD patients

    Directory of Open Access Journals (Sweden)

    Goldsmith Charles H

    2002-07-01

    Full Text Available Abstract Background The prevalence and role of Chlamydia pneumoniae in chronic obstructive pulmonary disease (COPD remain unclear. Methods Peripheral blood mononuclear cells were obtained from 100 outpatients with smoking-related, clinically stable COPD, and induced sputum was obtained in 62 patients. Results Patients had mean age (standard deviation of 65.8 (10.7 years, mean forced expiratory volume in one second of 1.34 (0.61 L, and 61 (61.0% were male. C. pneumoniae nucleic acids were detected by nested polymerase chain reaction in 27 (27.0%. Current smoking (odds ratio {OR} = 2.6, 95% confidence interval {CI}: 1.1, 6.6, P = 0.04, season (November to April (OR = 3.6, 95% CI: 1.4, 9.2, P = 0.007, and chronic sputum production (OR = 6.4, 95% CI: 1.8, 23.2, P = 0.005 were associated with detection of C. pneumoniae DNA. Conclusions Prospective studies are needed to examine the role of C. pneumoniae nucleic acid detection in COPD disease symptoms and progression.

  10. Development and Evaluation of Real-Time PCR-Based Fluorescence Assays for Detection of Chlamydia pneumoniae

    OpenAIRE

    Tondella, Maria Lucia C.; Talkington, Deborah F.; Holloway, Brian P.; Scott F Dowell; Cowley, Karyn; Soriano-Gabarro, Montse; Elkind, Mitchell S.; Fields, Barry S.

    2002-01-01

    Chlamydia pneumoniae is an important respiratory pathogen recently associated with atherosclerosis and several other chronic diseases. Detection of C. pneumoniae is inconsistent, and standardized PCR assays are needed. Two real-time PCR assays specific for C. pneumoniae were developed by using the fluorescent dye-labeled TaqMan probe-based system. Oligonucleotide primers and probes were designed to target two variable domains of the ompA gene, VD2 and VD4. The limit of detection for each of t...

  11. Chlamydia pneumoniae CopD Translocator Protein Plays a Critical Role in Type III Secretion (T3S) and Infection

    OpenAIRE

    Bulir, David C.; Waltho, Daniel A.; Stone, Christopher B.; Mwawasi, Kenneth A.; Nelson, Jordan C.; Mahony, James B.

    2014-01-01

    Pathogenic Gram-negative bacteria use type III secretion (T3S) to inject effector proteins into the host cell to create appropriate conditions for infection and intracellular replication. Chlamydia spp. are believed to use T3S to infect their host cell, and the translocator proteins are an essential component of this system. Chlamydia pneumoniae contains genes encoding two sets of translocator proteins; CopB and CopD, and CopB2 and CopD2. In this study, we identified novel interactions betwee...

  12. The Type III Secretion System-Related CPn0809 from Chlamydia pneumoniae.

    Directory of Open Access Journals (Sweden)

    Astrid C Engel

    Full Text Available Chlamydia pneumoniae is an intracellular Gram-negative bacterium that possesses a type III secretion system (T3SS, which enables the pathogen to deliver, in a single step, effector proteins for modulation of host-cell functions into the human host cell cytosol to establish a unique intracellular niche for replication. The translocon proteins located at the top of the T3SS needle filament are essential for its function, as they form pores in the host-cell membrane. Interestingly, unlike other Gram-negative bacteria, C. pneumoniae has two putative translocon operons, named LcrH_1 and LcrH_2. However, little is known about chlamydial translocon proteins. In this study, we analyzed CPn0809, one of the putative hydrophobic translocators encoded by the LcrH_1 operon, and identified an 'SseC-like family' domain characteristic of T3S translocators. Using bright-field and confocal microscopy, we found that CPn0809 is associated with EBs during early and very late phases of a C. pneumoniae infection. Furthermore, CPn0809 forms oligomers, and interacts with the T3SS chaperone LcrH_1, via its N-terminal segment. Moreover, expression of full-length CPn0809 in the heterologous host Escherichia coli causes a grave cytotoxic effect that leads to cell death. Taken together, our data indicate that CPn0809 likely represents one of the translocon proteins of the C. pneumoniae T3SS, and possibly plays a role in the translocation of effector proteins in the early stages of infection.

  13. Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patients

    OpenAIRE

    Esposito, Pasquale; Tinelli, Carmine; Libetta, Carmelo; Gabanti, Elisa; Rampino, Teresa; Dal Canton, Antonio

    2010-01-01

    Autoimmunity to heat shock protein 60 (HSP60) has been related to atherosclerosis. Chlamydia pneumoniae (CP), the most studied infectious agent implicated in promoting atherosclerosis, produces a form of HSP60, which can induce an autoimmune response, due to high antigenic homology with human HSP60 (hHSP60). In this study, we evaluated the correlations among anti-hHSP60 antibodies, CP infection, and cardiovascular disease (CVD) in a high-risk population, such as patients undergoing hemodialys...

  14. Asociación entre enfermedad cardiovascular y anticuerpos contra Chlamydia pneumoniae

    Directory of Open Access Journals (Sweden)

    García-Elorriaga Guadalupe de los A

    2002-01-01

    Full Text Available Objetivo. Precisar si existe asociación entre enfermedad cardiovascular (ECV y anticuerpos contra Chlamydia en población mexicana. Material y métodos. Estudio transversal, realizado en la Unidad de Investigación en Inmunología e Infectología -Hospital de Infectología del Centro Médico Nacional La Raza (CMNR- y en el Servicio de Cirugía Cardiovascular y Asistencia Circulatoria, del Hospital General del CMNR, Instituto Mexicano del Seguro Social (IMSS, de agosto de 1998 a abril de 2000. Se determinaron anticuerpos IgG e IgM contra C. psittaci, C. trachomatis y C. pneumoniae mediante microinmunofluorescencia, en suero de 70 pacientes con ECV hospitalizados en el CMNR, mayores de 30 años, de uno u otro sexo, y se compararon con 140 sanos, pareados por edad y sexo. Se utilizaron muestras aleatorias simples, con un tamaño poblacional de 110, una prevalencia de 50% y un nivel de confianza de 99%. Para establecer la diferencia entre las proporciones de los títulos se utilizó ji cuadrada y se calculó la razón de momios. Resultados. El 94.3% (66/70 de los pacientes presentó IgG en contra de C. pneumoniae vs 37% (52/140 de los individuos sanos (p<0.001. Conclusiones. Existe una fuerte asociación entre anticuerpos IgG hacia C. pneumoniae y ECV.

  15. Effect of a Mycoplasma hominis-Like Mycoplasma on the Infection of HEp-2 Cells by the TW-183 Strain of Chlamydia pneumoniae

    OpenAIRE

    Castilla, Elias A.; Wadowsky, Robert M.

    2000-01-01

    We isolated a Mycoplasma hominis-like mycoplasma from a stock culture of Chlamydia pneumoniae TW-183 obtained from the American Type Culture Collection and eradicated the contaminant by treating the stock suspension with a nonionic detergent, Igepal CA-630. The M. hominis-like mycoplasma neither inhibits nor enhances the infectivity of C. pneumoniae for HEp-2 cells.

  16. Quantificação morfométrica de Chlamydia pneumoniae e Mycoplasma pneumoniae em aneurismas de aorta abdominal humana Morphometrical quantification of Chlamydia pneumoniae and Mycoplasma pneumoniae in human atherosclerotic abdominal aortic aneurysms

    Directory of Open Access Journals (Sweden)

    Lucas José Tachotti Pires

    2007-09-01

    Full Text Available OBJETIVO: A inflamação aterosclerótica, com possível papel de agentes infecciosos, pode contribuir na patogênese dos aneurismas da aorta abdominal (AAA. O achado de Chamydia pneumoniae (CP nessas lesões, em estudos prévios, sem quantificação, variou de 0-100%. O objetivo é quantificar a presença de CP e de Mycoplasma pneumoniae (MP nos AAA. MÉTODO: A espessura, o número de células positivas para CP detectadas por imunoperoxidase e a porcentagem de área ocupada por MP detectada por hibridização "in situ", nas três camadas da aorta, foram medidos com sistema de análise de imagens, em 10 aortas abdominais aneurismáticas. Usouse três grupos-controle: 1 amostras das mesmas aortas, fora do aneurisma, exceto se a dilatação tomasse toda a porção sub-renal da artéria (n=7; 2 aortas com aterosclerose grave, mas sem aneurismas (n=10; 3 aortas sem aterosclerose ou com grau leve da doença (n=10. Todos os espécimes foram obtidos em necropsias. Usou-se o teste de Wald para comparar os grupos; fixou-se o nível de significância em 5%. RESULTADOS: A íntima era mais fina e a média mais espessa nos casos normais que nos outros grupos (p0,05. Também se detectou MP em todos os grupos. Este agente predominou no grupo de pacientes com aterosclerose, mas sem aneurisma na íntima e na adventícia; entretanto, as diferenças entre os grupos não foram significativas (p>0,05. CONCLUSÕES: Nossos dados sugerem que os agentes enfocados não têm papel importante na patogênese dos AAA.OBJECTIVE: Atherosclerotic inflammation, with a possible role of infectious agents, could contribute to the pathogenesis of abdominal aortic aneurysms (AAA. Finding of Chlamydia pneumoniae (CP in these lesions in previous, non-quantifying studies ranged from 0-100%. The objective is to quantify the presence of CP and Mycoplasma pneumoniae (MP in AAA. METHODS: Thickness, number of cells positive for CP by immunohistochemistry and percent area occupied by MP

  17. Comparison of koala LPCoLN and human strains of Chlamydia pneumoniae highlights extended genetic diversity in the species

    Directory of Open Access Journals (Sweden)

    Carrasco Jose A

    2010-07-01

    Full Text Available Abstract Background Chlamydia pneumoniae is a widespread pathogen causing upper and lower respiratory tract infections in addition to a range of other diseases in humans and animals. Previous whole genome analyses have focused on four essentially clonal (> 99% identity C. pneumoniae human genomes (AR39, CWL029, J138 and TW183, providing relatively little insight into strain diversity and evolution of this species. Results We performed individual gene-by-gene comparisons of the recently sequenced C. pneumoniae koala genome and four C. pneumoniae human genomes to identify species-specific genes, and more importantly, to gain an insight into the genetic diversity and evolution of the species. We selected genes dispersed throughout the chromosome, representing genes that were specific to C. pneumoniae, genes with a demonstrated role in chlamydial biology and/or pathogenicity (n = 49, genes encoding nucleotide salvage or amino acid biosynthesis proteins (n = 6, and extrachromosomal elements (9 plasmid and 2 bacteriophage genes. Conclusions We have identified strain-specific differences and targets for detection of C. pneumoniae isolates from both human and animal origin. Such characterisation is necessary for an improved understanding of disease transmission and intervention.

  18. Systems Biology Approaches for the Prediction of Possible Role of Chlamydia pneumoniae Proteins in the Etiology of Lung Cancer.

    Science.gov (United States)

    Khan, Shahanavaj; Imran, Ahamad; Khan, Abdul Arif; Abul Kalam, Mohd; Alshamsan, Aws

    2016-01-01

    Accumulating evidence has recently supported the association of bacterial infection with the growth and development of cancers, particularly in organs that are constantly exposed to bacteria such as the lungs, colon, cervical cancer etc. Our in silico study on the proteome of Chlamydia pneumoniae suggests an unprecedented idea of the etiology of lung cancer and have revealed that the infection of C. pneumoniae is associated with lung cancer development and growth. It is reasonable to assume that C. pneumoniae transports its proteins within host-intracellular organelles during infection, where they may work with host-cell proteome. The current study was performed for the prediction of nuclear targeting protein of C. pneumoniae in the host cell using bioinformatics predictors including ExPASy pI/Mw tool, nuclear localization signal (NLS) mapper, balanced sub cellular localization predictor (BaCeILo), and Hum-mPLoc 2.0. We predicted 47/1112 nuclear-targeting proteins of C. pneumoniae connected with several possible alterations in host replication and transcription during intracellular infection. These nuclear-targeting proteins may direct to competitive interactions of host and C. pneumoniae proteins with the availability of same substrate and may be involved as etiological agents in the growth and development of lung cancer. These novel findings are expected to access in better understanding of lung cancer etiology and identifying molecular targets for therapy.

  19. Members of the Pmp protein family of Chlamydia pneumoniae mediate adhesion to human cells via short repetitive peptide motifs.

    Science.gov (United States)

    Mölleken, Katja; Schmidt, Eleni; Hegemann, Johannes H

    2010-11-01

    Chlamydiae sp. are obligate intracellular pathogens that cause a variety of diseases in humans. Adhesion of the infectious elementary body to the eukaryotic host cell is a pivotal step in chlamydial pathogenesis. Here we describe the characterization of members of the polymorphic membrane protein family (Pmp), the largest protein family (with up to 21 members) unique to Chlamydiaceae. We show that yeast cells displaying Pmp6, Pmp20 or Pmp21 on their surfaces, or beads coated with the recombinant proteins, adhere to human epithelial cells. A hallmark of the Pmp protein family is the presence of multiple repeats of the tetrapeptide motifs FxxN and GGA(I, L, V) and deletion analysis shows that at least two copies of these motifs are needed for adhesion. Importantly, pre-treatment of human cells with recombinant Pmp6, Pmp20 or Pmp21 protein reduces infectivity upon subsequent challenge with Chlamydia pneumoniae and correlates with diminished attachment of Chlamydiae to target cells. Antibodies specific for Pmp21 can neutralize infection in vitro. Finally, a combination of two different Pmp proteins in infection blockage experiments shows additive effects, possibly suggesting similar functions. Our findings imply that Pmp6, Pmp20 and Pmp21 act as adhesins, are vital during infection and thus represent promising vaccine candidates.

  20. Antibodies to Chlamydia trachomatis heat shock proteins in women with tubal factor infertility are associated with prior infection by C. trachomatis but not by C. pneumoniae

    DEFF Research Database (Denmark)

    Persson, K; Osser, S; Birkelund, Svend;

    1999-01-01

    The antibody response to heat shock proteins 60 and 10 were studied in 163 patients with tubal factor infertility and in 163 age-matched pregnant women. The associations of these antibodies with specific antibodies to Chlamydia trachomatis and to Chlamydia pneumoniae as well as with antibodies to...... shock proteins and to C. trachomatis but no independent influence of antibodies to C. pneumoniae. No interaction between C. trachomatis and C. pneumoniae suggesting a synergistic effect was found although the heat shock proteins from these two organisms are immunologically similar. Antibodies to the...... the common chlamydial lipopolysaccharide antigen were studied. Patients with tubal factor infertility had significantly higher frequencies and titres of all antibodies except to C. pneumoniae. In a logistic regression model an association was found between the prevalence of antibodies to the heat...

  1. Association of carotid plaque Lp-PLA(2 with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.

    Directory of Open Access Journals (Sweden)

    Berna Atik

    Full Text Available BACKGROUND: We previously showed that the burden of Chlamydia pneumoniae in carotid plaques was significantly associated with plaque interleukin (IL-6, and serum IL-6 and C-reactive protein (CRP, suggesting that infected plaques contribute to systemic inflammatory markers in patients with stroke risk. Since lipoprotein-associated phospholipase A2 (Lp-PLA(2 mediates inflammation in atherosclerosis, we hypothesized that serum Lp-PLA(2 mass and activity levels and plaque Lp-PLA(2 may be influenced by plaque C. pneumoniae infection. METHODOLOGY/PRINCIPAL FINDINGS: Forty-two patients underwent elective carotid endarterectomy. Tissue obtained at surgery was stained by immunohistochemistry for Lp-PLA(2 grade, macrophages, IL-6, C. pneumoniae and CD4+ and CD8+ cells. Serum Lp-PLA(2 activity and mass were measured using the colorimetric activity method (CAM and ELISA, respectively. Serum homocysteine levels were measured by HPLC. Eleven (26.2% patients were symptomatic with transient ischemic attacks. There was no correlation between patient risk factors (smoking, coronary artery disease, elevated cholesterol, diabetes, obesity, hypertension and family history of genetic disorders for atherosclerosis and serum levels or plaque grade for Lp-PLA(2. Plaque Lp-PLA(2 correlated with serum homocysteine levels (p = 0.013, plaque macrophages (p<0.01, and plaque C. pneumoniae (p<0.001, which predominantly infected macrophages, co-localizing with Lp-PLA(2. CONCLUSIONS: The significant association of plaque Lp-PLA(2 with plaque macrophages and C. pneumoniae suggests an interactive role in accelerating inflammation in atherosclerosis. A possible mechanism for C. pneumoniae in the atherogenic process may involve infection of macrophages that induce Lp-PLA(2 production leading to upregulation of inflammatory mediators in plaque tissue. Additional in vitro and in vivo research will be needed to advance our understanding of specific C. pneumoniae and Lp-PLA(2

  2. Serine-to-Asparagine Substitution in the GyrA Gene Leads to Quinolone Resistance in Moxifloxacin-Exposed Chlamydia pneumoniae

    OpenAIRE

    Rupp, Jan; Gebert, Andreas; Solbach, Werner; Maass, Matthias

    2005-01-01

    Quinolone resistance of Chlamydia pneumoniae has not been described previously. Serial subcultures of C. pneumoniae under increasing moxifloxacin concentrations (0.0125 to 6.4 mg/liter) resulted in a 256-fold MIC increase compared to moxifloxacin-naive strains. GyrA gene sequencing revealed a novel point mutation with a Ser→Asn substitution. Subcultures under rifalazil and macrolides did not alter the respective MICs.

  3. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study

    Directory of Open Access Journals (Sweden)

    Pazoki Raha

    2006-12-01

    Full Text Available Abstract Background The metabolic syndrome together with insulin resistance and their consequences are basic factors in pathogenesis of atherosclerosis. Chronic infections with herpes simplex virus type 1 (HSV-1, cytomegalovirus (CMV, and Chlamydia pneumoniae are associated with the development of atherosclerosis and coronary heart disease. The infectious aspects of metabolic syndrome have not been investigated. Methods In a cross-sectional, population-based study, we used National Cholesterol Education Program (NCEP-Adult Treatment Panel (ATP-III criteria in 1791 subjects, aged 25 years and over, selected by cluster random sampling in three Iranian ports in the northern Persian Gulf. Sera were analyzed for IgG antibodies to Chlamydia pneumoniae, HSV-1, Helicobacter pylori (H. pylori and CMV using ELISA. Results In multiple logistic regression analysis, of the infectious agents, CMV [OR = 1.81 (1.05–3.10; p = 0.03], H. pylori [OR = 1.50 (1.12–2.00; p = 0.007] and Chlamydia pneumoniae [OR = 1.69 (1.27–2.25; p Conclusion The metabolic syndrome, which occurs very frequently in the general population, has a significant association with prior infection with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus and herpes simplex virus type 1. Hypothesis about participation of infection in pathogenesis of metabolic syndrome should be investigated.

  4. Parvovirus B19 Test

    Science.gov (United States)

    ... be done. Viral detection If a parvovirus B19 DNA test is positive, then the person is currently infected ... The PCR assay is used to detect viral DNA and is the optimal method for detecting chronic ... a reticulocyte test may be performed along with parvovirus B19 testing ...

  5. Lack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteries

    Directory of Open Access Journals (Sweden)

    Oehme Albrecht

    2005-04-01

    Full Text Available Abstract Background Recent publications brought up the hypothesis that an infection with Chlamydia Pneumoniae (CP might be a major cause of coronary artery disease (CAD. Therefore, we investigated whether endothelial dysfunction (ED as a precursor of atherosclerosis might be detectable in patients with previous infection with CP but without angiographic evidence of CAD. Methods We included 16 patients (6 male / 10 female of 52 consecutive patients with normal coronary angiography who had typical angina pectoris and pathologic findings in the stress test. Exclusion criteria were: active smoker, elevated cholesterol, hypertension, age > 65 years, diabetes mellitus, treatment with ACE-inhibitors, or known CAD. Blood sample analysis for serum titer against CP (aCP-IgG was performed after coronary angiography. We looked for endothelial dysfunction analyzing the diameter of the left anterior descending coronary artery (LAD before and after acetylcholine (ACh i. c. Quantitative analysis of luminal diameter (LD was performed in at least two planes during baseline conditions and after ACh for 2 minutes in dosages of 7.2 μg/min and 36 μg/min with an infusion speed of 2 ml/min. Using Doppler guide wire, the coronary flow velocity was measured continuously in the LAD. The coronary flow velocity reserve (CFVR was measured after 20 μg adenosine i. c. Results 10 patients had an elevated aCP-IgG (> 1:8. 6 patients with negative titers (aCP-IgG ≤ 1:8 served as control (CTRL. Both groups were comparable in age, gender, angina class, results of non-invasive stress-test and the baseline values of LD and flow. In the CP positive group 3 patients (30% did not show an increase of LD after ACh as evidence of ED. In the CTRL group 4 patients (67 % had ED. There was no association between aCP-IgG and changes of coronary blood flow after ACh. All patients showed normal CFVR (3.0 ± 0.27 irrespective of their aCP-IgG values. Conclusion In patients with typical

  6. 肺炎衣原体实时定量PCR检测方法的建立%Detection of chlamydia pneumonia with real-time PCR

    Institute of Scientific and Technical Information of China (English)

    李林海; 陈丽丹; 廖杨; 陈建芸; 石玉玲

    2012-01-01

    Objective:To investigate real-time PCR as a method to detect chlamydia pneumonia in clinical settings. Methods:Primers were designed according to conserved DNA region of chlamydia pneumonia from GenBank. Mycoplasma pneumonia, pneumococci, influenza B virus, para influenza virus and adenovirus were used to examine the specificity of primers. Two hundred and sixty- eight patients with respiratory tract infections were determined by real-time PCR and fluorescent antibody. Accuracy of measurement was compared between real-time PCR and fluorescent antibody. Results:Real-time PCR showed that primer specificity on Mycoplasma pneumonia, Pneumococci, Influenza virus, Para influenza virus and Adenovirus were negative but was positive on Chlamydia pneumonia. The primers were only specific for Chlamydia pneumonia. The diagnostic accuracy of real- time PCR was better than that of immunofluorescence. Conclusions:Real time quantitative PCR can be used as a clinical diagnostic assay with chlamydia pneumonia for high sensitivity and short period.%目的:探讨实时定量PCR检测肺炎衣原体(chlamydia pneumonia,Cpn)的方法.方法:根据GenBank提供的肺炎衣原体基因序列,选取高特异性和保守型的区域进行引物设计,并建立实时定量PCR(real-time PCR,RT-PCR)的检测方法.同时用肺炎支原体、肺炎双球菌、流感病毒、副流感病毒以及腺病毒对Cpn引物的特异性进行分析.对呼吸道感染患者200个咽拭子样本和68个肺泡冲洗液样本进行检测,以荧光抗体检测法作对照,评价实时定量PCR检测Cpn的准确性.结果:Cpn PCR引物对肺炎支原体、肺炎双球菌、流感病毒、副流感病毒以及腺病毒均显示阴性,对Cpn显示为阳性,特异性良好;荧光实时定量PCR技术检测的准确性优于荧光抗体检测法.结论:荧光实时定量PCR技术检测Cpn体灵敏度高、周期短,可作为临床诊断Cpn的手段.

  7. Parvovirus B19.

    Science.gov (United States)

    Landry, Marie Louise

    2016-06-01

    Primary parvovirus B19 infection is an infrequent, but serious and treatable, cause of chronic anemia in immunocompromised hosts. Many compromised hosts have preexisting antibody to B19 and are not at risk. However, upon primary infection, some patients may be able to mount a sufficient immune response to terminate active parvovirus B19 infection of erythroid precursors. The most common consequence of B19 infection in the compromised host is pure red-cell aplasia, resulting in chronic or recurrent anemia with reticulocytopenia. Anemia persists until neutralizing antibody is either produced by the host or passively administered. Parvovirus B19 should be suspected in compromised hosts with unexplained or severe anemia and reticulocytopenia, or when bone-marrow examination shows either giant pronormoblasts or absence of red-cell precursors. Diagnosis is established by detection of B19 DNA in serum in the absence of IgG antibody to B19. In some cases, IgG antibody is detected but is not neutralizing. Anti-B19 IgM may or may not be present. Therapy includes any or all of the following: red-cell transfusion, adjustment in medications to restore or improve the patient's immune system, and administration of intravenous immunoglobulin (IVIG). Following treatment, patients should be closely monitored, especially if immunosuppression is unchanged or increased. Should hematocrit trend downward and parvovirus DNA trend upward, the therapeutic options above should be revisited. In a few instances, monthly maintenance IVIG may be indicated. Caregivers should be aware that B19 variants, though rarely encountered, can be missed or under-quantitated by some real-time polymerase-chain reaction methods. PMID:27337440

  8. Specific serum immunoglobulin g to chlamydia pneumoniae in healthy children and adults (south-east of iran)

    International Nuclear Information System (INIS)

    Chlamydia pneumoniae (C. pneumonia) is an obligate intracellular bacterium and recognized as a risk factor for several diseases such as asthma, atherosclerosis and arthritis. The aim of this study was to determine the sero-prevalence of C. pneumonia in healthy subjects in different age groups. Methods: The serum levels of anti C. pneumonia IgG were measured by using of ELISA. Results: Totally, 630 subjects (164 children and 466 adults) were included into study. The sero-prevalence and the mean titer of anti C. pneumonia antibody were 11.3% and 14.48 ± 2.18 RU/mL; at age = 10 years, 15% and 17.47 ± 2.40 RU/mL at age 11-20 years, 21% and 25.15 ± 4.56 RU/mL at age 21-30 years group, 40% and 53.77 ± 6.40 RU/mL at age 31-40 years, 94% and 146.41 ± 8.95 RU/mL at age 41-50 years, 98% and 153.59+-10.38 RU/mL at age 51-60 years, 96% and 138.80 ± 12.78 RU/mL at age 61-70 years, respectively. The differences of the sero-prevalence and the mean titer of anti C. pneumonia antibody between age groups were significant (p<0.0001). The sero-prevalence and the mean titer of anti C. pneumonia antibody were 11.6% and 14.33 ± 1.49 RU/mL in children and 65.5% and 97.40 ± 4.46 RU/mL in adults. The sero-prevalence and the mean titer of anti C. pneumonia antibody were significantly higher in adults in comparison with those in children (p<0.0001). Conclusion: These findings showed that the sero-prevalence and titer of anti C. pneumonia IgG were increased with advanced ages and were higher in adults as compared to children. (author)

  9. Cellulite orbitaire retroseptale à Chlamydiae pneumoniae et VIH/SIDA: à propos d’un cas Orbital

    Directory of Open Access Journals (Sweden)

    PW. Atipo-Tsiba

    2014-06-01

    Full Text Available Introduction: L’infection à Chlamydia pneumoniae est typiquement une pneumonie ou une bronchite bénigne. La localisation de ce germe au niveau de l’œil ou d’une de ses structures annexes est exceptionnelle. Nous rapportons l’extension orbitaire d’une pneumonie due à cet agent pathogène dans un contexte de VIH/SIDA. Méthodes : Un patient de 35 ans, infecté par le VIH1, sous anti rétroviraux depuis 3 ans, a consulté notre département pour une exophtalmie unilatérale fébrile évoluant depuis 7 jours. Résultats : Son examen avait noté une cécité droite, une exophtalmie et une ophtalmoplégie complète homolatérales, des râles bronchiques, une fievre à 38.5ºC. La radiographie thoracique était normale, le scanner était sans particularité en dehors d’un œdème des tissus orbitaires. Le bilan biologique s’était révélé sans particularité (numération formule sanguine, intra dermoréaction à la tuberculine, examen des crachats et des sécrétions nasales à la recherche d’un germe banal ou des BAAR, hémoculture, sérologie syphilis, sérologie lyme à l’exception d’une vitesse de sédimentation très accélérée, d’un taux de CD4 bas et d’une sérologie à chlamydiae positive. La symptomatologie pulmonaire associée était en faveur du genre pneumoniae, d’où le diagnostic d’une extension orbitaire d’un foyer de pneumonie à Chlamydia pneumoniae. Le décès était survenu au 5ème jour d’hospitalisation dans un contexte d’insuffiance hépatorénale aigue. Conclusion : L’expression clinique de certains agents pathogènes habituellement peu agressifs peut être totalement modifie en cas d’infection par le VIH.

  10. Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods.

    Science.gov (United States)

    Paldanius, Mika; Leinonen, Maija; Virkkunen, Hanna; Tenkanen, Leena; Sävykoski, Tiina; Mänttäri, Matti; Saikku, Pekka

    2006-11-01

    The lack of specific tests for the diagnosis of chronic Chlamydia pneumoniae infection has led to the use of enzyme immunoassay (EIA) instead of the gold standard, that is, microimmunofluorescence (MIF), in the measurement of C. pneumoniae antibodies. We assessed the predictive values of C. pneumoniae antibody levels and seroconversions measured by MIF and EIA for coronary events in the prospective Helsinki Heart Study. Sera from 239 cases with coronary events and 239 controls were available at the baseline and data from 210 cases and 211 controls before and after the event. The agreement between MIF and EIA antibody levels was best in high antibody titers. In conditional logistic regression analysis, only high IgA MIF titers (>/=40) at the baseline predicted future coronary events, and the participants with MIF seroconversion between consecutive sera had a higher (nonsignificant) risk for coronary events than the controls. The difference in the kinetics of EIA and MIF antibodies demonstrated that MIF should remain the gold standard. PMID:16757141

  11. Chlamydia pecorum is the endemic intestinal species in cattle while C. gallinacea, C. psittaci and C. pneumoniae associate with sporadic systemic infection.

    Science.gov (United States)

    Li, Jing; Guo, Weina; Kaltenboeck, Bernhard; Sachse, Konrad; Yang, Yi; Lu, Guangwu; Zhang, Jilei; Luan, Lu; You, Jinfeng; Huang, Ke; Qiu, Haixiang; Wang, Yaoyao; Li, Min; Yang, Zhangping; Wang, Chengming

    2016-09-25

    To investigate the prevalence and diversity of bovine Chlamydia spp. in cattle, whole blood from dairy and beef cattle in 11 provinces of China (n=2003) and vaginal swabs, whole blood samples, feces, milk samples from cows in a Yangzhou dairy farm (n=108) were examined using genus- and species-specific PCRs. In cattle from 11 provinces, 2.4% (48/2003) of whole-blood samples were positive for Chlamydia spp., and four Chlamydia species (C. pneumoniae, 41.7%, 20/48; C. psittaci, 22.9%, 11/48; C. gallinacea, 20.8%, 10/48; C. pecorum, 6.3%, 3/48) were identified. In a further study on a Yangzhou dairy farm, 64.8% (70/108) of the cows were positive for Chlamydia spp. C. pecorum was the intestinal endemic species (51/51, 100%), and C. gallinacea was the most frequent species in vaginal swabs (24/27, 88.9%), whole blood buffy coats (5/8, 62.5%) and milk (4/6, 66.7%). C. psittaci and C. pneumoniae were infrequently detected. DNA sequencing of the ompA gene demonstrated the presence of multiple in-herd C. pecorum serovars and single C. gallinacea and C. psittaci serovars which were identical with those of poultry from Yangzhou. This is the first report of C. gallinacea and C. pneumoniae in cattle. Further study is required to address the transmission of Chlamydia spp., in particular of C. gallinacea and C. pneumoniae from their natural hosts, and their potential pathogenic effect on health and production of cattle. PMID:27599935

  12. Chlamydia pecorum is the endemic intestinal species in cattle while C. gallinacea, C. psittaci and C. pneumoniae associate with sporadic systemic infection.

    Science.gov (United States)

    Li, Jing; Guo, Weina; Kaltenboeck, Bernhard; Sachse, Konrad; Yang, Yi; Lu, Guangwu; Zhang, Jilei; Luan, Lu; You, Jinfeng; Huang, Ke; Qiu, Haixiang; Wang, Yaoyao; Li, Min; Yang, Zhangping; Wang, Chengming

    2016-09-25

    To investigate the prevalence and diversity of bovine Chlamydia spp. in cattle, whole blood from dairy and beef cattle in 11 provinces of China (n=2003) and vaginal swabs, whole blood samples, feces, milk samples from cows in a Yangzhou dairy farm (n=108) were examined using genus- and species-specific PCRs. In cattle from 11 provinces, 2.4% (48/2003) of whole-blood samples were positive for Chlamydia spp., and four Chlamydia species (C. pneumoniae, 41.7%, 20/48; C. psittaci, 22.9%, 11/48; C. gallinacea, 20.8%, 10/48; C. pecorum, 6.3%, 3/48) were identified. In a further study on a Yangzhou dairy farm, 64.8% (70/108) of the cows were positive for Chlamydia spp. C. pecorum was the intestinal endemic species (51/51, 100%), and C. gallinacea was the most frequent species in vaginal swabs (24/27, 88.9%), whole blood buffy coats (5/8, 62.5%) and milk (4/6, 66.7%). C. psittaci and C. pneumoniae were infrequently detected. DNA sequencing of the ompA gene demonstrated the presence of multiple in-herd C. pecorum serovars and single C. gallinacea and C. psittaci serovars which were identical with those of poultry from Yangzhou. This is the first report of C. gallinacea and C. pneumoniae in cattle. Further study is required to address the transmission of Chlamydia spp., in particular of C. gallinacea and C. pneumoniae from their natural hosts, and their potential pathogenic effect on health and production of cattle.

  13. Aerobic bacteria, Chlamydia trachomatis, Pneumocystis carinii and Cytomegalovirus as agents of severe peneumonia in small infants Bactérias aeróbias, Chlamydia trachomatis, Pneumocystis carinii e Cytomegalovirus: agentes causadores de pneumonia grave em pequenos lactentes

    Directory of Open Access Journals (Sweden)

    Bernardo Ejzenberg

    1996-02-01

    Full Text Available The authors studied 58 infants hospitalized for pneumonia in a semi-intensive care unit. Age ranged from 1 complete to 6 incomplete months. The infants were sent from another hospital in 20 cases and from home in a further 38. Pulmonary involvement, which was alveolar in 46 cases and interstitial in 12, was bilateral in 31 children. The investigation was carried out prospectively on the etiological agents associated with respiratory infection to look for evidence of aerobic bacteria (blood cultures, Chlamydia trachomatis and Cytomegalovirus (serology, and Pneumocystis carinii (direct microscopy of tracheal aspirated material. The following infectious agents were diagnosed in 21 children (36.2%: Aerobic bacteria (8, Chlamydia trachomatis (5, Pneumocystis carinii (3, Cytomegalovirus (3, Cytomegalovirus and Chlamydia trachomatis (1, Aerobic bacteria and Cytomegalovirus (1. Seven cases of infection by Chlamydia trachomatis and/or Cytomegalovirus were diagnosed out of the 12 cases with pulmonary interstitial involvement.Os autores estudaram prospectivamente 58 lactentes internados por pneumonia em unidade semi-intensiva. A idade foi limitada entre 1 mês completo e 6 meses incompletos. A procedência das crianças foi de outro hospital em 20 casos e domiciliar em 38. O acometimento pulmonar era alveolar em 46 casos, intersticial em 12 e bilateral em 31 crianças. Foram pesquisados agentes etiológicos associados à infecção respiratória dos lactentes jovens: Bactérias aeróbias (Hemoculturas, Chlamydia trachomatis e Cytomegalovirus (sorologia, e Pneumocystis carinii (microscopia direta do aspirado traqueal. Foram diagnosticadas infecções em 21 crianças (36,2%: Bactérias aeróbias (8, Chlamydia trachomatis (5, Cytomegalovirus (3, Pneumocystis carinii (3, Cytomegalovirus e Chlamydia trachomatis (1, Bactéria aeróbia e Cytomegalovirus (1. Foram diagnosticadas 7 infecções por Chlamydia trachomatis e/ou Cytomegalovirus entre as 12 crianças com

  14. Prevalência de Chlamydia Pneumoniae e Mycoplasma Pneumoniae em diferentes formas da doença coronariana Prevalencia de Chlamydia Pneumoniae y Mycoplasma Pneumoniae en diferentes formas de la enfermedad coronaria Prevalence of Chlamydia Pneumoniae and Mycoplasma Pneumoniae in different forms of coronary disease

    Directory of Open Access Journals (Sweden)

    Irineu Luiz Maia

    2009-06-01

    Full Text Available FUNDAMENTO: Vários agentes infecciosos foram investigados desde que se demonstrou a associação entre infecção e aterosclerose, porém os resultados desses estudos são conflitantes. OBJETIVO: Testar a associação entre títulos séricos de anticorpos anti-Chlamydia e anti-Mycoplasma em diferentes formas de síndromes coronarianas agudas (SCA. MÉTODOS: Cento e vinte e seis pacientes foram divididos em quatro grupos: SCA com elevação do segmento ST (32 pacientes, SCA sem elevação do segmento ST (30 pacientes, doença arterial coronariana crônica (30 pacientes e doadores de sangue sem doença coronariana conhecida (34 pacientes - grupo-controle. Nos primeiros dois grupos, amostras de soro foram coletadas na admissão (primeiras 24 horas de hospitalização e após 6 meses de seguimento. Nos outros dois grupos, colheu-se apenas uma amostra basal. Em todas as amostras, anticorpos IgG anti-Chlamydia e anti-Mycoplasma foram dosados por imunofluorescência indireta. RESULTADOS: Diferenças significativas foram observadas entre a medida basal e após 6 meses de seguimento nos pacientes com infarto do miocárdio com elevação do segmento ST, tanto para Chlamydia (650±115,7 vs. 307±47,5, p = 0,0001 quanto para Mycoplasma (36,5±5,0 vs. 21,5±3,5, p = 0,0004. Os grupos com SCA tiveram níveis séricos de anticorpos anti-Chlamydia e anti-Mycoplasma mais altos na dosagem basal, em relação aos pacientes com doença arterial coronariana crônica e grupo-controle, mas as diferenças obtidas não tiveram significância estatística. CONCLUSÃO: O presente estudo mostrou associação entre os títulos de anticorpos anti-Chlamydia e anti-Mycoplasma na fase aguda dos pacientes com angina instável ou infarto do miocárdio.FUNDAMENTO: Se han investigado diversos agentes infecciosos desde que se evidenció la asociación entre infección y aterosclerosis, sin embargo esos estudios ofrecen resultados conflictivos. OBJETIVO: Probar la asociación entre

  15. Construction of a highly flexible and comprehensive gene collection representing the ORFeome of the human pathogen Chlamydia pneumoniae

    Directory of Open Access Journals (Sweden)

    Maier Christina J

    2012-11-01

    Full Text Available Abstract Background The Gram-negative bacterium Chlamydia pneumoniae (Cpn is the leading intracellular human pathogen responsible for respiratory infections such as pneumonia and bronchitis. Basic and applied research in pathogen biology, especially the elaboration of new mechanism-based anti-pathogen strategies, target discovery and drug development, rely heavily on the availability of the entire set of pathogen open reading frames, the ORFeome. The ORFeome of Cpn will enable genome- and proteome-wide systematic analysis of Cpn, which will improve our understanding of the molecular networks and mechanisms underlying and governing its pathogenesis. Results Here we report the construction of a comprehensive gene collection covering 98.5% of the 1052 predicted and verified ORFs of Cpn (Chlamydia pneumoniae strain CWL029 in Gateway® ‘entry’ vectors. Based on genomic DNA isolated from the vascular chlamydial strain CV-6, we constructed an ORFeome library that contains 869 unique Gateway® entry clones (83% coverage and an additional 168 PCR-verified ‘pooled’ entry clones, reaching an overall coverage of ~98.5% of the predicted CWL029 ORFs. The high quality of the ORFeome library was verified by PCR-gel electrophoresis and DNA sequencing, and its functionality was demonstrated by expressing panels of recombinant proteins in Escherichia coli and by genome-wide protein interaction analysis for a test set of three Cpn virulence factors in a yeast 2-hybrid system. The ORFeome is available in different configurations of resource stocks, PCR-products, purified plasmid DNA, and living cultures of E. coli harboring the desired entry clone or pooled entry clones. All resources are available in 96-well microtiterplates. Conclusion This first ORFeome library for Cpn provides an essential new tool for this important pathogen. The high coverage of entry clones will enable a systems biology approach for Cpn or host–pathogen analysis. The high yield of

  16. Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity

    DEFF Research Database (Denmark)

    Christiansen, Gunna; Boesen, Thomas; Hjernø, Karin;

    1999-01-01

    present on the surface of the bacteria, we analyzed what components are present on the C pneumoniae surface. We identified a family of proteins, the GGAI or Omp4-15 proteins, of which at least 3 are present on the surface of C pneumoniae. We immunized rabbits with recombinant GGAI proteins and used...

  17. Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study

    OpenAIRE

    Guti??rrez-Fern??ndez, Jos??; Luna Del Castillo, Juan De Dios; Ma??anes-Gonz??lez, Sara; Carrillo-??vila, Jos?? Antonio; Guti??rrez, Blanca; Cervilla, Jorge A; Sorl??zano Puerto, Antonio

    2015-01-01

    In the present study we have performed both a meta-analysis and an analytical study exploring the presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii antibodies in a sample of 143 schizophrenic patients and 143 control subjects. The meta-analysis was performed on papers published up to April 2014. The presence of serum immunoglobulin G and immunoglobulin A was performed by enzyme-linked immunosorbent assay test. The detection of microbial...

  18. Characterization of a secreted Chlamydia protease

    DEFF Research Database (Denmark)

    Shaw, Allan C; Vandahl, Brian; Larsen, Martin Røssel;

    2002-01-01

    Chlamydia. Several secretion candidates from Chlamydia trachomatis D and Chlamydia pneumoniae were detected by this method. Two protein spots were identified among the candidates. These represent fragments of the 'chlamydial protease- or proteasome-like activity factor' (CPAF) and were clearly present in 2D...... fragments of CPAF exist in C. pneumoniae as well as in C. trachomatis....

  19. GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, impairs neovascularization by decreasing endothelial progenitor cell function.

    Directory of Open Access Journals (Sweden)

    Yi-Wen Lin

    Full Text Available The number and function of endothelial progenitor cells (EPCs are sensitive to hyperglycemia, hypertension, and smoking in humans, which are also associated with the development of atherosclerosis. GroEL1 from Chlamydia pneumoniae has been found in atherosclerotic lesions and is related to atherosclerotic pathogenesis. However, the actual effects of GroEL1 on EPC function are unclear. In this study, we investigate the EPC function in GroEL1-administered hind limb-ischemic C57BL/B6 and C57BL/10ScNJ (a toll-like receptor 4 (TLR4 mutation mice and human EPCs. In mice, laser Doppler imaging, flow cytometry, and immunohistochemistry were used to evaluate the degree of neo-vasculogenesis, circulating level of EPCs, and expression of CD34, vWF, and endothelial nitric oxide synthase (eNOS in vessels. Blood flow in the ischemic limb was significantly impaired in C57BL/B6 but not C57BL/10ScNJ mice treated with GroEL1. Circulating EPCs were also decreased after GroEL1 administration in C57BL/B6 mice. Additionally, GroEL1 inhibited the expression of CD34 and eNOS in C57BL/B6 ischemic muscle. In vitro, GroEL1 impaired the capacity of differentiation, mobilization, tube formation, and migration of EPCs. GroEL1 increased senescence, which was mediated by caspases, p38 MAPK, and ERK1/2 signaling in EPCs. Furthermore, GroEL1 decreased integrin and E-selectin expression and induced inflammatory responses in EPCs. In conclusion, these findings suggest that TLR4 and impaired NO-related mechanisms could contribute to the reduced number and functional activity of EPCs in the presence of GroEL1 from C. pneumoniae.

  20. Identification of Sphingomyelinase on the Surface of Chlamydia pneumoniae: Possible Role in the Entry into Its Host Cells

    Directory of Open Access Journals (Sweden)

    Tuula A. Peñate Medina

    2014-01-01

    Full Text Available We have recently suggested a novel mechanism, autoendocytosis, for the entry of certain microbes into their hosts, with a key role played by the sphingomyelinase-catalyzed topical conversion of sphingomyelin to ceramide, the differences in the biophysical properties of these two lipids providing the driving force. The only requirement for such microbes to utilize this mechanism is that they should have a catalytically active SMase on their outer surface while the target cells should expose sphingomyelin in the external leaflet of their plasma membrane. In pursuit of possible microbial candidates, which could utilize this putative mechanism, we conducted a sequence similarity search for SMase. Because of the intriguing cellular and biochemical characteristics of the poorly understood entry of Chlamydia into its host cells these microbes were of particular interest. SMase activity was measured in vitro from isolated C. pneumoniae elementary bodies (EB and in the lysate from E. coli cells transfected with a plasmid expressing CPn0300 protein having sequence similarity to SMase. Finally, pretreatment of host cells with exogenous SMase resulting in loss plasma membrane sphingomyelin attenuated attachment of EB.

  1. Chlamydia pneumoniae infection induced allergic airway sensitization is controlled by regulatory T-cells and plasmacytoid dendritic cells.

    Science.gov (United States)

    Crother, Timothy R; Schröder, Nicolas W J; Karlin, Justin; Chen, Shuang; Shimada, Kenichi; Slepenkin, Anatoly; Alsabeh, Randa; Peterson, Ellena; Arditi, Moshe

    2011-01-01

    Chlamydia pneumoniae (CP) is associated with induction and exacerbation of asthma. CP infection can induce allergic airway sensitization in mice in a dose- and time-dependent manner. Allergen exposure 5 days after a low dose (mild-moderate), but not a high dose (severe) CP infection induces antigen sensitization in mice. Innate immune signals play a critical role in controlling CP infection induced allergic airway sensitization, however these mechanisms have not been fully elucidated. Wild-type, TLR2-/-, and TLR4-/- mice were infected intranasally (i.n.) with a low dose of CP, followed by i.n. exposure to human serum albumin (HSA) and challenged with HSA 2 weeks later. Airway inflammation, immunoglobulins, eosinophils, and goblet cells were measured. Low dose CP infection induced allergic sensitization in TLR2-/- mice, but not in TLR4-/- mice, due to differential Treg responses in these genotypes. TLR2-/- mice had reduced numbers of Tregs in the lung during CP infection while TLR4-/- mice had increased numbers. High dose CP infection resulted in an increase in Tregs and pDCs in lungs, which prevented antigen sensitization in WT mice. Depletion of Tregs or pDCs resulted in allergic airway sensitization. We conclude that Tregs and pDCs are critical determinants regulating CP infection-induced allergic sensitization. Furthermore, TLR2 and TLR4 signaling during CP infection may play a regulatory role through the modulation of Tregs. PMID:21695198

  2. Chlamydia pneumoniae infection induced allergic airway sensitization is controlled by regulatory T-cells and plasmacytoid dendritic cells.

    Directory of Open Access Journals (Sweden)

    Timothy R Crother

    Full Text Available Chlamydia pneumoniae (CP is associated with induction and exacerbation of asthma. CP infection can induce allergic airway sensitization in mice in a dose- and time-dependent manner. Allergen exposure 5 days after a low dose (mild-moderate, but not a high dose (severe CP infection induces antigen sensitization in mice. Innate immune signals play a critical role in controlling CP infection induced allergic airway sensitization, however these mechanisms have not been fully elucidated. Wild-type, TLR2-/-, and TLR4-/- mice were infected intranasally (i.n. with a low dose of CP, followed by i.n. exposure to human serum albumin (HSA and challenged with HSA 2 weeks later. Airway inflammation, immunoglobulins, eosinophils, and goblet cells were measured. Low dose CP infection induced allergic sensitization in TLR2-/- mice, but not in TLR4-/- mice, due to differential Treg responses in these genotypes. TLR2-/- mice had reduced numbers of Tregs in the lung during CP infection while TLR4-/- mice had increased numbers. High dose CP infection resulted in an increase in Tregs and pDCs in lungs, which prevented antigen sensitization in WT mice. Depletion of Tregs or pDCs resulted in allergic airway sensitization. We conclude that Tregs and pDCs are critical determinants regulating CP infection-induced allergic sensitization. Furthermore, TLR2 and TLR4 signaling during CP infection may play a regulatory role through the modulation of Tregs.

  3. Characterization of serine hydroxymethyltransferase GlyA as a potential source of D-alanine in Chlamydia pneumoniae

    Directory of Open Access Journals (Sweden)

    Stefania eDe Benedetti

    2014-02-01

    Full Text Available For intracellular Chlamydiaceae, there is no need to withstand osmotic challenges, and a functional cell wall has not been detected in these pathogens so far. Nevertheless, penicillin inhibits cell division in Chlamydiaceae resulting in enlarged aberrant bodies, a phenomenon known as chlamydial anomaly.D-alanine is a unique and essential component in the biosynthesis of bacterial cell walls. In free-living bacteria like Escherichia coli, penicillin-binding proteins such as monofunctional transpeptidases PBP2 and PBP3, the putative targets of penicillin in Chlamydiaceae, cross-link adjacent peptidoglycan strands via meso-diaminopimelic acid and D-Ala-D-Ala moieties of pentapeptide side chains. In the absence of genes coding for alanine racemase Alr and DadX homologs, the source of D-Ala and thus the presence of substrates for PBP2 and PBP3 activity in Chlamydiaceae has puzzled researchers for years. Interestingly, Chlamydiaceae genomes encode GlyA, a serine hydroxymethyltransferase that has been shown to exhibit slow racemization of D- and L- alanine as a side reaction in E. coli. We show that GlyA from Chlamydia pneumoniae can serve as a source of D-Ala. GlyA partially reversed the D-Ala auxotrophic phenotype of an E. coli racemase double mutant. Moreover, purified chlamydial GlyA had racemase activity on L-Ala in vitro and was inhibited by D-cycloserine, identifying GlyA, besides D-Ala ligase MurC/Ddl, as an additional target of this competitive inhibitor in Chlamydiaceae. Proof of D-Ala biosynthesis in Chlamydiaceae helps to clarify the structure of cell wall precursor lipid II and the role of chlamydial penicillin-binding proteins in the development of non-dividing aberrant chlamydial bodies and persistence in the presence of penicillin.

  4. Comparative Study of ELISA and IIFT in Detecting Chlamydia Pneumoniae Specific IgG Antibodies in Patients of Acute Coronary Syndrome (ACS

    Directory of Open Access Journals (Sweden)

    Bhuva S P, Bhuva P J, Javdekar T B, Jain M R, Mulla S A

    2012-01-01

    Full Text Available Background: Chlamydia pnaumoniae is reported to be associated with coronary heart disease (CHD. Efficacy of available serologic tests for detecting C.pneumoniae antibodies has been debated. The aim of present study was to compare Enzyme Linked Immunosorbant Assay (ELISA and Indirect Immunofluorescent Test (IIFT for detecting specific antichlamydial antibodies in patients of Acute Coronary Syndrome (ACS. Materials and Methods: Serum samples from 100 patients of ACS and 90 healthy controls were tested for the presence of Chlamydial IgG antibodies using ELISA and IIFT. To assess agreement between ELISA and IIFT, we used ‘nominal scale variables”. Agreement analysis was done using sensitivity, specificity, positive and negative predictive values (PPV and NPV and diagnostic accuracy of the test. Results: The ELISA and IIFT detected C.pneumoniae IgG antibodies in 66% and 48% respectively in patients of ACS, and 29% and 20% respectively of healthy controls. In patients of ACS, sensitivity and specificity of ELISA as compared to IIFT were 70.8% and 38.4% respectively. The PPV of ELISA for C.pneumoniae was 51.5% and NPV was 58.8%. The diagnostic accuracy of ELISA for C.pneumoniae was 54.6%. The two tests correlated in 54% of samples with a moderate agreement of =0.51. Conclusions: The results of present study indicate that ELISA test was inferior to IIFT in detecting C.pneumoniae antibodies in patients of ACS.

  5. No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial

    DEFF Research Database (Denmark)

    Westerhout, Cynthia M; Gnarpe, Judy; Chang, Wei-Ching;

    2007-01-01

    BACKGROUND: Although relationships between chronic Chlamydia pneumoniae (Cpn) infection and the risk of coronary events in stable coronary artery disease patients have been reported, a similar link in acute coronary syndrome (ACS) patients has not been consistently observed. METHODS: In a nested ...

  6. Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and estimation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair

    DEFF Research Database (Denmark)

    Mygind, Tina; Østergaard, Lars; Birkelund, Svend;

    2003-01-01

    To date PCR detection of Chlamydia pneumoniae DNA in atherosclerotic lesions from Danish patients has been unsuccessful. To establish whether non-detection was caused by a suboptimal DNA extraction method, we tested five different DNA extraction methods for purification of DNA from atherosclerotic...

  7. Fifth Disease (Parvovirus B19)

    Science.gov (United States)

    ... Español Text Size Email Print Share Fifth Disease (Parvovirus B19) Page Content Article Body Fifth disease, also called ... cheeks. It is caused by a virus called parvovirus B19 and can be spread from one person to ...

  8. Parvovirus B19 and Other Illnesses

    Science.gov (United States)

    ... Cheek Rash Parvovirus B19 and Other Illnesses References Parvovirus B19 and Other Illnesses Recommend on Facebook Tweet Share ... disease is the most common illness caused by parvovirus B19 infection. Learn More Parvovirus B19 infection can cause ...

  9. Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patients.

    Science.gov (United States)

    Esposito, Pasquale; Tinelli, Carmine; Libetta, Carmelo; Gabanti, Elisa; Rampino, Teresa; Dal Canton, Antonio

    2011-03-01

    Autoimmunity to heat shock protein 60 (HSP60) has been related to atherosclerosis. Chlamydia pneumoniae (CP), the most studied infectious agent implicated in promoting atherosclerosis, produces a form of HSP60, which can induce an autoimmune response, due to high antigenic homology with human HSP60 (hHSP60). In this study, we evaluated the correlations among anti-hHSP60 antibodies, CP infection, and cardiovascular disease (CVD) in a high-risk population, such as patients undergoing hemodialysis (HD). Thirty-two patients (67.9 ± 13.9 years; male/female, 23:9) on regular HD were enrolled. Global absolute cardiovascular risk (GCR) was assessed using the Italian CUORE Project's risk charts, which evaluate age, gender, smoking habits, diabetes, systolic blood pressure, and serum cholesterol. The occurrence of cardiovascular events during a 24-month follow-up was recorded. Seropositivity to CP and the presence of anti-hHSP60 antibodies were tested by specific enzyme-linked immunosorbent assays. Inflammation was assessed by measurement of C-reactive protein (CRP) serum levels. Fifteen healthy sex and age-matched (61.9 ± 9.5 years; male/female, 11:4) subjects were the control group. Fifteen of 32 patients resulted seropositive for CP. CP + patients were older than CP-, while they did not differ for GCR, CRP, and dialytic parameters. CVD incidence was significantly higher in CP+ (9 CP+ vs 2 CP-, p < 0.05). Cox analysis recognized that the incidence of CVD was independently correlated with seropositivity to CP (HR, 7.59; p = 0.01; 95% CI = 1.63-35.4). On the other hand, there were no significant differences in anti-hHSP60 levels among CP+, CP- and healthy subjects: 18.11 μg/mL (14.8-47.8), 31.4 μg/mL (23.2-75.3), and 24.72 μg/mL (17.7-41.1), respectively. Anti-hHSP60 did not correlate to GCR, CRP, and incidence of CVD. In conclusion, our data suggest that anti-hHSP60 autoimmune response is not related to CP infection and CP-related CVD risk

  10. Oral azithromycin in extended dosage schedule for chronic, subclinical Chlamydia pneumoniae infection causing coronary artery disease: a probable cure in sight? Results of a controlled preliminary trial

    Directory of Open Access Journals (Sweden)

    Dogra J

    2012-06-01

    Full Text Available Jaideep DograPoly Clinic, Central Government Health Scheme, Jaipur, Rajasthan, IndiaPurpose: Two mega trials have raised the question as to whether the hypothesis that infection plays a role in atherosclerosis is still relevant. This controlled preliminary trial investigated an extended dose of azithromycin in the treatment of Chlamydia pneumoniae infection causing coronary artery disease (CAD.Patients and methods: Forty patients with documentary evidence of CAD were screened for immunoglobulin G titers against C. pneumoniae and grouped into either the study group (patients with positive titer, n = 32 or control group (patients with negative titer, n = 8. Cases who met inclusion criteria could not have had coronary artery bypass graft surgery or percutaneous coronary intervention in the preceding 6 months. Informed consent was obtained from every patient. Baseline blood samples were analyzed for red blood cell indices, serum creatinine, and liver function tests, and repeated every 2 months. A primary event was defined as the first occurrence of death by any cause, recurrent myocardial infarction, coronary revascularization procedure, or hospitalization for angina. Patients in the study group received 500 mg of oral azithromycin once daily for 5 days, which was then repeated after a gap of 10 days (total of 24 courses in the 1-year trial period. The control group did not have azithromycin added to their standard CAD treatment.Results: In the study group, 30 patients completed the trial. Two patients had to undergo percutaneous coronary intervention in the initial first quarter of the 1-year trial period. In the control group, one patient died during the trial, one had to undergo coronary artery bypass graft surgery, and one had percutaneous coronary intervention.Conclusion: The patients tolerated the therapy well and there was a positive correlation between azithromycin and secondary prevention of CAD.Keywords: azithromycin, Chlamydia pneumoniae

  11. 新生儿衣原体肺炎24例临床分析%Retrospective clinical analysis of neonatal Chlamydia trachomatis pneumonia in 24 cases

    Institute of Scientific and Technical Information of China (English)

    翟倩; 曹云; 蒋思远; 陈超; 帕米尔

    2012-01-01

    目的 分析24例新生儿沙眼衣原体肺炎患儿相关临床资料,提高对新生儿沙眼衣原体肺炎的认识.方法应用实时荧光定量聚合酶链反应(PCR)检测2005年6月至2011年10月因肺炎收治复旦大学附属儿科医院新生儿科患儿呼吸道标本中的DNA,回顾性分析24例惠儿的病史特点、临床表现、实验室检查、影像学特点、治疗及转归情况.结果 新生儿沙眼衣原体肺炎主要表现为阵发性咳嗽、无热或低热、外周血嗜酸性粒细胞计数增高及X线胸片双肺广泛间质和(或)肺泡浸润,予红霉素或阿奇霉素治疗,均好转或治愈.初始误诊为肺结核5例,误诊率20.8%.结论 新生儿衣原体肺炎无特异的临床及影像学表现,尤其是X线胸片易误诊为肺结核,应尽早行病原学检查,有利于及时诊治,减少并发症,红霉素或阿奇霉素是治疗衣原体肺炎有效的首选抗生素.%Objective To analyze clinical features of neonatal Chlamydia trachomatis pneumonia to improve clinical management. Methods The data of 24 confirmed Chlamydia trachomatis cases were retrospectively reviewed, including epidemiological data, clinical manifestations, laboratory features, imaging, treatment and prognosis. Real-time poly-merase chain reaction (PCR) was conducted for detection of Chlamydia trachomatis DNA of deep respiratory samples of hospitalized children with pneumonia in Children' s Hospital of Fudan University, from June 2005 to October 2011. Results The main clinical features were: paroxysmal cough, afebrile, and increased peripheral blood eosinophil count. Chest X-ray features were extensive infiltrates of interstitial lung and (or) alveolar! After being confirmed, the patients were treated with erythromycin or azithromycin. All the patients were cured or improved. Initially ,20.8%(5/24)of the patients were misdiagnosed as tuberculosis. Conclusion Neonatal Chlamydia trachomatis pneumonia has no specific clinical and imaging

  12. Determination of PCR efficiency in chelex-100 purified clinical samples and comparison of real-time quantitative PCR and conventional PCR for detection of Chlamydia pneumoniae

    OpenAIRE

    Jensen Jørgen; Østergaard Lars; Birkebæk Niels H; Birkelund Svend; Mygind Tina; Christiansen Gunna

    2002-01-01

    Abstract Background Chlamydia pneumoniae infection has been detected by serological methods, but PCR is gaining more interest. A number of different PCR assays have been developed and some are used in combination with serology for diagnosis. Real-time PCR could be an attractive new PCR method; therefore it must be evaluated and compared to conventional PCR methods. Results We compared the performance of a newly developed real-time PCR with a conventional PCR method for detection of C. pneumon...

  13. Epidemiologic study of human parvovirus B19 infection in East China.

    Science.gov (United States)

    Zhang, Lahong; Cai, Chengsong; Pan, Feng; Hong, Liquan; Luo, Xian; Hu, Sha; Xu, Jiali; Chen, Zhaojun

    2016-07-01

    Human parvovirus B19 (B19V) infection causes a number of diseases in humans, and, in some circumstances, can be life threatening. To understand the epidemiology of B19V infection in the greater metropolitan area of Hangzhou, East China, we performed surveys of IgM and IgG antibodies against B19V and quantification of B19V DNA, by using enzyme-linked immunosorbent assay and quantitative PCR, respectively, in plasma samples from diverse groups. These groups included anemia patients, Mycoplasma pneumonia- and Treponema pallidum-infected patients, HIV-positive individuals, and healthy blood donor volunteers. Our results demonstrated a low level of B19V IgG antibody presence, ranging from 21.9% to 41.8% in all the groups tested, suggesting a low prevalence of B19V infection in the area. Of note, we found that two healthy blood donors and one Mycoplasma pneumonia-infected patient had B19V IgM antibody among 1,290 plasma samples tested. The Mycoplasma pneumonia-infected patient had viremia with viral genome copies of 2.86 × 10(6) per ml of plasma. We detected a high rate of B19V DNA (7.1%) in HIV-positive injection drug users. Importantly, an amino acid mutation of P558S in the large non-structural protein NS1 was identified to be conserved among 14 B19V isolates from the HIV-positive group but not in the B19V isolate of the Mycoplasma pneumonia-infected patient, representing a hallmark of B19V isolates that circulate in HIV1-positive patients in the greater metropolitan area of Hangzhou, East China. PMID:26705119

  14. Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study

    Directory of Open Access Journals (Sweden)

    Twardella Dorothee

    2006-04-01

    Full Text Available Abstract Background There have been suggestions of an association between Chlamydia pneumoniae, chlamydial heat shock protein (Ch-hsp 60 and human heat shock protein (h-hsp 60 infection sero-status and development of secondary cardiovascular events. Patients with diabetes might be at higher risk since they are prone to infections. The objective of this study was to investigate prospectively the role of Chlamydia pneumoniae (CP, chlamydial heat shock protein (Ch-hsp 60 and a possible intermediate role of human heat shock protein (h-hsp 60 sero-status in the development of secondary cardiovascular disease (CVD events in patients with coronary heart disease (CHD under special consideration of diabetes mellitus. Methods Patients aged 30–70 undergoing an in-patient rehabilitation program after acute manifestation of coronary heart disease (International Classification of Disease, 9th Rev. pos. 410–414 between January 1999 and May 2000 in one of two participating rehabilitation clinics in Germany were included in this analysis. Chlamydia pneumoniae (CP, chlamydial heat shock protein (Ch-hsp 60 and human heat shock protein (h-hsp 60 status at baseline were measured by serum immunoglobulin G and A antibodies. Secondary CVD events (myocardial infarction, stroke, and cardiovascular death were recorded during a mean follow-up period of 33.5 months (response = 87%. Results Among the 1052 subjects 37.4% and 39.3% were sero-positive to CP IgA and IgG respectively, 22.2% were sero-positive to Ch-hsp 60 IgG and 8.4% were positive to h-hsp 60 IgG at baseline. During follow-up, secondary CVD events occurred among 71 (6.8% participants. Occurrence of a secondary CVD event was more common among CP (IgA and CP (IgG sero-positive than among sero-negative patients (p-values 0.04 and 0.1, respectively. The risk of secondary CVD events was increased among patients with both a positive CP sero-status and diabetes compared to infection negative, non-diabetic patients

  15. Human parvovirus B19 and rheumatoid arthritis

    OpenAIRE

    Sasaki, Takeshi

    2007-01-01

    Human parvovirus B19B19) is single stranded DNA virus, that causes erythema infectinosum in infantand/or acute onset polyarthritis in adult. We present the evidence showing the role of B19 on the etiopathogy ofrheumatoid arthritis( RA).( 1) B19 DNA could be frequently amplifi ed in the samples from rheumatoid joints. Thedetection B19 RNA and B19 protein VP1 was specific for RA, and positive at T cells, B cells, macrophages andfollicular dendritic cells in rheumatoid synovium. ( 2) B19 infec...

  16. Parvovirus B19-Induced Apoptosis of Hepatocytes

    OpenAIRE

    Poole, Brian D.; Karetnyi, Yuory V.; Naides, Stanley J.

    2004-01-01

    Parvovirus B19 (B19 virus) can persist in multiple tissues and has been implicated in a variety of diseases, including acute fulminant liver failure. The mechanism by which B19 virus induces liver failure remains unknown. Hepatocytes are nonpermissive for B19 virus replication. We previously reported that acute fulminant liver failure associated with B19 virus infection was characterized by hepatocellular dropout. We inoculated both primary hepatocytes and the hepatocellular carcinoma cell li...

  17. The prevalence of Chlamydia pneumoniae in the aortic wall and in peripheral blood of patients scheduled for coronary artery bypass grafting.

    Science.gov (United States)

    Kuczaj, A; Stryjewski, P J; Fudal, M; Domal-Kwiatkowska, D; Ryfiński, B; Sliupkas-Dyrda, E; Smolik, S; Węglarz, L; Mazurek, U; Nowalany-Kozielska, E

    2016-01-01

    Some reports confirm a potential role of Chlamydia pneumoniae (ChP) in atherogenesis. In order to explore possible association between ChP and atherosclerosis, investigations were carried out in which the frequency of ChP in the arterial wall and peripheral blood was assessed in a group of patients with chronic coronary artery disease (CAD). Fifty-seven patients were enrolled in the study, 13 women and 44 men aged 61.8±6.5 (47-74), with previously diagnosed CAD, scheduled for planned coronary artery bypass grafting due to clinical indications. Vessel specimens retrieved from the ascending aorta (as a part of routine proximal venous graft development procedure) and peripheral blood mononuclear cells (PBMCs) from venous blood were evaluated for the presence of ChP DNA. Genomic DNA was extracted from PBMCs and vessel specimens. Quantitative real-time polymerase chain reaction (qPCR) was performed to detect ChP DNA. A statistically more frequent occurrence of ChP was observed in aortic tissues compared to blood samples (70.2% vs 56.1%, respectively). Similarly, the number of ChP DNA genomic copies [n/1μg genomic DNA] was significantly higher in tissue specimens compared to blood samples (89±91 vs 41±77, respectively; p=0.0046). In patients without ChP in blood specimens, we observed significantly higher amounts of ChP in tissue specimens compared to patients with ChP in blood specimens (156±71 vs 107±88, respectively; p=0.0453). No correlation was found between the number of ChP DNA copies [n/1μg genomic DNA] in blood and in aortic specimens. The infection of ChP in the aortic wall was connected with hypercholesterolemia (p=0.029) and diabetes (p=0.03). We conclude that Chlamydia pneumoniae is a pathogen frequently occurring in the aortic wall of patients with CAD. The occurrence of ChP DNA in the aortic tissue is related to classic CAD risk factors such as diabetes and dyslipidemia. PMID:27358129

  18. 哮喘患儿肺炎衣原体及肺炎支原体感染的临床特征分析%Clinical characteristics of Chlamydia pneumoniae and Mycoplasma pneumoniae infections in children with asthma

    Institute of Scientific and Technical Information of China (English)

    王爱虹; 王景刚; 宋永辉

    2015-01-01

    目的:观察分析哮喘急性发作患儿肺炎衣原体及肺炎支原体感染的临床特征,以降低哮喘患儿医院感染率。方法选取2012年3月-2013年3月儿科收治的哮喘急性发作患儿共180例,统计分析患儿哮喘病程长短与肺炎衣原体感染和肺炎支原体感染的关系及其药敏检测结果。结果哮喘急性发作患儿肺炎支原体感染22.2%、肺炎衣原体感染22.8%;其中哮喘病程≤3个月的患儿中肺炎衣原体的感染率为41.0%,比哮喘病程3~6个月和>6个月的患儿感染率高,3者比较差异有统计学意义(P<0.05);而肺炎支原体在哮喘病程>6个月的患儿中感染率最高,为38.3%;患儿年龄≤3岁的肺炎衣原体和支原体的感染率分别为39.6%和33.3%,均高于年龄3~6、>6岁患儿;肺炎衣原体对红霉素耐药率最低,为17.1%,对四环素耐药率最高,为78.0%;肺炎支原体对红霉素耐药率最低,为22.5%,对庆大霉素耐药率最高,为77.5%。结论肺炎衣原体和肺炎支原体感染是导致哮喘急性发作的主要病原体,其中患儿≤3岁,哮喘病程≤3个月和>6个月的患儿感染肺炎支原体和衣原体的概率较高。%OBJECTIVE To observe the clinical characteristics of Chlamydia pneumoniae and Mycoplasma pneu‐moniae infections in the children with acute exacerbation of asthma so as to reduce the incidence of nosocomial in‐fections in the children with asthma .METHODS A total of 180 children with acute exacerbation of asthma ,who were treated in the department of pediatrics from Mar 2012 to Mar 2013 ,were enrolled in the study ;the relation‐ship between the course of asthma and the C .pneumoniae and M .pneumoniae infections was observed ,and the re‐sults of drug susceptibility testing for the C .pneumoniae and M .pneumoniae were statistically analyzed .RESULTS The incidence of M .pneumoniae infection was 22

  19. Chlamydia Testing

    Science.gov (United States)

    ... Amplification Test (NAAT); Chlamydia trachomatis Culture; Chlamydia trachomatis DNA Probe Related tests: Gonorrhea Testing , HIV Antibody and HIV Antigen , Syphilis Tests , Herpes Testing , HPV Test , Trichomonas Testing All content on Lab Tests Online has ...

  20. Pneumonia

    Science.gov (United States)

    ... restroom and before eating. Use lukewarm water and soap for at least 20 seconds. If soap and water are not available, using an alcohol- ... at higher risk for pneumonia? Do I have bacterial, viral or fungal pneumonia? What’s the best treatment? ...

  1. Advances in Human B19 Erythrovirus Biology▿

    OpenAIRE

    Servant-Delmas, Annabelle; Lefrère, Jean-Jacques; Morinet, Frédéric; Pillet, Sylvie

    2010-01-01

    Since its discovery, human parvovirus B19 (B19V), now termed erythrovirus, has been associated with many clinical situations (neurological and myocardium infections, persistent B19V DNAemia) in addition to the prototype clinical manifestations, i.e., erythema infectiosum and erythroblastopenia crisis. In 2002, the use of new molecular tools led to the characterization of three different genotypes of human B19 erythrovirus. Although the genomic organization is conserved, the geographic distrib...

  2. Parvovirus B19 associated acute cholestatic hepatitis

    Directory of Open Access Journals (Sweden)

    S. Perrini

    2014-12-01

    Full Text Available There are few reports in the literature of hepatitis as a manifestation of Parvovirus B19 infection. We describe a case of Parvovirus B19 associated acute cholestatic hepatitis diagnosed based on a positive serologic test (IgM and molecular detection of parvovirus B19 DNA in peripheral blood. Parvovirus B19 infection should be considered in the differential diagnosis of patient presenting with acute hepatitis of unknown etiology.

  3. Parvovirus B19 associated acute cholestatic hepatitis

    OpenAIRE

    Perrini, S; B. Guidi; Torelli, P; A. Forte

    2014-01-01

    There are few reports in the literature of hepatitis as a manifestation of Parvovirus B19 infection. We describe a case of Parvovirus B19 associated acute cholestatic hepatitis diagnosed based on a positive serologic test (IgM) and molecular detection of parvovirus B19 DNA in peripheral blood. Parvovirus B19 infection should be considered in the differential diagnosis of patient presenting with acute hepatitis of unknown etiology.

  4. 7 CFR 15b.19 - New construction.

    Science.gov (United States)

    2010-01-01

    ... Uniform Federal Accessibility Standards (USAF) (appendix A to 41 CFR subpart 101-19.6) shall be deemed to... 7 Agriculture 1 2010-01-01 2010-01-01 false New construction. 15b.19 Section 15b.19 Agriculture... ACTIVITIES RECEIVING FEDERAL FINANCIAL ASSISTANCE Accessibility § 15b.19 New construction. (a) Design...

  5. Pneumonia

    Science.gov (United States)

    ... better than treating it. Vaccines are available to prevent pneumococcal pneumonia and the flu. Other preventive measures include washing your hands frequently and not smoking. NIH: National Heart, Lung, and Blood Institute

  6. Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae.Infect Immun. 1999 Jan;67(1):375-83

    DEFF Research Database (Denmark)

    Knudsen, K; Madsen, AS; Mygind, P;

    1999-01-01

    of putative outer membrane proteins encoded by the Chlamydia psittaci and Chlamydia trachomatis gene families. By use of a monospecific polyclonal antibody against purified recombinant Omp4, it was shown that without heating, the protein migrated at 65 to 75 kDa in sodium dodecyl sulfate...

  7. Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F in a sepsis model.

    Directory of Open Access Journals (Sweden)

    Fabio Cafini

    Full Text Available BACKGROUND: Specific antibodies are likely to be present before S. pneumoniae infection. We explored cefditoren (CDN total and free values of serum concentrations exceeding the MIC (t>MIC related to efficacy in a mice sepsis model, and the effect of specific gammaglobulins on in-vitro phagocytosis and in-vivo efficacy. METHODOLOGY/PRINCIPAL FINDINGS: We used three pneumococcal isolates (serotype, MIC OF CDN: Strain 1 (6B, 1 microg/ml, Strain 2 (19F, 2 microg/ml and Strain 3 (23F, 4 microg/ml. Hyperimmune serum (HS was obtained from mice immunized with heat-inactivated strains. In-vitro, phagocytosis by HS diluted 1/10 in presence/absence of sub-inhibitory concentrations was measured by flow cytometry including fluorescent bacteria and a neutrophil cell line. In-vivo dose-ranging experiments with HS (dilutions 1/2-1/16 and CDN (6.25 mg/kg-100 mg/kg tid for 48 h were performed to determine the minimal protective dilution/dose (highest survival and the non-protective highest dilution/dose (highest mortality: HS-np dilution and CDN-np dose over 7 days. Efficacy of CDN-np in animals pre-immunized with HS-np (combined strategy was explored and blood bacterial clearance determined. The CDN measured protein binding was 86.9%. In-vitro, CDN significantly increased phagocytosis (vs. HS 1/10. In non pre-immunized animals, t>MIC values for CDN of approximately 35% (total and approximately 19% (free were associated with 100% survival. Significant differences in survival were found between HS-np alone (MIC (total/free of 22.8%/14.3%, 26.8%/16.0%, and 22.4%/12.7% for Strains 1, 2 and 3, respectively. Prior to the second dose (8 h, median bacterial counts were significantly lower in animals surviving vs. dead at day 7. CONCLUSIONS/SIGNIFICANCE: In mice (CDN protein binding similar to humans total t>MIC values of approximately 35% (approximately 19% free were efficacious, with a decrease in the required values in pre-immunized animals. This reinforces that

  8. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection

    OpenAIRE

    Mahon, Bernard P.; Doyle, Sean; Kavanagh, Kevin; Corcoran, Amanda; Ennis, O.

    2001-01-01

    Background :The presence of anti-parvovirus B19 (B19V) IgM against viral capsid proteins (VP1 and VP2) has long been used to detect recent infection. The utility of antibodies directed against B19V NS1 protein has received less attention as a serological indicator of recent infection, although anti-B19V NS1 IgG has been associated with persistent infection. Objecties : To elucidate the role of anti-B19V NS1 antibody detection in recent infection, full-length B19V NS1 was expressed and p...

  9. Fifth Disease (Parvovirus B19) and Pregnancy

    Science.gov (United States)

    Fifth Disease (parvovirus B19) In every pregnancy, a woman starts out with a 3-5% chance of having a baby with a ... infectiosum, is a viral illness caused by human parvovirus B19. It occurs most commonly in children ages 4 ...

  10. 60例小儿哮喘肺炎支原体、衣原体感染血清学分析%Serological analysis of 60 cases of pediatric asthmamycoplasma pneumonia and chlamydia

    Institute of Scientific and Technical Information of China (English)

    李丽娜; 张英芝

    2012-01-01

    Objective To investigate the acute onset status of asthma mycoplasma pneumoniae. pneumonia chlamydia infection. Methods Using enzyme-linked immunosorbent adsorption method to make some experiments , comparing 60 patients with asthma and 20 cases of normal controls. We test their normal controls MP-IgM antibodies and CP-igM in serum antibodies and get the judgment positive according to standard. We also analyze the result according to the age, sext etc. Results Men can easily catch Mycoplasma pneumoniaeand Pneumonia chlamydia than women. All have significant differences. Age is different. Comparing Asthma patients with normal rcpmaj, pneumonia mycoplasma infection have obvious difference, chlamydia has an extremely obvious difference. Conclusion According to the test for Serum antibodies specific antibodies MP-IgM and CP - IgM antibodies on children who has acute attack of asthma, the test has the vital significance.%目的 探讨小儿哮喘急性发作时肺炎支原体、衣原体感染状况.方法 对60例哮喘患儿和20例正常对照组儿童采用酶联免疫吸附方法检测其血清中MP-IgM抗体和CP-IgM抗体,按照阳性标准判断结果.从感染年龄、性别与对照组进行比较分析.结果 肺炎支原体和衣原体感染男性高于女性,差异有显著性(P<0.05);年龄无差异.哮喘患儿与正常对照组比较,肺炎支原体感染有明显差异(P<0.01),衣原体感染亦有差异(P<0.05).结论 对哮喘息性期发作患儿进行血清特异性MP-IgM抗体和CP-IgM抗体检测,对明确病因,指导临床用药具有重要意义.

  11. Human parvovirus B19 (B19V) infection in systemic sclerosis patients

    DEFF Research Database (Denmark)

    Zakrzewska, K.; Corcioli, F.; Carlsen, Karen Marie;

    2009-01-01

    BACKGROUND: Our previous reports suggested a possible association between parvovirus B19 (B19V) infection and systemic sclerosis (SSc), based on higher prevalence of B19V DNA in SSc patients in respect to controls. METHODS: In the present study, to further evaluate the differences in the pattern...

  12. Gonorrhea, Chlamydia, and Syphilis

    Science.gov (United States)

    ... Advocacy For Patients About ACOG Gonorrhea, Chlamydia, and Syphilis Home For Patients Search FAQs Gonorrhea, Chlamydia, and ... FAQ071, February 2016 PDF Format Gonorrhea, Chlamydia, and Syphilis Gynecologic Problems What are gonorrhea, chlamydia, and syphilis? ...

  13. Parvovirus B19: Past, present and future

    Directory of Open Access Journals (Sweden)

    Alfaro C Bassols AC

    2016-03-01

    Full Text Available Parvovirus B19 (B19V is a world-wide distributed virus member of the Parvoviridae family, generae Erythrovirus. It causes a wide list of diseases whose pathological mechanisms are majorly unknown. Many theories have emerged in an attempt to explain the pathogenics of B19V in each of its target organs, most interestingly in bone marrow, myocardium, and endothelium. Persistent infection in these organs allows the virus to infect cells despite presence of adequate antibodies formation. Developings from all over the world report that B19V is encountered in an ever changing manner variety of clinical entities. This new understanding opens the doors to future developments amid of a yet to be discover pathogenesis.

  14. Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway.

    Science.gov (United States)

    Niessner, Alexander; Kaun, Christoph; Zorn, Gerlinde; Speidl, Walter; Türel, Zeynep; Christiansen, Gunna; Pedersen, Anna-Sofie; Birkelund, Svend; Simon, Susan; Georgopoulos, Apostolos; Graninger, Wolfgang; de Martin, Rainer; Lipp, Joachim; Binder, Bernd R; Maurer, Gerald; Huber, Kurt; Wojta, Johann

    2003-07-01

    We tested whether polymorphic membrane proteins (PMPs) of Chlamydia pneumoniae might play a role in triggering an inflammatory response in human endothelial cells. Of 15 purified, recombinant chlamydial PMPs tested, 2 (PMP 20 and PMP 21) dose-dependently increased the production of the inflammatory mediators interleukin (IL)-6 and monocyte chemoattractant protein-1 (MCP-1), in cultured human endothelial cells; production of IL-8 was also increased. When endothelial cells were infected by live C. pneumoniae, an increase in the production of IL-6, IL-8, and MCP-1 was seen. We used adenovirus-induced overexpression of IkappaBalpha-an inhibitor of nuclear factor (NF)-kappaB-to demonstrate that PMP 20 and PMP 21 increase the production of IL-6 and MCP-1 in human endothelial cells by activation of the NF-kappaB pathway, because, in cells overexpressing IkappaBalpha, treatment with the respective PMP did not result in increased production of IL-6 and MCP-1. Thus, C. pneumoniae could, by interactions of its PMPs with the endothelium, contribute to the process of vascular injury during the development and progression of atherosclerotic lesions.

  15. Polymicrogyria and Congenital Parvovirus B19 Infection

    Directory of Open Access Journals (Sweden)

    Grant S. Schulert

    2011-12-01

    Full Text Available Fetal parvovirus B19 infection causes anemia, hydrops, and pregnancy loss but is generally not considered teratogenic. Nevertheless, disturbances of neuronal migration have been described with congenital parvovirus infection. We evaluated a term infant with congenital parvovirus disease and polymicrogyria. We compared this case with four other reports of central nervous system disease after birth to parvovirus-infected mothers. After an extensive diagnostic evaluation, this infant was found to have congenital parvovirus disease with severe anemia and nonimmune hydrops as well as extensive polymicrogyria. Although rare, this report and literature review suggest that parvovirus B19 has the potential to disrupt normal neurodevelopment. We suggest that infants with severe congenital parvovirus infection have close developmental surveillance and if symptomatic undergo neuroimaging to assess for disorders of neuromigration.

  16. Parvovírus B19

    OpenAIRE

    Rodrigues, Francisco

    2008-01-01

    Parvovírus são pequenos vírus, cuja designação deriva do latim parvus. Possui duas subfamílias: Parvovirinae e Densovirinae. A subfamília Parvivirinae possui três géneros: Parvovirus, Eritrovirus e Dependovirus. Apenas o género Eritrovirus possui um vírus potencialmente patogénico para o ser humano, o parvovirus B19.

  17. Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection

    OpenAIRE

    Kerr, J R; McCoy, M; Burke, B; Mattey, D L; Pravica, V.; Hutchinson, I V

    2003-01-01

    Background: The immune system has been implicated in the pathogenesis of certain clinical manifestations of parvovirus B19 infection, including rash and arthralgia. Cytokines feature in the pathogenesis of parvovirus B19 infection, so inherited variability in cytokine responses to B19 infection might have a bearing on the symptomatology of parvovirus B19 infection.

  18. Genome Sequences of Parvovirus B19 Reference Strains

    OpenAIRE

    Trösemeier, Jan-Hendrik; Branting, Annika; Lukashov, Vladimir V.; Blümel, Johannes; Baylis, Sally A

    2014-01-01

    We report here the sequences of two reference strains of parvovirus B19 (B19V) used for quantitation of B19V DNA. One reference strain has been established by the World Health Organization (WHO) and the other by the European Pharmacopeia (Ph. Eur.) and belong to B19V genotype 1a1 and 1a2, respectively.

  19. Untersuchung des Rezeptor-vermittelten Aufnahmemechanismus von Parvovirus B19 bei der endothelialen Parvovirus B19-Infektion und Adenovirus-induzierte Reaktivierung von Parvovirus B19 in Endothelzellen

    OpenAIRE

    Pozzuto, Tanja

    2012-01-01

    Human Parvovirus B19 (B19V) is the causative agent of erythema infectiosum, hydrops fetalis, aplastic crises and polyarthritis. B19V displays a very narrow cell and tissue tropism with productive infection thought to be restricted exclusively to erythroid progenitor cells in the bone marrow and fetal liver. However, over the last years increasing evidence for the presence of B19V DNA in other cell types and tissues such as synovial fibroblasts, tonsilles and skin as well as endothelial cells ...

  20. Is there a Relation between Chlamydia Infection and Primary Biliary Cirrhosis?

    Science.gov (United States)

    Leung, Patrick S. C.; Park, Ogyi; Matsumura, Shuji; Ansari, Aftab A.; Coppel, Ross L.; Gershwin, M. Eric

    2003-01-01

    Over the past two decades, a number of studies have failed to provide direct evidence of specific microbial chronic infection in primary biliary cirrhosis (PBC). However, a recent report suggests that there is a specific association of Chlamydia pneumoniae in patients with PBC and that C. pneumoniae or similar antigens might play a role in the pathogenesis of disease. To determine if Chlamydia infection is associated with PBC, we applied a combination of immunological and molecular approaches to investigate (a) the serological reactivity against two common Chlamydia human pathogens, C. pneumoniae and C. trachomatis, by immunoblotting, (b) the presence of Chlamydia in liver samples of patients with PBC and controls by PCR amplification of Chlamydia specific 16S rRNA and (c) the presence of Chlamydia proteins in liver samples of patients with PBC and controls by immunohistochemical staining. By immunoblotting, C. trachomatis and C. pneumoniae specific serological antibodies were found in 52/57 (91.2%) AMA positive PBC, 7/33 (21/2%) of AMA negative PBC, 1/25 (4%) PSC, 0/15 (0%) Sjorgen's syndrome and 0/20 (0%) systemic lupus erythematosus patients and 0/20 (0%) healthy volunteers at 1:200 sera dilution. PBC sera reacted to Chlamydia and E. coli lysates in western blots up to a maximum of 10-4 dilution. However, PCR amplification of the Chlamydia specific 16S rRNA gene was negative in 25/25 PBC livers but positive in 1/4 PSC liver, 3/6 in other liver disease controls and 1/4 normal liver samples. While two commercially available specific monoclonal antibodies stained positive controls (Chlamydia infected HEp-2 cells) they failed to detect Chlamydia antigens in PBC livers. The detection of Chlamydia specific antibodies but not Chlamydia rRNA gene and Chlamydia antigens in PBC suggests that Chlamydia infection is not involved in PBC. PMID:14768955

  1. Chlamydia bacteriophages.

    Science.gov (United States)

    Śliwa-Dominiak, Joanna; Suszyńska, Ewa; Pawlikowska, Małgorzata; Deptuła, Wiesław

    2013-11-01

    Phages are called "good viruses" due to their ability to infect and kill pathogenic bacteria. Chlamydia are small, Gram-negative (G-) microbes that can be dangerous to human and animals. In humans, these bacteria are etiological agents of diseases such as psittacosis or respiratory tract diseases, while in animals, the infection may result in enteritis in cattle and chronic bowel diseases, as well as miscarriages in sheep. The first-known representative of chlamydiaphages was Chp1. It was discovered in Chlamydia psittaci isolates. Since then, four more species of chlamydiaphages have been identified [Chp2, Chp3, φCPG1 φCPAR39 (φCpn1) and Chp4]. All of them were shown to infect Chlamydia species. This paper described all known chlamydiaphages. They were characterised in terms of origin, host range, and their molecular structure. The review concerns the characterisation of bacteriophages that infects pathogenic and dangerous bacteria with unusual, intracellular life cycles that are pathogenic. In the era of antibiotic resistance, it is difficult to cure chlamydophilosis. Those bacteriophages can be an alternative to antibiotics, but before this happens, we need to get to know chlamydiaphages better. PMID:23903989

  2. 宁波地区呼吸道感染患儿肺炎衣原体检测及分析%Detection and analysis of respiratory Chlamydia pneumoniae infection in children of Ningbo

    Institute of Scientific and Technical Information of China (English)

    周明雅

    2013-01-01

    Objective:To understand the situation of children with respiratory Chlamydia pneumoniae (CP) infections in Ningbo.Methods:All of 984 blood samples from children with respiratory infections were collected from January 2011 to December 2011.Antibody of CP-IgG and IgM were detected by ELISA.Results:In 984 cases,the positive rates of CP-IgG and CP-IgM were 10.1% and 10.6% respectively,and highest in 5 ~ 14 years old age group among different age groups.Compared with the detection rate in all diseases,the positive rates of CP-IgG and CP-IgM in upper respiratory tract infection were both high.There were positive correlation between CP-IgM of lobar-pneumonia and broncho-pneumonia.The positive rate of winter and spring were higher than summer and autumn.Conclusion:Children with respiratory infections should be carried out antibody detection of CP-IgG and IgM.%目的:了解宁波地区呼吸道感染患儿肺炎衣原体感染情况.方法:收集2011年1月-至2011年12月住院患儿984例中呼吸道感染者血标本,用酶联免疫吸附试验检测血清CP-IgG和CP-IgM抗体.结果:984例中,CP-IgG阳性率为10.1%,CP-IgM阳性率为10.6%;各年龄组中,5岁~ 14岁组阳性率高于其他各组;将呼吸道感染患儿不同病种间作比较,上呼吸道感染组CP-IgG、CP-IgM阳性率均高;冬春季CP-IgM阳性率高于夏秋季.结论:呼吸道感染患儿应进行CP-IgG和CP-IgM抗体检测.

  3. High-Sensitivity PCR Detection of Parvovirus B19 Plasma

    OpenAIRE

    Doyle, Sean; Mahon, Bernard; Corcoran, A; Daly, P.

    2002-01-01

    Parvovirus B19 (B19) is a human pathogen transmitted to susceptible individuals via respiratory secretions and contaminated blood or blood products. B19 levels in pooled plasma of less than 104 genome equivalents/ml may not be infectious, while those greater than 107/ml are capable of transmitting infection. A World Health Organization (WHO) B19 DNA international standard has been recently introduced. The purpose of the present work was to develop a PCR-enzyme-linked immunosorbent as...

  4. Atypical Papular Purpuric Eruption Induced by Parvovirus B19 Infection

    OpenAIRE

    Şeyma Kayalı; Nilden Tuygun; Halise Akça; Can Demir Karacan

    2016-01-01

    Parvovirus B19 infection’s most common dermatological manifestation is erythema infectiosum as also known the fifth disease. Rare clinical presentations of parvovirus B 19 like papulopurpuric gloves and socks syndrome and acropetechial syndrome has also been described re­cently. This study presents report of a case with atypical feature and distribution of rash due to parvovirus B19 in­fection. We want to emphasize that pediatricians should consider parvovirus B19 infection of any patient who...

  5. Seroprevalence of erythrovirus B19 in Saudi pregnant women

    OpenAIRE

    Johargy, Ayman K.

    2016-01-01

    Background: Erythrovirus B19 infection is associated with clinical symptoms that range from mild to severe. The common clinical presentation of B19 virus (B19V) infection is erythema infectiosum, arthropathy, aplastic crisis, and fetal infection. Infection in seronegative pregnant women can lead to fetal hydrops. Objectives: To determine the seroprevalence of immunoglobulin G (IgG) to erythrovirus B19 in Saudi pregnant women in the cities of Makkah and Jeddah in Saudi Arabia. Materials and Me...

  6. Genetic diversity of Chlamydia among captive birds from central Argentina.

    Science.gov (United States)

    Frutos, María C; Monetti, Marina S; Vaulet, Lucia Gallo; Cadario, María E; Fermepin, Marcelo Rodríguez; Ré, Viviana E; Cuffini, Cecilia G

    2015-01-01

    To study the occurrence of Chlamydia spp. and their genetic diversity, we analysed 793 cloacal swabs from 12 avian orders, including 76 genera, obtained from 80 species of asymptomatic wild and captive birds that were examined with conventional nested polymerase chain reaction and quantitative polymerase chain reaction. Chlamydia spp. were not detected in wild birds; however, four species (Chlamydia psittaci, Chlamydia pecorum, Chlamydia pneumoniae and Chlamydia gallinacea) were identified among captive birds (Passeriformes, n = 20; Psittaciformes, n = 15; Rheiformes, n = 8; Falconiformes n = 2; Piciformes n = 2; Anseriformes n = 1; Galliformes n = 1; Strigiformes n = 1). Two pathogens (C. pneumoniae and C. pecorum) were identified simultaneously in samples obtained from captive birds. Based on nucleotide-sequence variations of the ompA gene, three C. psittaci-positive samples detected were grouped into a cluster with the genotype WC derived from mammalian hosts. A single positive sample was phylogenetically related to a new strain of C. gallinacea. This report contributes to our increasing understanding of the abundance of Chlamydia in the animal kingdom. PMID:25469538

  7. Prolonged remission in a child with chronic myeloid leukemia following Parvo virus B19 (B19V infection

    Directory of Open Access Journals (Sweden)

    A Kumar

    2015-01-01

    Full Text Available Parvovirus B19 (B19V has been associated with a wide spectrum of clinico-pathological disorders in human beings depending upon the host immunity. The present report describes a child with chronic myeloid leukemia ( CML on hydroxyurea in haematological remission, who developed profound erythroid suppression following B19V infection requiring multiple transfusions and withdrawal of hydroxyurea. Despite being off-therapy the child remained in complete clinical and haematological remission till anti B19V antibodies appeared. This case illustrates the ability of B19V infection in suppressing neoplastic myeloid clone, a phenomenon not described earlier.

  8. Clueing in on Chlamydia.

    Science.gov (United States)

    Gibbons, Wendy

    1991-01-01

    Chlamydia's role in female infertility is discussed. The relationship of this organism to other diseases such as leprosy and tuberculosis is explained. Conditions caused by Chlamydia such as Pelvic Inflammatory Disease (PID) are described. (KR)

  9. Association between human parvovirus B19 infection and arthritis.

    OpenAIRE

    Cassinotti, P; Bas, S; Siegl, G; Vischer, T L

    1995-01-01

    OBJECTIVE--To gain information concerning the association between parvovirus B19 infection and arthritis. METHODS--Blood or synovial fluid, or both, from a total of 77 adult patients with various arthropathies (rheumatoid arthritis 13; mechanical arthropathies 11; crystal induced arthritis 13; idiopathic mono/oligoarthritis 25; suspicion of viral arthritis 15) were tested for the presence of the viral genome and anti-B19 antibodies. B19 DNA in blood and synovial fluid was investigated by nest...

  10. RELATIONSHIP BETWEEN HUMAN PARVOVIRUS B19 INFECTION AND APLASTIC ANEMIA

    Institute of Scientific and Technical Information of China (English)

    钱新宏; 郑跃杰; 张国成; 焦西英; 李佐华

    2001-01-01

    Objective. To explore the relationship between human parvovirus B 19 (HPV B 19) infection and aplastic anemia (AA) and to investigate the role of HPV B19 in the occurrence of AA.``Methods. The presence of HPV B19 DNA was detected in the peripheral blood samples of 60 patients with AA (children 38 and adults 22) by nested polymerase chain reaction (PCR) assay, and 30 healthy persons were selected as control.``Results. Sixteen (26. 7 % ) of 60 AA cases were HPV B19 DNA positive, while all the samples in the control group were negative for HPV B19 ( P = 0. 000914). Among the case group, the positive rates of HPV B19DNA were 21.4% (6 /28), 30.0% (3 / 10), 20.0% (1 / 5) and 35.3 % (6 / 17) in children acute AA (AAA), children chronic AA (CAA), adults AAA and adults CAA patients respectively, which were significantly higher than that in the control group. Furthermore, there was no remarkable difference between children AA and adults AA in the 16 HPV B19 DNA positive patients; neither was there between AAA and CAA.``Conclusions. HPV B19 infection is not only correlated with the occurrence of children AAA and CAA, but also with adults AAA and CAA, and might be an important viral cause for AA in humans.

  11. RELATIONSHIP BETWEEN HUMAN PARVOVIRUS B19 INFECTION AND APLASTIC ANEMIA

    Institute of Scientific and Technical Information of China (English)

    钱新宏; 郑跃杰; 张国成; 焦西英; 李佐华

    2001-01-01

    Objective. To explore the relationship between human parvovirus B19 (HPV B19) infection and aplastic anemia (AA) and to investigate the role of HPV B19 in the occurrence of AA. Methods. The presence of HPV B19 DNA was detected in the peripheral blood samples of 60 patients with AA (children 38 and adults 22) by nested polymerase chain reaction (PCR) assay, and 30 healthy persons were selected as control. Results. Sixteen (26. 7 % ) of 60 AA cases were HPV B19 DNA positive, while all the samples in the control group were negative for HPV B19 (P = 0. 000914). Among the case group, the positive rates of HPV B19 DNA were21.4% (6 /28), 30.0% (3 / 10), 20.0% (1 /5) and 35.3% (6 / 17) in children acute AA (AAA), children chronic AA (CAA), adults AAA and adults CAA patients respectively, which were significant-ly higher than that in the control group, Furthermore, there was no remarkable difference between children AA and adults AA in the 16 HPV B19 DNA positive patients; neither was there between AAA and CAA. Conclusions. HPV B19 infection is not only correlated with the occurrence of children AAA and CAA, but also with adults AAA and CAA, and might be an important viral cause for AA in humans.

  12. Atypical Papular Purpuric Eruption Induced by Parvovirus B19 Infection

    Directory of Open Access Journals (Sweden)

    Şeyma Kayalı

    2016-03-01

    Full Text Available Parvovirus B19 infection’s most common dermatological manifestation is erythema infectiosum as also known the fifth disease. Rare clinical presentations of parvovirus B 19 like papulopurpuric gloves and socks syndrome and acropetechial syndrome has also been described re­cently. This study presents report of a case with atypical feature and distribution of rash due to parvovirus B19 in­fection. We want to emphasize that pediatricians should consider parvovirus B19 infection of any patient who has leukopenia presenting with petechial/purpuric eruption of an unclear origin.

  13. Immunohistological Detection of Parvovirus B19 (B19V) Capsid Proteins and B19V Specific Antibody Profiles in Patients with Acute Myocarditis and Dilated Cardiomyopathy

    OpenAIRE

    Sabi, Titus Mbah

    2010-01-01

    Inflammatory cardiomyopathy (DCMi) is a complex disease which can be induced and sustained by a multiplicity of different etiologies. The clinical course can be acute or chronic. A progression from acute Myokarditis (AMC) to chronic dilated cardiomyopathy (DCM) is possible, although the detailed mechanisms are not well known. Acute Infection with cardiotropic viruses and virus persistence seem to play a vital role. Parvovirus B19 (B19V) has been identified as the most common...

  14. Neurologiske symptomer og akut hepatitis associeret til parvovirus B19

    DEFF Research Database (Denmark)

    Giørtz-Carlsen, Birgitte; Rittig, Søren; Thelle, Thomas

    2007-01-01

    The spectrum of symptoms correlated to parvovirus B19 infections has expanded greatly during the past years. We report a case of anaemia, encephalitis-like symptoms and acute hepatitis in a 15-months-old Danish girl associated with parvovirus B19, verified by positive serum IgM og IgG antibodies...

  15. Acute cerebellar ataxia with human parvovirus B19 infection

    OpenAIRE

    Shimizu, Y; Ueno, T.; Komatsu, H.; Takada, H.; Nunoue, T.

    1999-01-01

    A 2 year old boy developed acute cerebellar ataxia in association with erythema infectiosum. During the disease, genomic DNA and antibodies against human parvovirus B19 were detected in serum but not in cerebrospinal fluid. Parvovirus B19 associated acute cerebellar ataxia might occur due to transient vascular reaction in the cerebellum during infection.



  16. Aseptic meningitis caused by human parvovirus B19.

    OpenAIRE

    Okumura, A.; Ichikawa, T

    1993-01-01

    Reports on aseptic meningitis caused by human parvovirus B19 are extremely rare. A case of aseptic meningitis is described in which human parvovirus B19 DNA was detected in the acute phase in cerebrospinal fluid by the polymerase chain reaction.

  17. Chlamydia species-dependent differences in the growth requirement for lysosomes.

    Directory of Open Access Journals (Sweden)

    Scot P Ouellette

    Full Text Available Genome reduction is a hallmark of obligate intracellular pathogens such as Chlamydia, where adaptation to intracellular growth has resulted in the elimination of genes encoding biosynthetic enzymes. Accordingly, chlamydiae rely heavily on the host cell for nutrients yet their specific source is unclear. Interestingly, chlamydiae grow within a pathogen-defined vacuole that is in close apposition to lysosomes. Metabolically-labeled uninfected host cell proteins were provided as an exogenous nutrient source to chlamydiae-infected cells, and uptake and subsequent labeling of chlamydiae suggested lysosomal degradation as a source of amino acids for the pathogen. Indeed, Bafilomycin A1 (BafA1, an inhibitor of the vacuolar H(+/ATPase that blocks lysosomal acidification and functions, impairs the growth of C. trachomatis and C. pneumoniae, and these effects are especially profound in C. pneumoniae. BafA1 induced the marked accumulation of material within the lysosomal lumen, which was due to the inhibition of proteolytic activities, and this response inhibits chlamydiae rather than changes in lysosomal acidification per se, as cathepsin inhibitors also inhibit the growth of chlamydiae. Finally, the addition of cycloheximide, an inhibitor of eukaryotic protein synthesis, compromises the ability of lysosomal inhibitors to block chlamydial growth, suggesting chlamydiae directly access free amino acids in the host cytosol as a preferred source of these nutrients. Thus, chlamydiae co-opt the functions of lysosomes to acquire essential amino acids.

  18. Update of the human parvovirus B19 biology.

    Science.gov (United States)

    Servant-Delmas, A; Morinet, F

    2016-02-01

    Since its discovery, the human parvovirus B19 (B19V) has been associated with many clinical situations in addition to the prototype clinical manifestations, i.e. erythema infectiosum and erythroblastopenia crisis. The clinical significance of the viral B19V DNA persistence in sera after acute infection remains largely unknown. Such data may constitute a new clinical entity and is discussed in this manuscript. In 2002, despite the genetic diversity among B19V viruses has been reported to be very low, the description of markedly distinct sequences showed a new organization into three genotypes. The most recent common ancestor for B19V genotypes was estimated at early 1800s. B19V replication is enhanced by hypoxia and this might to explain the high viral load detected by quantitative PCR in the sera of infected patients. The minimum infectious dose necessary to transmit B19V infection by the transfusion of labile blood products remains unclear. At the opposite, the US Food and Drug Administration proposed a limit of 10(4)IU/mL of viral DNA in plasma pools used for the production of plasma derivatives. Recently, a new human parvovirus (PARV4) has been discovered. The consequences on blood transfusion of this blood-borne agent and its pathogenicity are still unknown. PMID:26778837

  19. Seroprevalence of erythrovirus B19 in Saudi pregnant women

    Directory of Open Access Journals (Sweden)

    Ayman K Johargy

    2016-01-01

    Full Text Available Background: Erythrovirus B19 infection is associated with clinical symptoms that range from mild to severe. The common clinical presentation of B19 virus (B19V infection is erythema infectiosum, arthropathy, aplastic crisis, and fetal infection. Infection in seronegative pregnant women can lead to fetal hydrops. Objectives: To determine the seroprevalence of immunoglobulin G (IgG to erythrovirus B19 in Saudi pregnant women in the cities of Makkah and Jeddah in Saudi Arabia. Materials and Methods: A total of 364 blood (serum samples were tested for erythrovirus B19-specific-IgG antibody in Saudi pregnant women in the cities of Makkah and Jeddah in Saudi Arabia. Results: Erythrovirus B19-specific-IgG antibodies were detected in 182/364 (50% of Saudi pregnant women of different age groups. Conclusion: This study indicated that B19V is clearly circulating in the community in a way that is similar to what is found in most nontemperate countries.

  20. Chronic hepatitis caused by persistent parvovirus B19 infection

    Directory of Open Access Journals (Sweden)

    Mogensen Trine H

    2010-08-01

    Full Text Available Abstract Background Human infection with parvovirus B19 may lead to a diverse spectrum of clinical manifestations, including benign erythema infectiosum in children, transient aplastic crisis in patients with haemolytic anaemia, and congenital hydrops foetalis. These different diseases represent direct consequences of the ability of parvovirus B19 to target the erythroid cell lineage. However, accumulating evidence suggests that this virus can also infect other cell types resulting in diverse clinical manifestations, of which the pathogenesis remains to be fully elucidated. This has prompted important questions regarding the tropism of the virus and its possible involvement in a broad range of infectious and autoimmune medical conditions. Case Presentation Here, we present an unusual case of persistent parvovirus B19 infection as a cause of chronic hepatitis. This patient had persistent parvovirus B19 viraemia over a period of more than four years and displayed signs of chronic hepatitis evidenced by fluctuating elevated levels of ALAT and a liver biopsy demonstrating chronic hepatitis. Other known causes of hepatitis and liver damage were excluded. In addition, the patient was evaluated for immunodeficiency, since she had lymphopenia both prior to and following clearance of parvovirus B19 infection. Conclusions In this case report, we describe the current knowledge on the natural history and pathogenesis of parvovirus B19 infection, and discuss the existing evidence of parvovirus B19 as a cause of acute and chronic hepatitis. We suggest that parvovirus B19 was the direct cause of this patient's chronic hepatitis, and that she had an idiopathic lymphopenia, which may have predisposed her to persistent infection, rather than bone marrow depression secondary to infection. In addition, we propose that her liver involvement may have represented a viral reservoir. Finally, we suggest that clinicians should be aware of parvovirus B19 as an unusual

  1. 小儿造血系统疾病细小病毒B19感染%Detection of human parvovirus B19 in children with hemopathy

    Institute of Scientific and Technical Information of China (English)

    曹玉红; 张国成; 许东亮

    2002-01-01

    @@ 0 引言人细小病毒B19(Human parvovirus B19, B19),与人类造血系统疾病关系最为密切[1].为探讨我国血液病患儿B19病毒感染状况,我们对儿童常见血液病患者血清进行B19抗体及B19-DNA检测.

  2. Generalized edema associated with parvovirus B19 infection

    Directory of Open Access Journals (Sweden)

    Pieter J. Vlaar

    2014-12-01

    Full Text Available Generalized edema is a rare presentation of human parvovirus B19 infection. The etiology of this edema is unclear, particularly because signs of heart or renal failure are often not present. We report the case of a young adult presenting with generalized edema with serological and PCR evidence of parvovirus B19 infection, and discuss the potential mechanisms of edema based on the previous literature.

  3. A Case Report on Parvovirus B19 Associated Myositis

    OpenAIRE

    Oliver, Nathan D.; Auleen Millar; Adrian Pendleton

    2012-01-01

    Introduction: Whilst there are reports of viral myopathies affecting children and the immunocompromised, infective myositis is a relatively rare inflammatory myopathy in adults. The clinical spectrum can range from benign myalgias to more serious complications in certain risk groups. Case Presentation: We present two cases of myositis as a result of parvovirus B19 infection. Conclusion: Viral myositis and parvovirus B19 associated myositis should be considered in adults presenting with signif...

  4. Generalized edema associated with parvovirus B19 infection

    OpenAIRE

    Pieter J. Vlaar; Glen Mithoe; Janssen, Wilbert M

    2014-01-01

    Generalized edema is a rare presentation of human parvovirus B19 infection. The etiology of this edema is unclear, particularly because signs of heart or renal failure are often not present. We report the case of a young adult presenting with generalized edema with serological and PCR evidence of parvovirus B19 infection, and discuss the potential mechanisms of edema based on the previous literature.

  5. Understanding Pneumonia

    Science.gov (United States)

    ... and Diseases > Lung Disease Lookup > Pneumonia Learn About Pneumonia 5 Facts You Should Know about Pneumonia Pneumonia ... vaccinated and practicing good health habits What Is Pneumonia? Pneumonia is an infection in one or both ...

  6. Clinical features of patients with human parvovirus B19 infection:An analysis of 19 cases%人微小病毒B19感染所致肝损害19例临床分析

    Institute of Scientific and Technical Information of China (English)

    潘蕾; 马春燕; 彭梅娟; 魏欣; 谢玉梅; 白雪帆; 贾战生

    2012-01-01

    目的 探讨B19病毒感染所致肝损害的临床表现、实验室检查特点及治疗与转归.方法 对人微小病毒B19感染患者19例的临床资料进行回顾性分析.结果 在人微小病毒B19感染的19例患者,主要症状有乏力(12例)、黄疸(10例)、脾肿大(10例),伴有发热(10例)、皮疹(6例)及肌肉关节疼痛(6例),有6例伴有如下疾病或并发症:如妊娠(1例)、急性肝功能衰竭(2例)、精神分裂症(1例)、急性骨髓停滞(1例)和肺炎(1例).以血清天门冬氨酸氨基转移梅(AST)升高为主,黄疸大多数表现为轻到中度,容易出现凝血酶原活动度(PTA)下降,但胆碱脂酶(CHE)下降不明显.经积极对症支持治疗,肝功能等各项指标正常后治愈出院.人微小病毒B19可致肝功能受损,导致急性肝炎或急性重型肝炎.结论 对临床上非甲~戊型肝炎病人,应注意检查血清抗B19病毒IgM.该病毒感染是一个急性或亚急性过程,呈良性经过,有自愈倾向.%Objective To observe the clinical manifestation, laboratory examinations and therapy of patients with human parvovirus B19 infection. Methods 19 hospitalized patients in our hospital from August, 2008 to July, 2010 infected with human parvcvirus B19 were investigated by clinical presentation, laboratory examinations and related therapy. Results The 19 hospitalized patients infected with human parvovirus B19 mainly presented symptoms with fatigue (12 cases),jaundice (10 cases),splenomegaly(10 cases),fever (10 cases),rash (6 cases), myalgia and arthralgia (6 cases). Six patients out of the 19 patients had following diseases or complications,such as pregnancy (1 case),acute liver failure (2 cases),schizophrenia (1 case),acute myelosuppressicn (1 case) and pneumonia (1 case). The characteristics of liver dysfiinction showed elevated liver enzymes (AST/ALT),mild or moderate jaundice, decreased PTA and normal CHE. The laboratory examinations in the 19 hospitalized patients with human

  7. Prevalence and Viral Load of Human Parvovirus B19 (B19V) Among Blood Donors in South-East Brazil.

    Science.gov (United States)

    Slavov, Svetoslav Nanev; Otaguiri, Katia Kaori; Covas, Dimas Tadeu; Kashima, Simone

    2016-06-01

    The infection of human parvovirus B19 (B19V) is a common event in the general population, including volunteer blood donors. In some cases it can be asymptomatic and can remain persistent for a long period of time. The objective of this study was to examine the B19V DNA prevalence and viral load in first-time volunteer blood donors. Blood samples were collected from 91 primary blood donors at the Regional Blood Center of Ribeirão Preto, Southeast Brazil. Viral detection and quantitation was performed by an in-house TaqMan(®) real-time PCR with high sensitivity. B19V DNA was detected in one male blood donor (1.0 %) and was characterized by a very low viral load (537.36 copies/mL). Our studies demonstrate that B19V DNA at low titer may be present in apparently healthy individuals. Sensitive molecular diagnostic tools can be applied for the screening of fresh blood derived products in order to prevent transfusion-transmitted B19V infection. PMID:27408426

  8. The frequency of human parvovirus B19 infections in Vojvodina

    Directory of Open Access Journals (Sweden)

    Milošević Vesna

    2007-01-01

    Full Text Available Introduction. Human parvovirus B19 is found worldwide. It causes various infections, including fifth disease (erythema infectiosum in small children, acute arthropathy in adults, transient aplastic crisis and chronic anemia in immmunocompromised patients and even fetal infection, which may result in intrauterine fetal death or fetal hydrops. Many of these manifestations of B19 infection are caused by infection of erythroid precursor cells in bone marrow. Material and Methods. The aim of this paper was to establish the frequency of parvovirus B19 infection in the population of Vojvodina, as well as to indicate the significance of further investigations particularly in highly vulnerable population groups such as small children, pregnant women and immune deficient persons. A total of 244 serum samples of out- and in-patients of different age were analyzed using SERION ELISA classic parvovirus B19 IgG/IgM quantitative and qualitative tests for identification of specific antibodies against human parvovirus B19. Results. Acute infection was found in 35% of examinees, whereas parvoviurs B19 was identified in 32% of examined persons. Our tests results proved that 20% of examined pregnant women in our surroundings have acute HPB19 infection. At the same time, 45% of pregnant women have no specific antibodies, so they are at risk of infection during pregnancy. Acute infection was diagnosed in 41 children (43%: 22 samples (23% were positive only to IgG antibodies and in 32 samples (34% neither IgM nor IgG antibodies were identified. Acute infection was more frequently found in preschool children, i.e. in children aged 4 to 6 years (29%. Conclusion. In the absence of complete data on the frequency of particular diseases caused by this virus in our population, tests for human parvovirus B19 are strongly recommended.

  9. The prevalence and clinical significance of Chlamydia infection in island and mainland populations of Victorian koalas (Phascolarctos cinereus).

    Science.gov (United States)

    Patterson, Jade L S; Lynch, Michael; Anderson, Garry A; Noormohammadi, Amir H; Legione, Alistair; Gilkerson, James R; Devlin, Joanne M

    2015-04-01

    Chlamydia infection is known to impact the health of koalas (Phascolarctos cinereus) in New South Wales (NSW) and Queensland, but the clinical significance of Chlamydia infections in Victorian koalas is not well described. We examined the prevalence of Chlamydia infection and assessed associated health parameters in two Victorian koala populations known to be Chlamydia positive. The same testing regimen was applied to a third Victorian population in which Chlamydia had not been detected. We examined 288 koalas and collected samples from the urogenital sinus and conjunctival sacs. Detection and differentiation of Chlamydia species utilized real-time PCR and high-resolution melting curve analysis. Chlamydia pecorum was detected in two populations (prevalences: 25% and 41%, respectively) but only from urogenital sinus swabs. Chlamydia was not detected in the third population. Chlamydia pneumoniae was not detected. Chlamydia pecorum infection was positively associated with wet bottom (indicating chronic urinary tract disease) in one Chlamydia-positive population and with abnormal urogenital ultrasound findings in the other Chlamydia-positive population. The prevalence of wet bottom was similar in all populations (including the Chlamydia-free population), suggesting there is another significant cause (or causes) of wet bottom in Victorian koalas. Ocular disease was not observed. This is the largest study of Chlamydia infection in Victorian koalas, and the results suggest the potential for epidemiologic differences related to Chlamydia infections between Victorian koalas and koalas in Queensland and NSW and also between geographically distinct Victorian populations. Further studies to investigate the genotypes of C. pecorum present in Victorian koalas and to identify additional causes of wet bottom in koalas are indicated.

  10. Parvovirus B19 infection prevalens in North-West Russia

    Directory of Open Access Journals (Sweden)

    A. Y. Antipova

    2011-01-01

    Full Text Available The aim of this study is to estimate parvovirus B19 (PV B19 infection (infectious erythema prevalence in North-West Russia. In 2009-2011 anti-IgM antibodies against PV B19 among 12,5% of patients with exanthematous disease was detected in 9 (from 11 administrative territories of N-W region. Prevalence of anti-IgG antibodies in pregnant females (risk group vary from 37,5 to 83,3%% in various age groups. Sufficient that most reproductively active females age group (18–35 yo belongs to the group of risk: 49,2% (in St-Petersburg and 40,5% (in Vologda were anti-IgG PV B19 negative. Rational clinical laboratory diagnostics and modern surveilliance of PV B19 and other exanthematous diseases were discussed.

  11. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009

    NARCIS (Netherlands)

    K. Kooistra; H.J. Mesman; M. de Waal; M.H.G.M. Koppelman; H.L. Zaaijer

    2011-01-01

    Background and Objectives Plasma derivatives and blood components with low levels of parvovirus B19 (B19) seem not infectious, but recently infected, highly viraemic donors may transmit B19. We studied the incidence of high-level B19 viraemia (B19 DNA > 106 IU/ml) in 6 center dot 5 million Dutch blo

  12. Chlamydia and Women

    Centers for Disease Control (CDC) Podcasts

    2009-04-02

    This women's health podcast focuses on chlamydia, its severe health consequences for women if left untreated, and the importance of annual chlamydia screening.  Created: 4/2/2009 by Office of Women’s Health (OWH) and National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).   Date Released: 4/2/2009.

  13. Parvovirus B19-akut hepatitis hos immunkompetent patient

    DEFF Research Database (Denmark)

    Larsen, Lykke

    2011-01-01

    This article describes a case of acute hepatitis in an adult person without subsequent complications caused by parvovirus B19 (PVB19). The diagnosis was made by detection of PVB19 IgM and IgG antibody in the blood using ELISA. There was not made any affirmative polymerase chain reaction for DNA...

  14. Substitution rate and natural selection in parvovirus B19

    Science.gov (United States)

    Stamenković, Gorana G.; Ćirković, Valentina S.; Šiljić, Marina M.; Blagojević, Jelena V.; Knežević, Aleksandra M.; Joksić, Ivana D.; Stanojević, Maja P.

    2016-01-01

    The aim of this study was to estimate substitution rate and imprints of natural selection on parvovirus B19 genotype 1. Studied datasets included 137 near complete coding B19 genomes (positions 665 to 4851) for phylogenetic and substitution rate analysis and 146 and 214 partial genomes for selection analyses in open reading frames ORF1 and ORF2, respectively, collected 1973–2012 and including 9 newly sequenced isolates from Serbia. Phylogenetic clustering assigned majority of studied isolates to G1A. Nucleotide substitution rate for total coding DNA was 1.03 (0.6–1.27) x 10−4 substitutions/site/year, with higher values for analyzed genome partitions. In spite of the highest evolutionary rate, VP2 codons were found to be under purifying selection with rare episodic positive selection, whereas codons under diversifying selection were found in the unique part of VP1, known to contain B19 immune epitopes important in persistent infection. Analyses of overlapping gene regions identified nucleotide positions under opposite selective pressure in different ORFs, suggesting complex evolutionary mechanisms of nucleotide changes in B19 viral genomes. PMID:27775080

  15. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V

    Directory of Open Access Journals (Sweden)

    Rotellini Matteo

    2010-10-01

    Full Text Available Abstract Background PARV4 is a new member of the Parvoviridae family not closely related to any of the known human parvoviruses. Viremia seems to be a hallmark of PARV4 infection and viral DNA persistence has been demonstrated in a few tissues. Till now, PARV4 has not been associated with any disease and its prevalence in human population has not been clearly established. This study was aimed to assess the tissue distribution and the ability to persist of PARV4 in comparison to parvovirus B19 (B19V. Results PARV4 and B19V DNA detection was carried out in various tissues of individuals without suspect of acute viral infection, by a real time PCR and a nested PCR, targeting the ORF2 and the ORF1 respectively. Low amount of PARV4 DNA was found frequently (>40% in heart and liver of adults individuals, less frequently in lungs and kidneys (23,5 and 18% respectively and was rare in bone marrow, skin and synovium samples (5,5%, 4% and 5%, respectively. By comparison, B19V DNA sequences were present in the same tissues with a higher frequency (significantly higher in myocardium, skin and bone marrow except than in liver where the frequency was the same of PARV4 DNA and in plasma samples where B19V frequency was significantly lower than that of PARV4 Conclusions The particular tropism of PARV4 for liver and heart, here emerged, suggests to focus further studies on these tissues as possible target for viral replication and on the possible role of PARV4 infection in liver and heart diseases. Neither bone marrow nor kidney seem to be a common target of viral replication.

  16. Aspiration pneumonia

    Science.gov (United States)

    Anaerobic pneumonia; Aspiration of vomitus; Necrotizing pneumonia; Aspiration pneumonitis ... The type of bacteria that caused the pneumonia depends on: Your ... facility, for example) Whether you were recently hospitalized ...

  17. Isolated velopalatine paralysis associated with parvovirus B19 infection

    Directory of Open Access Journals (Sweden)

    Soares-Fernandes João P.

    2006-01-01

    Full Text Available A case of isolated velopalatine paralysis in an 8-year-old boy is presented. The symptoms were sudden-onset of nasal speech, regurgitation of liquids into the nose and dysphagia. Brain MRI and cerebrospinal fluid examination were normal. Infectious serologies disclosed an antibody arrangement towards parvovirus B19 that was typical of recent infection. In the absence of other positive data, the possibility of a correlation between the tenth nerve palsy and parvovirus infection is discussed.

  18. Parvovirus B19 infections serological diagnostics in rheumatic diseases

    Directory of Open Access Journals (Sweden)

    L P Ananjeva

    2005-01-01

    Full Text Available Objective. To study contamination with parvovirus B19 of a group of patients with rheumatic diseases (RD. Methods. 77 pts with RD (mean age 42,5 years, 79% female admitted to Institute of Rheumatology of RAMS were examined. 34 of them had rheumatoid arthritis (RA, 11 - systemic lupus erythematosus (SLE and Sjogren's disease (SD, 15 with osteoarthritis (OA and seronegative spondyloarthritides (SS and 17 with early (before a year undifferentiated arthritis (EUA. Quantitative determination of IgM and IgG serum antibodies to parvovirus BI9 was performed by I FA with IBL kits (Hamburg, Germany. Results. Anti-B19 IgG antibodies were found in 52% of pts, IgM antibodies - only in one case. Mean antibodies values in pts with RD of disease duration less then 6 months were significantly higher then in pts with longer disease duration (21,5+36 U/ml and 8,4+14.7 U/ml respectively, p<0,05. Anti-B 19 antibodies were present in 62% of pts with RA, 53% of pts with EUA, 45% of pts with SD, 33% of pts with OA and SS. High levels of antibodies (4-10 times higher positivity threshold were revealed in 13 pts with different RD with short duration of joint syndrome (6,3±7,6 months and fever at presentation. A case of B19 parvovirus infection in a boy of 3 years age accompanied by symptoms of Still's disease is described.

  19. Isolated velopalatine paralysis associated with parvovirus B19 infection

    OpenAIRE

    Soares-Fernandes João P.; Maré Ricardo

    2006-01-01

    A case of isolated velopalatine paralysis in an 8-year-old boy is presented. The symptoms were sudden-onset of nasal speech, regurgitation of liquids into the nose and dysphagia. Brain MRI and cerebrospinal fluid examination were normal. Infectious serologies disclosed an antibody arrangement towards parvovirus B19 that was typical of recent infection. In the absence of other positive data, the possibility of a correlation between the tenth nerve palsy and parvovirus infection is discussed.

  20. Aberrant cellular immune responses in humans infected persistently with parvovirus B19

    DEFF Research Database (Denmark)

    Isa, Adiba; Norbeck, Oscar; Hirbod, Taha;

    2006-01-01

    A subset of parvovirus B19 (B19) infected patients retains the infection for years, as defined by detection of B19 DNA in bone marrow. Thus far, analysis of B19-specific humoral immune responses and viral genome variations has not revealed a mechanism for the absent viral clearance. In this study...

  1. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19.

    OpenAIRE

    Bruu, A L; Nordbø, S A

    1995-01-01

    The following commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19 were evaluated: Ideia Parvovirus B19-IgM, MRL Diagnostics Human Parvovirus B19 IgM ELISA, Parvoscan-B19, and Biotrin Parvo B19 IgM EIA and IF. A total of 203 serum specimens from patients who probably have current B19 infections or have other viral infections and sera with rheumatoid factor were investigated. Between 75 and 79 of 102 serum samples from patients thought to have current B19 infec...

  2. Postinfectious glomerulonephritis secondary to Erythrovirus B19 (Parvovirus B19): case report and review of the literature.

    Science.gov (United States)

    Marco, Helena; Guermah, Imane; Matas, Lurdes; Hernández, Alba; Navarro, Maruja; Lopez, Dolores; Bonet, Josep

    2016-04-01

    A previously healthy 32-yearold woman developed arterial hypertension, proteinuria, and hematuria (nephritic syndrome) with normal renal function and was diagnosed with post-infectious glomerulonephritis secondary to parvovirus B19 infection. The renal biopsy showed endocapillary glomerulonephritis, with positive IgG, C3, and C1q immunoreactivity in the capillary walls and ultrastructural evidence of subendothelial deposits. The diagnosis of parvovirus B19 infection was confirmed by IgG/IgM serological positivity and parvovirus DNA demonstration in both peripheral blood and kidney tissue. Glomerular involvement improved spontaneously. To be noted are the atypical signs and symptoms of our patient who, unlike previously reported cases, failed to show fever, skin rash, or affected relatives. PMID:26833301

  3. Parvovirus B19 1A complete genome from a fatal case in Brazil

    Directory of Open Access Journals (Sweden)

    Liliane Costa Conteville

    2015-09-01

    Full Text Available Parvovirus B19 (B19V infects individuals worldwide and is associated with an ample range of pathologies and clinical manifestations. B19V is classified into three distinct genotypes, all identified in Brazil. Here, we report a complete sequence of a B19V genotype 1A that was obtained by high-throughput metagenomic sequencing. This genome provides information that will contribute to the studies on B19V epidemiology and evolution.

  4. Seroepidemiological survey of Chlamydia in North West zone of Nigeria

    Institute of Scientific and Technical Information of China (English)

    Agbonlahor DE; Okoror LE; Esumeh FI

    2009-01-01

    Objective:Chlamydia is made of organism responsible for respiratory as well as genital infections with very se-rious sequelae.In Nigeria there is paucity of information regards relative frequencies of Chlamydia infection of which this study reports in North West zone of Nigeria.Methods:Three hundred and thirty three (333)blood samples were collected from individuals attending various clinics in North West zone of Nigeria and tested for Chlamydia complement fixing antibody.Swabs collected from positive patients were re-tested using the Ro-manowsky-Giemsa staining technique.Statistical analysis were carried out in epi-info epidemiological software package.Results:From the total of 333 samples collected and tested for Chlamydia complement fixing anti-body (CCFA)only 287 (86%)were positive.The culture showed that 215 (75%)were positive for Chlamydia trachomatis while only 135 (47%)were positive for Chlamydia pneumoniae.Seventy-one (71)fe-males had symptomatic infection while 31 males were symptomatic.Of the 104 individuals who were asympto-matic 67 were females while 92 were males.Of the 31 symptomatic males were 22 positive to Chlamydia pneu-moniae and the symptoms being that of respiratory syndrome while 9 had difficulty urinating.All the symptom-atic women had symptoms resembling that of the pelvic inflammatory disease (PID)and vaginal discharge. Age groups 31-35 had the highest positive samples while the extreme ages had the lowest number of positive in-dividuals and also the lowest number of samples.The number of samples as well as the positive results were validated using the epi-info statistical package version 3.4.1.There was no significant difference in the num-ber of samples from both males and females (χ2 =1.360,CI =99%).Conclusion:A high percentage of pos-itive result as validated by statistical analysis shows that Chlamydia infections are endemic in the population and efforts should be made to screen for the organism to avoid the "silent epidemics".

  5. 肺炎衣原体感染与急性脑梗死的相关性研究%Correlation between Chlamydia pneumoniae infection and acute cerebral infarction

    Institute of Scientific and Technical Information of China (English)

    刘红; 郭娜; 薛新红; 赵敏; 郭栋; 曲怀谦

    2015-01-01

    OBJECTIVE To study the influence of Chlamydia pneumoniae (CP) infection on the levels of blood lip-ids and C-reactive protein (CRP) as well as hemorheological parameters so as to explore the relationship between the CP infection and the acute cerebral infarction .METHODS Totally 65 patients with acute cerebral infarction who were treated from Jan 2013 to Jan 2014 were randomly assigned as the study group ,meanwhile 65 healthy volun-teers who received physical examination were chosen as the study group .The levels of the serum CP specific IgA , IgM ,and IgG of the two groups of participants were determined by using micro-immunofluorescence assay ,and the levels of the low-density lipoprotein (LDL ) ,hyperlipidemia ,total cholesterol (TC) ,high-density lipoprotein (HDL) ,and CRP as well as the hemorheological parameters were detected and compared between the two groups . RESULTS The positive rate of IgA antibody was 81 .54% in the study group ,41 .54% in the control group ;the positive rate of IgG antibody was 88 .62% in the study group ,61 .54% in the control group ;the incidence of chro-nic infections was 73 .85% in the study group ,12 .31% in the control group ;the levels of the above indicators of the study group were significantly higher than those of the control group ,however ,there was no statistically sig-nificant difference in the positive rate of IgM or the incidence of acute infections between the two groups .The lev-els of the TC ,LDL ,heperlipidemia ,and CRP of the study group were significantly higher than those of the con-trol group ;however ,the level of HDL of the study group was significantly lower than that of the control group , there was significant difference in the blood lipid or CRP between the patients with infections and the patients without infections in the study group (P< 0 .05) .The whole blood viscosity ,hematocrit ,plasma viscosity ,and e-rythrocyte aggregation index of the patients with infections in the study group were

  6. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients

    DEFF Research Database (Denmark)

    Lundqvist, Anders; Isa, Adiba; Tolfvenstam, Thomas;

    2005-01-01

    BACKGROUND: Human parvovirus B19 (B19) polymerase chain reaction (PCR) is now a routine analysis and serves as a diagnostic marker as well as a complement or alternative to B19 serology. The clinical significance of a positive B19 DNA finding is however dependent on the type of tissue or body fluid...... analysed and of the immune status of the patient. OBJECTIVES: To analyse the clinical significance of B19 DNA positivity in bone marrow samples from rheumatic patients. STUDY DESIGN: Parvovirus B19 DNA was analysed in paired bone marrow and serum samples by nested PCR technique. Serum was also analysed...... negative group. A high frequency of parvovirus B19 DNA was thus detected in bone marrow samples in rheumatic patients. The clinical data does not support a direct association between B19 PCR positivity and rheumatic disease manifestation. Therefore, the clinical significance of B19 DNA positivity in bone...

  7. Chlamydia infections in women

    Science.gov (United States)

    ... for laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2014. MMWR 2014;63(No. RR-2):1 - 24. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. 2010. MMWR. 2010;59(RR-12):1- ...

  8. 人类微小病毒B19感染与急性肝炎的关系%Human parvovirus B19 infection associated with acute hepatitis

    Institute of Scientific and Technical Information of China (English)

    束晓梅; 陈雪梅; 冒青

    2002-01-01

    目的探讨B19感染在急性肝炎病因学中的作用.方法对21例急性非甲~戊型肝炎病人、32例健康儿及36例甲肝病儿进行近期B19感染的检查,包括B19 DNA检查、间接免疫荧光法检测B19表面蛋白抗原,并比较B19阳性组、甲肝组、病因未明组的临床、实验室特征及肝功恢复时间.结果21例中B19 DNA阳性4例(19%),对照组B19 DNA均阴性,差异有显著意义.B19 DNA阳性4例中2例检测到B19特异性抗原,对照组均阴性,差别无显著意义.4例B19感染病人、17例病因未明者及甲型肝炎病人在发热、黄疸及关节症状方面无显著差异;但B19感染组皮疹的发生高于另外两组.血清ALT及胆红素水平3组间无明显差异.B19感染组肝功能迅速恢复正常,3例于2周内恢复,4周全部恢复正常.结论B19感染可能为小儿急性肝炎的较重要病毒病因.

  9. 人微小病毒B19感染与自然流产的关系%Relationship between human parvovirus B19 and spontaneous abortion

    Institute of Scientific and Technical Information of China (English)

    刘元元; 简子娟; 高骞; 彭婉婵; 谷秀梅; 刘文恩

    2011-01-01

    目的 通过分析自然流产与正常妊娠晚期待产孕妇人微小病毒B19(HPV B19)DNA及IgM抗体检测情况,探讨HPV B19与自然流产的关系.方法 采集自然流产孕妇(观察组,28例)与正常待产孕妇(对照组,33例)的静脉血,以聚合酶链反应(PCR)法检测HPV B19 DNA,酶联免疫吸附试验(ELISA)检测HPV B19 IgM抗体.结果 观察组HPV B19 DNA阳性率为28.57%(8/28),对照组为9.09%(3/33),两组HPV B19 DNA阳性率比较,差异有统计学意义(x2=3.98,P<0.05).观察组检测出1例(3.57%,1/28)HPV B19 IgM抗体阳性,对照组未检测到阳性者(0.00%).结论 自然流产孕妇HPV B19感染率高于妊娠晚期待产孕妇,推测HPV B19感染可能是导致自然流产的原因之一.%Objective To investigate the relationship between human parvovirus B19 and spontaneous abortion by detecting human parvovirus B19 DNA and IgM of women in normal pregnancy and spontaneous abortion. Methods The blood of women in abortion (observation group, 28 cases) and normal pregnancy (control group, 33 cases)were collected, human parvovirus B19 DNA and IgM were detected with PCR and ELISA. Results The positive rate of human parvovirus B19 DNA was 28. 57% (8/28) in observation group and 9. 09% (3/33) in control group,there was significant difference between two groups(x2 = 3. 98, P<0. 05); human parvovirus B19 IgM was detected in one sample of observation group (3. 57%, 1/28), positive samples were not detected in the control group (0. 00%). Conclusion Human parvovirus B19 infection rate is higher in women of spontaneous abortion than in normal pregnant women, suggesting that human parvovirus B19 infection may be one of the causes leading to abortion.

  10. Chlamydia Serine Protease Inhibitor, targeting HtrA, as a New Treatment for Koala Chlamydia infection.

    Science.gov (United States)

    Lawrence, Amba; Fraser, Tamieka; Gillett, Amber; Tyndall, Joel D A; Timms, Peter; Polkinghorne, Adam; Huston, Wilhelmina M

    2016-01-01

    The koala, an iconic marsupial native to Australia, is a threatened species in many parts of the country. One major factor in the decline is disease caused by infection with Chlamydia. Current therapeutic strategies to treat chlamydiosis in the koala are limited. This study examines the effectiveness of an inhibitor, JO146, which targets the HtrA serine protease for treatment of C. pecorum and C. pneumoniae in vitro and ex vivo with the aim of developing a novel therapeutic for koala Chlamydia infections. Clinical isolates from koalas were examined for their susceptibility to JO146. In vitro studies demonstrated that treatment with JO146 during the mid-replicative phase of C. pecorum or C. pneumoniae infections resulted in a significant loss of infectious progeny. Ex vivo primary koala tissue cultures were used to demonstrate the efficacy of JO146 and the non-toxic nature of this compound on peripheral blood mononuclear cells and primary cell lines established from koala tissues collected at necropsy. Our results suggest that inhibition of the serine protease HtrA could be a novel treatment strategy for chlamydiosis in koalas.

  11. 人微小病毒B19感染的研究进展%Advances in the Infection of Human Parvovirus B19

    Institute of Scientific and Technical Information of China (English)

    曹虹; 贡树基; 赵卫; 仲华; 张文炳

    2007-01-01

    近年来人微小病毒B19(human parvovirus B19)作为人类疾病的重要病原已愈来愈广泛受到重视.大量研究成果不但揭示了B19病毒的致病机理,Th-1介导的细胞免疫应答,而且发展了B19感染的诊断和B19污染血制品的筛查技术,并且为疫苗的研制奠定了基础.这里对人类B19病毒的病原学特征、致病机理、临床症状及实验室诊断方法和技术进行了较全面的综述.

  12. Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.

    OpenAIRE

    Srivastava, C H; Samulski, R J; L. Lu; Larsen, S H; A Srivastava

    1989-01-01

    To facilitate genetic analysis of the human pathogenic parvovirus B19, we constructed a hybrid B19 viral genome in which the defective B19 inverted terminal repeats were replaced with the full-length inverted terminal repeats from a nonpathogenic human parvovirus, the adeno-associated virus 2 (AAV). The hybrid AAV-B19 genome was rescued from a recombinant plasmid and then the DNA was replicated upon transfection into adenovirus 2-infected human KB cells in the presence of AAV genes coding for...

  13. Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors

    OpenAIRE

    Kishore Janak; Srivastava Manisha; Choudhary Nabjyoti

    2010-01-01

    Backgound and Objectives: Parvovirus B19 (B19) being a non-enveloped DNA virus is hence thermo-stable to the current methods of viral inactivation. Therefore transfusion of blood or its component from a viremic donor to non-immune recipients may result in transfusion-transmitted B19 infection with occasional sinister complications. The serologically naοve blood donor population in our country has not been studied. Hence a study was designed to find the sero-status of B19 virus in normal ...

  14. Human parvovirus B19 infection in a renal transplant recipient: a case report

    OpenAIRE

    Alves Michelle Teodoro; Vilaça Sandra Simone; Carvalho Maria das Graças; Fernandes Ana Paula; Dusse Luci Maria Sant’ Ana; Gomes Karina Braga

    2013-01-01

    Abstract Background Parvovirus B19 presents tropism for human erythroid progenitor cells, causing chronic anemia in organ transplant recipients, due to their suppressed humoral and cellular responses. Diagnosis may be achieved through serological tests for detection of anti-B19 antibodies. However, renal transplant recipients are not routinely tested for parvovirus B19 infection, since there is scanty data or consensus on screening for B19 infection, as well as for treatment or preventive man...

  15. Human parvovirus B19: a mechanistic overview of infection and DNA replication

    OpenAIRE

    Luo, Yong; Qiu, Jianming

    2015-01-01

    Human parvovirus B19 (B19V) is a human pathogen that belongs to genus Erythroparvovirus of the Parvoviridae family, which is composed of a group of small DNA viruses with a linear single-stranded DNA genome. B19V mainly infects human erythroid progenitor cells and causes mild to severe hematological disorders in patients. However, recent clinical studies indicate that B19V also infects nonerythroid lineage cells, such as myocardial endothelial cells, and may be associated with other disease o...

  16. High-Sensitivity PCR Detection of Parvovirus B19 in Plasma

    OpenAIRE

    Daly, P.; Corcoran, A; Mahon, B. P.; Doyle, S.

    2002-01-01

    Parvovirus B19 (B19) is a human pathogen transmitted to susceptible individuals via respiratory secretions and contaminated blood or blood products. B19 levels in pooled plasma of less than 104 genome equivalents/ml may not be infectious, while those greater than 107/ml are capable of transmitting infection. A World Health Organization (WHO) B19 DNA international standard has been recently introduced. The purpose of the present work was to develop a PCR-enzyme-linked immunosorbent assay (PCR-...

  17. Acute Hepatitis as a Manifestation of Parvovirus B19 Infection ▿

    OpenAIRE

    Hatakka, Aleisha; Klein, Julianne; He, Runtao; Piper, Jessica; Tam, Edward; Walkty, Andrew

    2011-01-01

    There are few reports in the literature of hepatitis as a manifestation of parvovirus B19 infection. We describe a case of parvovirus B19-associated acute hepatitis diagnosed based on a positive serologic test (IgM) and molecular detection of parvovirus B19 DNA in a liver biopsy specimen. Parvovirus B19 infection should be considered in the differential diagnosis of patients presenting with acute hepatitis.

  18. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis

    OpenAIRE

    Weissbrich, Benedikt; Süß-Fröhlich, Yvonne; Girschick, Hermann J.

    2007-01-01

    Parvovirus (PV) B19 is the causative agent of the childhood disease erythema infectiosum. An association of PV B19 with chronic arthropathies, sometimes resembling rheumatoid arthritis or juvenile idiopathic arthritis (JIA), has repeatedly been described. Other studies, however, have failed to identify any such relationship. In order to study further whether there is a link between PV B19 and JIA, we determined the prevalence of PV B19 specific IgG antibodies in serum samples from children wi...

  19. Detection of Parvovirus B19 Infection in Thalasemic Patients in Isfahan Province, Iran

    OpenAIRE

    Nikoozad, Razieh; Mahzounieh, Mohammad Reza; Ghorani, Mohammad Reza

    2015-01-01

    Background: Parvovirus B19, a member of the Erythrovirus genus of Parvoviridae family, causes various clinical illnesses including infectious erythema, arthropathy, hydrops fetalis or congenital anemia, and transient aplastic crises. The B19 virus can be transmitted through respiratory secretions, blood products, and blood transfusion. Objectives: The aim of this study was to detect the B19 virus in thalassemia patients in Isfahan, Iran. Patients and Methods: The prevalence of parvovirus B19 ...

  20. Prolonged activation of virus-specific CD8+T cells after acute B19 infection

    DEFF Research Database (Denmark)

    Isa, Adiba; Kasprowicz, Victoria; Norbeck, Oscar;

    2005-01-01

    BACKGROUND: Human parvovirus B19 (B19) is a ubiquitous and clinically significant pathogen, causing erythema infectiosum, arthropathy, transient aplastic crisis, and intrauterine fetal death. The phenotype of CD8+ T cells in acute B19 infection has not been studied previously. METHODS AND FINDINGS...

  1. Cytokine responses in acute and persistent human parvovirus B19 infection

    DEFF Research Database (Denmark)

    Isa, A; Lundqvist, A; Lindblom, A;

    2007-01-01

    The aim of this study was to characterize the proinflammatory and T helper (Th)1/Th2 cytokine responses during acute parvovirus B19 (B19) infection and determine whether an imbalance of the Th1/Th2 cytokine pattern is related to persistent B19 infection. Cytokines were quantified by multiplex beads...

  2. Aplastic crisis caused by parvovirus B19 in an adult patient with sickle-cell disease

    OpenAIRE

    Setúbal Sérgio; Gabriel Adelmo H.D.; Nascimento Jussara P.; Oliveira Solange A.

    2000-01-01

    We describe a case of aplastic crisis caused by parvovirus B19 in an adult sickle-cell patient presenting with paleness, tiredness, fainting and dyspnea. The absence of reticulocytes lead to the diagnosis. Anti-B19 IgM and IgG were detected. Reticulocytopenia in patients with hereditary hemolytic anemia suggests B19 infection.

  3. Human parvovirus B19 can infect cynomolgus monkey marrow cells in tissue culture.

    OpenAIRE

    Gallinella, G.; Anderson, S M; Young, N S; Brown, K E

    1995-01-01

    The human pathogenic parvovirus B19 cannot be grown in standard tissue culture but propagates in human bone marrow, where it is cytotoxic to erythroid progenitor cells. We now show that parvovirus B19 can replicate in cynomolgus bone marrow. Cynomolgus monkeys may be a suitable animal model for pathogenesis studies of parvovirus B19.

  4. 人类微小病毒B19感染与川崎病的关系%Relationship of kawasaki disease and human parvovirus B19 infection

    Institute of Scientific and Technical Information of China (English)

    束晓梅; 杨平; 周华

    2004-01-01

    目的探讨人类微小病毒B19感染与川崎病(KD)的关系.方法对60例KD患儿及42例健康儿童进行近期B19感染检查,包括B19 DNA检查、间接免疫荧光法检测B19表面蛋白抗原.结果 60例KD患儿中B19 DNA阳性6例(10.0 %),对照组阳性2例(4.8 %),两组差异无显著意义(χ2 = 0.94 P>0.05).但B19 DNA阳性6例中,<1岁患儿与>1岁患儿两组阳性率差异有统计学意义(P<0.01).KD组3例检测B19抗原阳性,对照组阳性1例,两组差异无差异(χ2 = 0.45 P>0.05).结论人类微小病毒B19感染与KD可能无明确关系.

  5. The molecular biology and diagnostics of Chlamydia trachomatis

    DEFF Research Database (Denmark)

    Birkelund, Svend

    1992-01-01

    The rapid development of biotechnological methods provides the potential of dissecting the molecular structure of microorganisms. In this review the molecular biology of chlamydia is described. The genus Chlamydia contains three species C. trachomatis, C. psittaci, and C. pneumonia which all...... negative bacteria since incubation of EB with antibodies against LPS will liberate it from the chlamydial surface. Therefore the surface localized LPS may be important for chlamydial survival. OMP1 varies between the different serovar of C. trachomatis. Several very conserved regions are separated....... Patient serum samples will recognize the chlamydial DnaK-like protein. From the determined DNA sequence the amino acid sequence was determined. It was 57% homologous to the Eschrichia coli DnaK protein. Also the GroEL-like protein is antigenic and very conserved. Factors of importance for pathogenicity...

  6. Chlamydia trachomatis serotype A infections in the Amazon region of Brazil: prevalence, entry and dissemination

    Directory of Open Access Journals (Sweden)

    Marluísa de Oliveira Guimarães Ishak

    2015-04-01

    Full Text Available INTRODUCTION: Chlamydia infection is associated with debilitating human diseases including trachoma, pneumonia, coronary heart disease and urogenital diseases. Serotypes of C. trachomatis show a fair correlation with the group of diseases they cause, and their distribution follows a well-described geographic pattern. Serotype A, a trachoma-associated strain, is known for its limited dissemination in the Middle East and Northern Africa. However, knowledge on the spread of bacteria from the genus Chlamydia as well as the distribution of serotypes in Brazil is quite limited. METHODS: Blood samples of 1,710 individuals from ten human population groups in the Amazon region of Brazil were examined for antibodies to Chlamydia using indirect immunofluorescence and microimmunofluorescence assays. RESULTS: The prevalence of antibodies to Chlamydia ranged from 23.9% (Wayana-Apalai to 90.7% (Awa-Guaja with a mean prevalence of 50.2%. Seroreactivity was detected to C. pneumoniae and to all serotypes of C. trachomatis tested; furthermore, we report clear evidence of the as-yet-undescribed occurrence of serotype A of C. trachomatis. CONCLUSIONS: Specific seroreactivity not only accounts for the large extent of dissemination of C. trachomatis in the Amazon region of Brazil but also shows an expanded area of occurrence of serotype A outside the epidemiological settings previously described. Furthermore, these data suggest possible routes of Chlamydia introduction into the Amazon region from the massive human migration that occurred during the 1,700s.

  7. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.

    Science.gov (United States)

    Kerr, Jonathan R

    2016-04-01

    Human parvovirus B19 is a single-stranded DNA virus which preferentially targets the erythroblasts in the bone marrow. B19 infection commonly causes erythema infectiosum, arthralgia, fetal death, transient aplastic crisis in patients with shortened red cell survival, and persistent infection in people who are immunocompromised. Less common clinical manifestations include atypical skin rashes, neurological syndromes, cardiac syndromes, and various cytopenias. B19 infection has also been associated with development of a variety of different autoimmune diseases, including rheumatological, neurological, neuromuscular, cardiovascular, haematological, nephrological and metabolic. Production of a variety of autoantibodies has been demonstrated to occur during B19 infection and these have been shown to be key to the pathogenesis of the particular disease process in a significant number of cases, for example, production of rheumatoid factor in cases of B19-associated rheumatoid arthritis and production of anti-glutamic acid decarboxylase (GAD) in patients with B19-associated type 1 diabetes mellitus. B19 infection has also been associated with the development of multiple autoimmune diseases in 12 individuals. Documented mechanisms in B19-associated autoimmunity include molecular mimicry (IgG antibody to B19 proteins has been shown to cross react with a variety of recognised human autoantigens, including collagen II, keratin, angiotensin II type 1 receptor, myelin basic protein, cardiolipin, and platelet membrane glycoprotein IIb/IIIa), B19-induced apoptosis with presentation of self-antigens to T lymphocytes, and the phospholipase activity of the B19 unique VP1 protein. PMID:26644521

  8. The Immune Response to Parvovirus B19 Exposure in previously Seronegative and Seropositive Individuals

    OpenAIRE

    Doyle, Sean; Corcoran, Amanda

    2006-01-01

    Little information is available on the immune response to parvovirus B19 after the administration of contaminated blood products. In the present study, we found that levels of B19 IgG in B19-seropositive recipients protect against reinfection and, after transfusion with pooled plasma containing B19 DNA ( IU/mL), increase from 1.6108 19–39 IU/mL to 50–100 IU/mL. We found that, in the presence of 1.6–2.2 108 IU of B19 DNA/mL in B19-seronegative recipients, a pooled-plasma B19 IgG...

  9. Investigation of Relationship Between Parvovirus B19 Infection and Psoriasis

    Directory of Open Access Journals (Sweden)

    Mehmet Yıldırım

    2010-12-01

    Full Text Available Background and Design: Psoriasis is a common, chronic, relapsing skin disease, characterized by the formation of typical scaly papules or plaques. The three factors well-recognized as triggering the onset, causing new lesions or inducing a flare in the disease are: stress, skin injury and infection. Various microorganisms are associated with provocation and/or exacerbation of psoriasis. The aim of this study was to investigate the relationship between parvovirus B19 (PVB19 and psoriasis/psoriasis area severity index (PASI. Material and Method: Sixty patients with psoriasis (36 men, 24 women and 40 healthy volunteers (22 men, 18 women were included in our study. PVB19 DNA was quantified by real-time polymerase chain reaction. Results: PVB19 DNA was detected in 27 of 60 subjects in the patient group (45% and in 9 of 40 controls (22.5% (p0.05. The relationship between the viral load and the subtypes of psoriasis was not statistically significant (p>0.05.Conclusion: According to the results of this study, it was concluded that a relationship may be present between psoriasis and PVB 19 infection.

  10. Analysis of the humoral immune response to Chlamydia outer membrane protein 2

    DEFF Research Database (Denmark)

    Mygind, P; Christiansen, Gunna; Persson, K;

    1998-01-01

    The humoral immune response to Chlamydia outer membrane protein 2 (Omp2) was studied. Omp2 is a highly genus-conserved structural protein of all Chlamydia species, containing a variable N-terminal fragment. To analyze where the immunogenic parts were localized, seven highly purified truncated...... patient sera, Omp2 was found to be a major immunogen of both C. pneumoniae and C. trachomatis infections (P humoral immune responses were not confined to any particular region of the Omp2 protein, and no species-specific anti-Omp2 immunoglobulins were detected....

  11. Chlamydia cell biology and pathogenesis.

    Science.gov (United States)

    Elwell, Cherilyn; Mirrashidi, Kathleen; Engel, Joanne

    2016-06-01

    Chlamydia spp. are important causes of human disease for which no effective vaccine exists. These obligate intracellular pathogens replicate in a specialized membrane compartment and use a large arsenal of secreted effectors to survive in the hostile intracellular environment of the host. In this Review, we summarize the progress in decoding the interactions between Chlamydia spp. and their hosts that has been made possible by recent technological advances in chlamydial proteomics and genetics. The field is now poised to decipher the molecular mechanisms that underlie the intimate interactions between Chlamydia spp. and their hosts, which will open up many exciting avenues of research for these medically important pathogens.

  12. 细小病毒B19感染对胎儿的影响

    Institute of Scientific and Technical Information of China (English)

    吴福根; 林峰

    2005-01-01

    自1975年Cossart首先发现人细小病毒B19(Human Parvovirus B19,下简称:B19病毒)以来,其感染人的危险性已逐渐被认识。1984年Brown等首次报道B19病毒可通过胎盘感染胎儿,相继的许多研究也表明,B19病毒感染胎儿后可导致胎儿非免疫性水肿、胎儿贫血、流产、早产甚至死胎或畸形。本文就围产期B19感染方面的研究作如下综述。

  13. 儿童细小病毒B19感染的诊断方法%Diagnostic methods of children parvovirus B19 infection

    Institute of Scientific and Technical Information of China (English)

    曹玉红; 张光运; 张国成; 李如英; 曹艳华

    2003-01-01

    目的: 评价巢式PCR,ELISA,间接免疫荧光法(IIF)诊断B19感染的价值.方法: 用ELISA及巢式PCR对129例小儿血液病和结缔组织病患者血清进行B19-IgM,DNA 检测;用IIF及巢式PCR对50例血液病患者骨髓进行B19抗原及DNA检测. 结果: 病例组129例,血清B19-DNA阳性41例,阳性率31.8%;IgM阳性28例,阳性率21.7%;B19-DNA及 IgM同时阳性26例,仅IgM阳性2例,B19感染率为33.3%. 对照组50例,B19-DNA阳性率2%,IgM阳性率0%,B19感染率为2%. 血液病患者50例骨髓B19-DNA阳性17例,阳性率34%;抗原阳性8例,阳性率16%. 与巢式PCR相比,ELISA法的灵敏度为63.4%,特异度为97.7%,符合率为86.8%,阳性预告值为(+PV)为92.8%,阴性预告值(-PV)为85.1%;IIF法的灵敏度为47.0%,特异度为100%,符合率为82.0%,+PV为100%,-PV为78.6%. 结论: ELISA及IIF敏感性低于巢式PCR,诊断B19感染时最好同时检测B19-DNA和IgM或抗原.

  14. Human parvovirus B19 infection in HIV-positive patients Infecção por parvovirus humano B19 em pacientes HIV-positivos

    Directory of Open Access Journals (Sweden)

    Fábio S. Aguiar

    2001-06-01

    Full Text Available Parvovirus B19 infects predominantly erythroid cells, leading to transient inhibition of erythropoiesis. Immunocompromised patients may be unable to produce neutralizing antibodies and may develop severe chronic anemia. Epidemiological studies done on Niterói population showed that B19 infection occurs periodically in late spring and summer. We report a study from 55 HIV infected patients attending an infectious diseases outpatient clinic in this city during a 5-month period in which B19 circulation was well documented. All patients were under anti-retroviral therapy. No anti-B19 IgM was found, but a high prevalence of IgG anti-B19 (91% was observed. In six patients, B19 DNA was found by dot-blot hybridization techniques, but this was not confirmed by PCR. None of these 6 patients manifested anemia and only one had CD4 cell count below 200 x 10(7/L. We conclude that persistent infection causing anemia is an infrequent finding in our HIV positive patients under drug therapy.O parvovírus B19 infecta predominantemente células eritróides, causando inibição transitória da eritropoiese. Pacientes imunocomprometidos podem ser incapazes de produzir anticorpos neutralizantes, evoluindo com grave anemia crônica. Estudos epidemiológicos da população de Niterói mostraram que a infecção ocorre periodicamente no final da primavera e no verão. Descrevem-se 55 pacientes infectados pelo HIV atendidos num ambulatório de doenças infecciosas nesta cidade num período de cinco meses, no qual a circulação do parvovírus B19 foi documentada. Todos os pacientes estavam sob terapia anti-retroviral. Não se encontrou IgM anti-B19, mas notou-se uma prevalência alta de IgG anti-B19 (91%. Em seis pacientes verificou-se a presença de DNA do B19 por hibridização em dot-blot, o que não se confirmou por PCR. Nenhum destes seis pacientes tinha anemia, e apenas um tinha células CD4 abaixo de 200 x 10(7/L. Conclui-se que infecção persistente causando

  15. 人细小病毒B19与疾病相关性研究

    Institute of Scientific and Technical Information of China (English)

    黄俊琳; 梁太英

    2003-01-01

    @@ 人细小病毒B19(Human Parvovirus B19,HPVB19)是近十余年来发现的一个重要病原体,文献报告与人类多种疾病相关.为研究梧州及周边地区B19感染的疾病谱,现将我院门诊及住院患者检测情况作一总结报告.

  16. Acute hepatitis and myositis associated with Erythema infectiosum by Parvovirus B19 in an adolescent

    OpenAIRE

    Koliou, Maria; Karaoli, Evaggelia; Soteriades, Elpidoforos S; Pavlides, Sylvie; Bashiardes, Stavros; Christodoulou, Christina

    2014-01-01

    Background: Erythema infectiosum is the most common clinical manifestation of Parvovirus B19 infection although it has also been associated with rheumatologic diseases and various types of systemic vasculitides. Acute hepatitis and benign myositis however are rarely reported in association with Parvovirus B19 infection. Case presentation: Here we report a 14-year old male, who developed acute hepatitis and benign myositis associated with erythema infectiosum following Parvovirus B19 infection...

  17. The seroprevalence of parvovirus B19 among kidney transplant recipients: A single-center study

    OpenAIRE

    Zakieh Rostamzadeh Khameneh; Nariman Sepehrvand; Vahid Sohrabi; Nazafarin Ghasemzadeh

    2014-01-01

    Parvovirus B19 is a DNA virus that is responsible for causing several diseases in humans. Parvovirus B19-induced persistent anemia is one of its manifestations that is relatively common in transplant recipients. This study was aimed to investigate the seroprevalence of parvovirus B19 among kidney transplant recipients. Ninety-one transplant recipients were selected randomly and were investigated for several variables including age, gender, educational status, history of hemodialysis (HD), his...

  18. Acute hepatitis and myositis associated with Erythema infectiosum by Parvovirus B19 in an adolescent

    OpenAIRE

    Koliou, Maria; Karaoli, Evaggelia; Soteriades, Elpidoforos S; Pavlides, Sylvie; Bashiardes, Stavros; Christodoulou, Christina

    2014-01-01

    Background Erythema infectiosum is the most common clinical manifestation of Parvovirus B19 infection although it has also been associated with rheumatologic diseases and various types of systemic vasculitides. Acute hepatitis and benign myositis however are rarely reported in association with Parvovirus B19 infection. Case presentation Here we report a 14-year old male, who developed acute hepatitis and benign myositis associated with erythema infectiosum following Parvovirus B19 infection. ...

  19. A pilot study on parvovirus B19 infection in paediatric haematological malignancies

    OpenAIRE

    Kishore, Janak; Sen, Manodeep; Kumar, Ashutosh; Kumar, Archana

    2011-01-01

    Background & objectives: Leukaemia and lymphoma are common paediatric haematological malignancies acquiring human parvovirus B19 (B19) infection. In some studies anaemia has been found in children with acute lymphoblastic leukaemia (ALL) during maintenance therapy and rarely in lymphoma. We studied frequency of B19 infection and its implications in new onset acute leukaemia (mostly ALL) and lymphoma in children. Methods: Seventy serum samples from 35 children (age

  20. New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.

    OpenAIRE

    Schwarz, T F; Modrow, Susanne; Hottenträger, B; Höflacher, B.; Jäger, G; Scharti, W.; Sumazakl, R.; Wolf, Hans J.; Middeldorp, J.; Roggendorf, M

    1991-01-01

    A new, highly sensitive and specific enzyme immunoassay using oligopeptides as antigen (enzyme-linked immunosorbent assay [ELISA] B19-OP) for detecting parvovirus B19-specific immunoglobulin G (IgG) was established. As antigens, B19-specific oligopeptides of 24 and 30 kDa derived from a 196-kDa fusion protein of beta-galactosidase and viral capsid protein (VPI) of B19 after CNBr cleavage and separation by high-pressure liquid chromatography were used. Of 139 serum specimens tested in parallel...

  1. Parvovirus B19 Infection and Severe Anemia in Renal Transplant Recipients

    OpenAIRE

    Antonio Carraturo; Valentina Catalani; Donatella Ottaviani; Patrizia Menichelli; Maurizio Rossini; Delia Terella; Brunello Biondi

    2012-01-01

    Kidney transplant (KT) recipients can develop symptomatic Parvovirus (PV) B19 infections, frequently associated with persistent anemia. The aim of this study was to evaluate the prevalence and clinical significance of PV B19 infection in anemic and non-anemic KT patients. Overall, out of 64 patients monitored for the presence of PV B19 by real-time PCR, 2 (3.12%) had an active PV B19 infection, in absence of other viral coinfections. The 2 cases occurred in nonanemic kidney transplant patient...

  2. Parvovirus B19-assoziierte inflammatorische Kardiomyopathie: Dysregulation der inflammatorischen Signaltransduktion durch parvovirale Proteine

    OpenAIRE

    Utta, Friederike Nora

    2013-01-01

    Das humanpathogene Parvovirus B19 (B19V) wurde vor Kurzem als neu identifizierter Erreger entzündlicher Herzmuskelerkrankungen beschrieben. Die Infektion myokardialer Endothelzellen mit B19V kann mit einer endothelialen Dysfunktion und sekundärer Schädigung der Myozyten einhergehen, die zur inflammatorischen Kardiomyopathie (iCMP) führen kann. Das virale Effektorprotein NS1 des Parvovirus B19 ist essentiell für die Initiierung der viralen Replikation durch seine Helikase, Nickase- und ATPase-...

  3. Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19.

    OpenAIRE

    Patou, G.; Pillay, D.; Myint, S; Pattison, J.

    1993-01-01

    The characterization and application of a nested polymerase chain reaction (PCR) assay for the detection of human parvovirus B19 DNA is described. The assay was evaluated with 149 diagnostic serum samples (collected up to 150 days after the onset of symptoms) previously tested by dot blot hybridization for B19 DNA and by class-specific capture radioimmunoassays for the detection of B19 immunoglobulin M (IgM) and IgG. B19 DNA was detectable by the PCR in 70% of the sera. There was a statistica...

  4. Acute encephalitis and encephalopathy associated with human parvovirus B19 infection in children.

    Science.gov (United States)

    Watanabe, Toru; Kawashima, Hideshi

    2015-11-01

    Reports of neurologic manifestations of human parvovirus B19 (B19) infection have been on the rise. Acute encephalitis and encephalopathy is the most common, accounting for 38.8% of total B19-associated neurological manifestations. To date, 34 children with B19 encephalitis and encephalopathy have been reported, which includes 21 encephalitis and 13 encephalopathy cases. Ten (29%) were immunocompromised and 17 (39%) had underlying diseases. Fever at the onset of disease and rash presented in 44.1% and 20.6% of patients, respectively. Neurological manifestations include alteration of consciousness occurred in all patients, seizures in 15 (44.1%) patients, and focal neurologic signs in 12 (35.3%) patients. Anemia and pleocytosis in cerebrospinal fluid (CSF) occurred in 56.3% and 48.1% of patients, respectively. Serum Anti-B19 IgM (82.6%) and CSF B19 DNA (90%) were positive in the majority of cases. Some patients were treated with intravenous immunoglobulins and/or steroids, although an accurate evaluation of the efficacy of these treatment modalities cannot be determined. Nineteen (57.6%) patients recovered completely, 11 (33.3%) patients had some neurological sequelae and 3 (8.8%) patients died. Although the precise pathogenesis underlying the development of B19 encephalitis and encephalopathy is unclear, direct B19 infection or NS1protein of B19 toxicity in the brain, and immune-mediated brain injuries have been proposed. PMID:26566485

  5. Prevention of Chlamydia trachomatis infections

    OpenAIRE

    Boman, Jens

    2013-01-01

    Urogenital chlamydia infection, caused by the bacterium Chlamydia trachomatis (CT), is the most common sexually transmitted bacterial infection in Sweden. In 2008 it was estimated by WHO that there were 105.7 million new cases of CT worldwide, an increase by 4.2 million cases (4.1%) compared to 2005. If untreated, CT infections can progress to serious reproductive health problems, especially in women. These complications include subfertility/infertility, ectopic pregnancy and chronic pain. Th...

  6. Endometritis caused by Chlamydia trachomatis.

    OpenAIRE

    Mårdh, P A; Møller, B R; Ingerselv, H J; Nüssler, E; Weström, L; Wølner-Hanssen, P

    1981-01-01

    Chlamydia trachomatis was found to be the aetiological agent of endometritis in three women with concomitant signs of salpingitis. All patients developed a significant antibody response to the organism. Chlamydia were recovered from aspirated uterine contents of two patients and darkfield examination of histological sections showed chlamydial inclusions in endometrial cells in one patient. Thus, C trachomatis can be recovered from the endometrium of patients in whom the cervical culture resul...

  7. The Number, Organization, and Size of Polymorphic Membrane Protein Coding Sequences as well as the Most Conserved Pmp Protein Differ within and across Chlamydia Species.

    Science.gov (United States)

    Van Lent, Sarah; Creasy, Heather Huot; Myers, Garry S A; Vanrompay, Daisy

    2016-01-01

    Variation is a central trait of the polymorphic membrane protein (Pmp) family. The number of pmp coding sequences differs between Chlamydia species, but it is unknown whether the number of pmp coding sequences is constant within a Chlamydia species. The level of conservation of the Pmp proteins has previously only been determined for Chlamydia trachomatis. As different Pmp proteins might be indispensible for the pathogenesis of different Chlamydia species, this study investigated the conservation of Pmp proteins both within and across C. trachomatis,C. pneumoniae,C. abortus, and C. psittaci. The pmp coding sequences were annotated in 16 C. trachomatis, 6 C. pneumoniae, 2 C. abortus, and 16 C. psittaci genomes. The number and organization of polymorphic membrane coding sequences differed within and across the analyzed Chlamydia species. The length of coding sequences of pmpA,pmpB, and pmpH was conserved among all analyzed genomes, while the length of pmpE/F and pmpG, and remarkably also of the subtype pmpD, differed among the analyzed genomes. PmpD, PmpA, PmpH, and PmpA were the most conserved Pmp in C. trachomatis,C. pneumoniae,C. abortus, and C. psittaci, respectively. PmpB was the most conserved Pmp across the 4 analyzed Chlamydia species.

  8. Investigation on the Maternal-Infantile Infection with Human Parvovirus B19

    Institute of Scientific and Technical Information of China (English)

    王净; 窦骏; 过志君; 许桦; 任慕兰; 蒋黎

    2004-01-01

    To investigate the maternal-infantile infection with human parvovirus B19, the IgG and IgM antibodies against human parvovirus and the B19-DNA in serum and peripheral blood mononuclear cells (PBMC) of pregnant women as well as the serum IgM antibody against B19 and the B19-DNA in serum and cord blood nucleated cells (CBNC) of newborns were determined by ELISA and nested PCR respectively. It was found that the positive rate of the IgG antibody against human parvovirus B19 in sera of 92 pregnant women was 38.04% (35/92), and that of the IgM antibody in 720 pregnant women was 9.03% (65/720). However, the IgM antibody against human parvoviras B19 was negative in the cord blood sera of 95 newborns. As to the human parvoviras B19 DNA, none of 720 pregnant women and 95 newborns was proved to be positive in their sera, Nevertheless, the positive rate of the parvoviras B19 DNA in PBMC was 3.06% (3/98) in98 pregnant women and 1.12% (1/89) in CBNC of 89 newborns. It is concluded that the history of infection with human parvoviras B19 exists in certain pregnant women with a small percentage of pregnant women infected with recent or acute infections of B19 virus. The detection rates of the B19 viral DNA in PBMC of pregnant women and CBNC of newborns were higher than those in sera, indicating that the risk for vertical transmission is very low.

  9. Pneumonia (image)

    Science.gov (United States)

    Pneumonia is an inflammation of the lungs caused by an infection. Many different organisms can cause it, including bacteria, viruses, and fungi. Pneumonia is a common illness that affects millions of ...

  10. Mycoplasma pneumonia

    Science.gov (United States)

    ... this page: //medlineplus.gov/ency/article/000082.htm Mycoplasma pneumonia To use the sharing features on this page, please enable JavaScript. Mycoplasma pneumonia is an infection of the lungs by ...

  11. Population-Based Study on the Seroprevalence of Parvovirus B19 in Amsterdam

    NARCIS (Netherlands)

    G.G.C. van Rijckevorsel; G.J.B. Sonder; M.F. Schim van der Loeff; J.A.R. van den Hoek

    2009-01-01

    A study was undertaken to estimate the seroprevalence of parvovirus B19 infection in the general adult population of Amsterdam, The Netherlands. To our knowledge this is the first study testing parvovirus B19 in a random sample of the Dutch adult population. The study was a cross-sectional survey, a

  12. Development of a Hypersensitive Detection Method for Human Parvovirus B19 DNA

    OpenAIRE

    Sato, Kazuaki; Matsuda, Eiji; Kamisango, Keiichi; Iwasaki, Hiroaki; Matsubara, Shuzo; Matsunaga, Yasuko

    2000-01-01

    A new detection method for human parvovirus B19 DNA was established using PCR coupled with a hybridization protection assay. The amplified product was detected using acridinium ester-labeled DNA probes. By this method, a few copies of B19 DNA were detected in human serum albumin.

  13. Detection of human parvovirus B19 in a patient with hepatitis

    Directory of Open Access Journals (Sweden)

    J.R.R. Pinho

    2001-09-01

    Full Text Available Parvovirus B19 has been associated by some investigators with cases of severe hepatitis. The aim of the present study was to determine the presence of active parvovirus B19 infection among 129 Brazilian patients with non-A-E hepatitis. The patients were assayed for antibodies against parvovirus B19, IgM class, by ELISA. In IgM-positive cases, parvovirus B19 DNA was assayed by PCR in serum and liver tissue and parvovirus VP1 antigen in liver tissue was assayed by immunohistochemistry. Antibodies against parvovirus B19, IgM class, were detected in 3 (2.3% of 129 patients with non-A-E hepatitis. Previous surgery and blood transfusions were reported by these 3 patients. One patient was a 56-year-old female with severe hepatitis, with antimitochondrial antibody seropositivity and submassive necrosis at liver biopsy, who responded to corticosteroid therapy. Strong evidence for active parvovirus B19 infection was found in this patient, with parvovirus B19 DNA being detected by PCR in liver tissue. Furthermore, parvovirus VP1 antigen was also detected in liver tissue by immunohistochemistry. The other two IgM-positive patients were chronic hepatitis cases, but active infection was not proven, since neither viral DNA nor antigen were detected in their liver tissues. This and other reports suggest a possible relation between parvovirus B19 infection and some cases of hepatitis.

  14. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells.

    Science.gov (United States)

    Bonvicini, Francesca; Bua, Gloria; Manaresi, Elisabetta; Gallinella, Giorgio

    2016-07-15

    Human parvovirus B19 (B19V) commonly induces self-limiting infections but can also cause severe clinical manifestations in patients with underlying haematological disorders or with immune system deficits. Currently, therapeutic options for B19V entirely rely on symptomatic and supportive treatments since a specific antiviral therapy is not yet available. Recently a first step in the research for active compounds inhibiting B19V replication has allowed identifying the acyclic nucleoside phosphonate cidofovir (CDV). Herein, the effect of CDV against B19V replication was characterized in human erythroid progenitor cells (EPCs) cultured and infected following different experimental approaches to replicate in vitro the infection of an expanding erythroid cell population in the bone marrow. B19V replication was selectively inhibited both in infected EPCs extendedly exposed to CDV 500μM (viral inhibition 82%) and in serially infected EPCs cultures with passage of the virus progeny, constantly under drug exposure (viral inhibition 99%). In addition, a potent inhibitory effect against B19V (viral inhibition 92%) was assessed in a short-term infection of EPCs treated with CDV 500μM 1day before viral infection. In the evaluated experimental conditions, the enhanced effect of CDV against B19V might be ascribed both to the increased intracellular drug concentration achieved by extended exposure, and to a progressive reduction in efficiency of the replicative process within treated EPCs population. PMID:27071853

  15. Parvovirus B19 Infection in the First Trimester of Pregnancy and Risk of Fetal Loss

    DEFF Research Database (Denmark)

    Lassen, Jonathan; Jensen, Anne K V; Bager, Peter;

    2012-01-01

    Because parvovirus B19 infection during pregnancy has been associated with increased risk of fetal loss in small or selected study populations, the authors evaluated the risk in a population-based study. A nested case-control study was conducted by using a population-based screening for syphilis...... were tested for parvovirus B19 immunoglobulin M positivity. Parvovirus B19 immunoglobulin M positivity was associated with a 71% increased risk of fetal loss (odds ratio = 1.71, 95% confidence interval: 1.02, 2.86). Adjustment for number of children or stratifying for gestational age at loss did...... not change the risk estimate. Assuming causality, only 0.1% of fetal losses were attributable to parvovirus B19 positivity, a proportion which could increase to approximately 1% during epidemic periods. In conclusion, acute parvovirus B19 infection during the first trimester of pregnancy was associated...

  16. 细小病毒B19感染的研究进展

    Institute of Scientific and Technical Information of China (English)

    赵蔓

    2002-01-01

    @@ 人细小病毒B19(human parvovirus B19,B19)业已证明是细小病毒属中同人类疾病相关的一种小DNA病毒,可引起急性再生障碍性贫血(再障),传染性红斑、关节炎、紫癜等多种儿童疾病[1,2].儿童有较高的感染率和发病率,同时也是B19感染的主要传播者[3],国内对该病的研究较少,现就B19的生物学特性及其感染后的临床表现、发病机制,实验室诊断及治疗进展综述如下.

  17. [Epidemiology of community-acquired pneumonia in children. Current data].

    Science.gov (United States)

    Marguet, C; Bocquel, N; Mallet, E

    1998-01-01

    Viruses, particularly syncitial respiratory virus, are the main aetiology of community-acquired lower respiratory tract infections in infants, while bacterial agents are more frequently responsible in children older than 3 years. Antimicrobial therapy must take into account the development of reduced susceptibility of penicillin to strains of Streptoccocus pneumoniae and Haemophilus influenzae with beta-lactamase, and high frequency of Mycoplasma pneumoniae and Chlamydia pneumoniae infections. Although the mortality rate has remained low in France, the morbidity appeared to increase in recent years. PMID:10223154

  18. Functional mapping of the genome of the B19 (human) parvovirus by in vitro translation after negative hybrid selection.

    OpenAIRE

    Ozawa, K; Ayub, J; Young, N.

    1988-01-01

    We have analyzed the coding capacity of B19 parvovirus transcripts by in vitro translation using the negative hybrid selection technique. Five different antisense oligonucleotides (18-mers) corresponding to different portions of the B19 genome were hybridized to RNA samples extracted from human erythroid bone marrow cells infected with B19 parvovirus in vitro, and RNase H was added to cleave specific B19 RNA molecules at selected sites. B19-specific translation products of these RNA samples w...

  19. Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood.

    OpenAIRE

    Schwarz, T F; Serke, S; Hottenträger, B; von Brunn, A; Baurmann, H; Kirsch, A.; Stolz, W.; Huhn, D; Deinhardt, F.; Roggendorf, M

    1992-01-01

    Erythroid progenitor cells generated in vitro from peripheral human blood in the presence of interleukin-3 and erythropoietin were infected with human parvovirus B19. B19 virus DNA replication was highest 48 to 72 h after infection, and maximum levels of B19 virus proteins were detected in culture supernatants at 72 to 96 h after infection. B19 virus propagated in vitro was infectious. This cell culture system with peripheral blood cells facilitates studies in vitro of B19 virus replication.

  20. Establishment of Functional B Cell Memory Against Parvovirus B19 Capsid Proteins May be Associated With Resolution of Persistent Infection

    OpenAIRE

    Corcoran, A; Crowley, B.; Dewhurst, C.; Pizer, B L; Doyle, Sean

    2006-01-01

    Parvovirus B19 (B19) infection can occur during acute lymphoblastic leukemia and persistent viral infection can occur despite intravenous immunoglobulin administration. Here, evidence is presented that resolution of persistent B19 infection in an acute lymphoblastic leukemia patient may be associated with the simultaneous strengthening of antigen-specific B cell memory against the B19 capsid protein VP2 and diminution in the memory response against the B19 non-structural protein 1 (NS1). Dete...

  1. Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.

    Directory of Open Access Journals (Sweden)

    Claudia Bönsch

    Full Text Available BACKGROUND: An unexpectedly high seroprevalence and pathogenic potential of human parvovirus B19 (B19V have been observed in certain malaria-endemic countries in parallel with local use of chloroquine (CQ as first-line treatment for malaria. The aims of this study were to assess the effect of CQ and other common antimalarial drugs on B19V infection in vitro and the possible epidemiological consequences for children from Papua New Guinea (PNG. METHODOLOGY/PRINCIPAL FINDINGS: Viral RNA, DNA and proteins were analyzed in different cell types following infection with B19V in the presence of a range of antimalarial drugs. Relationships between B19V infection status, prior 4-aminoquinoline use and anemia were assessed in 200 PNG children <10 years of age participating in a case-control study of severe infections. In CQ-treated cells, the synthesis of viral RNA, DNA and proteins was significantly higher and occurred earlier than in control cells. CQ facilitates B19V infection by minimizing intracellular degradation of incoming particles. Only amodiaquine amongst other antimalarial drugs had a similar effect. B19V IgM seropositivity was more frequent in 111 children with severe anemia (hemoglobin <50 g/L than in 89 healthy controls (15.3% vs 3.4%; P = 0.008. In children who were either B19V IgM or PCR positive, 4-aminoquinoline use was associated with a significantly lower admission hemoglobin concentration. CONCLUSIONS/SIGNIFICANCE: Our data strongly suggest that 4-aminoquinoline drugs and their metabolites exacerbate B19V-associated anemia by promoting B19V replication. Consideration should be given for choosing a non-4-aminoquinoline drug to partner artemisinin compounds in combination antimalarial therapy.

  2. Parvovirus B19 and non-immune fetal hydrops%细小病毒B19与胎儿水肿

    Institute of Scientific and Technical Information of China (English)

    曹懿; 李芬

    2003-01-01

    孕妇感染细小病毒B19可引起自然流产、非免疫性胎儿水肿和胎儿死亡等并发症,其中最常见的是非免疫性胎儿水肿.本文就细小病毒B19的生物学特性和感染特征,引起非免疫性胎儿水肿的流行病学,发病机制与临床表现,诊断治疗及预防作一综述.

  3. Atypical pathogens in community acquired pneumonia of Egyptian children

    Institute of Scientific and Technical Information of China (English)

    Deraz TE; El Sahriggy SA; Shaheen MA; Motawea AA; Gomaa HE; Fawzy SH; Mohamed AA

    2009-01-01

    Objective:Diagnosis of atypical pathogens as an aetiology for community-acquired pneumonia (CAP)in chil-dren is a challenge world wide.The aim of this study was to detect the frequency of atypical pathogens as a cause of community-acquired pneumonia (CAP)in Egyptian children.Methods:From 50 children (with age ranged from 2 months to 1 2 years)hospitalized for community-acquired pneumonia;respiratory sputum samples were collected by induction or spontaneously.All samples were subjected to conventional cultures and Polymer-ase Chain Reaction(PCR)technique DNA extraction for identification of Mycoplasma,Chlamydia pneumoniae and Legionella pneumophila.Results:A definite pathogen was identified in 78% of the studied children;30%typical bacteria,8% candida albicans and atypical bacteria in 40% of the pneumonic children.Chlamydia pneumoniae was isolated from 26% of the children while Mycoplasma pneumoniae was isolated from 1 4%, whereas Legionella pneumophilla was not isolated at all.Conclusion:Atypical pathogens are evident as a po-tential aetiology for community-acquired pneumonia in (1 3.3%)of young and (80%)of older Egyptian chil-dren.

  4. Severe anemia and hydrops in a neonate with parvovirus B19 infection: a case report

    Directory of Open Access Journals (Sweden)

    Negar Sajjadian

    2013-12-01

    Full Text Available Background: Anemia at the time of birth may cause some problem like asphyxia, heart failure shock or even death in a neonate. Different etiologies can be considered for this problem. Parvovirus B19, as a viral organism, can cause hydrops fetalis and neonatal anemia and consequent complications. We present here a case of newborn infant with severe anemia who had human parvovirus B19 infection.Case Presentation: A male newborn with gestational age of 36 week was born from a mother with poor prenatal care and history of contact with domestic animal. The neonate was very pale with Apgar score 2 at 1 min and received resuscitation, mechanical ventilation and repeated blood transfusion The hemoglobin level was significantly low. Analysis was made based on the clinical presentations. According to the case history, physical and laboratory findings, neonatal severe anemia induced by parvovirus B19 infection was suggested and Laboratory work up documented his infection with parovirus B19.Conclusion: Parvovirus B19 (B19 virus is the smallest single strand linear DNA virus in animal viruses, which is the only strain of parvovirus that is pathogenic in humans. Human parvovirus B19 may cross the placenta and result in fetal infection, morbidity and death. Parvovirus is an uncommon cause of neonatal anemia and hydrops fetalis so this etiology must be considered in differential diagnosis of anemia at birth.

  5. The seroprevalence of parvovirus B19 among kidney transplant recipients: A single-center study

    Directory of Open Access Journals (Sweden)

    Zakieh Rostamzadeh Khameneh

    2014-01-01

    Full Text Available Parvovirus B19 is a DNA virus that is responsible for causing several diseases in humans. Parvovirus B19-induced persistent anemia is one of its manifestations that is relatively common in transplant recipients. This study was aimed to investigate the seroprevalence of parvovirus B19 among kidney transplant recipients. Ninety-one transplant recipients were selected randomly and were investigated for several variables including age, gender, educational status, history of hemodialysis (HD, history of blood transfusion and immunosuppressive therapy. Two milliliters of blood samples were collected via venipuncture and evaluated for anti-Parvovirus B19 IgG antibody using enzyme-linked immunosorbent assay. All recipients were anemic, with 72.5% of them suffering from severe anemia (Hb ≤ 11 in men and ≤ 10 in women. Sixty-three patients (69.2% were seropositive for Parvovirus B19. There was no significant difference in age, sex, educational status, history of blood transfusion, history of HD and immunosuppressive therapy between seropositive and seronegative groups. The seroprevalence of Parvovirus B19 was relatively high in kidney transplant recipients in Urmia, Iran. Our study failed to find a correlation between the severity of anemia and the seropositivity of Parvovirus B19.

  6. 妊娠期微小病毒B19感染

    Institute of Scientific and Technical Information of China (English)

    王艳霞; 方群

    2001-01-01

    @@ 人微小病毒B19(human parvovirus B19,B19)于1975年由Cossart等人首次在献血者血清中发现.1984年Brown等人在苏格兰人微小病毒爆发感染时发现B19病毒感染与胎儿水肿及自发性流产的关系.近年由于TORCH感染等研究的进一步发展,以及对孕妇TORCH感染的重视,使其可得到早期诊断和处理,所以TORCH感染与胚胎及胎儿发育关系的重要性下降.因为B19病毒感染十分普遍,妊娠期B19病毒感染与优生的关系就变的非常重要.本文拟对B19病毒宫内感染的病因、作用机制、危险因素、临床表现、对胎儿的近、远期影响、感染孕妇及胎儿的诊断、处理作一综述.

  7. No Definite Association between Human Parvovirus B19 Infection and Behçet Disease

    Directory of Open Access Journals (Sweden)

    Mojtaba Habibagahi

    2015-11-01

    Full Text Available Background: The etiology of the Behçet disease (BD has remained obscured. There have been studies to show the association of BD to infections like herpes simplex, hepatitis, and parvovirus B19 however, the findings are rather controversial. Materials and Methods: We selected 55 patients with the best matched symptoms of BD and measured the loads of B19 DNA in their plasma by quantitative real time PCR and verified their seropositivity by ELISA. All findings were compared to the results from 42 healthy persons. Results: Patients showed a wide spectrum of BD symptoms. Serologic studies showed high prevalence of B19 IgG among the tested patients which was not statistically different with the healthy population (72.7% vs. 85.7%, respectively. Similarly, the prevalence of B19 IgM between patients and controls was not different (18% vs. 11.9%, respectively. No correlation was found between the presence of anti-B19 antibodies and the clinical observations. Only one person from the patient and control groups had detectable levels of B19 DNA without any difference or correlation with the disease symptoms. Conclusion: Our data could not establish an association between B19 parvovirus infection and Behçet disease, although there have been reports of such correlation. Nevertheless, there might be indirect relation in genetically susceptible individuals after viral infections. More studies on designed animal models and surveys on patients should be done to resolve this controversy.

  8. The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells

    Science.gov (United States)

    Leisi, Remo; Von Nordheim, Marcus; Ros, Carlos; Kempf, Christoph

    2016-01-01

    Parvovirus B19 (B19V) is a small non-enveloped virus and known as the causative agent for the mild childhood disease erythema infectiosum. B19V has an extraordinary narrow tissue tropism, showing only productive infection in erythroid precursor cells in the bone marrow. We recently found that the viral protein 1 unique region (VP1u) contains an N-terminal receptor-binding domain (RBD), which mediates the uptake of the virus into cells of the erythroid lineage. To further investigate the role of the RBD in connection with a B19V-unrelated capsid, we chemically coupled the VP1u of B19V to the bacteriophage MS2 capsid and tested the internalization capacity of the bioconjugate on permissive cells. In comparison, we studied the cellular uptake and infection of B19V along the erythroid differentiation. The results showed that the MS2-VP1u bioconjugate mimicked the specific internalization of the native B19V into erythroid precursor cells, which further coincides with the restricted infection profile. The successful mimicry of B19V uptake demonstrates that the RBD in the VP1u is sufficient for the endocytosis of the viral capsid. Furthermore, the recombinant VP1u competed with B19V uptake into permissive cells, thus excluding a significant alternative uptake mechanism by other receptors. Strikingly, the VP1u receptor appeared to be expressed only on erythropoietin-dependent erythroid differentiation stages that also provide the necessary intracellular factors for a productive infection. Taken together, these findings suggest that the VP1u binds to a yet-unknown erythroid-specific cellular receptor and thus restricts the virus entry to permissive cells. PMID:27690083

  9. Endometritis caused by Chlamydia trachomatis.

    Science.gov (United States)

    Mårdh, P A; Møller, B R; Ingerselv, H J; Nüssler, E; Weström, L; Wølner-Hanssen, P

    1981-01-01

    Chlamydia trachomatis was found to be the aetiological agent of endometritis in three women with concomitant signs of salpingitis. All patients developed a significant antibody response to the organism. Chlamydia were recovered from aspirated uterine contents of two patients and darkfield examination of histological sections showed chlamydial inclusions in endometrial cells in one patient. Thus, C trachomatis can be recovered from the endometrium of patients in whom the cervical culture result is negative. In one patient curettage showed endometritis with a characteristic plasma-cell infiltration. The occurrence of chlamydial endometritis may explain why irregular bleeding is a common finding in patients with salpingitis. It also suggests a canalicular spread of chlamydia from the cervix to the Fallopian tubes. Images PMID:7237083

  10. 人细小病毒B19与胎停育的关系

    Institute of Scientific and Technical Information of China (English)

    梁建芳; 郑绘霞; 武丽娜; 王玉贤; 王晓兰; 赵玉泽

    2008-01-01

    @@ 胎停育临床十分常见,严重危害着女性的身心健康.胎停育病因复杂,其与病毒之间的关系日益受到重视.人类细小病毒B19(Human Parvovirus B19,HPV B19)与病理性妊娠之间的关系成为近年来关注的热点,但对于其与胎停育的关系尚无系统研究.

  11. Detection of human parvovirus B19 in cancer patients using ELISA and real-time PCR

    OpenAIRE

    Zaki, S. A.

    2012-01-01

    Purpose: Parvovirus B19 (B19) is associated with a wide range of diseases in humans, whose severity depends on the immunological and haematological status of the host. Objective: To determine the incidence of B19 DNA and specific IgM and IgG frequency among patients suffering from different haematological malignancies and to determine the viral load using real-time PCR. Materials and Methods: A total of 70 patients were included in the study, in addition to a control group consisting of 20 ap...

  12. Recent Research Progress in Human Parvovirus B19 Infection%人类微小病毒B19感染的最新进展

    Institute of Scientific and Technical Information of China (English)

    邵惠训

    2011-01-01

    人类微小病毒B19主要侵袭人体骨髓造血系统,损害人体多种脏器,是儿科出疹性疾病--传染性红斑的病原.还可使慢性溶血患者发生再障危象、关节病、血管性紫癜和雷诺肢端综合征等.在免疫缺陷患者,可造成持续感染.妊娠期受到病毒侵害,引发宫内感染,可导致流产、胎儿水肿和死胎.此外,还与多种造血系统异常(中性粒细胞减少症和血小板减少症等)有关.%Human parvovirus B19( HPV B19 ), which mainly invades human hematopoietic system, damaging multiple human organs,is the pathogen of pediatric rash illness-infectious erythema. It may also cause aplastic crisis,arthropathy, vascular purpura, and Raynaud acromegaly syndrome of the patients with chronic hemolytic, and continuous infection in the immunocompromised patients. Abortion, fetal hydrops and stillbirth are complications of intrauterine HPV B19 infection. Besides,it's also related with a variety of hematopoietic system abnormalities( neutropenia and thrombocytopenia ).

  13. Inhibitory activity of the isoflavone biochanin a on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation

    DEFF Research Database (Denmark)

    Hanski, Leena; Genina, Natalja; Uvell, Hanna;

    2014-01-01

    Chlamydia growth inhibitor among the studied isoflavones, with an IC50 = 12 µM on C. pneumoniae inclusion counts and 6.5 µM on infectious progeny production, both determined by immunofluorescent staining of infected epithelial cell cultures. Encouraged by the permeation of biochanin A across porcine buccal......Given the established role of Chlamydia spp. as causative agents of both acute and chronic diseases, search for new antimicrobial agents against these intracellular bacteria is required to promote human health. Isoflavones are naturally occurring phytoestrogens, antioxidants and efflux pump...

  14. Viral pneumonia

    Science.gov (United States)

    ... off infection. Vaccines may help prevent pneumonia in children, the elderly, and people with diabetes, asthma, emphysema , HIV, cancer, or other chronic conditions. A drug called palivizumab ( ...

  15. THE ROLE OF PARVOVIRUS B19 IN THE DEVELOPMENT OF INFLAMMATORY CARDIOMYOPATHY

    Directory of Open Access Journals (Sweden)

    A. Yu. Shchedrina

    2013-01-01

    Full Text Available The problem of inflammatory cardiomyopathy is discussed. The etiology, pathogenesis, diagnosis and treatment of inflammatory cardiomyopathy are considered with focus on the role of parvovirus B19.

  16. Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation

    Institute of Scientific and Technical Information of China (English)

    Darin S Krygier; Urs P Steinbrecher; Martin Petric; Siegfried R Erb; Stephen W Chung; Charles H Scudamore; Andrzej K Buczkowski; Eric M Yoshida

    2009-01-01

    Parvovirus B19 induced acute hepatitis and hepatic failure have been previously reported,mainly in children.Very few cases of parvovirus induced hepatic failure have been reported in adults and fewer still have required liver transplantation.We report the case of a 55-year-old immunocompetent woman who developed fulminant hepatic failure after acute infection with Parvovirus B19 who subsequently underwent orthotopic liver transplantation.This is believed to be the first reported case in the literature in which an adult patient with fulminant hepatic failure associated with acute parvovirus B19 infection and without hematologic abnormalities has been identified prior to undergoing liver transplantation.This case suggests that Parvovirus B19 induced liver disease can affect adults,can occur in the absence of hematologic abnormalities and can be severe enough to require liver transplantation.

  17. Acute Heart Failure Caused by Parvovirus B-19 Myocarditis Treated with Human Immunoglobulin

    OpenAIRE

    Luca Alberti; Marco Loffi; Gabriele Fragasso; Roberto Spoladore; Carlo Ballarotto; Alberto Margonato

    2012-01-01

    We describe the case of a 42-year-old woman developing cardiogenic shock with cardiac tamponade due to an acute myo-pericarditis caused by Parvovirus B19 (PVB19), successfully treated with intravenous (iv) immunoglobulin administration.

  18. 人细小病毒B19相关神经系统疾病

    Institute of Scientific and Technical Information of China (English)

    曹玉红; 张光运; 张国成

    2000-01-01

    @@ 人细小病毒B19(Human parvovirus B19,HPVB19)系动物细小病毒属中唯一致人类疾病的一种小DNA病毒,可引起传染性红斑,一过性再障危象、血小板减少性紫癜、关节炎、胎儿水肿、死胎、流产等多种疾病.

  19. Die Serumprävalenz von Parvovirus B19 bei rheumatischen Erkrankungen im Kindesalter

    OpenAIRE

    Süß-Fröhlich, Yvonne

    2005-01-01

    Ziel dieser Studie war es, einen möglichen Zusammenhang zwischen einer Parvovirus B19-Infektion und der Ätiologie und Pathogenese der Juvenilen idiopathischen Arthritis (JIA) zu untersuchen. Hierzu wurden von insgesamt 382 Patienten der Rheumasprechstunde der Kinderpoliklinik der Universität Würzburg Serumproben auf das Vorhandensein von Parvovirus B19-IgG-Antikörpern gestestet. Der Nachweis dieser Antikörper erfolgte mittels indirektem Immunfluoreszenztest (IFT). Das gleiche Verfahren wurde ...

  20. High Rate of Severe Fetal Outcomes Associated with Maternal Parvovirus B19 Infection in Pregnancy

    OpenAIRE

    Beigi, Richard H.; Wiesenfeld, Harold C.; Daniel V. Landers; Simhan, Hyagriv N.

    2008-01-01

    Objective. To augment the understanding of parvovirus B19 infection in pregnancy with respect to maternal characteristics and their corresponding fetal outcomes. Study Design. Retrospective case-series of all women referred to Magee-Women_s Hospital with serologically-documented parvovirus B19 infection during pregnancy from 1998–2001. Results. All 25 cases that are available for analysis occurred from January through June. The frequency of cases varied substantially from year to year, with 1...

  1. Human parvovirus B19 surveillance in patients with rash and fever from Belarus.

    Science.gov (United States)

    Yermalovich, Marina A; Hübschen, Judith M; Semeiko, Galina V; Samoilovich, Elena O; Muller, Claude P

    2012-06-01

    Human parvovirus B19 (B19V) infection in immunocompetent patients usually has a mild clinical course, but during pregnancy it can cause serious and even fatal complications in the fetus. The most common clinical presentation of B19V infection is erythema infectiosum and in this case laboratory confirmation is required for differentiation from other exanthematous diseases. Measles and rubella negative sera collected in Belarus between 2005 and 2008 from 906 patients with a rash and fever were screened for B19V infection by ELISA. More than 35% of the samples (322/906) were positive for B19V. The proportion ranged from 10.1% in 2008 to 53.2% in 2006 when an outbreak took place in Minsk city. All B19V outbreaks and cluster cases occurred during the winter-spring period, but sporadic cases were recorded basically throughout the year. The majority of the cases (56.5%) occurred among the 2 till 10 year old children, and 27.3% of the cases were observed in adults between 19 and 53 years. All 104 B19V strains sequenced in the NS1/VP1u region belonged to genotype 1 with a maximal genetic distance of 1.75%. The two phylogenetic clusters reflected the geographic origins of the viruses within the country. Forty-two unique nucleotide mutations as compared to sequences downloaded from GenBank were found in the VP1u and NS1 regions; most of these changes were nonsynonymous. This report highlights the importance of B19V infection in patients with a rash and fever in Belarus.

  2. Clinical and epidemiological aspects of parvovirus B19 infections in Ireland, January 1996-June 2008.

    LENUS (Irish Health Repository)

    Nicolay, N

    2009-01-01

    Parvovirus B19 infection may be mistakenly reported as measles or rubella if laboratory testing is not performed. As Europe is seeking to eliminate measles, an accurate diagnosis of fever\\/rash illnesses is needed. The main purpose of this study was to describe the epidemiological pattern of parvovirus B19, a common cause of rash, in Ireland between January 1996 and June 2008, using times series analysis of laboratory diagnostic data from the National Virus Reference Laboratory. Most diagnostic tests for presumptive parvovirus B19 infection were done in children under the age of five years and in women of child-bearing age (between 20-39 years-old). As a consequence, most of the acute diagnoses of B19 infection were made in these populations. The most commonly reported reasons for testing were: clinical presentation with rash, acute arthritis, influenza-like symptoms or pregnancy. The time series analysis identified seasonal trends in parvovirus B19 infection, with annual cycles peaking in late winter\\/spring and a six-year cycle for parvovirus B19 outbreaks in Ireland.

  3. 人微小病毒B19与异常妊娠

    Institute of Scientific and Technical Information of China (English)

    谭继英; 高峻; 吴小红; 兰中芬; 代荫梅

    2001-01-01

    @@ 人微小病毒B19(human parvovirus B19,HPV B19)感染多发生在冬春季,孕妇和儿童感染多见,23%~45%的孕妇为易感者,围生期感染HPV B19病毒引起的宫内感染可导致胎儿非免疫性水肿,而且,还可能与胎儿畸形有关,孕妇感染HPV B19后,围生儿可能出现非免疫性胎儿全身水肿、死胎或流产,其发生率可达5%~38%,并可导致5%~20%的死亡率.其相对危险比较严重,因此,在妊娠期对HPV B19的感染越来越多地引起关注.

  4. 结缔组织病患儿B19病毒感染的意义%Human parvovirus B19 infection in children with common connective tissue diseases

    Institute of Scientific and Technical Information of China (English)

    曹玉红; 张国成; 钱新宏; 成胜权; 许东亮; 汪萍

    2003-01-01

    目的: 研究我国小儿常见结缔组织病患者B19病毒感染的状况及其临床意义. 方法: 用巢式PCR法对95例小儿常见结缔组织病患者进行B19-DNA检测,对其中50例患者同时进行B19主要衣壳蛋白抗体IgM(B19-VP2-IgM)检测. 结果: 病例组95例,B19-DNA阳性34例(36%),健康对照组50例,B19-DNA阳性2例(4%);病例组B19-DNA阳性率与对照组相比有显著差异(P0.05). 50例患者B19-DNA, B19-VP2-IgM同时检测结果:10例B19-DNA, B19-VP2-IgM均阳性,1例仅B19-VP2-IgM阳性,7例仅B19-DNA阳性.病例组B19阳性率为37%(35/95). 结论: 我国结缔组织疾病患儿有较高的B19感染率.B19与小儿结缔组织病密切相关,可能是导致这些疾病的主要病原体之一.

  5. 人细小病毒B19感染与小儿川崎病的关系%Relationship between human parvovirus B19 infection and Kawasaki disease in children

    Institute of Scientific and Technical Information of China (English)

    曹玉红; 张光运; 张国成; 丁翠玲; 曹艳华; 杨欣伟; 沈青

    2005-01-01

    目的: 探讨人细小病毒B19感染与小儿川崎病的关系.方法: 用巢式PCR法对46例川崎病患儿进行B19-DNA检测,用ELISA法对其中的30例患儿进行B19-VP2-IgM检测.结果: 病例组46例,B19-DNA阳性14例(30%),对照组50例B19-DNA阳性2例,两组间差异显著(P<0.01).病例组B19-VP2-IgM阳性7/30例,对照组50例均阴性.两组间差异极显著(P<0.01).30例川崎病患者中B19-DNA,B19-VP2-IgM均阳性6例;1例仅B19-VP2-IgM阳性;4例仅B19-DNA阳性;B19-DNA和B19-VP2-IgM 同时阴性19例,B19-DNA和B19-VP2-IgM 一致率为83.3%,有一致性(P<0.01).B19阳性与阴性川崎病患儿在性别、年龄、常见临床表现、预后等方面无差别.结论: 我国川崎病患儿B19病毒感染率较高可能是导致川崎病的主要病原体之一.

  6. Molecular epidemiology of Chlamydia trachomatis

    NARCIS (Netherlands)

    R.J.M. Bom

    2014-01-01

    Chlamydia trachomatis infections are the most prevalent bacterial sexually transmitted infections (STT) worldwide. A better understand of the transmission of C. trachomatis may contribute to improved screening and prevention programs in the future and ultimately alleviate this burden. Through the us

  7. Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study

    Directory of Open Access Journals (Sweden)

    Tuju James

    2010-04-01

    Full Text Available Abstract Background During acute Human parvovirus B19 (B19 infection a transient reduction in blood haemoglobin concentration is induced, due to a 5-7 day cessation of red cell production. This can precipitate severe anaemia in subjects with a range of pre-existing conditions. Of the disease markers that occur during B19 infection, high IgM levels occur closest in time to the maximum reduction in haemoglobin concentration. Previous studies of the contribution of B19 to severe anaemia among young children in Africa have yielded varied results. This retrospective case/control study seeks to ascertain the proportion of severe anaemia cases precipitated by B19 among young children admitted to a Kenyan district hospital. Methods Archival blood samples from 264 children under 6 years with severe anaemia admitted to a Kenyan District Hospital, between 1999 and 2004, and 264 matched controls, were tested for B19 IgM by Enzyme Immunosorbent Assay and 198 of these pairs were tested for B19 DNA by PCR. 536 samples were also tested for the presence of B19 IgG. Results 7 (2.7% cases and 0 (0% controls had high B19 IgM levels (Optical Density > 5 × cut-off value (McNemar's exact test p = 0.01563, indicating a significant association with severe anaemia. The majority of strongly IgM positive cases occurred in 2003. 10/264 (3.7% cases compared to 5/264 (1.9% controls tested positive for B19 IgM. This difference was not statistically significant, odds ratio (OR = 2.00 (CI95 [0.62, 6.06], McNemar's exact test p = 0.3018. There was no significant difference between cases and controls in the B19 IgG (35 (14.8% vs 32 (13.6%, OR = 1.103 (CI95 [0.66, 1.89], McNemar's exact test, p = 0.7982, or the detection of the B19 DNA (6 (3.0% vs 5 (2.5%, OR = 1.2 (CI95 [0.33, 4.01], McNemar's exact test p = 1. Conclusions High B19 IgM levels were significantly associated with severe anaemia, being found only among the cases. This suggests that 7/264 (2.7% of cases of severe

  8. Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia

    Directory of Open Access Journals (Sweden)

    Zili Mohamed

    2007-10-01

    Full Text Available Abstract Background Human parvovirus B19 is the etiologic agent of erythema infectiosum in children. It is also associated with other clinical manifestations in different target groups. Patients with chronic hemolytic anemia are at high risk of developing acute erythroblastopenia following infection by the virus. They usually become highly viremic and pose an increased risk of virus transmission. Close monitoring of such high risk groups is required for epidemiologic surveillance and disease prevention activities. Here we report a molecular epidemiological study on B19 virus infection in Tunisian patients with chronic hemolytic anemia. Methods This study was conducted on 92 young chronic hemolytic anemia patients who attended the same ward at the National Bone Marrow Transplantation Center of Tunis and 46 controls from a different hospital. Screening for IgM and IgG anti-B19 antibodies was performed using commercially available enzyme immunoassays and B19 DNA was detected by nested PCR in the overlapping VP1/VP2 region. DNA was sequenced using dideoxy-terminator cycle sequencing technology. Results Anti-parvovirus B19 IgG antibodies were detected in 26 of 46 sickle-cell anemia patients, 18 of 46 β-thalassemia and 7 of 46 controls. Anti-parvovirus B19 IgM antibodies were detected only in 4 of the sickle-cell anemia patients: two siblings and two unrelated who presented with acute erythroblastopenia at the time of blood collection for this study and had no history of past transfusion. B19 DNA was detected only in sera of these four patients and the corresponding 288 bp nested DNA amplicons were sequenced. The sequences obtained were all identical and phylogenetic analysis showed that they belonged to a new B19 virus strain of Genotype1. Conclusion A new parvovirus B19 strain of genotype1 was detected in four Tunisian patients with sickle-cell anemia. Virus transmission appeared to be nosocomial and resulted in acute erythroblastopenia in the four

  9. 人细小病毒B19与疾病相关性的研究

    Institute of Scientific and Technical Information of China (English)

    黄俊琳; 梁太英

    2002-01-01

    @@ 人细小病毒B19(human parvovirus B19,HPV B19)是近十余年来发现的一个重要病原体.为研究梧州市及周边地区B19感染的疾病谱,现将该地区健康自然人群及患者检测情况作一总结报告.

  10. No evidence of persistent parvovirus B19 viremia among Iranian patients with HIV after a 1-year follow-up.

    Science.gov (United States)

    Aghakhani, Arezoo; Mohraz, Minoo; Azadmanesh, Kayhan; Moayedi-Nia, Saeedeh; Kazemimanesh, Monireh; Mamishi, Setareh; Banifazl, Mohammad; Ramezani, Amitis

    2016-05-01

    Recent studies have demonstrated that, in common with other latent viruses, parvovirus B19 infection can be controlled by the host immune response but may persist in some places such as the bone marrow. Persistent B19 infection has been found in both immunocompetent and immunocompromised individuals, such as patients infected with human immunodeficiency virus (HIV). However, there is limited data regarding long-term B19 viremia in HIV patients. In this study, we investigated virological and hematological findings, and also the clinical outcome, of seven cases of HIV/B19 coinfection (confirmed by PCR) after one year. These cases were provided from a previous study on patients with HIV infection that found B19 DNA in 13 cases. Seven of these 13 patients were available after 1 year, and we retested them for B19 viremia and B19-specific antibodies. B19 IgG was tested by ELISA, and B19 DNA was assessed by nested PCR. Anemia was not observed in these cases. All subjects had cleared viremia, but B19 IgG seroconversion occurred in two cases. No significant changes in CD4 and hemoglobin occurred. The results of this study indicate that B19 infection in HIV patients is a subtle infection and that B19 viremia is not a long-term event. PMID:26860911

  11. Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles

    International Nuclear Information System (INIS)

    Although sharing a T = 1 icosahedral symmetry with other members of the Parvoviridae family, it has been suggested that the fivefold channel of the human parvovirus B19 VP2 capsids is closed at its outside end. To investigate the possibility of placing a relatively large protein moiety at this site of B19, fluorescent virus-like particles (fVLPs) of B19 were developed. The enhanced green fluorescent protein (EGFP) was inserted at the N-terminus of the structural protein VP2 and assembly of fVLPs from this fusion protein was obtained. Electron microscopy revealed that these fluorescent protein complexes were very similar in size when compared to wild-type B19 virus. Further, fluorescence correlation spectroscopy showed that an average of nine EGFP domains were associated with these virus-like structures. Atomic force microscopy and immunoprecipitation studies showed that EGFP was displayed on the surface of these fVLPs. Confocal imaging indicated that these chimeric complexes were targeted to late endosomes when expressed in insect cells. The fVLPs were able to efficiently enter cancer cells and traffic to the nucleus via the microtubulus network. Finally, immunoglobulins present in human parvovirus B19 acute and past-immunity serum samples were able to detect antigenic epitopes present in these fVLPs. In summary, we have developed fluorescent virus-like nanoparticles displaying a large heterologous entity that should be of help to elucidate the mechanisms of infection and pathogenesis of human parvovirus B19. In addition, these B19 nanoparticles serve as a model in the development of targetable vehicles designed for delivery of biomolecules

  12. Original Research: Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era.

    Science.gov (United States)

    Hankins, Jane S; Penkert, Rhiannon R; Lavoie, Paul; Tang, Li; Sun, Yilun; Hurwitz, Julia L

    2016-04-01

    Parvovirus B19 infection causes transient aplastic crisis in sickle cell disease (SCD) due to a temporary interruption in the red blood cell production. Toxicity from hydroxyurea includes anemia and reticulocytopenia, both of which also occur during a transient aplastic crisis event. Hydroxyurea inhibits proliferation of hematopoietic cells and may be immunosuppressive. We postulated that hydroxyurea could exacerbate parvovirus B19-induced aplastic crisis and inhibit the development of specific immune responses in children with SCD. We conducted a retrospective review of parvovirus B19 infection in 330 children with SCD. Altogether there were 120 known cases of aplastic crisis attributed to parvovirus B19 infection, and 12% of children were on hydroxyurea treatment during the episode. We evaluated hematological and immune responses. Children with HbSS or HbSβ(0)-thalassemia treated with hydroxyurea, when compared with untreated children, required fewer transfusions and had higher Hb concentration nadir during transient aplastic crisis. Duration of hospital stays was no different between hydroxyurea-treated and untreated groups. Children tested within a week following aplastic crisis were positive for parvovirus-specific IgG. Immune responses lasted for the duration of the observation period, up to 13 years after transient aplastic crisis, and there were no repeat aplastic crisis episodes. The frequencies of parvovirus-specific antibodies in all children with SCD increased with age, as expected due to the increased likelihood of a parvovirus exposure, and were comparable to frequencies reported for healthy children. Approximately one-third of children had a positive parvovirus B19-specific IgG test without a documented history of transient aplastic crisis, and 64% of them were treated with hydroxyurea. Hydroxyurea may reduce requirements for blood transfusions and may attenuate symptoms during transient aplastic crisis episodes caused by parvovirus B19 infections

  13. Human parvovirus B19 in Iranian pregnant women: A serologic survey

    Directory of Open Access Journals (Sweden)

    Zakieh Rostamzadeh Khameneh

    2014-01-01

    Full Text Available Background: Parvovirus B19 infection is associated with clinical symptoms that vary in the spectrum from trivial to severe. The important clinical manifestations are erythema infectiosum or the fifth disease, transient aplastic anemia in patients with hemoglobinopathies, acute polyarthralgia syndrome in adults, hydrops fetalis, spontaneous abortion and stillbirth. Acute infection in nonimmune pregnant women can lead to fetal hydrops. In view of the many complications that can result from acute parvovirus B19 infections during pregnancy, documenting the seroprevalence of anti-parvovirus B19 IgG and its association with the history of abortion in an Iranian population of pregnant women would be of value. Materials and Methods: Serum samples from 86 pregnant women were collected between May and September 2011 in West Azerbaijan province of Iran. Every pregnant woman completed a questionnaire which included age, history of tattooing, blood transfusion, and abortion. Anti-B19 specific IgG was detected by using commercial enzyme-linked immunosorbent assays. Results: Anti-B19-specific IgG antibody was detected in (65/86, 75.6% of pregnant women. The mean age was 25.56 ± 5.30 years and three women had a documented history of blood transfusion (2 of them tested seropositive for B19. 16/18 (88.8% of women with a history of abortion were IgG positive. The frequency of abortion sessions in the seropositive group (25 sessions of abortion: 11 women experienced once, 2 twice, 2 thrice and one 4 times was 4.03 times greater than abortion in seronegative group (2 abortions/21 seronegative women. Conclusion: Our study reaffirms previous reports regarding the higher frequency of abortion among anti-B19 IgG seropositive pregnant women and a possible role of this viral infection in the pathogenesis of abortion.

  14. Diagnosis and treatment in children With parvovirus B19 infection%儿童微小病毒B19感染的诊断与治疗

    Institute of Scientific and Technical Information of China (English)

    张国成

    2008-01-01

    人微小病毒B19经常感染儿童,临床表现复杂,轻者表现为自限性的传染性红斑,重者可因血细胞减少而导致患儿死亡.在免疫缺陷的患儿可发生持续感染.文章对改进其诊断和治疗,作了探讨.

  15. Chlamydophila pneumoniae infection and cardiovascular disease

    Directory of Open Access Journals (Sweden)

    Rajnish Joshi

    2013-01-01

    Full Text Available Atherosclerosis is a multifactorial vascular inflammatory process; however, the inciting cause for inflammation remains unclear. Two decades ago, Chlamydophila pneumoniae (formerly Chlamydia pneumoniae infection was proposed as a putative etiologic agent. We performed a PubMed search using the keywords Chlamydia and atherosclerosis in a Boolean query to identify published studies on C. pneumoniae and its role in atherogenesis, and to understand research interest in this topic. We found 1,652 published articles on this topic between 1991 and 2011. We analyzed relevant published studies and found various serological, molecular, and animal modeling studies in the early period. Encouraged by positive results from these studies, more than a dozen antibiotic clinical-trials were subsequently conducted, which did not find clinical benefits of anti-Chlamydophila drug therapy. While many researchers believe that the organism is still important, negative clinical trials had a similar impact on overall research interest. With many novel mechanisms identified for atherogenesis, there is a need for newer paradigms in Chlamydophila-atherosclerosis research.

  16. Sequence Homologies between Mycoplasma and Chlamydia spp. Lead to False-Positive Results in Chlamydial Cell Cultures Tested for Mycoplasma Contamination with a Commercial PCR Assay▿

    OpenAIRE

    Maass, Viola; Kern, Jan Marco; Poeckl, Matthias; Maass, Matthias

    2011-01-01

    Mycoplasma contamination is a frequent problem in chlamydial cell culture. After obtaining contradictory contamination results, we compared three commercial PCR kits for mycoplasma detection. One kit signaled contamination in mycoplasma-free Chlamydia pneumoniae cultures. Sequencing of cloned PCR products revealed primer homology with the chlamydial genome as the basis of this false-positive result.

  17. Screening on urogenital Chlamydia trachomatis

    Directory of Open Access Journals (Sweden)

    Busse, Reinhard

    2005-12-01

    Full Text Available Introduction: Around 92 million urogenital infections are caused yearly by Chlamydia trachomatis worldwide [1]. The overall incidence of sexually transmitted diseases is increasing, as shown by the increases in the number of reported cases of syphilis and gonorrhea [2]. Chlamydia trachomatis infections are associated with various serious diseases in women, men and newborns, which could be, at least partially, avoided by means of early diagnosis and therapy. The Federal Joint Committee - responsible for decision-making concerning the benefit package of the German Social Health Insurance - has publicly announced the starting of deliberations on the issue of screening for Chlamydia trachomatis. Research Questions: The leading question to be answered is whether screening for Chlamydia trachomatis should be included in the German benefit basket. The aim of this report is to provide a summary of the available evidence concerning the issue of screening for Chlamydia trachomatis. Methods: The summary of published scientific evidence, including HTA reports, systematic reviews, guidelines and primary research is represented. The synthesis follows the structure given by the criteria of Wilson and Jungner [3] for the introduction of screening in a population: relevance of the condition, availability of an adequate test, effectiveness of screening, acceptance of the programme, and economical issues. A literature search was conducted for each aspect of the synthesis and the evidence has been summarised in evidence tables. Results: We identified five HTA reports from three European agencies [4], [5], [6], [7] and one from the USA [8]. In addition, we identified four guidelines from Northamerica [9], [10], [11], [12] and one from Europe [13]. A total of 56 primary research publications were included: relevance of the disease (n=26, availability of test (n=1, effectiveness of screening (n=11, acceptance of the programme (n=11, economical issues (n=7. Discussion

  18. 肺癌患者肺炎衣原体IgG阳性与放射性肺损伤相关细胞因子的关系%Correlation between Chlamydia Pneumoniae IgG Positive in Lung Cancer Patients and Cytokines Related to Radiation-induced Pulmonary Lesion

    Institute of Scientific and Technical Information of China (English)

    张文熠; 乔田奎; 周道安; 袁素娟

    2011-01-01

    Background and objective There exsits intimate relationship between infection with chlamydia pneumoniae (Cpn) and lung cancer incidence. But few studies have been reported about radiation-induced pulmonary lesion in lung cancer patients infected with Cpn. The aim of this study is to explore the correlation between cytokines related to radiation-induced pulmonary lesion and Cpn IgG positive in lung cancer patients. Methods A total of 69 patients with lung cancer received chest radiotherapy. Blood samples were collected and frozen before radiotherapy (pre-RT), middle radiotherapy (mid-RT) and after radiotherapy (post-RT). Cpn IgG and levels of IL-1β, SP-A, TGF-β, and TNF-α were measured by enzymelinked immunosorbent assay (ELISA). Results In the total of 69 patients, 21 patients were Cpn IgG positive, 48 patients negative. The positive rate was 30.43%. In mid-RT concentration of IL-1 β in Cpn IgG positive and negative group were (35.82 ± 1 0.09) ng/L and (30.01 ±6.46) ng/L, with statistically significant difference (P<0.05). Pre-RT and post-RT concentrations of IL- 1 β in Cpn IgG positive and negative group had no statistically significant difference. Mid-RT concentrations of SP-A in Cpn IgG positive group and negative group were (641.78±106.81) ng/L and (100.86±61.4) ng/L respectively, with statistically significant difference (P<0.05). Post-RT concentration of SP-A in Cpn IgG positive and negative group were (657.47± 115.19) ng/L and (93.23±47.15) ng/L respectively, with statistically significant difference (P<0.05). Concentrations of TNF-α in Cpn IgG positive and negative group had no statistically significant difference. Concentrations of TGF-β in Cpn IgG positive group were (710.67±358.16) pg/mL in pre-RT, (1,002.06±542.16) pg/mL in mid-RT, (2,125.16±1,522.29) pg/mL, in post-RT;those in negative group were (867.77±412.48) pg/mL, (914.05±425.70) pg/mL, (1,073.36±896.01) pg/mL. Concentration of TGF-β in post-RT between Cpn IgG positive

  19. Investigation of parvovirus B19 infection in 266 pregnant women in Zhengzhou%郑州市流产或死胎孕妇人微小病毒B19感染情况测定

    Institute of Scientific and Technical Information of China (English)

    靳静; 冷弘; 徐慧丹; 刘全离; 赵国强

    2005-01-01

    目的:了解郑州市流产或死胎孕妇人微小病毒B19的感染情况.方法:采用ELISA和PCR方法分别检测郑州市237例正常孕妇及29例不明原因流产或死胎孕妇血清中B19-IgG、B19-IgM和B19 DNA表达情况.结果:29例流产或死胎孕妇B19-IgG、B19-IgM和B19 DNA阳性率分别为51.7%(15/29)、6.9%(2/29)和13.8%(4/29),237例正常孕妇B19-IgG、B19-IgM和B19 DNA阳性率分别30.4%(72/237)、1.3%(3/237)和2.5%(6/237),差异均有统计学意义(P<0.05).结论:郑州市孕妇中存在人微小病毒B19的感染,可能导致不明原因流产或死胎.

  20. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.

    Science.gov (United States)

    Rezaei, Farhad; Sarshari, Behrang; Ghavami, Nastaran; Meysami, Parisa; Shadab, Azadeh; Salimi, Hamid; Mokhtari-Azad, Talat

    2016-06-01

    Human Parvovirus B19 (B19V) is a prototype of the Erythroparvovirus genus in Parvoviridae family. B19V infections are often associated with fever and rash, and can be mistakenly reported as measles or rubella. Differential diagnosis of B19V illness is necessary for case management and also for public health control activities, particularly in outbreak situations in which measles or rubella is suspected. To investigate the causative role of B19V infection in children with measles- and rubella-like illness, a total of 583 sera from children with exanthema were tested for presence of B19V by determining anti-B19V IgG and IgM antibodies by ELISA as well as B19V DNA detection by nested PCR. DNA positive samples were assessed further for determination of viral load and sequence analysis by Real-Time PCR and Sanger sequencing method, respectively. Out of 583 patients, 112 (19.21%) patients were positive for B19V-IgM antibody, 110 (18.87%) were positive for B19V-IgG antibody, and 63 (10.81%) were positive for B19V viral DNA. The frequency of B19V-IgG antibodies were increased with age; that is children under 6 year old showed 7.11% seroprevalence for B19V-IgG as compared to 18.39% and 28.91% for age groups 6 to >11 and 11-14 years old, respectively. Phylogenetic analysis of the NS1-VPu1 overlapping region revealed that all sequenced B19V-DNA belonged to genotype 1. The results of this study may aid the surveillance programs aiming at eradicating measles/rubella virus in Iran, as infections with B19V can be mistakenly reported as measles or rubella if laboratory testing is not conducted. PMID:26538067

  1. Human parvovirus B19 and the safety of blood and blood-derived products%血液、血制品与人类微小病毒B19的传播

    Institute of Scientific and Technical Information of China (English)

    耿彦生; 张印法

    2007-01-01

    人类微小病毒B19(B19病毒)在人群中传播广泛,0.003%~0.6%的献血员带有B19病毒,在病毒血症早期献血员血液中B19DNA含量很高;血浆及血液制品中也经常能检测到B19DNA.通过输血或应用血制品能引起B19病毒的传播,B19病毒感染与多种疾病的发生有关.

  2. Chlamydia control in Europe: literature review

    DEFF Research Database (Denmark)

    Low, N; S, Redmond; Alexander, K;

    Executive summary The literature reviews in this report bring together published evidence about the prevalence and reproductive tract complications of chlamydia infection, and about the effectiveness and cost-effectiveness of chlamydia screening interventions. Population prevalence of chlamydia...... prevalence. Estimates of chlamydia positivity in surveys with low response rates should not be interpreted as estimates of population prevalence. Only two population-based surveys in EU/EEA Member States in this review had a response rate of >70%. The highest response rates were seen when specimens...

  3. Codon Optimization of Human Parvovirus B19 Capsid Genes Greatly Increases Their Expression in Nonpermissive Cells▿ †

    OpenAIRE

    Zhi, Ning; Wan, Zhihong; Liu, Xiaohong; Wong, Susan; Kim, Dong Joo; Young, Neal S.; Kajigaya, Sachiko

    2010-01-01

    Parvovirus B19 (B19V) is pathogenic for humans and has an extreme tropism for human erythroid progenitors. We report cell type-specific expression of the B19V capsid genes (VP1 and VP2) and greatly increased B19V capsid protein production in nonpermissive cells by codon optimization. Codon usage limitation, rather than promoter type and the 3′ untranslated region of the capsid genes, appears to be a key factor in capsid protein production in nonpermissive cells. Moreover, B19 virus-like parti...

  4. Etiology of community-acquired pneumonia in hospitalized patients in Jordan

    International Nuclear Information System (INIS)

    To ascertain the causative organisms of community acquired pneumonia (Cap) in Jordanian patients requiring hospital admission. A prospective study of both adults and children admitted to Princess Basma and Princess Rahma Teaching Hospitals in Irbid, Jordan with a diagnosis of CAP over a 6-month period from April to October 2002. A total of 35 adult patients were admitted with a mean age of 47 years, and 63 children with a mean age of 3 years. A pathogen was isolated from 25 (71%) adults, and from 17 (27%) children, and sputum cultures gave the best diagnostic yield. In adults Streptococcus pneumoniae was the most common isolate (26%), followed by Chlamydia pneumoniae (23%), Haemophilus influenzae (17%), Mycoplasma pneumoniae (9%), and Legionella pneumophila and Klebsiella pneumoniae (6%) each. Seven of the 9 gram negative isolates were from patients with some co morbid illness. While in children, Chlamydia pneumoniae was the most common (14%), followed by Mycoplasma pneumoniae (6%), and Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa (3%) each. Streptococcus pneumoniae and atypical microorganisms are the most common cause of CAP in previously healthy adults; while in those with associated co morbid illness, gram negative organisms are the likely cause. In children, the overall detection rate of causative organisms was low with atypical microorganisms being the most common. (author)

  5. Identification of recombination in the NS1 and VPs genes of parvovirus B19.

    Science.gov (United States)

    Shen, Hongxing; Zhang, Wen; Wang, Hua; Shao, Shihe

    2016-08-01

    Human parvovirus B19 (B19V), a member of the genus Erythrovirus of the family Parvoviridae, is a pathogenic virus distributed worldwide in the human population. In this study, we performed phylogenetic and recombination analysis of B19V based on the available nonstructural gene (NS1) and capsid proteins (VPs) genes in GenBank. Results indicated that recombination occurred between genotypes 3 and 1, leading to the recombinant cluster genotype 2. Other three inter-genotype recombination events were also discovered. Moreover, our results showed that among the four recombinant events in the present study, all of the major parents belonged to genotype 1, the minor parents were from genotypes 3 or 2, and all of the recombinants belonged to genotype 2. These recombinant events were confirmed by SimPlot Program and phylogenetic analysis. J. Med. Virol. 88:1457-1461, 2016. © 2016 Wiley Periodicals, Inc. PMID:26756922

  6. Viral pneumonia

    Science.gov (United States)

    More serious infections can result in respiratory failure, liver failure, and heart failure. Sometimes, bacterial infections occur during or just after viral pneumonia, which may lead to more serious forms ...

  7. Seroepidemiology of Human Parvovirus B19 in 5-25 Year Old Age People in Iran

    Directory of Open Access Journals (Sweden)

    V Salimi

    2008-12-01

    Full Text Available "nBackground: Parvovirus B19 (B19 is the only member of the family Parvoviridae associated with human infection. Al­though there are some studies to estimate the immunity to parvovirus in various populations but there is no seroepidemiologi­cal sur­vey from Iran until now thus the age-specific immunity to human parvovirus infection was esti­mated."nMethods:  A subset sample of 1500 study subjects in 2004 after Measles and Rubella mass campaign was selected from the original samples of 5000 sera kept at the Department of Virology in Tehran University of Medical Sciences. All sera were tested by a commercial ELISA kit."nResults: Totally, 1303 (86.6% of 1500 study subjects were seropositive for B19 IgG antibody. The seropositive rate of males and females were 85.3% and 88%, respectively (P= 0.129. The overall B19 seropositive rates in rural and urban were 84.3% and 88%, respectively (P= 0.044.  The seropositive rates were found to increase significantly with age and ranged from 79.3% in 5-9 year old group to 93.5% in 20-25 yr old group (P= 0.000."nConclusion: Our results indicate that in spite of high prevalence of B19 antibody the importance of routine diagnosis of B19 infection in order to elucidate the etiology of some unexplained 'exanthemata diseases' especially in measles elimina­tion and eradication phase is needed.

  8. The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.

    Science.gov (United States)

    Leisi, Remo; Di Tommaso, Chiarina; Kempf, Christoph; Ros, Carlos

    2016-03-01

    Parvovirus B19 (B19V) is known as the human pathogen causing the mild childhood disease erythema infectiosum. B19V shows an extraordinary narrow tissue tropism for erythroid progenitor cells in the bone marrow, which is determined by a highly restricted uptake. We have previously shown that the specific internalization is mediated by the interaction of the viral protein 1 unique region (VP1u) with a yet unknown cellular receptor. To locate the receptor-binding domain (RBD) within the VP1u, we analyzed the effect of truncations and mutations on the internalization capacity of the recombinant protein into UT7/Epo cells. Here we report that the N-terminal amino acids 5-80 of the VP1u are necessary and sufficient for cellular binding and internalization; thus, this N-terminal region represents the RBD required for B19V uptake. Using site-directed mutagenesis, we further identified a cluster of important amino acids playing a critical role in VP1u internalization. In silico predictions and experimental results suggest that the RBD is structured as a rigid fold of three α-helices. Finally, we found that dimerization of the VP1u leads to a considerably enhanced cellular binding and internalization. Taken together, we identified the RBD that mediates B19V uptake and mapped functional and structural motifs within this sequence. The findings reveal insights into the uptake process of B19V, which contribute to understand the pathogenesis of the infection and the neutralization of the virus by the immune system. PMID:26927158

  9. Prolonged activation of virus-specific CD8+T cells after acute B19 infection.

    Directory of Open Access Journals (Sweden)

    2005-12-01

    Full Text Available BACKGROUND: Human parvovirus B19 (B19 is a ubiquitous and clinically significant pathogen, causing erythema infectiosum, arthropathy, transient aplastic crisis, and intrauterine fetal death. The phenotype of CD8+ T cells in acute B19 infection has not been studied previously. METHODS AND FINDINGS: The number and phenotype of B19-specific CD8+ T cell responses during and after acute adult infection was studied using HLA-peptide multimeric complexes. Surprisingly, these responses increased in magnitude over the first year post-infection despite resolution of clinical symptoms and control of viraemia, with T cell populations specific for individual epitopes comprising up to 4% of CD8+ T cells. B19-specific T cells developed and maintained an activated CD38+ phenotype, with strong expression of perforin and CD57 and downregulation of CD28 and CD27. These cells possessed strong effector function and intact proliferative capacity. Individuals tested many years after infection exhibited lower frequencies of B19-specific cytotoxic T lymphocytes, typically 0.05%-0.5% of CD8+ T cells, which were perforin, CD38, and CCR7 low. CONCLUSION: This is the first example to our knowledge of an "acute" human viral infection inducing a persistent activated CD8+ T cell response. The likely explanation--analogous to that for cytomegalovirus infection--is that this persistent response is due to low-level antigen exposure. CD8+ T cells may contribute to the long-term control of this significant pathogen and should be considered during vaccine development.

  10. Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells.

    Science.gov (United States)

    Bua, Gloria; Manaresi, Elisabetta; Bonvicini, Francesca; Gallinella, Giorgio

    2016-01-01

    The pathogenic Parvovirus B19 (B19V) is characterized by a strict adaptation to erythroid progenitor cells (EPCs), a heterogeneous population of differentiating cells with diverse phenotypic and functional properties. In our work, we studied the dynamics of B19V infection in EPCs in dependence on the cell differentiation stage, in terms of distribution of infected cells, synthesis of viral nucleic acids and production of infectious virus. EPCs at early differentiation stage led to an abortive infection, without viral genome replication and a very low transcriptional activity. EPCs at later stages were permissive, with highest levels of viral replicative activity at day 9 (+3.0 Log from 2 to 48 hpi) and lower levels at day 18 (+1.5 Log from 2 to 48 hpi). B19V DNA increment was in accordance with the percentage of cells positive to flow-FISH assay (41.4% at day 9, 1.1% at day 18). Quantitation of total RNA indicated a close association of genome replication and transcription with viral RNA accumulation within infected cells related to viral DNA increase during the course of infection. Analysis of the different classes of mRNAs revealed two distinct pattern of genome expression profile with a fine regulation in the frequency utilization of RNA processing signals: an early phase, when cleavage at the proximal site leading to a higher relative production of mRNA for NS protein, and a late phase, when cleavage at the distal site was more frequent leading to higher relative abundance of mRNA for VP and 11 kDA proteins. Infectious virus was released from cells at day 6-15, but not at day 18. Our results, providing a detailed description of B19V replication and expression profile in differentiating EPCs, highlight the very tight adaptation of B19V to a specific cellular target defined both by its erythroid lineage and its differentiation stage. PMID:26845771

  11. Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells.

    Directory of Open Access Journals (Sweden)

    Gloria Bua

    Full Text Available The pathogenic Parvovirus B19 (B19V is characterized by a strict adaptation to erythroid progenitor cells (EPCs, a heterogeneous population of differentiating cells with diverse phenotypic and functional properties. In our work, we studied the dynamics of B19V infection in EPCs in dependence on the cell differentiation stage, in terms of distribution of infected cells, synthesis of viral nucleic acids and production of infectious virus. EPCs at early differentiation stage led to an abortive infection, without viral genome replication and a very low transcriptional activity. EPCs at later stages were permissive, with highest levels of viral replicative activity at day 9 (+3.0 Log from 2 to 48 hpi and lower levels at day 18 (+1.5 Log from 2 to 48 hpi. B19V DNA increment was in accordance with the percentage of cells positive to flow-FISH assay (41.4% at day 9, 1.1% at day 18. Quantitation of total RNA indicated a close association of genome replication and transcription with viral RNA accumulation within infected cells related to viral DNA increase during the course of infection. Analysis of the different classes of mRNAs revealed two distinct pattern of genome expression profile with a fine regulation in the frequency utilization of RNA processing signals: an early phase, when cleavage at the proximal site leading to a higher relative production of mRNA for NS protein, and a late phase, when cleavage at the distal site was more frequent leading to higher relative abundance of mRNA for VP and 11 kDA proteins. Infectious virus was released from cells at day 6-15, but not at day 18. Our results, providing a detailed description of B19V replication and expression profile in differentiating EPCs, highlight the very tight adaptation of B19V to a specific cellular target defined both by its erythroid lineage and its differentiation stage.

  12. Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans

    DEFF Research Database (Denmark)

    Norbeck, Oscar; Isa, Adiba; Pöhlmann, Christoph;

    2005-01-01

    Murine models have suggested that CD8+ T-cell responses peak early in acute viral infections and are not sustained, but no evidence for humans has been available. To address this, we longitudinally analyzed the CD8+ T-cell response to human parvovirus B19 in acutely infected individuals. We...... observed striking CD8+ T-cell responses, which were sustained or even increased over many months after the resolution of acute disease, indicating that CD8+ T cells may play a prominent role in the control of parvovirus B19 and other acute viral infections of humans, including potentially those generated...

  13. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.

    OpenAIRE

    Anderson, L J; Tsou, C; Parker, R. A.; Chorba, T L; Wulff, H; Tattersall, P; Mortimer, P P

    1986-01-01

    Acute-phase serum from a patient with aplastic crisis provided sufficient human parvovirus B19 to make a monoclonal antibody against B19 and to develop antigen and immunoglobulin M (IgM) and IgG antibody detection enzyme-linked immunosorbent assays (ELISAs). The indirect capture antibody method was used for all three assays. Antigen was detected in 8 of 29 sera drawn within 2 days of onset of illness from patients with aplastic crisis. These sera had high titers of virus by electron microscop...

  14. Detection of Chlamydia in postmortal formalin-fixed tissue

    DEFF Research Database (Denmark)

    Lundemose, A G; Banner, Jytte; Birkelund, Svend;

    1989-01-01

    A procedure to detect Chlamydia in postmortal formalin-fixed tissue is described. Monoclonal antibodies against a genus specific chlamydia epitope were used in immunofluorescence to detect chlamydia inclusions in formalin-fixed tissue sections. Lung sections from chlamydia-infected mice were exam...

  15. How Is Pneumonia Treated?

    Science.gov (United States)

    ... page from the NHLBI on Twitter. How Is Pneumonia Treated? Treatment for pneumonia depends on the type ... can go back to their normal routines. Bacterial Pneumonia Bacterial pneumonia is treated with medicines called antibiotics. ...

  16. Establishment ofin situ hybridization technique for detection of parvovirus B19 and its clinical application%原位杂交检测微小病毒B19方法的建立及临床应用

    Institute of Scientific and Technical Information of China (English)

    王晓明; 李源; 张国成; 韩美玉

    2000-01-01

    Objective To establish In situ bybridization(ISH) technique to detect parvovirus B19 and to knowthe viral location in cardiac tissue of congenital heart diseases(CHD). Methbods ISH method was establisbed with ran-domly primed,degoxigenin labeled B19 DNA probe of 1 112 bp long corresponding to parvovirus B19 capsid protein VP1genome. Results Dot blot hybridization showed that B19 DNA was positive with the sensitivity of 0.1 pg/μl, whileCMV 、HSV、TOX DNA were all negative. 7 out of 66 CHD cardiac tissues were B19 DNA positive by using ISH, while in38 cases of control group were all negative. B19 DNA positive signal was found in the nucleus of cardiac cell. Conclu-sion We have established ISH to detect B19 DNA that has high sensitivity(0.1 pg/μl)and specificity and have foundthat B19 DNA is located the nucleus of cardiac cell.%目的 建立原位杂交(ISH)方法 检测人微小病毒B19,并确定其在先天性心脏病(CHD)心脏组织细胞的定位分布。方法 以B19特异的衣壳蛋白VPl DNA内1 112 bp片段为模板,采用随机引物标记探针法,建立了ISH检测B19 DNA。结果 通过斑点杂交定性分析显示B19 DNA呈阳性,CMV、HSV和TOXDNA均呈阴性;定量分析B19 DNA浓度于0.1 pg/μl以上呈阳性。在66例先天性心脏病心脏组织中,检测到B19 DNA阳性7例,并发现B19 DNA阳性信号主要定位于心肌细胞核内,38例对照组健康心肌中均阴性。结论  建立的ISH检测先天性心脏病心脏组织B19的方法 有良好的特异性及敏感性,敏感性达0.1 pg/μl,并确定B19 DNA定位于心肌组织的心肌细胞核内。

  17. Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice.

    Directory of Open Access Journals (Sweden)

    Tsai-Ching Hsu

    Full Text Available Systemic lupus erythematosus (SLE is an autoimmune disorder with unknown etiology that impacts various organs including liver. Recently, human parvovirus B19 (B19 is recognized to exacerbate SLE. However, the effects of B19 on liver in SLE are still unclear. Herein we aimed to investigate the effects of B19 on liver in NZB/W F1 mice by injecting subcutaneously with PBS, recombinant B19 NS1, VP1u or VP2, respectively. Our experimental results revealed that B19 NS1 protein significantly enhanced the TGF-β/Smad fibrotic signaling by increasing the expressions of TGF-β, Smad2/3, phosphorylated Smad2/3, Smad4 and Sp1. The consequent fibrosis-related proteins, PAI-1 and α-SMA, were also significantly induced in livers of NZB/W F1 mice receiving B19 NS1 protein. Accordingly, markedly increased collagen deposition was also observed in livers of NZB/W F1 mice receiving B19 NS1 protein. However, no significant difference was observed in livers of NZB/W F1 mice receiving B19 VP1u or VP2 as compared to the controls. These findings indicate that B19 NS1 plays a crucial role in exacerbating liver fibrosis in NZB/W F1 mice through enhancing the TGF-â/Smad fibrotic signaling.

  18. 人细小病毒B19与异位妊娠关系的初步研究%Study on the relationship between human parvovirus B19 and ectopic pregnancy

    Institute of Scientific and Technical Information of China (English)

    吴小红; 谭继英; 高峻; 吴玉凤

    2002-01-01

    目的探讨异位妊娠与人细小病毒B19(HPV B19)的关系.方法用聚合酶连反应(PCR)检测异位妊娠和妊娠无异常妇女血清中的人细小病毒B19 DNA.结果病例组:76例异位妊娠组的血清中HPV B19 DNA有18例阳性,阳性率为23.68%;对照组:40例妊娠无异常孕妇HPV B19 DNA,有2例为阳性,阳性率为5.00%,P<0.05,两组有显著性差异.结论人细小病毒B19感染可能是异位妊娠的原因之一.

  19. Detection of Human Parvovirus B19 in Blood Cells of Pregnant Women and Newborns%母婴血细胞人微小病毒B19感染的检测

    Institute of Scientific and Technical Information of China (English)

    王净; 许桦; 窦骏; 过志君; 任慕兰; 蒋黎

    2004-01-01

    目的:配对调查母婴血细胞B19病毒感染情况.方法:用套式PCR分别检测孕妇外周血单个核细胞(PBMC)和新生儿脐血有核细胞(CBNC)B19病毒DNA.结果:孕妇PBMC B19病毒DNA阳性率3.06%(3/98),新生儿脐血CBNC B19病毒DNA阳性率1.12%(1/89).结论:孕妇PBMC和新生儿CBNC存在B19病毒感染,但母婴垂直传播B19病毒风险较低.

  20. Adult Reye-like syndrome associated with serologic evidence of acute parvovirus B19 infection

    Directory of Open Access Journals (Sweden)

    Paulo Sérgio Gonçalves da Costa

    2011-10-01

    Full Text Available Reye's syndrome is an infrequently diagnosed medical condition affecting mainly children. The etiology, epidemiology and natural history of Reye's syndrome have been cloudily written in footnotes of medical books and exotic papers since the initial description in early 1950s. We report here a case of adult Reye's syndrome associated with serologic evidence of parvovirus B19 infection.

  1. Erythrovirus B19 infection in acquired immunodeficiency syndrome: screening by histopathology, immunohistochemistry, and in situ hybridization

    Directory of Open Access Journals (Sweden)

    Sérgio Setúbal

    2006-06-01

    Full Text Available Erythrovirus B19 infects erythrocytic progenitors, transiently interrupting erythropoiesis. In AIDS patients it causes chronic anemia amenable to treatment. We looked for evidences of B19 infection in stored bone marrow material from patients with acquired immunodeficiency syndrome. Histological sections were made from stored paraffin blocks from 33 autopsies (39 blocks and 35 biopsies (45 blocks, 30 patients performed from 1988 to 2002. They were examined after hematoxylin-eosin (HE staining, immunohistochemical (IHC, and in situ hybridization. HE revealed intra-nuclear inclusion bodies ("lantern cells" suggesting B19 infection in 19 sections corresponding to 19 of 63 patients examined with this test. Seven of 78 sections subjected to immunohistochemistry were positive, corresponding to 7 of 58 patients examined with this test. Fourteen sections corresponding to 13 of the 20 HE and/or IHC positive patients were subjected to in situ hybridization, with six positives results. Among the 13 patients subjected to the three techniques, only one gave unequivocal positive results in all and was considered a true positive. The frequency of B19 infection (1/63 patients in the material examined can be deemed low.

  2. Estimation of serum concentration of parvovirus B19 DNA by PCR in patients with chronic anemia

    DEFF Research Database (Denmark)

    Hornsleth, A.; Carlsen, K. M.; Christensen, Laurids Siig;

    1994-01-01

    Parvovirus B19 DNA was detected in serum samples from 10 out of 42 patients with chronic anaemia, the majority of whom suffered from aplastic anaemia, haemolytic anaemia, pure red cell anaemia or myelodysplastic syndrome. Nested PCR methods with sensitivities of 0.005-0.05 fg DNA were developed...

  3. The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies

    DEFF Research Database (Denmark)

    Nielsen, Trine Skov; Hansen, Jakob; Nielsen, Lars Peter;

    2014-01-01

    of adenovirus, enterovirus, and parvovirus B19 (PVB) in myocardial autopsy samples from myocarditis related deaths and in non-inflamed control hearts in an effort to clarify their significance as the causes of myocarditis in a forensic material. METHODS: We collected all autopsy cases diagnosed with myocarditis...

  4. Slow clearance of human parvovirus B19 viremia following acute infection

    DEFF Research Database (Denmark)

    Lindblom, Anna; Isa, Adiba; Norbeck, Oscar;

    2005-01-01

    Parvovirus B19 is a common, clinically significant pathogen. Reassessment of the viral kinetics after acute infection showed that the virus is not rapidly cleared from healthy hosts, despite early resolution of symptoms. These findings challenge our current conception of the virus' pathogenesis...

  5. Hereditary Spherocytosis Unmasked by Human Parvovirus B19 Induced Aplastic Crisis in a Family

    Directory of Open Access Journals (Sweden)

    Samin Alavi

    2015-09-01

    Full Text Available Human parvovirus (HPV B19 induced aplastic crisis in a family leading to the diagnosis of hereditary spherocytosis (HS is a very rare condition being barely reported in the literature. We herein report a 4-year-old girl, her brother, and their mother who all presented with progressive pallor and jaundice after a febrile illness. The HPV B19 was diagnosed using polymerase chain reaction (PCR and positive serology for specific anti-HPV B19 IgM. They were further diagnosed with having HS. The clinical importance of this report is that in the case of an abrupt onset of unexplained severe anemia and jaundice, one should consider underlying hemolytic anemias mostly hereditary spherocytosis complicated by HPV B19 aplastic crisis. Herein, we report the occurrence of this condition, simultaneously in three members of a family. The distinguished feature of this report is that all affected family members developed some degrees of transient pancytopenia, not only anemia, all simultaneously in the course of their disease.

  6. Two family members with a syndrome of headache and rash caused by human parvovirus B19

    Directory of Open Access Journals (Sweden)

    Antonio Carlos M. Pereira

    2001-02-01

    Full Text Available Human parvovirus B19 infection can cause erythema infectiosum (EI and several other clinical presentations. Central nervous system (CNS involvement is rare, and only a few reports of encephalitis and aseptic meningitis have been published. Here, we describe 2 cases of B19 infection in a family presenting different clinical features. A 30 year old female with a 7-day history of headache, malaise, myalgias, joint pains, and rash was seen. Physical examination revealed a maculopapular rash on the patient's body, and arthritis of the hands. She completely recovered in 1 week. Two days before, her 6 year old son had been admitted to a clinic with a 1-day history of fever, headache, abdominal pain and vomiting. On admission, he was alert, and physical examination revealed neck stiffness, Kerning and Brudzinski signs, and a petechial rash on his trunk and extremities. Cerebrospinal fluid analysis was normal. He completely recovered in 5 days. Acute and convalescent sera of both patients were positive for specific IgM antibody to B19. Human parvovirus B19 should be considered in the differential diagnosis of aseptic meningitis, particularly during outbreaks of erythema infectiosum. The disease may mimic meningococcemia and bacterial meningitis.

  7. Anemia crônica no pós-transplante renal: parvovirose B19

    Directory of Open Access Journals (Sweden)

    Natália Calderia Loss Vincens

    2012-09-01

    Full Text Available A anemia é frequente em pacientes após o transplante renal (TxR e sua prevalência varia conforme o tempo pós-transplante e os critérios diagnósticos empregados. A infecção pelo Parvovírus B19 (PV B19 é causa subdiagnosticada de anemia nesta população. Para ilustrar a epidemiologia e espectro clínico, apresentamos caso de PV B19 que evoluiu com aplasia pura de série vermelha (APSV, ressaltando as dificuldades do diagnóstico e tratamento. O emprego da detecção do DNA viral pela reação em cadeia da polimerase e do diagnóstico das alterações da morfologia da medula óssea são particularmente úteis para o diagnóstico no paciente transplantado imunossuprimido que falha na produção da resposta humoral contra o PV B19.

  8. 26 CFR 31.3121(b)(19)-1 - Services of certain nonresident aliens.

    Science.gov (United States)

    2010-04-01

    ... 26 Internal Revenue 15 2010-04-01 2010-04-01 false Services of certain nonresident aliens. 31.3121... 1954) General Provisions § 31.3121(b)(19)-1 Services of certain nonresident aliens. (a) (1) Services performed after 1961 by a nonresident alien individual who is temporarily present in the United States as...

  9. Hereditary Spherocytosis Unmasked by Human Parvovirus B19 Induced Aplastic Crisis in a Family.

    Science.gov (United States)

    Alavi, Samin; Arabi, Nahid; Yazdi, Mohammad Kaji; Arzanian, Mohammad Taghi; Zohrehbandian, Farahnaz

    2015-09-01

    Human parvovirus (HPV) B19 induced aplastic crisis in a family leading to the diagnosis of hereditary spherocytosis (HS) is a very rare condition being barely reported in the literature. We herein report a 4-year-old girl, her brother, and their mother who all presented with progressive pallor and jaundice after a febrile illness. The HPV B19 was diagnosed using polymerase chain reaction (PCR) and positive serology for specific anti-HPV B19 IgM. They were further diagnosed with having HS. The clinical importance of this report is that in the case of an abrupt onset of unexplained severe anemia and jaundice, one should consider underlying hemolytic anemias mostly hereditary spherocytosis complicated by HPV B19 aplastic crisis. Herein, we report the occurrence of this condition, simultaneously in three members of a family. The distinguished feature of this report is that all affected family members developed some degrees of transient pancytopenia, not only anemia, all simultaneously in the course of their disease. PMID:26379354

  10. Parvovirus B19-Induced Constellation of Acute Renal Failure, Elevated Aminotransferases and Congestive Heart Failure

    Directory of Open Access Journals (Sweden)

    Iain W McAuley

    1997-01-01

    Full Text Available This report details a case of acute renal failure and elevated aminotransferases with subsequent development of congestive heart failure in a patient with history of exposure to parvovirus B19 and serological evidence of acute infection with this agent. This constellation of organ involvement has not been previously reported in the literature.

  11. 微小病毒B19感染与传染性红斑的研究进展%Development in the study of micro virus B19 and infectious erythema

    Institute of Scientific and Technical Information of China (English)

    翟云丽; 李海潮; 陆滨; 杨海

    2003-01-01

    @@ 人类微小病毒B19(Human Parvoviruses B19,HPV-B19)感染引起的具有典型特征、儿童多发的出疹性疾病--传染性红斑(Erythema Infectiosum,EI)也称第五病,早在1889年已有过详细描述,但确切病因不清.

  12. 小儿血液系统疾病人细小病毒B 19感染的研究%The investigation of HPV B19 infection on children with blood system diseases

    Institute of Scientific and Technical Information of China (English)

    许东亮; 张国成; 聂晓晶; 孙新; 吴海霞; 徐晓莉

    2014-01-01

    目的:探讨我国西北地区血液系统疾病患儿人细小病毒B19(H PV B19)感染情况及两者的相关性。方法:对特发性血小板减少性紫癜、再生障碍性贫血和白血病患儿的外周血分别采用PCR方法检测HPV B19-DNA和ELISA方法检测HPV B19-IgG。结果:特发性血小板减少性紫癜患儿HPV B19-IgG阳性率为43.08%(28/65),白血病患儿 HPV B19-IgG阳性率为41.07%(46/112),病例组较对照组比较有极显著性差异(P<0.01);再生障碍性贫血患儿 HPV B19-IgG阳性率为21.43%(6/28),病例组较对照组比较有显著性差异( P<0.05)。65例特发性血小板减少性紫癜患儿HPV B19-DNA阳性率为40.00%(26/65);28例再生障碍性贫血患儿 HPV B19-DNA阳性率为21.43%(6/28);112例白血病患儿 HPV B19-DNA 阳性率为27.68%(31/112);对照组 HPV B19-DNA检测均为阴性。结论:HPV B19感染与我国西北地区部分血液系统疾病患儿发病相关。%Objective:To investigate the relationship between human parvovirus B 19 (HPV B19 ) infection and children who had blood system disease .Methods :PCR and ELISA methods were used to detecte HPV B19-DNA and HPV B19-IgG in child who had idiopathic thrombocytopenic purpura ,aplastic anemia or leukemia .Results :The positive rate of HPV B19-IgG was 43 .08% in patient with idiopathic thrombocytopenic purpura ,the positive rate of HPV B19-IgG was 41 .07% in patient with leukemia ,and the positive rate of HPV B19-IgG was 21 .43% in patient with aplastic anemia .There were statistical differences between the experiment groups and the control group .The positive rate of HPV B19-DNA was 40 .00% in patient with idiopathic thrombocytopenic purpura ,the positive rate of HPV B19-DNA was 27 .68% in patient with leukemia ,and the positive rate of HPV B19-DNA was 21 .43% in patient with aplastic anemia .Conclusion :HPV B19 infection have relationship with some children

  13. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice.

    Science.gov (United States)

    Hsu, Tsai-Ching; Chiu, Chun-Ching; Chang, Shun-Chih; Chan, Hsu-Chin; Shi, Ya-Fang; Chen, Tzy-Yen; Tzang, Bor-Show

    2016-01-01

    Human parvovirus B19 (B19V) is a human pathogen known to be associated with many non-erythroid diseases, including hepatitis. Although B19V VP1-unique region (B19-VP1u) has crucial roles in the pathogenesis of B19V infection, the influence of B19-VP1u proteins on hepatic injury is still obscure. This study investigated the effect and possible inflammatory signaling of B19-VP1u in livers from BALB/c mice that were subcutaneously inoculated with VP1u-expressing COS-7 cells. The in vivo effects of B19-VP1u were analyzed by using live animal imaging system (IVIS), Haematoxylin-Eosin staining, gel zymography, and immunoblotting after inoculation. Markedly hepatocyte disarray and lymphocyte infiltration, enhanced matrix metalloproteinase (MMP)-9 activity and increased phosphorylation of p38, ERK, IKK-α, IκB and NF-κB (p-p65) proteins were observed in livers from BALB/c mice receiving COS-7 cells expressing B19-VP1u as well as the significantly increased CRP, IL-1β and IL-6. Notably, IFN-γ and phosphorylated STAT1, but not STAT3, were also significantly increased in the livers of BALB/c mice that were subcutaneously inoculated with VP1u-expressing COS-7 cells. These findings revealed the effects of B19-VP1u on liver injury and suggested that B19-VP1u may have a role as mediators of inflammation in B19V infection. PMID:26632342

  14. High Prevalence of Human Parvovirus B19 DNA in Myocardial Autopsy Samples from Subjects without Myocarditis or Dilative Cardiomyopathy▿

    OpenAIRE

    Schenk, Thomas; Enders, Martin; Pollak, Stefan; Hahn, Ralph; Huzly, Daniela

    2008-01-01

    Human parvovirus B19 has been linked to a variety of cardiac diseases, as well as to erythema infectiosum, acute arthropathy, and fetal hydrops. A causal association between viral infection and cardiac disease was frequently postulated following the detection of B19 DNA by PCR in endomyocardial biopsy specimens. Since the lifelong persistence of B19 DNA in bone marrow, skin, synovia, tonsils, and liver was previously reported, the aim of our study was to investigate the possibility of asympto...

  15. 人细小病毒B19感染与神经系统疾病

    Institute of Scientific and Technical Information of China (English)

    曹玉红; 张光运; 张国成

    2000-01-01

    @@本文就人细小病毒B19(Human parvovirus B19,简称B19)的生物学特征、脑病患者B19基因组特点、B19相关神经系统疾病的发病机制、临床表现、诊断、防治等,综述如下。 1 B19病毒的生物学特征 B19是动物病毒中体积最小、结构最简单的一种直径为23nm、无包膜、单链线状DNA病毒,含5.6kb碱基对。B19基因组编码两种衣壳蛋白即VP1(83ku)、VP2(58ku)和一个非结构蛋白NS1-1(77ku)。VP2氨基酸序列包含在VP1中,它们组成衣壳包裹在B19-DNA表面,构成B19的抗原性,参与机体的免疫反应;NS-1蛋白与B19毒力有关。B19的宿主范围为从红系爆式集落形成单位(BFU-E)到有核红细胞的红系细胞,其易感性随细胞分化而增加[1]。

  16. THE RELATIONSHIP OF HUMAN PARVOVIRUS B19 INFECTION WITH OCCURRENCE OF RHEUMATOID ARTHRITIS%人细小病毒B19感染与类风湿性关节炎发病的关联分析

    Institute of Scientific and Technical Information of China (English)

    王清; 伦立民; 孙美玲; 王丽华; 贾红岩

    2010-01-01

    [目的]探讨人细小病毒B19(B19)感染导致类风湿性关节炎(RA)的机理及免疫因素在其中的作用.[方法]随机抽取住院RA患者56例为病例组,外伤和骨关节炎55例作为对照组,应用聚合酶链反应(PCR)对其血液和关节液标本进行B19-DNA检测.同时对另外31例RA病例和11例对照的骨髓标本也进行B19-DNA检测.应用酶联免疫吸附测定法(ELISA)对上述血液标本进行B19-VP2-IgM检测以及血清中的炎症细胞因子(CK)TNF-α,IL-1,IL-6,IL-8的检测. [结果]病例组血标本B19-DNA阳性19例(33.9%),关节液标本B19-DNA阳性20例(35.7%);B19-VP2-IgM阳性14例(25.0%)与对照组间差异均有统计学意义(血x2=14.69,P<0.01,关节液x2=14.69,P<0.01.B19-VP2-IgM x2=10.272,P<0.05).在56例RA中,12例B19-DNA、B19-VP2-IgM阳性,2例仅B19-VP2-IgM阳性,7例仅B19-DNA阳性,同时B19-DNA、B19-VP2-IgM阴性35例;一致率为83.9%(P>0.05).RA患者31例骨髓标本中16例B19-DNA阳性,阳性率为51.6%,与对照组(9.1%)比较差异有统计学意义(x2=4.284,P<0.05).RA患者骨髓标本B19-DNA阳性宰高于血清(x2=4.313,P<0.05)和关节液(x2=4.313,P<0.05).病例组CK水平高于对照组,两组间差异具有统计学意义.病例组B19-DNA阳性和B19-DNA阴性间上述细胞因子水平的比较差异无统计学意义. [结论]RA患者有较高的B19病毒感染率,B19病毒与RA密切相关,但B19并非是导致RA的唯一因素,作为一种诱发刺激因素,与其他致病因素协同作用,导致部分患者免疫功能紊乱,从而导致RA的发生.

  17. Guillain-Barré Syndrome Associated with Primary Parvovirus B19 Infection in an HIV-1-Infected Patient

    OpenAIRE

    Caroline Bucher Praz; Cédric Dessimoz; Frank Bally; Sitthided Reymond; Nicolas Troillet

    2012-01-01

    Parvovirus B19 (B19V) infection has rarely been reported as responsible for Guillain-Barré syndrome (GBS). We present the case of a 63-year-old man with AIDS who presented with rapidly progressing weakness of his inferior limbs and a newly appeared pancytopenia. CSF examination and electromyography were characteristic for GBS. Very high CSF and serum B19V DNA concentrations were present, in the absence of IgG or IgM against B19V. The neurologic and hematologic abnormalities improved after a 5...

  18. Th17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: a possible linkage to parvovirus B19 infection.

    Directory of Open Access Journals (Sweden)

    Der-Yuan Chen

    Full Text Available Dilated cardiomyopathies (DCM are a major cause of mortality in patients with systemic lupus erythematosus (SLE. Immune responses induced by human parvovirus B19 (B19 are considered an important pathogenic mechanism in myocarditis or DCM. However, little is known about Th17-related cytokines in SLE patients with DCM about the linkage with B19 infection. IgM and IgG against B19 viral protein, and serum levels of Th17-related cytokines were determined using ELISA in eight SLE patients with DCM and six patients with valvular heart disease (VHD. Humoral responses of anti-B19-VP1u and anti-B19-NS1 antibody were assessed using Western blot and B19 DNA was detected by nested Polymerase Chain Reaction (PCR. Levels of interleukin (IL-17, IL-6, IL-1β, and tumor necrosis factor (TNF-α were significantly higher in SLE patients with DCM (mean ± SEM, 390.99±125.48 pg/ml, 370.24±114.09 pg/ml, 36.01±16.90 pg/ml, and 183.84±82.94 pg/ml, respectively compared to healthy controls (51.32±3.04 pg/ml, p<0.001; 36.88±6.64 pg/ml, p<0.001; 5.39±0.62 pg/ml, p<0.005; and 82.13±2.42 pg/ml, p<0.005, respectively. Levels of IL-17 and IL-6 were higher in SLE patients with DCM versus those with VHD (both p<0.01. Five (62.5% of DCM patients had detectable anti-B19-NS1 IgG and four (50.0% of them had anti-B19-VP1u IgG, whereas only one (16.7% of VHD patients had detectable anti-B19-NS1 IgG and anti-B19-VP1u IgG. Serum levels of IL-17, IL-6 and IL-1β were markedly higher in SLE patients with anti-B19-VP1u IgG and anti-B19-NS1 IgG compared to those without anti-B19-VP1u IgG or anti-B19-NS1 IgG, respectively. These suggest a potential association of B19 with DCM and Th17-related cytokines implicated in the pathogenesis of DCM in SLE patients.

  19. Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver.

    OpenAIRE

    Yaegashi, N; Shiraishi, H; Takeshita, T.; Nakamura, M.; Yajima, A; Sugamura, K

    1989-01-01

    Erythroid lineage cells derived from fetal liver were demonstrated to be target cells for human parvovirus B19 infection. B19 virus antigen-positive serum was inoculated into primary cultures containing erythroid lineage cells enriched from fetal liver. The B19 virus antigen was detected on about 5% of cells in the culture by immunofluorescence staining, and the stained cells were identified as erythroid lineage cells by double staining with anti-B19 virus-positive serum and anti-erythroid li...

  20. Comparison of different diagnostic methods for rapid detection of human parvovirus B19 infection%快速诊断人细小病毒B19感染方法学比较研究

    Institute of Scientific and Technical Information of China (English)

    许东亮; 张国成; 聂晓晶; 成胜权; 孙新; 李志宏; 杨晓蕾; 吕香萍

    2013-01-01

    目的 比较本实验室自行构建的ELISA法与德国ELISA试剂盒方法及PCR法快速诊断人细小病毒B19感染的临床应用价值.方法 血液标本215份,分别采用B19病毒VP1独特区(VP1u)蛋白包被ELISA板建立B19病毒抗体检测方法(自行构建ELISA法),德国ELISA试剂盒方法检测标本B19病毒IgM与IgG,并采用PCR法检测B19病毒DNA,分析自行构建E1ISA法检测B19病毒的敏感性、特异性及准确度.结果 自行构建的B19病毒ELISA体系最佳抗原包被量为25 ng/孔,最佳标本血清稀释倍数为1∶ 200;以德国B19病毒ELISA试剂盒为对照,自行构建ELISA法检测B19病毒IgM的敏感性、特异性及准确度分别为79.07%,87.18%,94.89%,检测B19病毒IgG的敏感性、特异性及准确度分别为88.46%,90.79%,93.53%;以PCR法检测B19病毒DNA为标准,自行构建ELISA法检测B19病毒IgG的敏感性、特异性及准确度分别为90.32%,77.77%,95.71%.结论 本实验室自行构建的ELISA检测方法与德国B19病毒抗体检测ELISA试剂盒法及PCR法检测B19病毒DNA有较好一致性,可作为B19病毒感染常规诊断方法.

  1. 人细小病毒B19感染在类风湿性关节炎发生中的作用%THE ROLE OF HUMAN PARVOVIRUS B19 INFECTION IN RHEUMATOID ARTHRITIS

    Institute of Scientific and Technical Information of China (English)

    常增民; 王清

    2007-01-01

    目的 探讨人细小病毒B19感染与类风湿性关节炎(RA)的关系.方法 采用聚合酶链反应和酶联免疫吸附法对56例类风湿性关节炎病人(观察组)及55例非类风湿性关节炎病人(对照组)进行血清B19-DNA和B19-VP2-IgM检测,并对31例RA病人和11例对照组病人骨髓进行了B19-DNA检测.结果 观察组血清B19-DNA阳性率为33.9%,对照组为5.5%,两组差异有极显著性(χ2=14.69,P<0.01).观察组血清B19-VP2-IgM阳性率为25.0%,对照组为3.6%,两组差异有显著性(χ2=10.27,P<0.05).在56例RA病人中,12例B19-DNA、B19-VP2-IgM阳性,2例仅B19-VP2-IgM阳性,7例仅B19-DNA阳性,B19-DNA、B19-VP2-IgM同时阴性35例,两者一致率为83.9%(P>0.05).成年RA病人骨髓标本中B19-DNA阳性率为51.6%,与对照组(9.1%)比较差异有显著性(P=0.02).讨论 RA病人B19病毒感染率较高,B19病毒感染与RA密切相关.

  2. Is parvovirus B19 infection congenital in congenital heart disease ?%B19病毒对先天性心脏病先天感染的探证及电镜观察

    Institute of Scientific and Technical Information of China (English)

    王晓明; 张国成; 韩美玉

    2001-01-01

    AIM To test if the parvovirus B19 infection in cardiac tissue in congenital heart disease (CHD) is congenital, and to observe the ultrastructural features of cardiac tissue of CHD. METHODS By using ELISA,B19-VP2-IgMwas detected in peripheral blood, and using PCR and ISH, B19-DNA was detected in cardiac tissue from 42 patients with congenital heart disease and 22 health controls; ultrastructure was observed by electron microscopy for B19-DNA positive cardiac tissue of CHD. RESULTS ① B19 -IgM positive rates were 4.7% and 4.1% in peripheral blood of CHD and controls, respectively. There was no significant difference (P>0.05). ② B19-DNA positive rates were 19.1% and 0% in cardiac tissue of CHD and control respectively. No significant difference was seen(P0.05);②CHD组中B19-DNA阳性8例(19%),与对照组均阴性相比有显著性差异(P<0.01),且与8例心肌B19-DNA阳性标本配对的血中B19-VP2-IgM均阴性;③ISH显示B19DNA定位于心肌细胞核内,电镜超微结构观察细胞胞质、核内均未见23 nm病毒样颗粒,也无细胞器的损害. 结论 B19病毒对先天性心脏病的感染系先天性感染所致,病毒基因可能整合于宿主细胞核内.

  3. Human Parvovirus B19 infection in blood donors of Yao nationality%瑶族无偿献血者人细小病毒B19感染研究

    Institute of Scientific and Technical Information of China (English)

    刘运保; 梁伟文; 喻红玲; 虢娟; 邓凯航; 林雪珍

    2014-01-01

    目的 了解广东瑶族无偿献血者人细小病毒B19感染现状.方法 采用ELISA法检测血液中抗-HPVB19 IgG,并用PCR法对部分血样进行HPV B19 DNA检测.结果 376名瑶族无偿献血者检出HPV B19 IgG阳性110例,阳性率29.26%,男、女阳性率分别为28.87%和29.67%.147例标本检出HPV B19 DNA 10例,阳性率6.80%,男、女HPV B19 DNA阳性率分别为6.58%和7.04%.42例HPV B19 IgG阳性血液中HPV B19 DNA阳性率9.52%,105例HPV B19 IgG阴性血液中HPV B19 DNA阳性率5.71%,HPV B19 IgG阳性标本与阴性标本中HPVB19 DNA阳性率差异无统计学意义(P>0.05).结论 瑶族无偿献血者存在较高HPV B19既往感染.

  4. TestPack Chlamydia, a new rapid assay for the direct detection of Chlamydia trachomatis.

    OpenAIRE

    Coleman, P.; Varitek, V; Mushahwar, I K; Marchlewicz, B; Safford, J; Hansen, J.; Kurpiewski, G; Grier, T

    1989-01-01

    TestPack Chlamydia (Abbott Laboratories) is a rapid enzyme immunoassay for the direct antigen detection of Chlamydia trachomatis in endocervical specimens. The assay is self-contained, requires no specialized equipment, and yields results in less than 30 min. The clinical performance of TestPack Chlamydia versus chlamydial cell culture was evaluated with a total of 1,694 paired endocervical specimens. Discordant samples were further investigated by immunofluorescent staining and by Chlamydiaz...

  5. Study on the infection of chlamydia pneumoniae affecting the proliferation and function of pancreatic β cells in vitro%肺炎衣原体感染影响胰岛β细胞增殖和功能的体外研究

    Institute of Scientific and Technical Information of China (English)

    陈思思; 于德民; 周赛君; 李君文; 王彤; 宋苗瑞; 张睿; 于珮

    2013-01-01

    目的 探讨肺炎衣原体(C.pn)感染对胰岛β细胞增殖和功能的影响.方法 将C.pn在人喉癌细胞系(HEp-2细胞)中增殖培养后,以感染复数为0.08、0.20,干预时间为6,24 h的C.pn感染体外培养的胰岛β细胞系(INS-1细胞),通过光镜下观察细胞形态变化及免疫荧光单克隆抗体染色方法确认感染模型的建立.在不同感染复数(0,0.04,0.08,0.10,0.12,0.14,0.16,0.20)、不同干预时间(2,4,6,8,16,24,36 h)的C.pn作用下,利用四甲基偶氮唑蓝法、台盼蓝活细胞计数及流式细胞仪观察C.pn感染对INS-1细胞增殖和凋亡的影响;并通过放射免疫法测定C.pn感染后经高糖(25 mmol/L)和低糖(5.6 mmol/L)刺激的INS-1细胞胰岛素分泌量.结果 与正常对照组相比,小剂量(0.08)加短时间(6 h)C.pn感染组INS-1细胞密度增加,细胞间隙变窄,大剂量(0.20)加长时间(24 h)C.pn感染组INS-1细胞骤缩、变圆、仍聚团生长.免疫荧光单克隆抗体染色显示特异性亮绿色荧光,证实C.pn感染INS-1细胞的体外模型成功建立.与正常对照组相比,小剂量(<0.20)加短时间(<24 h)的C.pn感染促进INS-1细胞增殖(t=-8.907,P <0.05)及INS-1细胞分泌胰岛素(t=-9.186,P<0.05),而大剂量(>0.20)加长时间(>24 h)的C.pn感染则促进INS-1细胞凋亡(t=-37.306,P<0.05)且抑制INS-1细胞分泌胰岛素(t=9.592,P<0.05).结论 C.pn感染对胰岛β细胞增殖和功能具有双向作用,可为2型糖尿病早期防治提供新思路.%Objective To explore the effects of infection of Chlamydia pneumonia (C.pn) on the proliferation and function of pancreatic β cells.Methods C.pn had been cultured in the human laryngeal epidermoid carcinoma cell line(HEp-2 cells).Then the pancreatic β cells (INS-1 cells) were infected by C.pn,the multiplicity of infection were 0.08 and 0.20,the time for intervention were 6 h and 24 h.The changes of cell morphology under the light microscopy and the immunofluorescence monoclonal

  6. Biology and intracellular life of chlamydia

    Directory of Open Access Journals (Sweden)

    Ranin Lazar

    2011-01-01

    Full Text Available Introduction. Chlamydiae are Gram-negative obligate intracellular bacteria. The developmental cycle of Chlamydiae is specific and different from other bacteria. The elementary body is the infectious form of the organism, responsible for attaching to the target host cell and promoting its entry. The reticulate body is the larger, metabolically active form of the organism, synthesizing deoxyribonucleic acid, ribonucleic acid and proteins. The elementary body and reticulate body represent evolutionary adaptations to extracellular and intracellular environments. Intracellular persistence of Chlamydia. Predisposition of Chlamydia to persist within the host cell has been recognized as a major factor in the pathogenesis of chlamydial disease. The persistence implies a long-term association between chlamydiae and their host cell that may not manifest as clinically recognizable disease. The ability of chlamydia to remain within one morphological state for a long time in response to exogenous factors suggests an innate ability of these organisms to persist intracellulary in a unique developmental form. Chlamydiae induce interferon γ and exhibit growth inhibition in their presence. While the high levels of interferon γ completely restrict the development of chlamydia, its low levels induce the development of morphologically aberrant intracellular forms. The persistent forms contain reduced levels of major outer membrane protein but high levels of chlamydial heat shock protein. Conclusion. Immunopathogenesis of chlamydial infection is one of the main focal points of current research into Chlamydia. Chlamydial infections are highly prevalent, usually asymptomatic and associated with serious sequelae. Screening programmes are the most important in the prevention of a long-term sequele.

  7. Prevent Pneumonia

    Centers for Disease Control (CDC) Podcasts

    2015-08-06

    CDC’s Matthew Westercamp explains what pneumonia is, its symptoms, and how to prevent it.  Created: 8/6/2015 by National Center for Immunization and Respiratory Diseases (NCIRD), Division of Bacterial Diseases (DBD), Respiratory Diseases Branch (RDB).   Date Released: 8/6/2015.

  8. Atypical pneumonia

    Science.gov (United States)

    ... America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis . 2007;44:S27-S72. PMID: 17278083 ... by: Denis Hadjiliadis, MD, Associate Professor of Medicine, Pulmonary, Allergy and Critical Care, Perelman ...

  9. 人微小病毒B19母婴感染的血清学调查%Serologic investigation of human parvovirus B19 infection in pregnant women and their newborns

    Institute of Scientific and Technical Information of China (English)

    王净; 过志君; 许桦; 窦骏; 任慕兰; 蒋黎

    2005-01-01

    目的:调查该地区B19病毒母婴感染情况.方法:用ELISA和套式PCR分别检测母婴血清B19病毒IgG、IgM抗体和DNA.结果:92例孕妇血清B19病毒IgG抗体阳性率37.04%,720例孕妇血清B19病毒IgM抗体阳性率9.02%,而95例婴儿脐血IgM抗体阴性;720例孕妇血清和95例婴儿脐血B19病毒DNA亦均为阴性.结论:部分孕妇存在B19病毒感染既往史,少数孕妇有近期或急性B19病毒感染,但母婴垂直传播B19病毒风险很低.

  10. 应用PCR法对临床血标本中人微小病毒B19的检测分析%Polymerase Chain Reaction Assay of Human Parvovirus B19 in Clinical Blood Specimens

    Institute of Scientific and Technical Information of China (English)

    董庆鸣; 魏红山; 宋淑静; 刘志英; 郝鹏; 刘顺爱; 张剑平; 戴旺苏; 张四平

    2005-01-01

    目的探讨PCR法检测临床血标本中人微小病毒B19(HPV B19)的应用价值.方法根据序列比对结果,在HPV B19核苷酸相对保守区设计引物进行PCR扩增.应用双脱氧链末端终止法对HPV B19阳性PCR产物进行克隆测序.结果应用该法最终检出HPV B19的血清稀释度为103.序列比较表明,用本法检出的1株HPV B19阳性标本与标准株(Au株)核苷酸序列同源性为92%.检测肝癌和肝硬化患者血清标本各14例, 结果HPV B19阳性分别为8例和5例.结论本法可用于HPV B19的临床诊断和流行病学调查.

  11. Quantitative direct probe method for the detection of parvovirus B19.

    Science.gov (United States)

    Boggino, H; Payne, D A

    2000-01-01

    Parvovirus B19 infection is associated with anemia and spontaneous abortions. While many qualitative assays are available, a few molecular-based quantitative methods have been described. This study reports the development and optimization of a quantitative direct-probe method for the detection of Parvovirus B19 DNA. Different concentrations of RNA probes were used to identify the optimal conditions for hybridizing to the target DNA. Detection of DNA was linear between concentrations of 2 ng/ml to 200 pg/ml. Because this method requires no enzymatic amplification, it is not susceptible to amplifier contamination or enzymatic inhibitors, and it can be applied to serum samples or paraffin-embedded tissue. PMID:10645984

  12. Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression.

    Directory of Open Access Journals (Sweden)

    Francesca Bonvicini

    Full Text Available CpG DNA methylation is one of the main epigenetic modifications playing a role in the control of gene expression. For DNA viruses whose genome has the ability to integrate in the host genome or to maintain as a latent episome, a correlation has been found between the extent of DNA methylation and viral quiescence. No information is available for Parvovirus B19, a human pathogenic virus, which is capable of both lytic and persistent infections. Within Parvovirus B19 genome, the inverted terminal regions display all the characteristic signatures of a genomic CpG island; therefore we hypothesised a role of CpG dinucleotide methylation in the regulation of viral genome expression.The analysis of CpG dinucleotide methylation of Parvovirus B19 DNA was carried out by an aptly designed quantitative real-time PCR assay on bisulfite-modified DNA. The effects of CpG methylation on the regulation of viral genome expression were first investigated by transfection of either unmethylated or in vitro methylated viral DNA in a model cell line, showing that methylation of viral DNA was correlated to lower expression levels of the viral genome. Then, in the course of in vitro infections in different cellular environments, it was observed that absence of viral expression and genome replication were both correlated to increasing levels of CpG methylation of viral DNA. Finally, the presence of CpG methylation was documented in viral DNA present in bioptic samples, indicating the occurrence and a possible role of this epigenetic modification in the course of natural infections.The presence of an epigenetic level of regulation of viral genome expression, possibly correlated to the silencing of the viral genome and contributing to the maintenance of the virus in tissues, can be relevant to the balance and outcome of the different types of infection associated to Parvovirus B19.

  13. Estimating the risk of parvovirus B19 infection in blood donors and pregnant women in Japan

    OpenAIRE

    難波江, 功二

    2014-01-01

    主査: 西脇祐司 /タイトル: Estimating the risk of parvovirus B19 infection in blood donors and pregnant women in Japan /著者: Koji Nabae, Hiroshi Satoh, Hiroshi Nishiura, Keiko Tanaka-Taya,Nobuhiko Okabe, Kazunori Oishi, Kunichika Matsumoto, Tomonori Hasegawa /掲載誌: PLoS ONE /巻号・発行年等: 9(3): e92519, 2014 /

  14. Excretion of Brucella abortus vaccine B19 strain during a reproductive cycle in dairy cows

    Directory of Open Access Journals (Sweden)

    W. A. Pacheco

    2012-06-01

    Full Text Available This paper aimed to determine the excretion period of B19 vaccine strain during a complete reproductive cycle (from estrus synchronization, artificial insemination, pregnancy and until 30 days after parturition of dairy cows from 3 to 9 years old that were previously vaccinated from 3 to 8 months. Three groups were monitored with monthly milk and urine collection during 12 months: G1 with seven cows from 3 to 4 years old; G2 with three cows from 5 to 6 years old; and G3 with four cows from 7 to 9 years old. Urine and milk samples were submitted to bacteriological culture and urine and PCR reactions for detection of Brucella spp. and PCR-multiplex for B19 strain identification. Ring test (RT was also performed in the milk samples, and serum samples were tested by buffered acidified plate antigen test (BAPA. All animals were serologically negative at BAPA and Brucella spp. was not isolated from both urine and milk samples. RT revealed 13/210 (6.2% positive milk samples. PCR reactions detected DNA of Brucella spp. in 86/420 (20.5% samples. In urine it was found a significantly higher frequency (35.2%; 74/210 than in milk (5.7%; 12/210, more frequently from the estrus to 150 days of pregnancy and after parturition (6.7%; 10/150, and from 150 days of pregnancy to parturition (3.4%; 2/60, and they were all identified as B19 strain. In three groups, intermittent excretion of B19 strain was detected mainly in urine samples, which confirmed its multiplication and persistence in cows for until 9 years.

  15. Complete Remission of Human Parvovirus B19 Associated Symptoms by Loxoprofen in Patients with Atopic Predispositions

    Directory of Open Access Journals (Sweden)

    Itsuro Kazama

    2012-01-01

    Full Text Available Two cases of women in their thirties with past histories of atopic dermatitis and allergic rhinitis developed a low grade fever, followed by a butterfly-shaped erythema, swelling of their fingers, and polyarthralgia. Despite such symptoms that overlap with those of systemic lupus erythematosus (SLE, the diagnostic criteria for SLE were not fulfilled. Due to positive results for human parvovirus B19 (HPV-B19 IgM antibodies in the serum, diagnoses of HPV-B19 infection were made in both cases. Although acetaminophen failed to improve their deteriorating symptoms, a nonsteroidal anti-inflammatory drug (NSAID, loxoprofen, completely removed the symptoms immediately after the administration. In those cases, since the patients were predisposed to atopic disorders, an increased immunological response based on the lymphocyte hypersensitivity was likely to be involved in the pathogenesis. The immunomodulatory property of NSAID was thought to repress such lymphocyte activity and thus provided a rapid and sustained remission of the disease.

  16. Analysis of Polymorphic Membrane Protein Expression in Cultured Cells Identifies PmpA and PmpH of Chlamydia psittaci as Candidate Factors in Pathogenesis and Immunity to Infection

    Science.gov (United States)

    Van Lent, Sarah; De Vos, Winnok H.; Huot Creasy, Heather; Marques, Patricia X.; Ravel, Jacques; Vanrompay, Daisy; Bavoil, Patrik; Hsia, Ru-ching

    2016-01-01

    The polymorphic membrane protein (Pmp) paralogous families of Chlamydia trachomatis, Chlamydia pneumoniae and Chlamydia abortus are putative targets for Chlamydia vaccine development. To determine whether this is also the case for Pmp family members of C. psittaci, we analyzed transcription levels, protein production and localization of several Pmps of C. psittaci. Pmp expression profiles were characterized using quantitative real-time PCR (RT-qPCR), immunofluorescence (IF) and immuno-electron microscopy (IEM) under normal and stress conditions. We found that PmpA was highly produced in all inclusions as early as 12 hpi in all biological replicates. In addition, PmpA and PmpH appeared to be unusually accessible to antibody as determined by both immunofluorescence and immuno-electron microscopy. Our results suggest an important role for these Pmps in the pathogenesis of C. psittaci, and make them promising candidates in vaccine development. PMID:27631978

  17. Global Co-Existence of Two Evolutionary Lineages of Parvovirus B19 1a, Different in Genome-Wide Synonymous Positions

    OpenAIRE

    Molenaar-de Backer, Marijke W. A.; Lukashov, Vladimir V.; van Binnendijk, Rob S.; Hein J Boot; Zaaijer, Hans L.

    2012-01-01

    Parvovirus B19 (B19V) can cause infection in humans. To date, three genotypes of B19V, with subtypes, are known, of which genotype 1a is the most prevalent genotype in the Western world. We sequenced the genome of B19V strains of 65 asymptomatic, recently infected Dutch blood donors, to investigate the spatio-temporal distribution of B19V strains, in the years 2003-2009. The sequences were compared to B19V sequences from Dutch patients with fifth disease, and to global B19V sequences as avail...

  18. Incidence of parvovirus B 19 infection. among an unselected population of pregnant women in the Netherlands : A prospective study

    NARCIS (Netherlands)

    van Gessel, Peter H.; Gaytant, Michael A.; Vossen, Ann C. T. M.; Galama, Joep M. D.; Ursem, Nicolette T. C.; Steegers, Eric A. P.; Wildschut, Hajo I. J.

    2006-01-01

    Objective: To evaluate seroprevalence of anti-parvovirus B19 IgG immunoglobulins and the rate of seroconversion in seronegative pregnant women. Design: Prospective assessment of anti-parvovirus B19 IgG immunoglobulins in an unselected population of pregnant women booked for antenatal care from 1998

  19. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.

    NARCIS (Netherlands)

    Gessel, P.H. van; Gaytant, M.A.; Vossen, A.C.; Galama, J.M.D.; Ursem, N.T.C.; Steegers, E.A.P.; Wildschut, H.I.J.

    2006-01-01

    OBJECTIVE: To evaluate seroprevalence of anti-parvovirus B19 IgG immunoglobulins and the rate of seroconversion in seronegative pregnant women. DESIGN: Prospective assessment of anti-parvovirus B19 IgG immunoglobulins in an unselected population of pregnant women booked for antenatal care from 1998

  20. Human parvovirus B19 DNA is not detected in Guthrie cards from children who have developed acute lymphoblastic leukemia

    DEFF Research Database (Denmark)

    Isa, Adiba; Priftakis, Peter; Broliden, Kristina;

    2004-01-01

    BACKGROUND: There has been much speculation about the cause of childhood acute lymphoblastic leukemia (ALL). It has been suggested, on the basis of findings in epidemiological studies, that ALL may be initiated by an in utero infection of the fetus. The human parvovirus B19 (B19) is etiologically...

  1. Parvovirus B19 Genotype Specific Amino Acid Substitution in NS1 Reduces the Protein's Cytotoxicity in Culture

    Directory of Open Access Journals (Sweden)

    Violetta Kivovich, Leona Gilbert, Matti Vuento, Stanley J. Naides

    2010-01-01

    Full Text Available A clinical association between idiopathic liver disease and parvovirus B19 infection has been observed. Fulminant liver failure, not associated with other liver-tropic viruses, has been attributed to B19 in numerous reports, suggesting a possible role for B19 components in the extensive hepatocyte cytotoxicity observed in this condition. A recent report by Abe and colleagues (Int J Med Sci. 2007;4:105-9 demonstrated a link between persistent parvovirus B19 genotype I and III infection and fulminant liver failure. The genetic analysis of isolates obtained from these patients demonstrated a conservation of key amino acids in the nonstructural protein 1 (NS1 of the disease-associated genotypes. In this report we examine a conserved residue identified by Abe and colleagues and show that substitution of isoleucine 181 for methionine, as occurs in B19 genotype II, results in the reduction of B19 NS1-induced cytotoxicity of liver cells. Our results support the hypothesis that in the setting of persistent B19 infection, direct B19 NS1-induced cytotoxicity may play a role in idiopathic fulminant liver failure.

  2. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19

    DEFF Research Database (Denmark)

    Heegaard, Erik D; Qvortrup, Klaus; Christensen, Jesper

    2002-01-01

    Diagnosis of erythrovirus B19 (B19) relies on serology and the detection of viral DNA. Recently, a distinct erythrovirus isolate termed V9, markedly different from erythrovirus B19 (> 11% nucleotide disparity), was isolated. Standard B19 PCR assays were inconclusive and serologic tests failed...... erythrovirus-like particles with a diameter of approximately 23 nm. Screening of a panel of 270 clinical samples for the presence of V9 IgM and IgG antibodies in ELISA showed 100% serologic cross-reactivity between B19 and V9 when comparing V9 VP2 capsids to a commercial B19 VP2 assay. This suggests that both...... a V9 and a B19 antibody response may be diagnosed equally well by ELISA using either V9 or B19 recombinant capsids as antigen source. Retrospectively, translation of the V9 sequence indicates that despite a significant genetic variation on the DNA level, the majority of the discrepant DNA sequence...

  3. 76 FR 29997 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2011-05-24

    ... . SUPPLEMENTARY INFORMATION: Airworthiness Directive 2011-07-06, amendment 39-16643 (76 FR 18024, April 1, 2011.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes AGENCY: Federal Aviation Administration (FAA.... Model CL-600-2B19 (Regional Jet Series 100 & 440) airplanes. In the AD as published, the reference...

  4. 75 FR 69609 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-11-15

    ... 12866; 2. Is not a ``significant rule'' under the DOT Regulatory Policies and Procedures (44 FR 11034.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes AGENCY: Federal Aviation Administration (FAA... Part 2, ``Airworthiness Limitations,'' of the Bombardier CL-600-2B19 Maintenance Requirements...

  5. 75 FR 10667 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-03-09

    ... Procedures (44 FR 11034, February 26, 1979); and 3. Will not have a significant economic impact, positive or..., Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes AGENCY: Federal Aviation.... Applicability (c) This AD applies to Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 &...

  6. 75 FR 25788 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-05-10

    ... 12866; 2. Is not a ``significant rule'' under the DOT Regulatory Policies and Procedures (44 FR 11034.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes AGENCY: Federal Aviation Administration (FAA...) sufficient heat switches/sensors on CL-600-2B19 aircraft are located at the inboard end of each wing...

  7. 76 FR 53046 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2011-08-25

    ... Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and 3. Will not have a significant.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes AGENCY: Federal Aviation Administration (FAA.... Affected ADs (b) None. Applicability (c) This AD applies to Bombardier, Inc. Model CL-600-2B19...

  8. NNDSS - Table II. Chlamydia to Coccidioidomycosis

    Data.gov (United States)

    U.S. Department of Health & Human Services — NNDSS - Table II. Chlamydia to Coccidioidomycosis - 2015.In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the...

  9. NNDSS - Table II. Chlamydia to Coccidioidomycosis

    Data.gov (United States)

    U.S. Department of Health & Human Services — NNDSS - Table II. Chlamydia to Coccidioidomycosis - 2016. In this Table, provisional* cases of selected†notifiable diseases (≥1,000 cases reported during the...

  10. Risk of reproductive complications following chlamydia testing

    DEFF Research Database (Denmark)

    Davies, Bethan; Turner, Katy M E; Frølund, Maria;

    2016-01-01

    individuals drawn from the population register (Danish Civil Registration System) who did not have a positive chlamydia test during this interval. The outcomes in the study were hospital episodes of health-care (inpatient, outpatient, and emergency department) with a diagnosis of pelvic inflammatory disease...... diagnosed chlamydia and episodes of hospital health care (inpatient, outpatient, and emergency department) for a reproductive complication. METHODS: We constructed and analysed a retrospective population-based cohort of women aged 15-44 years from administrative records in Denmark (1995-2012). We used a...... subset of the national Danish Chlamydia Study. The master dataset contains all residents of Denmark (including Greenland) who had a positive chlamydia test recorded by a public health microbiology laboratory from Jan 1, 1992, to Nov 2, 2011. Individuals were randomly matched (by age and sex) to four...

  11. Study on relationship between parvovirus B19 infection and peptic ulcer, superficial gastritis%微小病毒B19与消化性溃疡及浅表性胃炎的相关性研究

    Institute of Scientific and Technical Information of China (English)

    贺湘; 马志胜; 吴护群

    2015-01-01

    目的 分析微小病毒B19在消化性溃疡及浅表性胃炎患者中的表达情况,并对微小病毒B19与消化性溃疡及浅表性胃炎的相关性进行分析.方法 随机选取62例消化性溃疡患者、55例浅表性胃炎患者及60例健康体检者作为观察对象,以消化性溃疡者为A组、以浅表性胃炎者为B组、以健康体检者为C组,分别对三组患者血中微小病毒B19 DNA的阳性率进行分析,并对微小病毒B19与消化性溃疡及浅表性胃炎的相关性进行分析.结果 A组微小病毒B19 DNA阳性率为12.90%,B组微小病毒B19 DNA阳性率为12.73%,C组微小病毒B19 DNA阳性率为1.67%,A组、B组微小病毒B19 DNA阳性率均明显高于C组(P<0.05).同时,微小病毒B19与消化性溃疡及浅表性胃炎均存在显著的相关性(P<0.05).但微小病毒B19 DNA阳性率对消化性溃疡及浅表性胃炎无诊断价值(P>0.05).结论 微小病毒B19 DNA阳性率在消化性溃疡及浅表性胃炎中明显升高,且存在相关性.%Objective To analyze the expression of parvovirus B19 in patients with peptic ulcer and superficial gastritis, and correlation of parvovirus B19 infection and peptic ulcer and chronic superficial.Methods 62 patients with peptic ulcer (group A), 55 cases of superficial gastritis patients (group B) and 60 healthy subjects (group C) were selected as observation objects.Blood were collected from three group and parvovirus B19 DNA was detected , and the correlation of parvovirus B19 with peptic ulcer and chronic superficial gastritis were analyzed.Results The positive rate of parvovirus B19 DNA was 12.90% in group A, the positive rate of B group of parvovirus B19 DNA was 12.73% in group B, 1.67%in group C.There were statistical diffrences between group Aand group C(P < 0.05), group B and group C(P < 0.05).At the same time, parvovirus B19 infection and peptic ulcer, superficial gastritis were significant correlation (P < 0.05).Conclusions There

  12. 人类细小病毒B19感染与小儿风湿性疾病关系的探讨%Relationship between human parvovirus B19 and children′s common rheumatism

    Institute of Scientific and Technical Information of China (English)

    曹玉红; 张国成; 成胜权; 张光运; 许东亮

    2001-01-01

    目的研究人类细小病毒B19感染与小儿常见风湿性疾病的关系.方法用巢式PCR法对95例小儿常见风湿性疾病患者进行B19-DNA检测,对部分患者进行B19-IgM检测.结果 (1)病例组B19-DNA阳性33例(34.7%),健康对照组B19-DNA阳性2例(4.0%);病例组B19-DNA阳性率与对照组相比有显著差异(P<0.01).(2)病例组B19-IgM检测50例,阳性11例(22.0%),健康对照组B19-IgM均为阴性;B19-IgM阳性率与对照组相比有显著差异(P<0.01).(3)过敏性紫癜、幼年类风湿性关节炎、皮肌炎、系统性红斑狼疮、川崎病患儿B19-DNA及IgM阳性率分别为25%和20%、37.2%和20%、40%和20%、42.9%和28.6%、37.5%和25.0%.五种风湿性疾病B19-DNA及IgM阳性率无显著差异(P>0.05).(4)50例成对标本中,10例B19-DNA、IgM均阳性,1例仅B19-IgM阳性,7例仅B19-DNA阳性,B19-DNA和IgM 同时阴性32例,B19-DNA和IgM一致率为84.0%,两者结果有一致性 (P<0.01);50例中B19-DNA阳性17例(34.0%),IgM阳性11例 (22.0%),两者差异无显著意义(P>0.05).结论 (1)我国风湿性疾病患儿有较高的B19感染率.(2) B19与小儿风湿性疾病密切相关,可能是导致这些疾病的主要病原体之一.

  13. 济宁地区无偿献血者人细小病毒B19感染的相关研究%Research on human parvovirus B19 infection among blood donors in Jining

    Institute of Scientific and Technical Information of China (English)

    王志效; 周贝贝; 张娜; 黄海燕

    2015-01-01

    目的 为了解济宁地区献血人群中人细小病毒B19(human parvovirus B19,简称HPV B19)感染情况,探讨血浆合并对其检出率的影响情况,降低临床输血风险提供一定依据.方法 采用酶联免疫吸附法(ELISA)和实时荧光定量PCR(RT-PCR)法对采集的960份献血员血液样本进行单人份及随机8人份血浆合并样本进行HPV B19-IgG、IgM抗体及DNA检测.结果 单人份血浆与随机8人份血浆合并样本HPV B19 IgG抗体、IgM抗体阳性率分别为36.15%、5.94%、35.83%、12.50%,抗体阳性标本中单人份及血浆合并样本DNA阳性率分别为0.83%、5.00%.其中IgM抗体阳性组B19 DNA检出率明显高于IgG阳性组.结论 献血人群中存在较高的HPV B19感染率,血浆合并后IgM抗体及DNA检出率较高,未提示其传播风险降低,应对儿童、老年人、孕妇等免疫功能低下者选择性输注B19-IgG抗体滴度较高的血液制品.%Objective To estimate the prevalence of parvovirus B19 infection (B19 for short) among blood doners in Jining and explore the effect of plasma mixing on HPV B19 detection rate,in order to provide a basis for reducing the risk of clinical blood transfusions.Methods Enzyme-linked immuno-sorbent (ELISA) and real-time fluorescence quantitative PCR (RT-PCR for short) assays were used for HPV B19-IgG/IgM antibodies and DNA test from 960 blood samples and eight randomly selected mixed samples.Results The rates of positive B19 IgG and IgM antibodies in the individual samples were 36.15%,5.94% respectively.For the eight randomly selected mixed samples 35.83%,12.50% respectively.Positive B19-DNA rates for B19-IgM positive sera were 0.83% for individual samples and 5.00% for mixed samples.Moreover,B19-IgM antibody and B19-DNA positive rates of pooled plasma group were higher than those from the individual samples.Conclusions A high rate of B19 virus infection was found among blood donors.After plasma mixing,positive IgM antibody

  14. Autoimmune Hemolytic Anemia Triggered by Infection with Human Parvovirus B19 after Total Abdominal Colectomy for Ulcerative Colitis.

    Science.gov (United States)

    Iida, Tomoya; Satoh, Shuji; Nakagaki, Suguru; Shimizu, Haruo; Kaneto, Hiroyuki

    2016-01-01

    A 50-year-old man was admitted to our hospital for an adhesive ileus 14 years after total abdominal colectomy for ulcerative colitis (UC). The ileus decreased with conservative treatment, however, autoimmune hemolytic anemia (AIHA) was diagnosed due to worsening anemia, a positive direct Coombs test, low haptoglobin, high lactase dehydrogenase, reticulocytosis, and an increase in the erythroblastic series in a bone-marrow examination. Human parvovirus B19 (PV-B19) IgM and PV-B19 DNA were present, indicating the development of AIHA triggered by an infection with PV-B19. The patient is currently being monitored after spontaneous remission. This is the first report of UC after total abdominal colectomy complicated by AIHA triggered by PV-B19 infection. PMID:26984090

  15. Epidemiological Investigation of Human Parvovirus B19 among Women Reproductive Age in Nanning%南宁地区育龄妇女人类微小病毒B19流行病学调查

    Institute of Scientific and Technical Information of China (English)

    李东明; 张明铭; 何俊炜; 欧珊

    2011-01-01

    Objective To investigate the prevalence and characteristic of the human parvovirus B19(B19) infection among women reproductive age. Methods B19-IgM antibody was detected by using enzyme linked immunosorbent assay method in the serum. Results Among the 10 125 cases,the overall infection rate of B19 was 13. 04%,and that were 12. 20%,13. 18%and 13. 68% respectively in the past three years (P>0. 05). The infection rate of B19 in women with abnormal outcome ,pregnant women and pre-marital care were 17. 34% ,12. 61% and 10. 82% ,respectively (P<0. 01). The ratio of abnormal outcome in the un-infected group had significant difference,as compared with those in the infected group (P<0. 01).Conclusion The infection rate of B19 in women was high in Nanning. The surveillance of human Parvovirus B19 infection among women reproductive age should be performed.%目的 了解南宁地区育龄妇女人微小病毒B19(B19)感染状况及特点.方法 用酶联免疫吸附法检测2008~2010年南宁地区育龄妇女血清B19-IgM抗体,比较不良妊娠结局、妊娠和婚检妇女感染率及各年、季度感染情况.结果 10 125例育龄妇女,B19感染率为13.04%,不良妊娠结局组、妊娠组和婚检组感染度分别为17.69%,12.61%和10.82%,三组间感染率差异有统计学意义(P0.05).感染组与非感染组不良妊娠结局发生率差异有统计学意义(P<0.01).结论 南宁地区育龄妇女B19感染率较高,应加强育龄妇女B19感染监测.

  16. The relationship of the human parvovirus B19 infection and pediatric hematological diseases%人类微小病毒B19与小儿血液病的关系

    Institute of Scientific and Technical Information of China (English)

    严媚; 古丽娜·沙丁; 顾立达

    2003-01-01

    目的:探讨人类微小病毒B19与小儿血液病的关系.方法:采用酶联免疫吸附(ELISA)法,对37例血液病患儿的血清标本进行B19-IgM和B19-IgG检测,并与对照组进行比较.结果:在37例患儿血清标本中,原发性血小板减少性紫癜(ITP)B19-IgM的阳性检出率为44.47%,再生障碍性贫血(AA)B19-IgM阳性检出率为41.2%,与对照组相比,差异均有统计学意义(P<0.05),急性白血病(AL)与对照组相比差异无统计学意义(P>0.05).ITP、AA的B19-IgG的阳性检出率与对照组相比差异均无统计学意义(P>0.05).结论:人类微小病毒B19感染与ITP、AA有关.

  17. Detection of specific antibodies to human parvovirus B19 in 81 children with various diseases%81例不同疾病患儿人细小病毒B19特异性抗体检测

    Institute of Scientific and Technical Information of China (English)

    古丽娜·沙丁; 多里坤·木扎帕尔; 郭艳芳; 李维城

    2005-01-01

    目的调查细小病毒B19(human parvovirus B19, HPV B19)在新疆地区不同疾病患儿中的感染情况.方法用ELISA法对2001年8月至2002年12月该院儿科81例住院患儿和来自儿保体检门诊16例健康儿童(对照组)的血清标本进行了B19-IgM和B19-IgG检测.结果 B19-IgM阳性检出率在特发性血小板减少性紫癜和再生障碍性贫血最高,分别为 44.4%(4/9)和 41.2%(7/17).与对照组相比较差异有显著性(P<0.05),其它疾病组与对照组相比差异无显著性(P>0.05).而B19-IgG的检测结果,疾病组与对照组相比差异无显著性(P>0.05).结论新疆地区特发性血小板减少性紫癜和再生障碍性贫血患儿中有较高的HBV B19感染率.特发性血小板减少性紫癜和再生障碍性贫血与B19感染关系较为密切.

  18. Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.

    Directory of Open Access Journals (Sweden)

    Kanoktip Thammasri

    Full Text Available Human parvovirus B19 (B19V from the erythrovirus genus is known to be a pathogenic virus in humans. Prevalence of B19V infection has been reported worldwide in all seasons, with a high incidence in the spring. B19V is responsible for erythema infectiosum (fifth disease commonly seen in children. Its other clinical presentations include arthralgia, arthritis, transient aplastic crisis, chronic anemia, congenital anemia, and hydrops fetalis. In addition, B19V infection has been reported to trigger autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. However, the mechanisms of B19V participation in autoimmunity are not fully understood. B19V induced chronic disease and persistent infection suggests B19V can serve as a model for viral host interactions and the role of viruses in the pathogenesis of autoimmune diseases. Here we investigate the involvement of B19V in the breakdown of immune tolerance. Previously, we demonstrated that the non-structural protein 1 (NS 1 of B19V induces apoptosis in non-permissive cells lines and that this protein can cleave host DNA as well as form NS1-DNA adducts. Here we provide evidence that through programmed cell death, apoptotic bodies (ApoBods are generated by B19V NS1 expression in a non-permissive cell line. Characterization of purified ApoBods identified potential self-antigens within them. In particular, signature self-antigens such as Smith, ApoH, DNA, histone H4 and phosphatidylserine associated with autoimmunity were present in these ApoBods. In addition, when purified ApoBods were introduced to differentiated macrophages, recognition, engulfment and uptake occurred. This suggests that B19V can produce a source of self-antigens for immune cell processing. The results support our hypothesis that B19V NS1-DNA adducts, and nucleosomal and lysosomal antigens present in ApoBods created in non-permissive cell lines, are a source of self-antigens.

  19. FastStats: Pneumonia

    Science.gov (United States)

    ... this? Submit What's this? Submit Button NCHS Home Pneumonia Recommend on Facebook Tweet Share Compartir Data are ... Mortality data Centers for Disease Control and Prevention: Pneumonia American Lung Association : Pneumonia Get Email Updates To ...

  20. What Is Pneumonia?

    Science.gov (United States)

    ... page from the NHLBI on Twitter. What Is Pneumonia? Pneumonia (nu-MO-ne-ah) is an infection in ... such as bacteria, viruses, and fungi—can cause pneumonia. The infection inflames your lungs' air sacs, which ...

  1. Mycoplasma pneumoniae Infections

    Science.gov (United States)

    ... Issues Listen Español Text Size Email Print Share Mycoplasma pneumoniae Infections Page Content Article Body Some lung ... walking pneumonia), are caused by an organism called Mycoplasma pneumoniae. It is spread from person to person ...

  2. Progresses in diagnosis and treatment of intrauterine infection with cytomegalovirus and human parvovirus B19%巨细胞病毒和人细小病毒B19宫内感染的诊治进展

    Institute of Scientific and Technical Information of China (English)

    吴婉芳

    2003-01-01

    @@ 近20年来,国内外学者对TORCH感染做了大量工作,取得了很大的成绩.但也还有许多尚未解决的问题.现仅就巨细胞病毒(cytomegalovirus, CMV)和人细小病毒B19(human parvovirus B19,HPV B19)宫内感染的某些方面,提出以下意见供同道参考.

  3. 120例儿科患儿微小病毒B19感染的近期研究%A investigation on the infection of human parvovirus B19 in 120 cases children diseases

    Institute of Scientific and Technical Information of China (English)

    郑岩

    2007-01-01

    目的 探讨人类微小病毒B19(HPVB19)在儿科疾病中的感染状况.方法 应用巢式聚合酶链反应的方法(PCR)以及ELISA法,对120例患儿(观察组)及40例随机挑选本院门诊健康体检儿童(对照组)血浆中微小病毒B19-DNA以及B19-VP2-IgM检测.结果 120例患儿(观察组)B19-DNA检测总阳性检出率为31.7%(38/120),40例健康儿童(对照组)B19-DNA检测均为阴性,两组比较有显著差别(P<0.005).其中特发性血小板减少性紫癜(ITP)和心肌炎阳性检出率最高,分别为40%(12/30)和37.1%(13/35).120例患儿(观察组)B19-VP2- IgM总阳性检出率31.7% (38/120),40例健康儿童(对照组)B19-DNA检测均为阴性,两组比较有显著差别(P<0.005),B19 DNA和B19 VP2 IgM一致率为100%.40例健康儿童(对照组)B19-VP2- IgM均为阴性,两组比较有显著差别(P<0.005).结论 儿童对B19有较高的感染率,尤其ITP和心肌炎患儿与B19感染关系更为密切.

  4. 重庆市无偿献血者人细小病毒B19的感染状况研究%Study on the infection status of human parvovirus B19 among unpaid blood donors in Chongqing

    Institute of Scientific and Technical Information of China (English)

    秦伟斐; 廖红梅; 谭茜茜; 田耘博; 黄霞; 李亚斐

    2015-01-01

    目的:了解重庆市无偿献血者中人细小病毒B19感染状况,评估B19病毒的流行病学情况,为本市乃至中国未来制订实施更为科学合理的输血安全策略提供基础数据。方法用ELISA对无偿献血者血液进行B19 IgM 和IgG抗体筛查。结果1104份无偿献血者血液样本中,B19 IgM和IgG阳性率分别为5.07%和36.68%(P<0.05)。女性B19 IgM 抗体阳性率高于男性(P<0.05),而在男性和女性中B19 IgG抗体阳性率比较差异无统计学意义(P>0.05)。各年龄组中B19 IgM阳性率比较差异无统计学意义(P>0.05),B19 IgG阳性率随着年龄升高而升高(P<0.05)。不同血型人群比较、不同季节献血者B19 IgM和IgG阳性率比较,差异均无统计学意义(P>0.05)。乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)、HIV阳性样本与阴性样本中B19 Ig M 、B19 Ig G阳性率比较差异均无统计学意义( P>0.05)。结论重庆市献血者中,仍有少部分人群感染B19病毒,在尚未开展B19病毒筛查的情况下,存有输血传播该病毒的风险。%Objective To provide basic datas for enriching the scientific and reasonable security strategy of blood transfusion in Chongqing ,even for the national use in the future ,we studied the infection status of human parvovirus B19(B19V) among unpaid blood donors and evaluated the prevalence of B19V in Chongqing .Methods B19 IgM and B19 IgG antibody from blood donors were detected by the method of enzyme linked immunosorbent assay .Results Among 1 104 blood samples of blood donors ,the positive rate of B19 IgM was 5 .07% ,and the positive rate of B19 IgG was 36 .68% ,there was a significant difference between them(P 0 .05) .Comparing with various age groups ,There was still no significant difference of the positive rate of B19 IgM among them(P>0 .05) ,but the positive rates of B19 IgG increased with age increasing (P0 .05) .And there was

  5. Analysis of Synonymous Codon Usage Bias in Chlamydia

    Institute of Scientific and Technical Information of China (English)

    Hui L(ü); Wei-Ming ZHAO; Yan ZHENG; Hong WANG; Mei QI; Xiu-Ping YU

    2005-01-01

    Chlamydiae are obligate intracellular bacterial pathogens that cause ocular and sexually transmitted diseases, and are associated with cardiovascular diseases. The analysis of codon usage may improve our understanding of the evolution and pathogenesis of Chlamydia and allow reengineering of target genes to improve their expression for gene therapy. Here, we analyzed the codon usage of C. muridarum, C.trachomatis (here indicating biovar trachoma and LGV), C. pneumoniae, and C. psittaci using the codon usage database and the CUSP (Create a codon usage table) program of EMBOSS (The European Molecular Biology Open Software Suite). The results show that the four genomes have similar codon usage patterns,with a strong bias towards the codons with A and T at the third codon position. Compared with Homo sapiens, the four chlamydial species show discordant seven or eight preferred codons. The ENC (effective number of codons used in a gene)-plot reveals that the genetic heterogeneity in Chlamydia is constrained by the G+C content, while translational selection and gene length exert relatively weaker influences. Moreover,mutational pressure appears to be the major determinant of the codon usage variation among the chlamydial genes. In addition, we compared the codon preferences of C. trachomatis with those of E. coli, yeast,adenovirus and Homo sapiens. There are 23 codons showing distinct usage differences between C. trachomatis and E. coli, 24 between C. trachomatis and adenovirus, 21 between C. trachomatis and Homo sapiens, but only six codons between C. trachomatis and yeast. Therefore, the yeast system may be more suitable for the expression of chlamydial genes. Finally, we compared the codon preferences of C. trachomatis with those of six eukaryotes, eight prokaryotes and 23 viruses. There is a strong positive correlation between the differences in coding GC content and the variations in codon bias (r=0.905, P<0.001). We conclude that the variation of codon bias

  6. Investigation of the prevalence of human parvovirus B19 DNA in source plasma%原料血浆人细小病毒B19流行情况调查

    Institute of Scientific and Technical Information of China (English)

    曾飞翔; 何培德; 李贻娟; 罗萍; 张波; 杨显书; 谈丽君; 张燕

    2015-01-01

    目的 调查原料血浆人细小病毒B19流行情况和B19 IgG抗体阳性率,评价原料血浆进行B19病毒核酸筛查的必要性.方法 采用实时荧光定量PCR技术对原料血浆和投料合并血浆以及B19 DNA阳性合并血浆对应的成品进行B19 DNA检测,采用EHSA法进行IgG抗体检测,对B19 DNA阳性供血浆者进行跟踪分析.结果 从10 150份原料血浆筛查出B19 DNA阳性样品3份,流行率为0.03%,阳性样品均为低浓度;810份血浆样品中367份为B19 IgG抗体阳性,阳性率45.3%,均值为9.18 IU/mL;投料合并血浆B19 DNA阳性率为23.7%,不合格率为3.39%(>104 IU/mL);投料合并血浆IgG抗体含量均值为13.51 IU/mL,>11 IU/mL占88.1%.B19病毒>104 IU/mL的投料合并血浆生产出的人血白蛋白和免疫球蛋白B19 DNA均为阴性.免疫球蛋白B19 IgG抗体含量均值为234 IU/mL.结论 调查的原料血浆中B19 DNA流行率及载量均很低,原料血浆、投料合并血浆及免疫球蛋白中B19 IgG抗体含量较高,生产人血白蛋白和免疫球蛋白所采用的低温乙醇工艺对B19病毒具有良好的去除能力,调查中低温乙醇法生产的人血白蛋白和免疫球蛋白制品具有较高的B19病毒安全性.但原料血浆和投料合并血浆是否有必要进行B19核酸筛查,尚需更深入的研究.

  7. Parvovirus B19V infection in Israel: prevalence and occurrence of acute infection between 2008 and 2013.

    Science.gov (United States)

    Mor, O; Ofir, I; Pavel, R; Bassal, R; Kra-Oz, Z; Cohen, D; Shohat, T; Mendelson, E

    2016-01-01

    Differences in the seroprevalence and unique pattern of parvovirus B19 (B19V) acute infections have been documented around the world. This study was conducted to estimate the seroprevalence of anti-parvovirus B19V IgG antibodies in the Israeli population and to assess the pattern of acute infection based on data from two laboratories in Israel. The overall IgG prevalence in the 1008 representative sera samples was 61·4% and the age-adjusted prevalence rate was 58·2%. Seropositivity was significantly associated with age, ranging from 25·7% in children aged 20 years. While no significant differences in seropositivity were detected between sexes and population groups, significantly lower seroprevalence was observed in older Jews born in Africa or Asia. Acute infection rates of 4·1% (234 cases) were found based on the positive IgM results identified in samples from 5663 individuals collected between 2008 and 2013. Annual peaks of infection were observed in 2008 and 2011-2012 and major seasonal peak of B19V IgM positivity was identified in June each year. The number of requests for B19V serology was significantly higher for women aged 20-39 years while the majority IgM-positive cases were identified in young children. With more than 30% of the adult population being susceptible to B19V infection, monitoring B19V status should be considered in specific risk groups such as pregnant women. PMID:25990962

  8. Inhibitory activity of the isoflavone biochanin A on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation.

    Directory of Open Access Journals (Sweden)

    Leena Hanski

    Full Text Available Given the established role of Chlamydia spp. as causative agents of both acute and chronic diseases, search for new antimicrobial agents against these intracellular bacteria is required to promote human health. Isoflavones are naturally occurring phytoestrogens, antioxidants and efflux pump inhibitors, but their therapeutic use is limited by poor water-solubility and intense first-pass metabolism. Here, we report on effects of isoflavones against C. pneumoniae and C. trachomatis and describe buccal permeability and initial formulation development for biochanin A. Biochanin A was the most potent Chlamydia growth inhibitor among the studied isoflavones, with an IC50 = 12 µM on C. pneumoniae inclusion counts and 6.5 µM on infectious progeny production, both determined by immunofluorescent staining of infected epithelial cell cultures. Encouraged by the permeation of biochanin A across porcine buccal mucosa without detectable metabolism, oromucosal film formulations were designed and prepared by a solvent casting method. The film formulations showed improved dissolution rate of biochanin A compared to powder or a physical mixture, presumably due to the solubilizing effect of hydrophilic additives and presence of biochanin A in amorphous state. In summary, biochanin A is a potent inhibitor of Chlamydia spp., and the in vitro dissolution results support the use of a buccal formulation to potentially improve its bioavailability in antichlamydial or other pharmaceutical applications.

  9. Severe anemia due to parvovirus B19 in a silver haired boy.

    Science.gov (United States)

    Verma, Nishant; Kumar, Archana; Kushwaha, Rashmi

    2016-01-01

    Griscelli syndrome (GS) is a rare autosomal recessive immunodeficiency disorder in which the affected children present with characteristic silvery-white hairs. The hair microscopy of these children is characteristic and is helpful in differentiating GS from Chediak-Higashi syndrome which also presents with immunodeficiency and silver hairs. We report a 17-month-old boy with GS type 2 who presented with severe anemia. Bone marrow examination of the child suggested parvovirus B19 as the cause of severe anemia, which was later confirmed by DNA polymerase chain reaction. PMID:26960654

  10. Papular-purpuric "gloves and socks" syndrome caused by parvovirus B19

    Directory of Open Access Journals (Sweden)

    Pavlović Miloš D.

    2003-01-01

    Full Text Available This paper presents a 15-year-old boy with an acute febrile illness accompanied by purpuric and papular lesions located mostly on the dorsal areas of his hands and feet with the additional changes on his knees and elbows. Serologic studies confirmed the acute infection by parvovirus B19. Apart from mild leukocytosis there were no other abnormalities in hematologic and laboratory findings. The diagnosis of papular-purpuric "gloves and socks" syndrome (PPGSS was made. Cutaneous changes completely resolved two weeks later. Herein the patient's condition was described together with a brief overview of the PPGSS literature concerning this relatively rare viral exanthema.

  11. Severe anemia due to parvovirus B19 in a silver haired boy

    Directory of Open Access Journals (Sweden)

    Nishant Verma

    2016-01-01

    Full Text Available Griscelli syndrome (GS is a rare autosomal recessive immunodeficiency disorder in which the affected children present with characteristic silvery-white hairs. The hair microscopy of these children is characteristic and is helpful in differentiating GS from Chediak-Higashi syndrome which also presents with immunodeficiency and silver hairs. We report a 17-month-old boy with GS type 2 who presented with severe anemia. Bone marrow examination of the child suggested parvovirus B19 as the cause of severe anemia, which was later confirmed by DNA polymerase chain reaction.

  12. The Seropositivity Rate of Atypical Agents in Patients with Community-Acquired Pneumonia

    Directory of Open Access Journals (Sweden)

    Ruhan Karakoc Gunes

    2007-08-01

    Full Text Available The aim of this study was to investigate the IgM antibody positivities of atypical pneumonia agents in patients with community-acquired pneumonia (CAP, and to compare the results with controls. The serum samples which were collected from 87 adult patients and 21 healthy controls have been investigated by a commercial ELISA (Pneumobact ELISA IgM, Vircell, Spain in which four different atypical pneumonia agents were fixed onto a slide. In the patients group, IgM positivity rates for the agents were as follows, respectively; 2.3% for Legionella pneumophila, 56.3% Chlamydia pneumoniae, 33.3% for Mycoplasma pneumoniae, 9.2% for Coxiella burnetii. The rates of IgM positivities in the control group varied 7% for all of the agents except M. Pneumoniae and C. Pneumoniae and 2 of these controls were positive for L. Pneumophila IgM, one was positive for C. Burnetii IgM. According to the statistical evaluation, there were significant differences for IgM seropositivities to Mycoplasma pneumoniae and Chlamydia Pneumoniae,between the patient and the control groups (p0.05. We showed that the seropositivity rate of atypical agents in patients with CAP was significantly higher when compared to healthy control group. This result suggests us, atypical agents might be responsible in CAP patients in a great amount. Furthermore, our study also suggests that clinical and radiological findings are not useful for discriminating atypical from typical pneumonia. [TAF Prev Med Bull 2007; 6(4.000: 279-284

  13. 人细小病毒B19感染与类风湿性关节炎相关性%Relationship between infection of human parvovirus B19 and rheumatoid arthritis

    Institute of Scientific and Technical Information of China (English)

    成胜权; 张国成; 郑英文

    2001-01-01

    @@0 引言成人类风湿性关节炎(rheumatoid arthritis, RA)的病因迄今尚不清楚,近年的研究认为,其发病涉及感染、机体因素及免疫功能紊乱等多环节,其中关于人细小病毒B19B19)感染与RA的相关性,国外相继有报道[1,2]. 我们就我国RA患者B19的感染状况以及RA与B19感染的相关关系做一初步研究.

  14. 探讨人细小病毒B19与异位妊娠的关系%ON THE RELATIONSHIP BETWEEN HUMAN PARVOVIRUS B19 AND THE ECTOPIC PREGNANCY

    Institute of Scientific and Technical Information of China (English)

    谭继英; 高峻

    2003-01-01

    无菌留取85例异位妊娠妇女和43例妊娠无异常孕妇血清, 用聚合酶连反应(PCR)检测的人细小病毒B19 DNA,在异位妊娠组中人细小病毒B19 DNA有20例阳性,阳性率为23.53%.正常对照组中,人细小病毒B19 DNA有2例为阳性,阳性率为4.51%,用x2检验,x2=6.47,P<0.05,2组有显著性差异.由此总结,人细小病毒B19感染可能是异位妊娠的原因之一.

  15. 原料血浆和凝血因子类产品中人细小病毒B19污染情况调查%Contamination of human parvovirus B19 in source plasma and coagulation factor products

    Institute of Scientific and Technical Information of China (English)

    贾俊婷; 马玉媛; 郭逸; 赵雄; 赵福广; 章金刚

    2015-01-01

    Objective To detect human parvovirus B19(B19V)DNA in source plasma pools and coagulation factor products and determine its prevalence and the level of contamination .Methods A pair of primers and a probe selected from the highly conserved sequences encoding the non-structural protein(NS1)of B19 were designed and synthesized.With the primer-probe combination ,source plasma pools and four types of coagulation factor products were determined for B 19V DNA by TaqMan real-time quantitative PCR.Results One-hundred and sixteen from 195 (59.49%) source plasma pools contained B19 DNA and concentrations up to 1.35 ×1010 copies/ml were measured.High frequencies of contamination were detected in factor Ⅷ (29 of 31; 93.55%), thrombin (10 of 10; 100%), fibrinogen (6 of 7; 85.71%) and prothrombin complex (8 of 9;88.89%).Conclusion These data show that B19V is a common contaminator in Chinese source plasma pools and coagulation factor products .Thus,B19V screening in Chinese source plasma seems desirable and significant for the safety of plasma derivatives in China .%目的:检测混合原料血浆和凝血因子类产品中人细小病毒B19(human parvovirus B19B19病毒)核酸,分析我国原料血浆及凝血因子类产品中B19病毒的污染情况。方法针对B19病毒的保守区域NS1区合成引物及探针,采用TaqMan实时定量PCR法检测混合原料血浆和4类凝血因子类产品中B19病毒核酸。结果混合原料血浆的B19病毒核酸的阳性率为59.49%(116/195),最高浓度可达1.35×1010拷贝/ml。因子Ⅷ、凝血酶、纤维蛋白原以及凝血酶原复合物的阳性率分别为93.55%(29/31)、100%(10/10)、85.71%(6/7)和88.89%(8/9)。结论我国混合原料血浆与凝血因子类产品中B19病毒的污染率较高,有必要进行原料血浆的B19病毒筛查,对于保障血液制品的病毒安全性具有重要意义。

  16. [National consensus for management of community acquired pneumonia in adults].

    Science.gov (United States)

    Saldías P, Fernando; Pérez C, Carlos

    2005-01-01

    Community acquired pneumonia (CAP) is an acute respiratory infection that affects pulmonary parenchyma, and is caused by community acquired microorganisms. In Chile, pneumonia represents the main cause of death due to infectious diseases and is the third specific cause of mortality in adults. In 1999, an experts committee in representation of "Sociedad Chilena de Enfermedades Respiratorias", presented the first National Guidelines for the Treatment of Adult Community Acquired Pneumonia, mainly based in foreign experience and documents, and adapted it to our National Health System Organization. During the last decade, impressive epidemiological and technological changes have occurred, making the update of guidelines for treatment of NAC by several international scientific societies, necessary. These changes include: new respiratory pathogens that are being identified in CAP and affect adult patients (Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila); the increasing senescent adult population that carries multiple co-morbidities; the emergence of antimicrobial resistance among respiratory pathogens associated to massive antibiotic prescription; the development by the pharmaceutical industry of new drugs that are effective for pneumonia treatment (macrolides, ketolides and respiratory fluorquinolones); and the development of new diagnostic techniques for detection of antigens, antibodies, and bacterial DNA by molecular biology, useful in respiratory infections. Based on these antecedents, an Advisory Committee of "Sociedad Chilena de Enfermedades Respiratorias" and "Sociedad Chilena de Infectología" has reviewed the national and international evidence about CAP management in adults in order to update clinical recommendations for our country.

  17. Clinical value of measuring human parvovirus B19 antibody by ELISA%ELISA法检测人微小B19抗体及其临床应用评价

    Institute of Scientific and Technical Information of China (English)

    聂晓晶; 李小青; 张国成; 许东亮; 孙新; 李志宏; 张学红

    2008-01-01

    目的 建立检测人微小病毒B19的间接酶联免疫吸附(ELISA)法,评价其临床应用价值.方法 采用原保存的XA-B19 VP1独特区蛋白包被ELISA板,优化该方法检测B19抗体的最佳实验条件.与聚合酶链反应(PCR)、parvovirus B19 ELISA方法进行比较,评价其一致性.结果 最佳包被量为25 ng/孔,标本血清最佳稀释倍数为1:200.建立的间接ELISA检测体系与腺病毒、呼吸道合胞病毒、流感病毒、副流感病毒、疱疹病毒抗体阳性血清无交叉反应.其检测B19 IgM敏感性为88.37%,特异性为96.15%,与PCR方法一致性好(kappa值>0.75,P>0.05);与parvovirus B19 IgM ELISA方法符合性好,符合率为96.8%.与parvovirus B19IgG ELISA方法比较kappa值>0.75,P>0.05,两种检测方法一致性好.结论 建立的间接ELISA检测B19抗体的方法具有灵敏度高、特异性强、经济、快速、方便等优点,适合于流行病学调查和临床标本检测.

  18. Recent advance of pregnancy outcomes to parvovirus B19 infection in pregnant women%孕妇细小病毒 B19感染对母婴结局影响及其新进展

    Institute of Scientific and Technical Information of China (English)

    陈友鹏; 李桃源

    2015-01-01

    人细小病毒 B19属于细小病毒科细小病毒属,是唯一感染人类的细小病毒。其病毒感染呈世界范围分布,一年四季散发。主要经呼吸道传播给孕妇,孕妇主要经垂直传播的方式感染胎儿。应用血清学与分子生物学方法来明确诊断。它与自然流产、死胎、胎儿水肿、贫血、新生儿疾病等有关。本研究对细小病毒 B19病原学、孕妇感染现状、临床表现与母婴结局、诊断、预防治疗等最新进展综述。%Human parvovirus B19 belongs to the subfamily parvovirinae,the genus erythrovirus and human parvovirus B19 type species.The viral infection distributes worldwide,in which pregnant women are commonly acquired by air,and then vertically transmitted to their babies.Diagnosis should be done by the test of anti-B19 IgM/IgG antibodies and detection of B19 DNA.Its infection during pregnancy is associated with spontaneous abortion,stillbirth,fetal edema,anemia,neonatal illness and so on.The current knowledge of the characteristics of parvovirus B19,the prevalence of infection in pregnant women,clinical manifestations and pregnancy outcomes,diagnosis of B19 infection,prevention and treat-ment is described in this review.

  19. 微小病毒B19在自然流产患者中的感染状况研究%Study on the infection of human parvovirus B19 in patients with spontaneous abortion

    Institute of Scientific and Technical Information of China (English)

    胡方兴; 孙馨

    2015-01-01

    目的 检测自然流产患者中的HPV B19 IgM、IgG抗体及DNA,探讨其对自然流产的预防及诊治价值. 方法 收集病例组(自然流产孕妇)和对照组(中晚期正常妊娠孕妇)静脉血,采用ELISA法检测HPV B19 IgM、IgG抗体,PCR检测HPV B19 DNA,比较自然流产患者与正常待产孕妇感染率的差异. 结果 病例组检测到3例HPV B19 IgM阳性标本,对照组未检测到阳性标本;病例组HPV B19 IgG阳性率为46.15%,低于对照组阳性率63.46%;病例组HPV B19DNA阳性率为21.15%,显著高于对照组阳性率3.85%.两组差异有统计学意义(P<0.05). 结论 长沙地区自然流产孕妇中HPV B19的感染率高于正常妊娠孕妇,推测HPV B19感染与自然流产有相关性.

  20. Novel B19-like parvovirus in the brain of a harbor seal.

    Directory of Open Access Journals (Sweden)

    Rogier Bodewes

    Full Text Available Using random PCR in combination with next-generation sequencing, a novel parvovirus was detected in the brain of a young harbor seal (Phoca vitulina with chronic non-suppurative meningo-encephalitis that was rehabilitated at the Seal Rehabilitation and Research Centre (SRRC in the Netherlands. In addition, two novel viruses belonging to the family Anelloviridae were detected in the lungs of this animal. Phylogenetic analysis of the coding sequence of the novel parvovirus, tentatively called Seal parvovirus, indicated that this virus belonged to the genus Erythrovirus, to which human parvovirus B19 also belongs. Although no other seals with similar signs were rehabilitated in SRRC in recent years, a prevalence study of tissues of seals from the same area collected in the period 2008-2012 indicated that the Seal parvovirus has circulated in the harbor seal population at least since 2008. The presence of the Seal parvovirus in the brain was confirmed by real-time PCR and in vitro replication. Using in situ hybridization, we showed for the first time that a parvovirus of the genus Erythrovirus was present in the Virchow-Robin space and in cerebral parenchyma adjacent to the meninges. These findings showed that a parvovirus of the genus Erythrovirus can be involved in central nervous system infection and inflammation, as has also been suspected but not proven for human parvovirus B19 infection.

  1. Novel B19-like parvovirus in the brain of a harbor seal.

    Science.gov (United States)

    Bodewes, Rogier; Rubio García, Ana; Wiersma, Lidewij C M; Getu, Sarah; Beukers, Martijn; Schapendonk, Claudia M E; van Run, Peter R W A; van de Bildt, Marco W G; Poen, Marjolein J; Osinga, Nynke; Sánchez Contreras, Guillermo J; Kuiken, Thijs; Smits, Saskia L; Osterhaus, Albert D M E

    2013-01-01

    Using random PCR in combination with next-generation sequencing, a novel parvovirus was detected in the brain of a young harbor seal (Phoca vitulina) with chronic non-suppurative meningo-encephalitis that was rehabilitated at the Seal Rehabilitation and Research Centre (SRRC) in the Netherlands. In addition, two novel viruses belonging to the family Anelloviridae were detected in the lungs of this animal. Phylogenetic analysis of the coding sequence of the novel parvovirus, tentatively called Seal parvovirus, indicated that this virus belonged to the genus Erythrovirus, to which human parvovirus B19 also belongs. Although no other seals with similar signs were rehabilitated in SRRC in recent years, a prevalence study of tissues of seals from the same area collected in the period 2008-2012 indicated that the Seal parvovirus has circulated in the harbor seal population at least since 2008. The presence of the Seal parvovirus in the brain was confirmed by real-time PCR and in vitro replication. Using in situ hybridization, we showed for the first time that a parvovirus of the genus Erythrovirus was present in the Virchow-Robin space and in cerebral parenchyma adjacent to the meninges. These findings showed that a parvovirus of the genus Erythrovirus can be involved in central nervous system infection and inflammation, as has also been suspected but not proven for human parvovirus B19 infection.

  2. Estimating the risk of parvovirus B19 infection in blood donors and pregnant women in Japan.

    Directory of Open Access Journals (Sweden)

    Koji Nabae

    Full Text Available BACKGROUND: Seroepidemiological study of parvovirus B19 has not taken place for some 20 years in Japan. To estimate the risk of parvovirus B19 infection in Japan among blood donors and pregnant women in this century, a seroepidemiological survey and statistical modeling of the force of infection were conducted. METHODOLOGY/PRINCIPAL FINDINGS: The time- and age-specific seroprevalence data were suggestive of strong age-dependency in the risk of infection. Employing a piecewise constant model, the highest forces of infection of 0.05 and 0.12 per year were observed among those aged 0-4 and 5-9 years, respectively, while estimates among older individuals were less than 0.01 per year. Analyzing the antigen detection data among blood donors, the age-specific proportion positive was highest among those aged 30-39 years, agreeing with the presence of dip in seroprevalence in this age-group. Among pregnant women, up to 107 fetal deaths and 21 hydrops fetalis were estimated to have occurred annually across Japan. CONCLUSIONS: Seroepidemiological profiles of PVB19 infection in Japan was characterized with particular emphasis on the risk of infection in blood donors and the burden of infection among pregnant women. When a vaccine becomes available in the future, a similar seroepidemiological study is expected to play a key role in planning the appropriate immunization policy.

  3. Pneumonia adquirida na comunidade em pacientes tratados ambulatorialmente: aspectos epidemiológicos, clínicos e radiológicos das pneumonias atípicas e não atípicas

    Directory of Open Access Journals (Sweden)

    ROCHA ROSALI TEIXEIRA

    2000-01-01

    Full Text Available Objetivo: Avaliar o percentual etiológico das pneumonias atípicas tratadas ambulatorialmente. Identificar os fatores epidemiológicos, clínicos e radiológicos que permitam diferenciar pneumonia atípica de não atípica. Métodos: Os pacientes foram submetidos a avaliação clínica, radiológica, coleta de escarro para estudo pelo método de Gram e sangue para testes sorológicos, incluindo Legionella pneumophila, Chlamydia sp, Mycoplasma pneumoniae, vírus Influenza A e Influenza B, no primeiro dia e 21 dias após inclusão. As radiografias de tórax foram revistas por três observadores independentes que desconheciam o quadro clínico. Resultados: Avaliados inicialmente 129 pacientes durante 22 meses. A amostra final para estudo comparativo entre os grupos consistiu de 69 pacientes que tinham em média 37 anos, sendo 46 (67% homens e 23 (33% mulheres. O diagnóstico etiológico foi definido em 34 (50% dos pacientes. Chlamydia sp foi o agente atípico mais freqüente, com 11 (16% casos, seguido por M. pneumoniae com 7 (10%. Influenza A respondeu por 4 (6% dos casos e Legionella em 4 (6% pacientes. Infecções mistas foram evidenciadas, com associação de Chlamydia sp e M. pneumoniae em 5 (7% casos, Chlamydia sp e Influenza B em um caso e M. pneumoniae e Influenza A em outro. A presença de sintomas respiratórios e achados gerais sugestivos de pneumonia atípica foram comparados entre os grupos e não foram observadas diferenças significantes. A avaliação radiológica realizada por três observadores independentes mostrou discordância entre eles para os tipos de pneumonia. O diagnóstico radiográfico de cada observador comparado com o diagnóstico clínico não mostrou associação significante. Conclusões: A pneumonia causada por agente atípico ocorre em 50% dos pacientes com pneumonia adquirida na comunidade em tratamento ambulatorial. Não é possível distinguir pacientes com pneumonia atípica de pneumonia não atípica. A

  4. Quick preparations of human parvovirus B19 microarray probes using PCR%应用PCR快速制备细小病毒B19诊断芯片探针

    Institute of Scientific and Technical Information of China (English)

    吕梁; 马文丽; 王洪敏; 马晓冬; 孙朝晖; 郑文岭

    2003-01-01

    目的制备细小病毒诊断芯片探针.方法利用Primer Premier 5.0针对细小病毒B19基因保守区域设计PCR引物,将PCR产物克隆pMD-18 T载体.结果序列分析显示,PCR产物均为细小病毒B19特异保守基因.结论利用PCR扩增产物制备诊断芯片探针是一种简便有效的方法.%Objective To prepare DNA microarray probes for the detection of human parvovirus B19. Method Specific PCRprimers were designed with the Primer Premier 5.0 to amplify the conserved regions of human parvovirus B19 genome. ThePCR products were cloned into the pMD-18 T vector. Result Sequences analysis showed the PCR products conformed to thesequences contained in the genome of human parvovirus B19. Conclusion PCR amplification of the conserved and specifichuman parvovirus B19 genes is simple and effective to prepare the desired probes.

  5. 微小病毒B19与早期自然流产关系的研究%Study of Human Parvovirus B19 Infection in the First-Trimester Spontaneous Abortion

    Institute of Scientific and Technical Information of China (English)

    蔡文勤; 张元珍

    2007-01-01

    目的:应用聚合酶链反应(PCR)技术检测早期自然流产和正常早期妊娠孕妇血清中人微小病毒B19(B19病毒)非结构蛋白DNA,对比分析早期自然流产的原因.方法:收集40例早期自然流产和70例正常早期妊娠孕妇的血清,应用套式PCR技术检测两组孕妇血清中的B19病毒非结构蛋白DNA.结果:40例早期自然流产孕妇血清中,5例(12.5%)B19病毒阳性,70例对照组孕妇血清中1例(1.43%)B19病毒阳性.两者比较,差异有显著性(P<0.05).结论:B19病毒是导致早期自然流产的原因之一.

  6. 人细小病毒B19与自然流产关系的研究%Study on the relationship between human parvovirus B19 and the spontaneous abortion by polymerase chain reaction

    Institute of Scientific and Technical Information of China (English)

    谭继英; 高峻; 兰中芬

    2003-01-01

    无菌留取54例自然流产妇女和43例妊娠无异常孕妇血清,用聚合酶链反应(Polymerase Chain Reaction,PCR)检测的人细小病毒B19(Human Parvovirus B19,B19)DNA,在自然流产组中人细小病毒B19 DNA有15例阳性,阳性率为27.78%.正常对照组中,人细小病毒B19 DNA有2例为阳性,阳性率为4.65%,用x2检验,x2=8.86,P<0.01,两组有非常显著性差异.由此总结,人细小病毒B19感染可能是导致自然流产的原因之一.

  7. An association between human parvovirus B19 intrauterine infection and neonatal anemia%人类微小病毒B19宫内感染与新生儿贫血的关系探讨

    Institute of Scientific and Technical Information of China (English)

    郑吉善; 朱利华; 倪敏君

    2004-01-01

    目的探讨人类微小病毒B19(HPV B19)宫内感染与新生儿贫血的关系.方法采用酶联免疫吸附试验(ELISA)方法对30例不明原因贫血的新生儿进行HPV B19-IgM 及IgG的检测,并将48例正常新生儿作为对照组.结果 30例不明原因贫血的新生儿中,HPV B19-IgM阳性率46.67%(14/30),48例正常对照组HPV B19-IM阳性率4.17% (2/48),两组比较,差异有非常显著性意义(χ2=17.93,P<0.005 相对危险度RR =11.2).结论人类微小病毒B19宫内感染与新生儿不明原因贫血显著相关.

  8. 人细小病毒B19感染对妊娠影响的研究进展

    Institute of Scientific and Technical Information of China (English)

    薛承岩; 宋鸿儒

    2001-01-01

    人细小病毒B19(human parvovirus B19.B19V)是Cossart等于1975现和定名的一种能感染人类、属于微小病毒科的新病毒。现已发现,人类许多疾病的发生与B19V感染有关。如传染性红斑,再生障碍性贫血危象,血小板和血管性紫癜、急性多关节病,肝炎、心肌炎、中枢神经系统感染,流产、胎儿水肿、早产、死胎等。

  9. Human Parvovirus B19 VP2 Empty Capsids Bind to Human Villous Trophoblast Cells in vitro Via the Globoside Receptor

    OpenAIRE

    Wegner, Carole C.; Jordan, Jeanne A.

    2004-01-01

    BACKGROUND: Pregnant women acutely infected with human parvovirus B19 (B19) may transmit the virus to the developing fetus. The mechanism whereby the virus interacts with the placenta is unknown. It is known that globoside receptor is required for successful infection of the target cells, which are the highly undifferentiated, actively dividing colony and burst-form units of the erythroid series. Globoside is present on trophoblast cells which have intimate contact with maternal blood, and ma...

  10. Papular-purpuric "gloves and socks" syndrome caused by parvovirus B19 infection in Brazil: a case report

    OpenAIRE

    Marcos Tadashi Kakitani Toyoshima; Lilian Walsh Keller; Maria Luisa Barbosa; Edison Luiz Durigon

    2006-01-01

    Papular-purpuric "gloves and socks" syndrome (PPGSS) is a novel, rare, self-limiting dermatosis caused by human parvovirus B19. It consists of pruritic edema and erythema of the hands and feet in a gloves-and-socks distribution, and it is associated with oral lesions and fever. We present a case of PPGSS in a 22-year-old Brazilian woman. Clinical and laboratory evaluation, including serological tests, PCR and gene sequencing, confirmed the presence of human parvovirus B19.

  11. CT manifestations of adult mycoplasma pneumoniae pneumonia

    International Nuclear Information System (INIS)

    Objective: To study the conventional CT and HRCT manifestations of adult mycoplasma pneumoniae pneumonia. Methods: Conventional CT and HRCT were performed in 16 adult patients with mycoplasma pneumoniae pneumonia proven by serology. The CT images were retrospectively analyzed. Results: Areas of ground-glass opacity (GGO) were found in 12 cases. GGO showed lobular or patchy distribution in 9 cases. Air-space consolidation was observed in 8 cases, 'tree in bud' sign in 9, thickening of the interlobular septa in 3, and thickening of bronchovascular bundle in 1. 15 cases had two or more findings simultaneously. Conclusion: Mycoplasma pneumoniae pneumonia has some characteristic CT findings, which can help to distinguish it from bacterial pneumonia

  12. Progress in genotyping of Chlamydia trachomatis

    Institute of Scientific and Technical Information of China (English)

    Xia Yong; Xiong Likuan

    2014-01-01

    Objective To review the common genotyping techniques of Chlamydia trachomatis in terms of their principles,characteristics,applications and limitations.Data sources Data used in this review were mainly from English literatures of PubMed database.The search terms were "Chlamydia trachomatis" and "genotyping".Meanwhile,data from World Health Organization were also cited.Study selection Original articles and reviews relevant to present review's theme were selected.Results Different genotyping techniques were applied on different occasions according to their characteristics,especially in epidemiological studies worldwide,which pushed the study of Chlamydia trachomatis forward greatly.In addition,summaries of some epidemiological studies by genotyping were also included in this work for reference and comparison.Conclusions A clear understanding of common genotyping techniques could be helpful to genotype C.trachomatis more appropriately and effectively.Furthermore,more studies on the association of genotypes of Ch/amydia trachomatis with clinical manifestations should be performed.

  13. 人微小病毒B19感染与类风湿关节炎的临床研究

    Institute of Scientific and Technical Information of China (English)

    孙娥绒; 丁景春; 熊秀莲; 张静; 南秀兰

    2002-01-01

    @@ 人微小病毒B19(Human Parvovirus B19,HPV B19),系微小病毒属中同人类疾病密切相关的一种DNA病毒[1].我科应用PCR技术对156例类风湿关节炎RA患者进行HPV B19检测,探讨与类风湿关节炎的发病关系.

  14. The progress in research of the inactivation/removal of human parvovirus B19 in plasma-derived products%血浆制品中人细小病毒B19的灭活/去除研究进展

    Institute of Scientific and Technical Information of China (English)

    卜风荣; 于军; 宿艳笋

    2009-01-01

    存在于血浆制品中的人细小病毒B19(human parvovims B19,B19)是传播B19的潜在危险,尤其是B19可经污染的血浆制品的输注而在易感人群中传播.据认为,B19对普通的理化灭活方法有较强的抵抗力.然而,各项研究显示,B19对加热和低pH处理较敏感.因此,可以选择合适的方法来灭活B19.%The presence of human parvovirus B19(B19) in plasma-derived products indicates a potential risk of B19 transmission,and especially,B19 may be transmitted by transfusion of the contaminated plasma and plasma-derived products in susceptible individuals. It is believed that B19 is more resistant to common physicochemical inactivation methods. However,the various studies show that B19 is more sensitive to heat and low pH treatment. So suitable methods may be selected to inactivate B19.

  15. Human parvovirus B19 infection in child blood system diseases%小儿血液系统疾病人细小病毒B19感染的研究

    Institute of Scientific and Technical Information of China (English)

    许东亮; 张国成; 张笑飞; 钱新宏

    2002-01-01

    目的对84例特发性血小板减少性紫癜,54例急、慢性白血病,38例再生障碍性贫血患儿及30例正常儿童的骨髓或血液标本,进行人细小病毒B19(HPV-B19)检测.以了解我国上述血液系统疾病患儿的HPV-B19感染情况及其相关性.方法采用巢式PCR方法.结果 HPV-B19的阳性率,在特发性血小板减少性紫癜为 42.85%,急性淋巴细胞白血病为 41.17%,再生障碍性贫血为 23.68%,而对照组为 3.33%.与对照组比较均具有显著性差异.结论 HPV-B19感染与上述疾病可能存在一定的相关性.

  16. Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy.

    Science.gov (United States)

    Azumagawa, Kohji; Nomura, Shohei; Shigeri, Yasushi; Jones, Leslie Sargent; Sato, Douglas Kazutoshi; Nakashima, Ichiro; Kashiwagi, Mitsuru; Tanabe, Takuya; Shimakawa, Shuichi; Nakajima, Hideto; Tamai, Hiroshi

    2016-08-01

    The mechanism of post-vaccination acute disseminated encephalomyelitis (ADEM) has been hypothesized as resulting from vaccination-injected antigens cross-reacting with myelin components, however, a precise etiology has been uncertain. In this report, we describe the case of a 6-year-old Japanese boy who had multiphasic disseminated encephalomyelitis (MDEM), and was positive for both anti-myelin oligodendrocyte glycoprotein (MOG) antibodies and Chlamydophila pneumoniae antibodies. After vaccinations that were the second one for measles and rubella, and the booster immunization for Japanese encephalitis, the patient presented with fever, headache, vomiting, and a change in personality. He was treated with a high-dose of intravenous methylprednisolone in the diagnosis of ADEM. However, these symptoms recurred with different magnetic resonance imaging lesion, and he was diagnosed as MDEM. Retrospective testing for pathogens revealed C. pneumoniae IgM and IgG antibodies, and it was considered that he was infected with C. pneumoniae subclinically. The patient's serum indicated a positive response for the anti-MOG antibody from the onset of the ADEM diagnosis and in all recurrent episodes. Chlamydia species infection has been known to play a role in demyelinating diseases. It is also known that the anti-MOG antibody may be present but not exhibit its pathogenesis in the absence of a cell-mediated inflammatory response; however, the precise mechanism of action of the anti-MOG antibodies is not yet determined. We propose the possibility that post-vaccination demyelinating disease may result from the synergistic effects of a preceding anti-MOG antibody, possibly produced in response to a subclinical Chlamydia species infection. PMID:26922251

  17. Klebsiella pneumonia: An unusual cause of ophthalmia neonatorum in a healthy newborn.

    Science.gov (United States)

    Kumar, Jaya B; Silverstein, Evan; Wallace, David K

    2015-12-01

    Ophthalmia neonatorum is one of the most common infections during the neonatal period. Chlamydia trachomatis and Neisseria gonorrhoea must be ruled out, given their high virulence and systemic complications. We describe a case of ophthalmia neonatroum from Klebsiella pneumonia. Gram-negative organisms have been reported in hospital-acquired conjunctivitis (HAC), but we are unaware of any published reports of K. pneumonia conjunctivitis in an otherwise healthy full-term infant born in the United States who has received prophylaxis. It is important to promptly identify and treat Klebsiella conjunctivitis because it can lead to severe complications. PMID:26691043

  18. Association of Mycoplasma pneumoniae Infection with Myocardial Infarction

    Directory of Open Access Journals (Sweden)

    Abdolreza Sotoodeh Jahromy

    2009-01-01

    Full Text Available Problem statement: In addition to the major risk factors for atherosclerosis such as high plasma level of low density lipoprotein, low plasma level of high density lipoprotein, cigarette smoking, hypertension and diabetes mellitus, some studies introduce other agents such as Mycoplasma pneumoniae as risk factors for atherodclerosis and coronary artery diseases. Aim of this study was to clarify the risk of Mycoplasma pneumoniae for myocardial infarction in Iranian population. Approach: This was a case-control study, in which 90 patients studied. (March 2005-2007. First group (or case group include 45 units who had been admitted in hospital with diagnosis of myocardial infarction and second group include 45 units, who were healthy individuals without any positive history of ischemic heart disease. IgG antibodies was assessed by ELISA technique in both groups. Results: There was significant statistic difference in antimycoplasma antibody level. In the groups (p = 0.028 and the relative risk of mycoplasma infection for myocardial infarction estimated to be 2.7. Conclusion: Mycoplasma pneumoniae infection seems to be a risk factor for myocardial infarctin, in Iranian population. It is better to design other studies to evaluate the risk of coinfection of Mycoplasma pneumoniae and Chlamydia pneumoniae and also the risk of these infection plus conventional risk factors for myocardial infarction in this country.

  19. On damage of human body by infection of human parvovirus B19%关注人细小病毒B19感染对人类健康的危害

    Institute of Scientific and Technical Information of China (English)

    王凝芳; 董时军

    2005-01-01

    1975年Cossart等从1例无症状者血清标本电镜检查中发现直径20~25nm球形病毒样颗粒,编定为B19病毒,经证实该病毒属细小病毒。以往发现的细小病毒只能感染牛、猫、狗、水貂、小鼠等哺乳动物,不感染人,故将B19病毒命名为人细小病毒(human parvovirus,HPV)B19

  20. Correlation of parvovirus B19 with leukemia and lymphoma of children%细小病毒B19与儿童白血病及淋巴瘤的相关性

    Institute of Scientific and Technical Information of China (English)

    焦丽; 张国成; 郭新莉

    2001-01-01

    @@人微小病毒B19 (Human Parvovirus B19, HPVB19)业已证明是微小病毒属中同人类疾病密切相关的一种DNA病毒。白血病和淋巴瘤患儿可发生HPVB9感染,B19病毒感染可能是白知病和淋巴瘤患儿发生慢性贫血和骨髓衰竭状态最重要的因素[1~4]。本文就HPVB19的生物学特征及其感染后的临床表现、发病机制、实验室诊断及防治进展作一简要回顾。

  1. 病毒性心肌炎患儿微小病毒B19感染的近期研究%A studay on parvovirus B19 infection in viral myocardial children lately

    Institute of Scientific and Technical Information of China (English)

    郑岩

    2006-01-01

    目的 进一步探讨病毒性心肌炎患儿微小病毒B19(HPVB19)感染的状况及其相关性.方法 应用巢式聚合酶链反应的方法以及 ELISA法,对60例病毒性心肌炎患儿(观察组)及30例随机挑选本院门诊健康体检儿童(对照组)血浆中微小病毒B19-DNA检测,同时进行B19- VP2- IgM检测.对观察组中HPCB19-DNA检测阳性的与阴性的两组中血CK、CK-MB及心功能指标进行比较.统计方法采用χ2和t检验.结果 60例观察组,16例B19-DNA检测阳性,30例健康儿童B19-DNA检测均为阴性,阳性检出率为26.7%(16/60),两组比较有显著差别(P<0.01);60例观察组,B19-VP2- IgM阳性25%(15/60),对照组30例均为阴性极显著(P <0.01).60例观察组中,B19 DNA及B19 VP2 M均阳性15例;1例仅B19 DNA阳性;B19 DNA和B19 VP2 IgM同时阴性43例,B19 DNA和19 -VP2 -IgM一致率为93%,有一致性(P <0.01).观察组中HPCB19-DNA检测阳性的与阴性的两组中血CK、CK-MB值变化无显著性差异,P>0.05.但心功能指标LVSF比较有明显差异(P <0.01),SV比较亦有明显差异(P <0.005).结论 小儿病毒性心肌炎与HPVB19感染有关,HPVB19是小儿病毒性心肌炎主要病原之一,而且本研究发现HPVB19感染所致小儿病毒性心肌炎的心功能改变中左室功能受累程度较重.

  2. 西藏藏族人群中细小病毒B19基因与内地汉族人群的差异%Different human parvovirus B19 subgroup circulation in Tibet and Han population in China

    Institute of Scientific and Technical Information of China (English)

    朱娜; 佟瑞; 周为民; 谭心怡; 楼永良; 谭文杰

    2015-01-01

    目的 分析人细小病毒B19及人细小病毒4(PARV4)在西藏藏族人群中与内地汉族人群中的基因特点.方法 采用建立的B19与PARV4 PCR筛查方法,分别从西藏藏族人群中与内地汉族人群血液标本中获得人细小病毒B19及PARV4的部分基因片段,经纯化、测序后,进行基因进化树分析.结果 共获得10个B19 VP1基因片段序列(西藏,2个;四川,3个;浙江,5个);10个PAV4ORF1基因片段序列(西藏,2个;四川,2个;云南,1个;浙江,5个);西藏藏族人群中细小病毒B19基因与内地汉族人群同属基因1A亚型,但为不同进化分支;而西藏藏族与内地汉族人群PAV4基因属同一分支.结论 细小病毒B19基因在西藏藏族与内地汉族人群中的差异分析为该病的检测与控制提供了参考.%Objective To investigate the genetic diversity differences of human parvoviruse B19 and parvovirus 4 (PRVA4) in Tibet and Han population in China.Methods Phylogenetic analysis was performed on genome fragments of B19 or PARV4 obtained from the blood samples of Tibet and Han population in China by using a PCR followed by sequencing.Results Ten partial VP1 fragments of B19 (2 from Tibet,3 from Sichuan,5 from Zhejiang) and 10 partial ORF1 fragments of PAV4 (2 from Tibet,2 from Sichuan,1 Yunnan,5 from Zhejiang) were obtained.Phylogenetic analysis indicated that different B19 subgroup circulates in Tibet and Han population although they belong to the same 1A subtype.While the gene evolution of PAV4 is very conserved between the Tibet and Han population in China.Conclusion These studies on genetic diversity of B19 in different Chinese population provide a way for detection and prevention of B19 human parvovirus infection.

  3. Polarized Cell Division of Chlamydia trachomatis.

    Science.gov (United States)

    Abdelrahman, Yasser; Ouellette, Scot P; Belland, Robert J; Cox, John V

    2016-08-01

    Bacterial cell division predominantly occurs by a highly conserved process, termed binary fission, that requires the bacterial homologue of tubulin, FtsZ. Other mechanisms of bacterial cell division that are independent of FtsZ are rare. Although the obligate intracellular human pathogen Chlamydia trachomatis, the leading bacterial cause of sexually transmitted infections and trachoma, lacks FtsZ, it has been assumed to divide by binary fission. We show here that Chlamydia divides by a polarized cell division process similar to the budding process of a subset of the Planctomycetes that also lack FtsZ. Prior to cell division, the major outer-membrane protein of Chlamydia is restricted to one pole of the cell, and the nascent daughter cell emerges from this pole by an asymmetric expansion of the membrane. Components of the chlamydial cell division machinery accumulate at the site of polar growth prior to the initiation of asymmetric membrane expansion and inhibitors that disrupt the polarity of C. trachomatis prevent cell division. The polarized cell division of C. trachomatis is the result of the unipolar growth and FtsZ-independent fission of this coccoid organism. This mechanism of cell division has not been documented in other human bacterial pathogens suggesting the potential for developing Chlamydia-specific therapeutic treatments. PMID:27505160

  4. Chemical cross-linking of Chlamydia trachomatis

    DEFF Research Database (Denmark)

    Birkelund, Svend; Lundemose, AG; Christiansen, Gunna

    1988-01-01

    Purified elementary bodies (EBs) of Chlamydia trachomatis serovar L2 were analyzed by chemical cross-linking with disuccinimidyl selenodipropionate. The effect of the cross-linking was analyzed by immunoblotting sodium dodecyl sulfate-polyacrylamide gel electrophoresis-separated components which...

  5. Polarized Cell Division of Chlamydia trachomatis.

    Science.gov (United States)

    Abdelrahman, Yasser; Ouellette, Scot P; Belland, Robert J; Cox, John V

    2016-08-01

    Bacterial cell division predominantly occurs by a highly conserved process, termed binary fission, that requires the bacterial homologue of tubulin, FtsZ. Other mechanisms of bacterial cell division that are independent of FtsZ are rare. Although the obligate intracellular human pathogen Chlamydia trachomatis, the leading bacterial cause of sexually transmitted infections and trachoma, lacks FtsZ, it has been assumed to divide by binary fission. We show here that Chlamydia divides by a polarized cell division process similar to the budding process of a subset of the Planctomycetes that also lack FtsZ. Prior to cell division, the major outer-membrane protein of Chlamydia is restricted to one pole of the cell, and the nascent daughter cell emerges from this pole by an asymmetric expansion of the membrane. Components of the chlamydial cell division machinery accumulate at the site of polar growth prior to the initiation of asymmetric membrane expansion and inhibitors that disrupt the polarity of C. trachomatis prevent cell division. The polarized cell division of C. trachomatis is the result of the unipolar growth and FtsZ-independent fission of this coccoid organism. This mechanism of cell division has not been documented in other human bacterial pathogens suggesting the potential for developing Chlamydia-specific therapeutic treatments.

  6. Insights into epidemiology of human parvovirus B19 and detection of an unusual genotype 2 variant, Bulgaria, 2004 to 2013.

    Science.gov (United States)

    Ivanova, Stefka Krumova; Mihneva, Zafira Georgieva; Toshev, Andon Krumov; Kovaleva, Valentina Pavlova; Andonova, Lubena Georgieva; Muller, Claude P; Hübschen, Judith M

    2016-01-01

    The present study aimed to determine the role of human parvovirus В19 (B19V) as an aetiological agent in measles and rubella negative fever/rash patients from Bulgaria between 2004 and 2013. A total of 1,266 sera from all over the country were tested for B19V IgM antibodies and all positives were further investigated by polymerase chain reaction (PCR). Overall, 280 sera (22%) were B19V IgM positive and 227 of these (81%) were also PCR positive. The highest number of IgM positives was found among five to nine year-old children (27%). Eight infected women gave birth to healthy children; one fetus was aborted with hydrops fetalis. Of the 55 genetic sequences obtained, 54 belonged to genotype 1a and one grouped as a genotype 2 outlier. Phylogenetic analysis of all available genotype 2 sequences covering the 994 nucleotide non-structural protein 1(NS1)/capsid viral protein 1 (VP1) unique region junction, showed that only one other sequence grouped with the outlier strain, forming a clearly distinct and well-supported cluster of genotype 2 (between-group genetic distance: 3.32%). In accordance with B19V nomenclature, this cluster may represent a new subgenotype 2b. The study showed that B19V infections may be falsely identified as rubella or measles in ca 22% of cases, emphasising the need for laboratory confirmation. PMID:26847955

  7. Effect of Cytomegalovirus, Herpes Simplex Virus and Parvovirus B19 on Fetal Malformation%HCMV HSV Ⅱ和HPV-B19感染对胎儿畸形的影响

    Institute of Scientific and Technical Information of China (English)

    夏黎; 吉黎晓

    2001-01-01

    目的研究人巨细胞病毒(HCMV),单纯疱疹病毒Ⅱ型(HSVⅡ)及人微小病毒B19(HPV-B19)感染与胎儿畸形的关系.方法应用聚合酶链反应技术检测了畸形组16例和对照组25例围生期死亡病例的脑、肝、肺、肾、脾组织和妊母胎盘组织中的HCMV,HSVⅡ及HPV-B19 DNA.结果①畸形组HCMV,HSVⅡ,HPV-B19阳性率分别为:50.0%(8/16),37.5%(6/16)和31.3%(5/16),而对照组阳性率分别为8.0%(2/25),8.0%(2/25),12.0%(3/25),两组之间CMV,HSVⅡ感染有显著性差异(P<0.05).②HCMV易感器官为脑、肝、肺,畸形组中脑组织阳性率43.8%(7/16)与肾组织6.3%(1/16)有显著性差异,HSVⅡ易感器官主要为肝脏,HPV-B19主要为脾脏受累.结论 HCMV,HSVⅡ胎儿与畸形有密切关系,HPV-B19感染因例数较少与畸形无明显关系.

  8. Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells.

    OpenAIRE

    Wang, X S; Yoder, M C; Zhou, S. Z.; A Srivastava

    1995-01-01

    The pathogenic human parvovirus B19 is an autonomously replicating virus with a remarkable tropism for human erythroid progenitor cells. Although the target cell specificity for B19 infection has been suggested to be mediated by the erythrocyte P-antigen receptor (globoside), a number of nonerythroid cells that express this receptor are nonpermissive for B19 replication. To directly test the role of expression from the B19 promoter at map unit 6 (B19p6) in the erythroid cell specificity of B1...

  9. 类风湿关节炎患者B19病毒感染及细胞因子变化%Parvovirus B19 infection and cytokine alteration in patients wi th rheumatoid arthritis

    Institute of Scientific and Technical Information of China (English)

    成胜权; 张国成; 李琦; 许东亮; 马真胜

    2001-01-01

    目的了解国内类风湿关节炎(rheumatoid arthritis, RA), 幼年类风湿关节炎(juvenile rheumatoid arthritis, JRA)患者人细小病毒B19 (B19)的感染情况及其细胞因子(CK)IL- 6, IL-8, sIL-2R和TNF-α水平的变化. 方法采用巢式PCR技术和夹心 ELISA法对23例RA及30 例JRA患者血清(BS),4例JRA, 6例骨性关节炎(OA)和9例半月板损伤(MT)关节液(SF)进行B19-DNA和IL-6, IL-8, sIL-2R, TNF-α等CK水平的检测. 结果① 23例RA, 30例JRA患者 BS B19-DNA均12例阳性,阳性率分别为52.1%和40.0%,与对照组比较差异显著(P0.05);⑤ SF标本中,4例JRA患者的sIL-2R与其他两组有显著差异( P <0.01). 结论①国内RA, JRA患者有较高B19感染率,提示B19感染与 RA, JRA密切相关;② IL-6, sIL-2R与RA、JRA活动性有关,是类风湿活动性的主要指标 ;③ sIL-2R可能是参与JRA关节局部病理损伤最主要的CK 之一;④ BS中CK水平的变化与是否感染B19无关,即B19并非是导致RA, JRA的唯一因素.

  10. 胸腔积液检测人类微小病毒B19和人类巨细胞病毒分析%Analysis of detecting results of human parvovirus B19 and human cytomegalovirus in pleural effusion

    Institute of Scientific and Technical Information of China (English)

    陈宇; 庞桂芬; 薛承岩

    2005-01-01

    研究显示,人类微小病毒B19(human parvovirus B19,HPB19)和人类巨细胞病毒(human cytomegalovirus,HCMV)在胸液中有较高的阳性发现,此2种病毒感染可能是导致或加重胸腔积液的重要因素。选择2002—2003年本院胸腔积液住院病人180例分析报告如下。

  11. Relationship between human parovirous B19 infection and idiopathic thrombocytopenic purpura%特发性血小板减少性紫癜与人细小病毒B19的关系

    Institute of Scientific and Technical Information of China (English)

    严智先; 蔡定邦; 陈享

    2003-01-01

    目的探讨特发性血小板减少性紫癜(ITP)与人细小病毒B19感染性的关系.方法采用巢式聚合酶链反应技术分别对63例ITP患儿的血清、38例ITP患儿的骨髓液检测人细小病毒B19-DNA.并与对照组进行对比.结果①63例ITP静脉血中人细小病毒B19-DNA阳性12例,阳性率为19.1%,186例健康儿童11例阳性,阳性率为5.91%.血清的ITP组与对照组差异有显著意义(χ2=9.68,P<0.01).②38例ITP患儿的骨髓液中人细小病毒B19-DNA 16例阳性,阳性率为42.1%,对照组30例阳性3例,阳性率为10%,骨髓ITP组与对照组差异有显著意义(χ2=8.58,P<0.01).③血清的ITP组12例阳性病例中,11例是急性ITP,阳性率为23.4%;1例是慢性ITP,阳性率为5.9%,差异有显著意义(χ2=3.09,P<0.05).骨髓的ITP组急性29例,阳性15例,阳性率为51.7%;慢性9例,阳性1例,阳性率为11.1%.ITP组与对照组差异有显著意义(χ2=4.65,P<0.05).男女之间无差异.结论①ITP人群有较高的B19感染率,一部分ITP病儿与人细小病毒B19感染密切相关.②临床上一部分ITP患儿的发病可能为人细小病毒B19感染所导致.③B19感染相关性ITP以急性ITP为主.

  12. 微小病毒B19感染与甲状腺乳头状癌的关系%The Association between Parvovirus B19 Infection and Papillary Thyroid Carcinoma

    Institute of Scientific and Technical Information of China (English)

    王娟红; 黄高昇; 张伟平; 王(頔); 王璐; 王文清; 李袁飞; 王哲; 马忠

    2007-01-01

    目的:探讨人类微小病毒B19感染(parvovirus B19,B19)与甲状腺乳头状癌(Papillary thyroid carcinoma,PTC)的关系.方法:对38例手术切除的PTC患者甲状腺组织(其中30例伴有周围正常甲状腺组织)及16例甲状腺腺瘤患者腺瘤旁正常甲状腺组织,分别用巢式聚合酶链反应(nested polymerase chain reaction,nPCR)、原位杂交(in situ hybridization,ISH)和免疫组织化学(immunohistochemistry,IHC)检测B19病毒DNA和病毒蛋白的表达.结果:nPCR扩增出173bp的B19特异性目的条带.ISH和IHC检测出B19病毒DNA和蛋白分别位于肿瘤细胞胞核和胞浆内.在PTC中,nPCR、ISH和IHC阳性率分别为97.4%(37/38)、78.9%(30/38)和63.2%(24/38),而腺瘤旁正常甲状腺组织中,阳性率分别为43.8%(7/16)、12.5%(2/16)和6.25%(1/16).两者比较差异有统计学意义(3种方法均P<0.001).癌旁甲状腺组织ISH和IHC阳性率分别为23.3%(7/30)和10.0%(3/30),与之相对应的30例PTC(ISH:80.0%;IHC:60.0%)相比,差异有统计学意义(两者均P<0.001).结论:PTC患者甲状腺肿瘤组织中B19感染率明显高于腺瘤旁和癌旁正常甲状腺组织,提示B19感染在PTC的发生中可能起重要的作用.

  13. ASSOCIATION OF MYCOPLASMA PNEUMONIAE WITH RESPIRATORY TRACT INFECTIONS IN CHILDREN

    Directory of Open Access Journals (Sweden)

    Osama Mohammed Saed Abdul-Wahab

    2013-01-01

    study of its kind from the region reporting such a disease in children using a serological assay as ELISA. Further studies are required to evaluate the risk of coinfection by Mycoplasma pneumoniae, Streptococcus pneumoniae and Chlamydia pneumoniae. Evaluating and establishing a correlation between Mycoplasma pneumoniae and the onset of asthma among infected children can be a prospective field of study for further knowledge of the role of Mycoplasma pneumoniae in chronic respiratory tract infections.

  14. IL-17/il-23 and Chlamydia trachomatis.

    Science.gov (United States)

    Shavlakadze, N; Gorgoshidze, B

    2010-06-01

    Ch. trachomatis is a gram negative bacteria, infecting the most organs of the uro-genital tract and harming greatly the woman's or man's reproductive field. Moreover, as this is not the limit of its destructive nature, it can form a favorable ground for developing ulcer and tumor processes. As observed, a special place is occupied by Ch. trachomatis chronization skill, which is developed irrespective the mighty humoral and cellular respond to its intrusion into the host's organism. It is also known that T (CD4) lymphocytes and their products - cytokines are directly involved into these processes. IL-17 and its regulator IL-23 are among them. For the significance of the above-mentioned processes for expiring the chlamydiosis immune-pathogenesis we have studied the problem in the patients with IL-17 and IL-23 chlamydiosis. We have investigated 56 chlamydia infected patients; 31 non-infected patients who were the carriers of a different pathology flora and 21 healthy donors. The investigation covered some impaired localities as well as the organism overall. To gain the objective we analyzed clinical -anamnesis data and carried out the appropriate instrumental, laboratorial and immunological researches. Stating the chlamydia infection was carried on with the serological and immunofluorescentical and PCR methods. The study of IL-17 and IL-23 is done by ELISA and RT-PCR methods.The findings after the statistical analyses makes us drive to the following conclusions: IL-17 occurs in almost all the patients infected with chlamydia - their organs or systemic environment compared with the patients of non-chlamydia infection (97% against 21%, Pmetaplasy. The gained data point the opinion that Il-17 and IL-23 take part in Chlamydia Immune-pathogenesis. PMID:20622275

  15. 原料血浆及血液制品中人细小病毒B19 DNA的检测%Determination of human parvovirus B19 DNA in source plasma and blood products

    Institute of Scientific and Technical Information of China (English)

    侯继锋; 王敏; 马秋平

    2012-01-01

    目的 检测我国原料血浆及血液制品中人细小病毒B19( Human parvovirus B 19)的污染情况 方法 在B19基因组编码区的高度保守区2 000 ~2 300 bp之间设计PCR引物探针,采用荧光定量PCR法检测单人份血浆、生产用混合血浆、静注人免疫球蛋白、人纤维蛋白原、人凝血因子Ⅷ及人凝血酶原复合物中的B19病毒DNA.结果 单人份血浆、生产用混合血浆、静注人免疫球蛋白、人纤维蛋白原、人凝血因子Ⅷ和人凝血酶原复合物的B19病毒DNA阳性率分别为0.092%、82.41%、0、45.83%、67.86%和78.79%.结论 我国原料血浆及血液制品中B19病毒的污染情况略低于国外文献报道,可能与试剂盒的灵敏度及样本量有关,有必要对国内的相关制品作进一步的跟踪.%Objective To determine the contamination with human parvovirus B19 in source plasma and blood products in China. Methods Primers were designed based on the highly conserved sequence between 2 000 and 2 300 bp in the coding regions of B19 genome, with which individual human plasma samples, plasma pools for production, intravenous immunoglobulin, human fib-rinogen, human coagulation factor VC and human prothrombin complex were dete rmined for B19 DNA by fluorescent quantitative PCR, Results The positive rates of B19 DNA in individual human plasma samples, plasma pools for production, intravenous im-munoglobulin, human fibrinogen, human coagulation factor VII and human prothrombin complex were 0. 092%, 82.41%, 0, 45. 83%, 67. 86% and 78, 79% respectively. Conclusion The positive rates of B19 virus in source plasma and blood products in China were slightly lower than those reported in the documents abroad, which might be associated with the sensitivity of kit and the quantity of samples. It is necessary to follow the relative message of relevant domestic blood products.

  16. Pneumonia - adults - discharge

    Science.gov (United States)

    You have pneumonia, which is an infection in your lungs. In the hospital, your doctors and nurses helped you breathe better. ... body get rid of the germs that cause pneumonia. They also made sure you got enough liquids ...

  17. Pneumocystis Pneumonia (PCP)

    Science.gov (United States)

    ... 2014 Select a Language: Fact Sheet 515 Pneumocystis Pneumonia (PCP) WHAT IS PCP? HOW IS PCP TREATED? ... BEST? THE BOTTOM LINE WHAT IS PCP? Pneumocystis pneumonia (PCP or pneumocystis) is the most common opportunistic ...

  18. Focal epilepsy as a long term sequela of Parvovirus B19 encephalitis.

    Science.gov (United States)

    Palermo, Concetta Ilenia; Costanzo, Carmela Maria; Franchina, Concetta; Castiglione, Giacomo; Giuliano, Loretta; Russo, Raffaela; Conti, Alessandro; Sofia, Vito; Scalia, Guido

    2016-07-01

    Human Parvovirus B19 (PVB19), the etiological agent of the fifth disease, is associated with a large spectrum of pathologies, among which is encephalitis. Since it has been detected from the central nervous system in children or in immunocompromised patients, its causative role in serious neurological manifestations is still unclear. Here we report the case of an 18-year-old healthy boy who developed encephalitis complicated by prolonged status epilepticus. The detection of PVB19 DNA in his serum and, subsequently, in his cerebrospinal fluid supports the hypothesis that this virus could potentially play a role in the pathogenesis of neurological complications. In addition, the detection of viral DNA and the presence of specific IgM and IgG antibodies in serum, together with clinical findings such as skin rash, support the presence of a disseminated viral infection. In the presence of neurological disorders, especially when there are no specific signs, but seizures and rash are present, it is important to search for PVB19 both in immunocompromised and immunocompetent patients. Moreover, the introduction of the PVB19 DNA test into diagnostic protocols of neuropathies, especially those undiagnosed, could clarify the etiological agent that otherwise could remain unrecognized. PMID:27130981

  19. Papular-purpuric "gloves and socks" syndrome caused by parvovirus B19 infection in Brazil: a case report

    Directory of Open Access Journals (Sweden)

    Marcos Tadashi Kakitani Toyoshima

    2006-02-01

    Full Text Available Papular-purpuric "gloves and socks" syndrome (PPGSS is a novel, rare, self-limiting dermatosis caused by human parvovirus B19. It consists of pruritic edema and erythema of the hands and feet in a gloves-and-socks distribution, and it is associated with oral lesions and fever. We present a case of PPGSS in a 22-year-old Brazilian woman. Clinical and laboratory evaluation, including serological tests, PCR and gene sequencing, confirmed the presence of human parvovirus B19.

  20. Clinical and imaging features of neonatal chlamydial pneumonia

    International Nuclear Information System (INIS)

    Objective: To study the clinical and imaging features of chlamydial pneumonia in newborns. Methods: Medical records,chest X-Ray and CT findings of 17 neonates with chlamydia pneumonia were reviewed. The age was ranged from 9.0 to 28.0 days with mean of (16.8 ± 5.8) days. There were 11 males and 6 females. Sixteen were full term infants and one was born post term. All babies were examined with chest X-ray film, and 13 patients also underwent chest CT scan. Serologic test using immunofluorescence method for Chlamydia IgG and IgM antibodies were performed in all patients. Results: All newborns presented with cough but without fever. Positive results of the serologic tests were demonstrated. Chest films showed bilateral hyperventilation in 10 patients, diffuse reticular nodules in 10 patients including nodules mimicking military tuberculosis in 7 patients, and accompanying consolidation in 9 patients. CT features included interstitial reticular nodules in 13 patients with size, density, and distribution varied. Subpleural nodules (11 patients) and fusion of nodules (10 patients) predominated. Bilateral hyperinflation was found in 10 patients, which combined with infiltration in 12 patients, thickening of bronchovascular bundles in 10 patients, and ground glass sign in 5 patients. No pleural effusion and lymphadenopathy was detected in any patient. Conclusions: Bilateral hyperinflation and diffuse interstitial reticular nodules were the most common imaging features of neonatal chlamydial pneumonia. The main clinical characteristic of neonatal chlamydial pneumonia is respiratory symptoms without fever, which is helpful to its diagnosis. (authors)

  1. Identification of lectin-binding proteins in Chlamydia species.

    OpenAIRE

    Swanson, A F; Kuo, C. C.

    1990-01-01

    Lectin-binding proteins of chlamydiae were detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting. All three Chlamydia species tested expressed two proteins when whole-elementary-body lysates were reacted with the biotinylated lectin Dolichos biflorus agglutinin. The protein with a molecular mass of 18 kilodaltons (kDa) responded strongly compared with a higher-molecular-mass protein that varied from 27 to 32 kDa with each chlamydia strain tested. Among six l...

  2. Entry of genital Chlamydia trachomatis into polarized human epithelial cells.

    OpenAIRE

    Wyrick, P B; Choong, J; Davis, C H; Knight, S T; Royal, M O; Maslow, A S; Bagnell, C R

    1989-01-01

    To study the initial invasion process(es) of genital chlamydiae, a model system consisting of hormonally maintained primary cultures of human endometrial gland epithelial cells (HEGEC), grown in a polarized orientation on collagen-coated filters, was utilized. After Chlamydia trachomatis inoculation of the apical surface of polarized HEGEC, chlamydiae were readily visualized, by transmission electron microscopy, in coated pits and coated vesicles. This was true for HEGEC maintained in physiol...

  3. THE STUDY OF HUMAN PARVOVIRUS B19 INFECTION IN PERINATAL TRANSMISSION AND ABNORMAL FETUSES AND NEONATES IN GUANGDONG%广东地区人微小病毒B19母婴传播及异常胎儿和新生儿人微小病毒B19感染的研究

    Institute of Scientific and Technical Information of China (English)

    曹虹; 张文炳; 王香云; 钟梅

    2000-01-01

    This study was undertaken to investigate mother-to-infant transmission of human parvovirus B19 and the significance of prevalence of B19 virus in abnormal fetuses in Guandong. The polymerase chain reaction (PCR)was established to detect parvovirus B19 DNA in 700 sera from 350 maternal-infant pair groups. The prevalence of B19 virus DNA was 1.14% (4/350)and 0.28%(1/350)in the sera of pregnant women and cord blood of their neonates respectively. Parvovirus B19 DNA sequences were also detected in abnormal fetuses and new-born by PCR. The positive results were obtained in 5 samples of fetal tissues from 17 abnormal fetuses and in 3 those of neonatal tissues from 7 cases of neonatal death. The amplified products of PCR were identified to be the target DNA with Hae Ⅲ digestion. By in situ hybridization ,parvovirus DNA could be detected mainly in the nuclei of immature hematopoetic cells within fetal brain or spleen whose PCR tests were positive. The study results suggest that human parvovirus B19 infection does exist in maternal-infant transmission in Guangdong and might lead to harm on fetuses,but the prevalence rate of B19 virus may be very low. The evaluation of B19 virus infection might depend on reliable assay to determine present infection or past infection.%目的为研究人微小病毒B19在广东地区母婴及异常胎儿和新生儿中的感染状况。方法应用PCR方法检测700份孕妇外周血和新生儿脐血,PCR结合限制性内切酶分析以及原位杂交检测24份异常胎儿和新生儿组织。结果孕妇和胎儿血清中B19病毒的检出率分别为1.14%(4/350)和0.28%(1/350);17例异常胎儿和7例新生儿中,分别有5份胎儿和3份新生儿组织PCR结果阳性。PCR产物经限制性内切酶HaeI酶切分析,证实为PVB19特异的DNA片段。用原位杂交的方法,在部分异常胎儿的脑或脾组织小血管内或周围的原始红细胞核中检测到DNA阳性颗粒。结论广东地区孕妇B19

  4. 人微小病毒B19与自然流产的相关性研究%Correlation study between human parvovirus B19 and spontaneous abortion

    Institute of Scientific and Technical Information of China (English)

    李春容; 黄菊青

    2012-01-01

    目的 探讨人微小病毒B19(HPV B19)与自然流产的相关性.方法 选取30例自然流产患者作为病例组.随机抽取30例同期正常妊娠的孕妇作为对照组.所有受试者均记录自然流产的潜在危险因素.抽取所有受试者肘静脉血,采用巢式聚合酶链反应法检测HPV B19 DNA,采用ELISA法检测HPV B19 IgM抗体.采用Logistic多元回归分析法进行多因素分析.结果 两组孕次≥2次,合并高血压、糖尿病,HPV B19 DNA阳性率比较差异有统计学意义[43.3%( 13/30)比13.3%(4/30)、33.3%( 10/30)比6.7%(2/30)、30.0% (9/30)比6.7%(2/30)、36.7%(11/30)比3.3%(1/30)](P<0.05);而HPV B19 IgM抗体阳性率比较差异无统计学意义(P>0.05).多因素分析显示,孕次≥2次、合并高血压、HPV B19 DNA阳性是孕妇发生自然流产的独立危险因素(OR=1.85、1.95、4.85,P<0.05).HPV B19 DNA阳性患者早期自然流产发生的风险明显高于晚期自然流产,差异有统计学意义(P<0.05).结论 HPV B19感染是自然流产患者的独立危险因素,需要早期检测并对妊娠孕妇进行必要的干预,以降低自然流产的发生.%Objective To investigate the correlation between human parvovirus (HPV) B19 and spontaneous abortion.Methods Participants included 30 cases of spontaneous abortion patients (patients group) and 30 normal pregnancy (control group).The potential risk of spontaneous abortion factors were recorded.Extracting all subjects cubits venous blood,HPV B19 DNA was tested by nested polymerase chain reaction,and HPV B19 IgM antibodies were determined by ELISA.The more factors analysis were performed by Logistic multiple regression analysis.Results There were significant differences in gravidity more than 2 times,combined with hypertension,combined with diabetes,HPV B19 DNA positive expression between patients group and control group [43.3%(13/30) vs.13.3%(4/30),33.3%(10/30) vs.6.7%(2/30),30.0% (9/30) vs.6.7% (2/30),36.7

  5. 血液病儿童人细小病毒B19检测211例%The primary study on human parvovirus B19 infection with blood system disease in children

    Institute of Scientific and Technical Information of China (English)

    许东亮; 张国成; 曹玉红; 张笑飞; 钱新宏

    2000-01-01

    @@ 0 引言人细小病毒B19(Human parvovirus B19,HPV B19)是动物细小病毒属中同人类疾病密切相关的一种小DNA病毒,可能与一过性再障危象、血小板减少性紫癜、传染性红斑、关节病以及非免疫性胎儿水肿、死胎等疾病相关[1-3]. 国内儿童血液系统疾病H PV-B19的感染状况尚在探索之中. 本研究以套式PCR方法检测骨髓及外周血中HPVB19-DNA ,ELISA方法检测血清中HPVB19-IgM,探讨儿童血液系统疾病的病毒病因以及国内的感染状况.

  6. Aplastic crisis due to human parvovirus B19 infection in hereditary hemolytic anaemia Crise aplástica devido à infecção por parvovirus humano B19 em anemia hemolítica hereditária

    Directory of Open Access Journals (Sweden)

    R. C. N. Cubel

    1992-10-01

    Full Text Available Specific anti-B19 IgM was demonstrated in sera from three children showing transient aplastic crisis. A two years-old boy living in Rio de Janeiro suffering from sickle-cell anaemia showed the crisis during August, 1990. Two siblings living in Santa Maria, RS, developed aplastic crisis during May, 1991, when they were also diagnosed for hereditary spherocytosis. For a third child from this same family, who first developed aplastic crisis no IgM anti-B19 was detected in her sera.IgM específica anti-B19 foi demonstrada nos soros de três crianças apresentando aplasia transitória de medula. Um menino de dois anos de idade vivendo no Rio de Janeiro e sendo portador de anemia falciforme, apresentou a crise durante Agosto de 1990. Dois irmãos vivendo em Santa Maria - RS, desenvolveram crise de aplasia em Maio de 1991, quando foram também diagnosticados como portadores de microesferocitose. IgM anti-B19 não foi detectada no soro de uma terceira criança, desta mesma família, a qual primeiramente apresentou crise de aplasia.

  7. Detection of Chlamydia in postmortal formalin-fixed tissue

    DEFF Research Database (Denmark)

    Lundemose, AG; Lundemose, JB; Birkelund, Svend;

    1989-01-01

    A procedure to detect Chlamydia in postmortal formalin-fixed tissue is described. Monoclonal antibodies against a genus specific chlamydia epitope were used in immunofluorescence to detect chlamydia inclusions in formalin-fixed tissue sections. Lung sections from chlamydia-infected mice were...... examined and the effect of autolysis and tetracycline treatment was evaluated. Furthermore, lung tissue from two patients who died of ornithosis was examined. Inclusions detected in lung sections showed a bright apple-green fluorescence, and had a characteristic and easily recognizable morphology...... on retrospective investigations in formalin-fixed tissues....

  8. The effects of co-infection with human parvovirus B19 and Plasmodium falciparum on type and degree of anaemia in Ghanaian children

    Institute of Scientific and Technical Information of China (English)

    Kwabena Obeng Duedu; Kwamena William Coleman Sagoe; Patrick Ferdinand Ayeh-Kumi; Raymond Bedu Affrim; Theophilus Adiku

    2013-01-01

    Objective:To determin the extent to which parvovirus B19 (B19V) and co-infection of B19V and malaria contribute to risk of anaemia in children. Methods: B19V DNA and malaria parasites were screened for 234 children at the PML Children’s Hospital in Accra. The role of B19V and co-infection with B19V and malaria in anaemia was evaluated by analysing full blood cell counts, malaria and B19V DNA results from these children. Results: The prevalence of B19V, malaria and co-infection with B19V and malaria was 4.7%, 41.9%and 2.6%, respectively. Malaria posed a greater risk in the development of mild anaemia compared to severe anaemia (OR=5.28 vrs 3.15) whereas B19V posed a higher risk in the development of severe anaemia compared to mild anaemia (OR=4.07 vrs 1.00) from a non-anaemic child. Persons with co-infection with B19V and malaria had 2.23 times the risk (95%CI=0.40-12.54) of developing severe anaemia should they already have a mild anaemia. The degree of anaemia was about three times affected by co-infection (Pillai’s trace=0.551, P=0.001) as was affected by malaria alone (Pillai’s trace=0.185, P=0.001). B19V alone did not significantly affect the development of anaemia in a non-anaemic child. Microcytic anaemia was associated with B19V and co-infection with B19V and malaria more than normocytic normochromic anaemia. Conclusions: B19V was associated with malaria in cases of severe anaemia. The association posed a significant risk for exacerbation of anaemia in mild anaemic children. B19V and co-infection with B19V and malaria may be associated with microcytic anaemia rather than normocytic normochromic anaemia as seen in cases of B19V infection among persons with red cell abnormalities.

  9. Asymptomatic endemic Chlamydia pecorum infections reduce growth rates in calves by up to 48 percent.

    Directory of Open Access Journals (Sweden)

    Anil Poudel

    Full Text Available Intracellular Chlamydia (C. bacteria cause in cattle some acute but rare diseases such as abortion, sporadic bovine encephalomyelitis, kerato-conjunctivitis, pneumonia, enteritis and polyarthritis. More frequent, essentially ubiquitous worldwide, are low-level, asymptomatic chlamydial infections in cattle. We investigated the impact of these naturally acquired infections in a cohort of 51 female Holstein and Jersey calves from birth to 15 weeks of age. In biweekly sampling, we measured blood/plasma markers of health and infection and analyzed their association with clinical appearance and growth in dependence of chlamydial infection intensity as determined by mucosal chlamydial burden or contemporaneous anti-chlamydial plasma IgM. Chlamydia 23S rRNA gene PCR and ompA genotyping identified only C. pecorum (strains 1710S, Maeda, and novel strain Smith3v8 in conjunctival and vaginal swabs. All calves acquired the infection but remained clinically asymptomatic. High chlamydial infection associated with reduction of body weight gains by up to 48% and increased conjunctival reddening (P<10(-4. Simultaneously decreased plasma albumin and increased globulin (P<10(-4 suggested liver injury by inflammatory mediators as mechanisms for the growth inhibition. This was confirmed by the reduction of plasma insulin like growth factor-1 at high chlamydial infection intensity (P<10(-4. High anti-C. pecorum IgM associated eight weeks later with 66% increased growth (P = 0.027, indicating a potential for immune protection from C. pecorum-mediated growth depression. The worldwide prevalence of chlamydiae in livestock and their high susceptibility to common feed-additive antibiotics suggests the possibility that suppression of chlamydial infections may be a major contributor to the growth promoting effect of feed-additive antibiotics.

  10. Possible involvement of miRNAs in tropism of Parvovirus B19.

    Science.gov (United States)

    Anbarlou, Azadeh; AkhavanRahnama, Mahshid; Atashi, Amir; Soleimani, Masoud; Arefian, Ehsan; Gallinella, Giorgio

    2016-03-01

    Human Parvovirus B19 (PVB19) is one of the most important pathogens that targets erythroid lineage. Many factors were mentioned for restriction to erythroid progenitor cells (EPCs). Previous studies showed that in non-permissive cells VP1 and VP2 (structural proteins) mRNAs were detected but could not translate to proteins. A bioinformatics study showed that this inhibition might be due to specific microRNAs (miRNAs) present in non-permissive cells but not in permissive EPCs. To confirm the hypothesis, we evaluated the effect of miRNAs on VP expression. CD34(+) HSCs were separated from cord blood. Then, CD34(+) cells were treated with differentiation medium to obtain CD36(+) EPCs. To evaluate the effect of miRNAs on VP expression in MCF7 and HEK-293 cell lines (non-permissive cells) and CD36(+) EPCs, dual luciferase assay was performed in presence of shRNAs against Dicer and Drosha to disrupt miRNA biogenesis. QRT-PCR was performed to check down-regulation of Dicer and Drosha after transfection. All measurements were done in triplicate. Data means were compared using one-way ANOVAs. MicroRNA prediction was done by the online microRNA prediction tools. No significant difference was shown in luciferase activity of CD36(+) EPCs after co-transfection with shRNAs, while it was significant in non-permissive cells. Our study revealed that miRNAs may be involved in inhibition of VP expression in non-permissive cells, although further studies are required to demonstrate which miRNAs exactly are involved in regulation of PVB19 replication. PMID:26878856

  11. 76 FR 33658 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2011-06-09

    ... rule'' under the DOT Regulatory Policies and Procedures (44 FR 11034, February 26, 1979), 3. Will not... Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440); Model CL-600-2C10 (Regional Jet Series 700, 701, & 702); Model CL-600-2D15 (Regional Jet Series 705); and Model...

  12. 75 FR 63054 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-10-14

    ... published in the Federal Register on January 5, 2010 (75 FR 258). That NPRM proposed to correct an unsafe...'' under the DOT Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and 3. Will not have.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes AGENCY: Federal Aviation Administration...

  13. 76 FR 8605 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 and 440...

    Science.gov (United States)

    2011-02-15

    ... Register on November 15, 2010 (75 FR 69609). That NPRM proposed to correct an unsafe condition for the...'' under the DOT Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and 3. Will not have.... Model CL-600-2B19 (Regional Jet Series 100 and 440) Airplanes AGENCY: Federal Aviation...

  14. 75 FR 31324 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-06-03

    ... ``significant rule'' under the DOT Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and 3.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes AGENCY: Federal Aviation Administration (FAA..., dated May 7, 2008, to Appendix A--Certification Maintenance Requirements of Part 2 of the Bombardier...

  15. 76 FR 15823 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2011-03-22

    ... published in the Federal Register on August 5, 2010 (75 FR 47249). That NPRM proposed to correct an unsafe... Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and 3. Will not have a significant..., Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes, CL-600-2C10 (Regional Jet Series...

  16. 75 FR 64636 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-10-20

    ... 12866; 2. Is not a ``significant rule'' under the DOT Regulatory Policies and Procedures (44 FR 11034.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes AGENCY: Federal Aviation Administration (FAA... of on-ground hydraulic accumulator screw cap/end cap failure have been experienced on...

  17. 75 FR 34657 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-06-18

    ... rule'' under the DOT Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and 3. Will.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes; Model CL-600-2C10 (Regional Jet Series 700, 701, & 702) Airplanes; Model CL-600-2D15 (Regional Jet Series 705) Airplanes; and Model...

  18. 75 FR 59073 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-09-27

    ... to the specified products. That NPRM was published in the Federal Register on April 8, 2010 (75 FR... Order 12866; 2. Is not a ``significant rule'' under the DOT Regulatory Policies and Procedures (44 FR.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes; Model CL-600-2C10 (Regional Jet Series...

  19. 75 FR 17884 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-04-08

    ... rule'' under the DOT Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and 3. Will.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes; Model CL-600-2C10 (Regional Jet Series 700, 701, & 702) Airplanes; Model CL-600-2D15 (Regional Jet Series 705) and Model CL-600-2D24 (Regional...

  20. 76 FR 18024 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2011-04-01

    ... (75 FR 25788). That NPRM proposed to correct an unsafe condition for the specified products. The MCAI... ``significant rule'' under the DOT Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and 3.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes AGENCY: Federal Aviation Administration...

  1. 75 FR 52233 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-08-25

    ... products. That NPRM was published in the Federal Register on June 3, 2010 (75 FR 31324). That NPRM proposed... Procedures (44 FR 11034, February 26, 1979); and 3. Will not have a significant economic impact, positive or.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes AGENCY: Federal Aviation Administration...

  2. 75 FR 60604 - Airworthiness Directives; Bombardier, Inc. Model CL-600-2B19 (Regional Jet Series 100 & 440...

    Science.gov (United States)

    2010-10-01

    ... (75 FR 34657). That NPRM proposed to correct an unsafe condition for the specified products. The MCAI...'' under the DOT Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and 3. Will not have.... Model CL-600-2B19 (Regional Jet Series 100 & 440) Airplanes; Model CL-600-2C10 (Regional Jet Series...

  3. Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells.

    Science.gov (United States)

    Stuart, Elizabeth S; Webley, Wilmore C; Norkin, Leonard C

    2003-07-01

    Obligate intracellular bacterial pathogens of the genus Chlamydia are reported to enter host cells by both clathrin-dependent and clathrin-independent processes. C. trachomatis serovar K recently was shown to enter cells via caveolae-like lipid raft domains. We asked here how widespread raft-mediated entry might be among the Chlamydia. We show that C. pneumoniae, an important cause of respiratory infections in humans that additionally is associated with cardiovascular disease, and C. psittaci, an important pathogen in domestic mammals and birds that also infects humans, each enter host cells via cholesterol-rich lipid raft microdomains. Further, we show that C. trachomatis serovars E and F also use these domains to enter host cells. The involvement of these membrane domains in the entry of these organisms was indicated by the sensitivity of their entry to the raft-disrupting agents Nystatin and filipin, and by their intracellular association with caveolin-1, a 22-kDa protein associated with the formation of caveolae in rafts. In contrast, caveolin-marked lipid raft domains do not mediate entry of C. trachomatis serovars A, 36B, and C, nor of LGV serovar L2 and MoPn. Finally, we show that entry of each of these chlamydial strains is independent of cellular expression of caveolin-1. Thus, entry via the Nystatin and filipin-sensitive pathway is dependent on lipid rafts containing cholesterol, rather than invaginated caveolae per se.

  4. Intratracheal infection as an efficient route for testing vaccines against Chlamydia abortus in sheep.

    Science.gov (United States)

    Álvarez, D; Salinas, J; Buendía, A J; Ortega, N; del Río, L; Sánchez, J; Navarro, J A; Gallego, M C; Murcia-Belmonte, A; Cuello, F; Caro, M R

    2015-09-01

    Pregnant ewes have been widely used to test vaccines against Chlamydia abortus. However, this model entails many disadvantages such as high economic costs and long periods of pregnancy. The murine model is very useful for specific studies but cannot replace the natural host for the later stages of vaccine evaluation. Therefore, a non-pregnant model of the natural host might be useful for a vaccine trial to select the best vaccine candidates prior to use of the pregnant model. With this aim, two routes of infection were assessed in young non-pregnant sheep, namely, intranasal (IN) and intratracheal (IT). In addition, groups of non-vaccinated sheep and sheep immunised with an inactivated vaccine were established to investigate the suitability of the model for testing vaccines. After the experimental infection, isolation of the microorganism in several organs, with pathological and immunohistochemical analyses, antibody production assessment and investigation by PCR of the presence of chlamydia in the vagina or rectum were carried out. Experimental IT inoculation of C. abortus induced pneumonia in sheep during the first few days post-infection, confirming the suitability of the IT route for testing vaccines in the natural host. The course of infection and the resulting pathological signs were less severe in vaccinated sheep compared with non-vaccinated animals, demonstrating the success of vaccination. IN infection did not produce evident lesions or demonstrate the presence of chlamydial antigen in the lungs and cannot be considered an appropriate model for testing vaccines. PMID:26095034

  5. Azithromycin, fluoroquinolone and chloramphenicol resistance of non-chlamydia conjunctival bacteria in rural community of Ethiopia

    Directory of Open Access Journals (Sweden)

    Bayeh Abera

    2014-01-01

    Full Text Available Aim: To determine profiles of non-chlamydia conjunctival bacteria and their antimicrobial susceptibility from adults who underwent trachomatous trichiasis surgery in rural areas of Ethiopia. Materials and Methods: A cross-sectional study was conducted in rural districts in West Gojjam administrative zone. Conjunctival swabs were collected during surgery and transported using Stuart transport broth (Oxoid, UK. Antibiotic susceptibility of conjunctival isolates was determined using the Kirby-Bauer disc-diffusion method. Results: Non-chlamydia pathogenic bacteria were recovered from conjunctiva of 438 (31% participants before treatment. The isolated conjunctival bacteria were Staphylococcus aureus, coagulase-negative Staphylococci, Streptococcus group (A, C, F and G, Enterococci, Streptococcus pneumoniae, Moraxella spp., Escherichia coli, Citrobacter spp., Proteus spp., Klebsiella spp., Pseudomonas spp. and Enterobacter spp. Overall, resistance rates of 57.8% to azithromycin and 68.5% to chloramphenicol were found. However, 86-94.4% sensitivity was demonstrated to ciprofloxacin and norfloxacin. Moderate sensitivity rates (61.8-78.4% were observed to ceftriaxone, tetracycline and cotrimoxazole. Conclusion: Fluoroquinolones that have activity against the majority of bacterial isolates were potent at in vitro. However, unacceptably high levels of resistance to azithromycin and chloramphenicol in rural community indicated a need for further study and antimicrobial resistance surveillance.

  6. Chlamydia trachomatis Mip-like protein

    DEFF Research Database (Denmark)

    Lundemose, AG; Rousch, DA; Birkelund, Svend;

    1992-01-01

    A 27 kDa Chlamydia trachomatis Mip-like protein with homology of a 175-amino-acid C-terminal fragment to the surface-exposed Legionella pneumophila mip-gene product has previously been described. In this paper the entire chlamydia Mip-like sequence of C. trachomatis serovar L2 (lymphogranuloma...... venereum (LGV) biovar) is presented. The sequence shows high similarity to the legionella Mip protein and its C-terminal region, like that of the legionella Mip, has high amino acid similarity to eukaryotic and prokaryotic FK506-binding proteins. The chlamydial mip-like gene was detected by polymerase...... chain reaction (PCR) in other C. trachomatis serovars and by sequencing of the mip-like genes of serovars B and E (trachoma biovar) was shown to be highly conserved within the two major biovars of C. trachomatis. Monoclonal and polyclonal antibodies raised against the recombinant Mip-like protein failed...

  7. Chlamydia psittaci in birds of prey, Sweden

    Directory of Open Access Journals (Sweden)

    Maria Blomqvist

    2012-05-01

    Full Text Available Background: Chlamydia psittaci is an intracellular bacterium primarily causing respiratory diseases in birds but may also be transmitted to other animals, including humans. The prevalence of the pathogen in wild birds in Sweden is largely unknown. Methods: DNA was extracted from cloacae swabs and screened for C. psittaci by using a 23S rRNA gene PCR assay. Partial 16S rRNA and ompA gene fragments were sequence determined and phylogenies were analysed by the neighbour-joining method. Results and conclusion: The C. psittaci prevalence was 1.3% in 319 Peregrine Falcons and White-tailed Sea Eagles, vulnerable top-predators in Sweden. 16S rRNA and ompA gene analysis showed that novel Chlamydia species, as well as novel C. psittaci strains, are to be found among wild birds.

  8. Respiratory Review of 2012: Pneumonia

    OpenAIRE

    Yoon, Young-Soon

    2012-01-01

    Pneumonia is the cause of significant morbidity and mortality, despite advances in diagnosis and antibacterial treatment. Pneumonia is often misdiagnosed and mistreated up until recently. Recent classification of pneumonia consists of community-acquired pneumonia, health care-associated pneumonia, hospital-acquired pneumonia, and ventilator-associated pneumonia. The etiology, risk factors, and treatment are different among them. This article briefly introduces new concepts and ideas in biomar...

  9. Role of Chlamydia trachomatis in miscarriage

    OpenAIRE

    Baud D.; Goy G.; Jaton K.; Osterheld M.C.; Blumer S.; Borel N.; Vial Y.; Hohlfeld P.; Pospischil A.; Greub G

    2011-01-01

    To determine the role of Chlamydia trachomatis in miscarriage, we prospectively collected serum, cervicovaginal swab specimens, and placental samples from 386 women with and without miscarriage. Prevalence of immunoglobulin G against C. trachomatis was higher in the miscarriage group than in the control group (15.2% vs. 7.3%; p = 0.018). Association between C. trachomatis-positive serologic results and miscarriage remained significant after adjustment for age, origin, education, and number of...

  10. Programmed Death Ligand 1 Promotes Early-Life Chlamydia Respiratory Infection-Induced Severe Allergic Airway Disease.

    Science.gov (United States)

    Starkey, Malcolm R; Nguyen, Duc H; Brown, Alexandra C; Essilfie, Ama-Tawiah; Kim, Richard Y; Yagita, Hideo; Horvat, Jay C; Hansbro, Philip M

    2016-04-01

    Chlamydia infections are frequent causes of respiratory illness, particularly pneumonia in infants, and are linked to permanent reductions in lung function and the induction of asthma. However, the immune responses that protect against early-life infection and the mechanisms that lead to chronic lung disease are incompletely understood. In the current study, we investigated the role of programmed death (PD)-1 and its ligands PD-L1 and PD-L2 in promoting early-life Chlamydia respiratory infection, and infection-induced airway hyperresponsiveness (AHR) and severe allergic airway disease in later life. Infection increased PD-1 and PD-L1, but not PD-L2, mRNA expression in the lung. Flow cytometric analysis of whole lung homogenates identified monocytes, dendritic cells, CD4(+), and CD8(+) T cells as major sources of PD-1 and PD-L1. Inhibition of PD-1 and PD-L1, but not PD-L2, during infection ablated infection-induced AHR in later life. Given that PD-L1 was the most highly up-regulated and its targeting prevented infection-induced AHR, subsequent analyses focused on this ligand. Inhibition of PD-L1 had no effect on Chlamydia load but suppressed infection-induced pulmonary inflammation. Infection decreased the levels of the IL-13 decoy receptor in the lung, which were restored to baseline levels by inhibition of PD-L1. Finally, inhibition of PD-L1 during infection prevented subsequent infection-induced severe allergic airways disease in later life by decreasing IL-13 levels, Gob-5 expression, mucus production, and AHR. Thus, early-life Chlamydia respiratory infection-induced PD-L1 promotes severe inflammation during infection, permanent reductions in lung function, and the development of more severe allergic airway disease in later life.

  11. Hematolojik Maligniteli Hastalarda Parvovirus B19 Varlığının Araştırılması

    OpenAIRE

    GÜMÜŞTEKİN, Şaban; Tezcan, Seda; ÜLGER, Mahmut; TİFTİK, Naci; SERİN, Mehmet Sami; ASLAN, Gönül; EMEKDAŞ, Gürol

    2012-01-01

    Abstract An Investigation on the Presence of Parvovirus B19 in The Patients with Hematological Malignancies Aim: Parvovirus B19 is associated with a wide range of diseases in human, whose severity depends on the immunological and haematological status of the host. In this study, the aim was set to determine the presence of parvovirus B19 DNA and the assessment of the prevalance among patients suffering from different haematological malignancies and healty blood donors. Method: In this stud...

  12. Human parvovirus B19-induced aplastic crisis in an adult patient with hereditary spherocytosis: a case report and review of the literature

    OpenAIRE

    Kobayashi, Yujin; Hatta, Yoshihiro; Ishiwatari, Yusaku; Kanno, Hitoshi; Takei, Masami

    2014-01-01

    Background Although there are several case reports of human parvovirus B19 infection in patients with hereditary spherocytosis, no systematic reviews of adult patients with hereditary spherocytosis with human parvovirus B19 infection have been published as clinical case reports. In this study, we report a case of aplastic crisis due to human parvovirus B19 infection in an adult patient with hereditary spherocytosis. Case presentation A 33-year-old woman with hereditary spherocytosis and galls...

  13. Modelling the healthcare costs of an opportunistic chlamydia screening programme

    OpenAIRE

    Adams, E; Lamontagne, D; Johnston, A; Pimenta, J; Fenton, K; Edmunds, W.

    2004-01-01

    Objectives: To estimate the average cost per screening offer, cost per testing episode and cost per chlamydia positive episode for an opportunistic chlamydia screening programme (including partner management), and to explore the uncertainty of parameter assumptions, based on the costs to the healthcare system.

  14. Detection of Human Parvovirus B19 Nonstrutural Protein DNA by Nested-Polymerase Chain Reaction in Gravida Serum and Pregnant Tissues

    Institute of Scientific and Technical Information of China (English)

    2006-01-01

    A new nested-polymerase chain reaction (nested-PCR) assay was developed to detect human parvovirus B19 DNA corresponding to the nonstructural protein in clinical specimens in a routine diagnostic laboratory. The sensitivity of this highly specific assay was up to 0. 005 fg of B19 DNA. Parvovirus B19 was identified in sera of 20 pregnant women with abnormal pregnant outcome. Among these 20 cases, intrauterine parvovirus infection did exist in 7 pregnant women because parvovirus B19 DNA was detected in the pregnant tissues of them such as placenta tissues,chorionic villi, amniotic fluid, fetal spleen, liver and abdominal fluids.

  15. 中国献血人群中人细小病毒B19的分子流行病学调查

    Institute of Scientific and Technical Information of China (English)

    何苗; 柯玲; 李武平

    2010-01-01

    @@ 摘要:目的人细小病毒B19(Human parvovirus B19)属于细小病毒科(Parvoviridae),嗜红细胞病毒属(Erythrovirus).B19是1种单链无包膜病毒,其病毒基因组长约5.6kb,目前B19在世界范围的流行株有3种基因型.B19可通过呼吸道传播,引起胎儿水肿、官内死胎、自发性流产、传染性红斑、急性关节炎等多种疾病.B19还可通过血液和血液制品传播,并且可抵抗大多数病毒灭活/去除方法,显示其在输血安全中的重要性.然而其在中国献血人群中的存在情况、流行株和病毒的载量还不清楚.由于B19有较高的发病率,献血者B19感染时会出现较高的病毒血症,因而用于加工的大量汇集血浆中会含有B19病毒.

  16. Inclusion of the Central Exon of Parvovirus B19 Precursor mRNA Is Determined by Multiple Splicing Enhancers in both the Exon and the Downstream Intron ▿

    OpenAIRE

    Guan, Wuxiang; Cheng, Fang; Huang, Qinfeng; Kleiboeker, Steve; Qiu, Jianming

    2010-01-01

    Alternative splicing of the precursor mRNA (pre-mRNA) of human parvovirus B19 (B19V) plays a key role in posttranscriptional regulation of B19V gene expression. We report that the central exon of the B19V pre-mRNA is defined by three GAA motif-containing exonic splicing enhancers and a G/GU-rich intronic splicing enhancer that lies adjacent to the second donor site. Moreover, targeting of morpholino antisense oligonucleotides to the two splicing enhancers surrounding the second donor site led...

  17. Increased expression of Matrix Metalloproteinase 9 in liver from NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein

    Directory of Open Access Journals (Sweden)

    Hsu Gwo-Jong

    2009-01-01

    Full Text Available Abstract Background Human parvovirus B19 infection has been postulated to the anti-phospholipid syndrome (APS in autoimmunity. However, the influence of anti-B19-VP1u antibody in autoimmune diseases is still obscure. Methods To elucidate the effect of anti-B19-VP1u antibodies in systemic lupus erythematosus (SLE, passive transfer of rabbit anti-B19-VP1u IgG was injected intravenously into NZB/W F1 mice. Results Significant reduction of platelet count and prolonged thrombocytopenia time were detected in anti-B19-VP1u IgG group as compared to other groups, whereas significant increases of anti-B19-VP1u, anti-phospholipid (APhL, and anti-double strand DNA (dsDNA antibody binding activity were detected in anti-B19-VP1u group. Additionally, significant increases of matrix metalloproteinase-9 (MMP9 activity and protein expression were detected in B19-VP1u IgG group. Notably, phosphatidylinositol 3-phosphate kinase (PI3K and phosphorylated extracellular signal-regulated kinase (ERK proteins were involved in the induction of MMP9. Conclusion These experimental results firstly demonstrated the aggravated effects of anti-B19-VP1u antibody in disease activity of SLE.

  18. 9 CFR 113.71 - Chlamydia Psittaci Vaccine (Feline Pneumonitis), Live Chlamydia.

    Science.gov (United States)

    2010-01-01

    ... INSPECTION SERVICE, DEPARTMENT OF AGRICULTURE VIRUSES, SERUMS, TOXINS, AND ANALOGOUS PRODUCTS; ORGANISMS AND VECTORS STANDARD REQUIREMENTS Live Bacterial Vaccines § 113.71 Chlamydia Psittaci Vaccine (Feline... that used in such immunogenicity test but not less than 2.5 ID50 per dose. Inactivated...

  19. The History of Mycoplasma pneumoniae Pneumonia.

    Science.gov (United States)

    Saraya, Takeshi

    2016-01-01

    In the United States in the 1930s, although the pathogen was not known, atypical pneumonia was clinically distinguished from pneumococcal pneumonia by its resistance to sulfonamides. Reimann (1938) reported seven patients with an unusual form of tracheo bronchopneumonia and severe constitutional symptoms. He believed the clinical picture of this disease differed from that of the disease caused by influenza viruses or known bacteria and instead suspected "primary atypical pneumonia." For many years, the responsible infectious agent was tentatively classified as a filterable virus that could pass through a Seitz filter to remove bacteria and was reported to be a psittacosis-like or new virus. After that, Eaton et al. (1942, 1944, 1945) identified an agent that was the principal cause of primary atypical pneumonia using cotton rats, hamsters, and chick embryos. Eaton et al. (1942, 1944, 1945) did not perform an inoculation study in human volunteers. During the 1940s, there were three groups engaged in discovering the etiology of the primary atypical pneumonia. (1) Commission on Acute Respiratory Diseases Diseases directed by John Dingle, (2) Dr. Monroe Eaton's group, the Virus Research Laboratory of the California State Public Health Department, (3) The Hospital of the Rockefeller Institute for Medical Research directed by Horsfall. During 1940s, the members of the Commission on Acute Respiratory Diseases concluded that the bacteria-free filtrates obtained from the patients, presumably containing a virus, could induce primary atypical pneumonia in human volunteers via Pinehurst trials. During 1950s, serological approaches for identification of the Eaton agent developed such as Fluorescent-Stainable Antibody, and at the beginning of the1960s, the Eaton agent successfully grew in media, and finally accepted as a cause of primary atypical pneumonia. Thus, technical difficulties with visualizing the agent and failure to recognize the full significance of the Pinehurst

  20. A False Positive Dengue Fever Rapid Diagnostic Test Result in a Case of Acute Parvovirus B19 Infection.

    Science.gov (United States)

    Izumida, Toshihide; Sakata, Hidenao; Nakamura, Masahiko; Hayashibara, Yumiko; Inasaki, Noriko; Inahata, Ryo; Hasegawa, Sumiyo; Takizawa, Takenori; Kaya, Hiroyasu

    2016-01-01

    An outbreak of dengue fever occurred in Japan in August 2014. We herein report the case of a 63-year-old man who presented with a persistent fever in September 2014. Acute parvovirus B19 infection led to a false positive finding of dengue fever on a rapid diagnostic test (Panbio Dengue Duo Cassette(TM)). To the best of our knowledge, there are no previous reports of a false positive result for dengue IgM with the dengue rapid diagnostic test. We believe that epidemiological information on the prevalence of parvovirus B19 is useful for guiding the interpretation of a positive result with the dengue rapid diagnostic test. PMID:27181552

  1. How Can Pneumonia Be Prevented?

    Science.gov (United States)

    ... page from the NHLBI on Twitter. How Can Pneumonia Be Prevented? Pneumonia can be very serious and ... t last as long Fewer serious complications Pneumococcal Pneumonia Vaccine A vaccine is available to prevent pneumococcal ...

  2. Papular-purpuric "gloves and socks" syndrome due to parvovirus B19: report of a case with unusual features

    Directory of Open Access Journals (Sweden)

    PASSONI Luiz Fernando C.

    2001-01-01

    Full Text Available We present a case of papular-purpuric "gloves and socks" syndrome (PPGSS in an adult male with acute parvovirus B19 infection. The patient displayed the classical features of fever, oral lesions, and purpura on hands and feet, but the purpuric lesions on the feet evolved to superficial skin necrosis, a feature not previously described in this syndrome. We believe this is the first reported case of PPGSS occurring in Brazil.

  3. Paralisia velopalatina isolada associada a infecção por parvovírus B 19

    OpenAIRE

    Soares-Fernandes, JP; Maré, R

    2006-01-01

    A case of isolated velopalatine paralysis in an 8-year-old boy is presented. The symptoms were sudden-onset of nasal speech, regurgitation of liquids into the nose and dysphagia. Brain MRI and cerebrospinal fluid examination were normal. Infectious serologies disclosed an antibody arrangement towards parvovirus B19 that was typical of recent infection. In the absence of other positive data, the possibility of a correlation between the tenth nerve palsy and parvovirus infection is discussed.

  4. Symptoms, Diagnosis and Treatment of Pneumonia

    Science.gov (United States)

    ... Lung Health and Diseases > Lung Disease Lookup > Pneumonia Pneumonia Symptoms, Causes, and Risk Factors Anyone can get ... risk for pneumonia. What Are the Symptoms of Pneumonia? Pneumonia symptoms can vary from mild to severe, ...

  5. Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19

    DEFF Research Database (Denmark)

    Kasprowicz, Victoria; Isa, Adiba; Tolfvenstam, Thomas;

    2006-01-01

    The evolution of peptide-specific CD4(+) T-cell responses to acute viral infections of humans is poorly understood. We analyzed the response to parvovirus B19 (B19), a ubiquitous and clinically significant pathogen with a compact and conserved genome. The magnitude and breadth of the CD4(+) T...

  6. Study of chronic hemolytic anaemia patients in Rio de Janeiro: prevalence of anti-human parvovirus B19 IgG antibodies and the developement aplastic crises

    Directory of Open Access Journals (Sweden)

    SANT'ANNA Anadayr L.M.

    2002-01-01

    Full Text Available The prevalence of anti-human parvovirus B19 IgG antibodies was determined in sera from 165 chronic hemolytic anemia patients, receiving medical care at Instituto Estadual de Hematologia (IEHE, Rio de Janeiro, during the year of 1994. This sample represents around 10% of the chronic hemolytic anemia patients attending at IEHE. Most of these patients (140 have sickle cell disease. Anti-B19 IgG antibodies were detected in 32.1% of patients. No statistically significant difference (p > 0.05 was seen between IgG antibody prevalence in male (27.8% and female (35.5% patients. Anti-B19 IgG antibodies were more frequent in older (37.6% than younger (28.2% than 20 years old patients, although this difference had no statistical significance (p > 0.05. Anti-B19 IgG antibody prevalence showed that 67.9% of patients enrolled in the study were susceptible to B19 acute infection. With the aim to detect acute B19 infection, patients follow up continued until February 1996. During this period four patients presented transient aplastic crisis due to human parvovirus B19 as confirmed by the detection of specific IgM antibodies. All four patients were younger than 20 years old, and 3 were younger than 10 years old. Three of them were sickle cell disease patients. Three of the four acute B19 infection occurred during 1994 springtime.

  7. Marcadores inflamatórios e anticorpos anti-chlamydia em pacientes com síndrome metabólica

    Directory of Open Access Journals (Sweden)

    Rosecler Riethmuller Franco

    2011-02-01

    Full Text Available FUNDAMENTO: A síndrome metabólica está associada ao aumento de risco de eventos cardiovasculares. Marcadores inflamatórios e anticorpos anti-Chlamydia têm sido relacionados ao desenvolvimento e à progressão da aterosclerose e dos eventos cardiovasculares. OBJETIVO: Avaliar os marcadores inflamatórios interleucina-6 (IL-6 e fator de necrose tumoral-alfa (TNF-α e os anticorpos anti-Chlamydia pneumoniae em pacientes com síndrome metabólica (SM, com e sem eventos cardiovasculares. MÉTODOS: Estudo transversal constituído por 147 indivíduos. Desses, 100 (68% com SM e sem eventos cardiovasculares; e 47 (32% com SM e com eventos cardiovasculares. Dos indivíduos que sofreram eventos cardiovasculares, 13 (6,11% apresentam infarto agudo do miocárdio (IAM, e dez (4,7%, acidente vascular cerebral (AVC. O diagnóstico da SM foi determinado pelos critérios do NCEP-ATPIII. RESULTADOS: A média de idade dos sujeitos com eventos cardiovasculares foi de 61,26 ± 8,5 e de 59,32 ± 9,9 nos indivíduos sem esses eventos (p=0,279, havendo predomínio do sexo feminino. O grupo com SM e sem evento apresentou maior peso, altura, IMC e circunferência abdominal. Para os indivíduos com eventos cardiovasculares (p=0,001, os marcadores inflamatórios IL-6 e TNF-α e a doença vascular periférica foram significativamente maiores. Obtiveram-se níveis elevados de anticorpos IgG para Chlamydia pneumoniae no grupo SM, sem eventos e de IgA no grupo com eventos quando comparados os dois grupos. Com relação ao IAM e ao AVC, os anticorpos anti-Chlamydia pneumoniae não demonstraram significância estatística, comparados ao grupo sem eventos cardiovasculares. Associação foi observada com o uso de estatinas, hipoglicemiantes orais, injetáveis e anti-inflamatórios não esteroidais no grupo com esses eventos. CONCLUSÃO: Marcadores inflamatórios encontram-se significativamente elevados em pacientes com SM, com IAM e AVC. Anticorpos anti-Chlamydia n

  8. O impacto da infecção por Chlamydia em populações indígenas da Amazônia brasileira Dissemination of Chlamydia infection among native Indian groups of the Brazilian Amazon region

    Directory of Open Access Journals (Sweden)

    Marluísa de Oliveira Guimarães Ishak

    2001-03-01

    Full Text Available A disseminação das bactérias do gênero Chlamydia no Brasil, inclusive na região Amazônica, é pouco conhecida. Este estudo soroepidemiológico incluiu 2.086 amostras de soro de populações indígenas da Amazônia brasileira, empregando metodologia de triagem pela imunofluorescência indireta para pesquisa de anticorpos. Usou-se o sorotipo L2 da C. trachomatis como substrato; a seguir, para os quinze sorotipos de C. trachomatis e para a C. pneumoniae, discriminou-se a sororreatividade pela microimunofluorescência específica. A prevalência média de anticorpos para Chlamydia foi de 48,6%. Sua variação entre as comunidades indicou as que não tiveram contato com as bactérias e aquelas em que quase todos os testados tiveram. Por meio da titulação dos anticorpos IgG e a presença de IgM específica nas amostras com títulos altos viu-se que 6,1% dos infectados persistiam com a infecção, servindo de reservatórios à disseminação das espécies de Chlamydia. Pela resposta à C. trachomatis, evidenciou-se a circulação dos sorotipos A, B, Ba, D, E, G, H, I e L1. Ademais, constatou-se que há C. pneumoniae na região. As duas espécies causariam impacto significativo no hospedeiro humano.Knowledge is limited on the spread of bacteria from genus Chlamydia in Brazil. This study included a sero-epidemiological survey of 2,086 samples from native Indian populations of the Brazilian Amazon region. Sera were screened using indirect immunofluorescence assay for detection of antibodies to C. trachomatis serotype L2, followed by microimmunofluorescence assay using fifteen C. trachomatis and C. pneumoniae serotypes as antigen substrates. Antibody prevalence was 48.6%, but there was a large prevalence range among the groups, including those that had never been challenged with the bacteria, as well as those in which almost all individuals had been infected. Titration of IgG antibodies and detection of specific IgM in high-titer samples showed the

  9. Chlamydia in canine or feline coronary arteriosclerotic lesions

    Directory of Open Access Journals (Sweden)

    Grabarevic Zeljko

    2011-09-01

    Full Text Available Abstract Background There are numerous reports linking Chlamydia infection to human coronary atherosclerosis. However, there is a lack of data regarding this correlation in dogs and cats, and there are no reports investigating coronary arteriosclerosis and Chlamydia in these species. The aim of the present study was to examine whether there is a correlation between canine and feline spontaneous atherosclerosis or arteriosclerosis and the presence of Chlamydia. Archived histopathological samples of dogs (n = 16 and cats (n = 13 with findings of atherosclerosis or arteriosclerosis in heart tissue were examined for the presence of Chlamydiaceae using real-time PCR, ArrayTube Microarray and immunohistochemistry. Additionally, arteriosclerotic lesions of all cases were histologically classified and graded. Results Both canine atherosclerotic cases, and all 14 canine arteriosclerotic cases were negative for Chlamydia. Only one of the 13 arteriosclerotic feline cases was positive for Chlamydia by real-time PCR, revealing C. abortus by ArrayTube Microarray. To our knowledge, this is the first description of C. abortus in a cat. Overall, the type and grade of canine and feline arteriosclerotic lesions revealed similarities, and were predominantly moderate and hyperplastic. Conclusions These findings suggest that there is no obvious correlation between canine and feline coronary arteriosclerosis and the presence of Chlamydia. In order to draw final conclusions about the correlation between Chlamydia and canine atherosclerosis, examination of more samples is required.

  10. Comparison of the Clearview Chlamydia test, Chlamydiazyme, and cell culture for detection of Chlamydia trachomatis in women with a low prevalence of infection.

    OpenAIRE

    Skulnick, M; Small, G. W.; Simor, A E; Low, D E; Khosid, H; FRASER, S.; Chua, R

    1991-01-01

    Two antigen detection systems, Clearview Chlamydia (Unipath Ltd., Bedford, United Kingdom) and Chlamydiazyme (Abbott Laboratories, North Chicago, Ill.), were compared with culture for the diagnosis of chlamydia infection in women attending gynecological clinics. Chlamydia trachomatis was isolated from 43 (4.5%) of the 965 women tested. In comparison with tissue culture, the Clearview Chlamydia and Chlamydiazyme tests had sensitivities of 79.0 and 74.4%, respectively, and both had a specificit...

  11. Identification of Streptococcus pneumoniae

    OpenAIRE

    Kaijalainen, Tarja

    2006-01-01

    Objectives: Streptococcus pneumoniae, pneumococcus, is an importanthuman pathogen that causes both serious invasive infections, suchas septicaemia, meningitis and pneumonia, as well as mild upper respiratoryinfections. It also belongs to the normal nasopharyngeal microbialflora. The purpose of this study was to compare bacteriologicalphenotypic methods with genetechnological methods in the identificationof pneumococci, especially among suspect pneumococcal isolateslacking one or more typical ...

  12. Bronchitis and Pneumonia

    Science.gov (United States)

    ... What is the difference between bronchitis and pneumonia? Bronchitis is most often a bacte- rial or viral infection that causes swelling of the tubes (bronchioles) leading to the lungs. Pneumonia is an acute or chronic disease marked by inflammation of the ...

  13. Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia

    NARCIS (Netherlands)

    G.J.W. van der Windt; J.J. Hoogerwerf; A.F. de Vos; S. Florquin; T. van der Poll

    2010-01-01

    Klebsiella pneumoniae is a common cause of nosocomial pneumonia. Osteopontin (OPN) is a phosphorylated glycoprotein involved in inflammatory processes, some of which is mediated by CD44. The aim of this study was to determine the role of OPN during K. pneumoniae-induced pneumonia. Wild-type (WT) and

  14. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China

    Institute of Scientific and Technical Information of China (English)

    TAO Li-li; DENG Wei-wu; HU Bi-jie; HE Li-xian; WEI Li; XIE Hong-mei; WANG Bao-qing; LI Hua-ying; CHEN Xue-hua; ZHOU Chun-mei

    2012-01-01

    Background Appropriate antimicrobial therapy of community-acquired pneumonia (CAP) is mainly based on the distribution of etiology and antimicrobial resistance of major pathogens.We performed a prospective observational study of adult with CAP in 36 hospitals in China.Methods Etiological pathogens were isolated in each of the centers,and all of the isolated pathogens were sent to Zhongshan Hospital for antimicrobial susceptibility tests using agar dilution.Results A total of 593 patients were enrolled in this study,and 242 strains of bacteria were isolated from 225 patients.Streptococcus pneumoniae (79/242,32.6%) was the most frequently isolated pathogen,followed by Haemophilus influenzae (55/242,22.7%) and Klebsiella pneumoniae (25/242,10.3%).Totally 527 patients underwent serological tests for atypical pathogens; Mycoplasma pneumoniae and Chlamydia pneumoniae infections were identified in 205 (38.9%)and 60 (11.4%) patients respectively.Legionella pneumophila infections were identified in 4.0% (13/324) of patients.The non-susceptibility rate of isolated Streptococcus pneumoniae to erythromycin and penicillin was 63.2% and 19.1%respectively.Six patients died from the disease,the 30-day mortality rate was 1.1% (6/533).Conclusions The top three bacteria responsible for CAP in Chinese adults were Streptococcus pneumonia,Haemophitus influenza and Klebsiella pneumonia.There was also a high prevalence of atypical pathogens and mixed pathogens.The resistance rates of the major isolated pathogens were relatively low except for the high prevalence of macrolide resistance in Streptococcus pneumoniae.

  15. 人细小病毒B19-VP2-IgM的检测及其应用价值的研究%Detection of human parvovirus B19 major capsid protein IgM and its clinical appl ying value

    Institute of Scientific and Technical Information of China (English)

    曹玉红; 许东亮; 张国成; 孙新; 李飚

    2000-01-01

    目的评估ELISA法检测抗人细小病毒B19主要衣壳蛋白IgM(B19-VP2 -IgM)诊断B19病毒感染的价值;并初步了解B19病毒感染临床表现多样性. 方法对55例小儿常见疾病包括急性再生障碍性贫血(AA) 10例. 特发性血小板减少性紫癜(ITP) 10例、急性淋巴细胞白血病(ALL)15例、幼年类风湿关节炎(JRA) 12例、过敏性紫癜(SHP) 8例患者血清进行B19-VP2-IgM检测;并对上述标本用巢式PCR检测B19-DNA作为对照研究. 结果 ①ELISA法检测B19-VP2-IgM特异性高,稳定性好. ②B19-VP2-IgM总阳性率为10/55(18.2%),其中AA, ITP, ALL, JRA, SHP阳性率分别为:2/10(20.0%), 3/10(30 .0%), 2/15(13.3%), 2/12(16.7%), 1/8(12.5%). ③ B19-DNA总阳性率为17/ 55(30.9%),其中AA, ITP, ALL, JRA, SHP阳性率分别为:3/10 (30.0%), 4/10(40.0%), 4/15(26.7%), 4/12(33.3 %), 2/8(25.0%). ④ B19-VP2-IgM阳性率略小于B19-DNA阳性率,但统计学检验无显著差异(P >0.05). 结论① ELISA法检测B19-VP2-IgM简便快速,特异性高, 适用于B19病毒感染早期诊断. ②B19病毒感染临床表现多种多样,与小儿AA, ITP, ALL, JR A, SHP关系密切. ③ ELISA法检测B19-VP2-IgM与巢式PCR检测B19-DNA诊断B19病毒感染 的价值基本一致.

  16. 人细小病毒B19感染相关过敏性紫癜患儿的临床特征及治疗%Clinical Features and Treatment of Human Parvovirus B19 Infection Associated Henoch-Schonlein Purpura

    Institute of Scientific and Technical Information of China (English)

    曹玉红; 张光运; 张国成; 杨欣伟; 丁翠玲

    2006-01-01

    目的探讨人细小病毒B19(简称B19)感染相关过敏性紫癜患儿临床特征及治疗方法.方法采用巢式PCR和ELISA法对75例过敏性紫癜患儿进行B19-DNA及IgM检测;对B19-IgM阳性患儿进行临床特征分析,比较激素和丙种球蛋白的治疗效果.结果 1.病例组75例中B19-DNA阳性26例(34.67%),B19-IgM阳性21例(28.0%);健康对照组32例中B19-DNA、B19-IgM阳性各1例(3.13%),两组B19-DNA 和B19-IgM阳性率差异均有显著性(P均0.05),B19-IgM阳性患儿中混合型所占比例最大,皮肤型次之.3.激素组和丙种球蛋白组治疗关节肿痛、胃肠道症状、肾损害方面差异均无显著性,但在皮疹消退方面,后者疗效优于前者.4.激素组B19-DNA清除率25.0%,丙种球蛋白组B19-DNA清除率为81.82%,两组清除率具有显著差异(P<0.05).结论 B19可能是导致过敏性紫癜的主要病原体之一;B19感染相关过敏性紫癜患儿临床表现具有多样性;对过敏性紫癜患儿应进行B19病毒检测;应用丙种球蛋白治疗B19感染相关过敏性紫癜可取得良好疗效.

  17. Cynomolgus monkeys (Macaca fascicularis) experimentally infected with B19V and hepatitis A virus: no evidence of the co-infection as a cause of acute liver failure

    Science.gov (United States)

    Leon, Luciane Almeida Amado; Marchevsky, Renato Sergio; Gaspar, Ana Maria Coimbra; Garcia, Rita de Cassia Nasser Cubel; de Almeida, Adilson José; Pelajo-Machado, Marcelo; de Castro, Tatiana Xavier; do Nascimento, Jussara Pereira; Brown, Kevin E; Pinto, Marcelo Alves

    2016-01-01

    This study was conducted to analyse the course and the outcome of the liver disease in the co-infected animals in order to evaluate a possible synergic effect of human parvovirus B19 (B19V) and hepatitis A virus (HAV) co-infection. Nine adult cynomolgus monkeys were inoculated with serum obtained from a fatal case of B19V infection and/or a faecal suspension of acute HAV. The presence of specific antibodies to HAV and B19V, liver enzyme levels, viraemia, haematological changes, and necroinflammatory liver lesions were used for monitoring the infections. Seroconversion was confirmed in all infected groups. A similar pattern of B19V infection to human disease was observed, which was characterised by high and persistent viraemia in association with reticulocytopenia and mild to moderate anaemia during the period of investigation (59 days). Additionally, the intranuclear inclusion bodies were observed in pro-erythroblast cell from an infected cynomolgus and B19V Ag in hepatocytes. The erythroid hypoplasia and decrease in lymphocyte counts were more evident in the co-infected group. The present results demonstrated, for the first time, the susceptibility of cynomolgus to B19V infection, but it did not show a worsening of liver histopathology in the co-infected group. PMID:27074255

  18. 微小病毒B19感染可能是过敏性紫癜的病因

    Institute of Scientific and Technical Information of China (English)

    王懿林; 石军

    2004-01-01

    目的:探讨人类微小病毒(human parvovirus)B19感染与过敏性紫癜的关系.方法:对26例过敏性紫癜患儿(病例组)分别利用酶联免疫吸附试验(enzyme-linkedimmunosorbent assay,ELISA)和PCR进行抗人类微小病毒B19-IgM和人类微小病毒B19-脱氧核糖核酸(deoxyribonucleic acid,DNA)测定,另设28名健康儿童作为对照组.结果:病例组人类微小病毒B19-IgM或人类微小病毒B19-DNA阳性6例(23%),而对照组只有1例(4%)人类微小病毒B19-DNA阳性,两组差异有统计学意义(P<0.05).结论:人类微小病毒B19感染与过敏性紫癜有一定关系,可能是其发病原因之一.

  19. Cynomolgus monkeys (Macaca fascicularis) experimentally infected with B19V and hepatitis A virus: no evidence of the co-infection as a cause of acute liver failure.

    Science.gov (United States)

    Leon, Luciane Almeida Amado; Marchevsky, Renato Sergio; Gaspar, Ana Maria Coimbra; Garcia, Rita de Cassia Nasser Cubel; Almeida, Adilson José de; Pelajo-Machado, Marcelo; Castro, Tatiana Xavier de; Nascimento, Jussara Pereira do; Brown, Kevin E; Pinto, Marcelo Alves

    2016-04-01

    This study was conducted to analyse the course and the outcome of the liver disease in the co-infected animals in order to evaluate a possible synergic effect of human parvovirus B19 (B19V) and hepatitis A virus (HAV) co-infection. Nine adult cynomolgus monkeys were inoculated with serum obtained from a fatal case of B19V infection and/or a faecal suspension of acute HAV. The presence of specific antibodies to HAV and B19V, liver enzyme levels, viraemia, haematological changes, and necroinflammatory liver lesions were used for monitoring the infections. Seroconversion was confirmed in all infected groups. A similar pattern of B19V infection to human disease was observed, which was characterised by high and persistent viraemia in association with reticulocytopenia and mild to moderate anaemia during the period of investigation (59 days). Additionally, the intranuclear inclusion bodies were observed in pro-erythroblast cell from an infected cynomolgus and B19V Ag in hepatocytes. The erythroid hypoplasia and decrease in lymphocyte counts were more evident in the co-infected group. The present results demonstrated, for the first time, the susceptibility of cynomolgus to B19V infection, but it did not show a worsening of liver histopathology in the co-infected group. PMID:27074255

  20. Computed tomographic study on Mycoplasma pneumoniae pneumonia

    International Nuclear Information System (INIS)

    Serologically proven 21 patients with Mycoplasma pneumoniae pneumonia that showed infiltrative shadows on chest radiograms were studied by computed tomography (CT). Localization of the lesion and the fashion of its progression through the lung were analyzed. Following 3 loci were defined on the basis of the investigations of critical analysis of the chest radiograms, and of radiopathological analysis of the experimental animal model of mycoplasmal pneumonia with soft X-ray image. I: Peribronchial and periarterial interstitium. II: Bronchiole and its surroundings. III: Lung parenchyma, on hilar area as IIIh, on marginal area as IIIm. Even in the early phase of this disease, radiopathological findings on CT have been distributed in all loci mentioned above. The Shadow disappeared from locus III approximately 14th day from the onset. The shadow have remained, however, loci I, II for a long period. Those findings suggest that locus I and II are one of the major focus of Mycoplasma neumoniae pneumonia. Volume loss in the locus III was observed 78 % of the cases at 28th day from the onset. The shadow on locus IIIh was more prominent than locus IIIm. Reported analytical method with CT could be widely applied to disclose a radiopathological details in other infectious diseases of the lung. (author)

  1. Screening for Chlamydia trachomatis in Low-Risk Obstetric Patients

    Directory of Open Access Journals (Sweden)

    Robert K. Gribble

    1994-01-01

    Full Text Available Objective: The purpose of this study was to evaluate the prevalence of Chlamydia trachomatis in our rural obstetric population and assess the appropriateness of selective vs. universal prenatal screening.

  2. Mouse Study Offers Hope for Vaccine Against Chlamydia

    Science.gov (United States)

    ... page: https://medlineplus.gov/news/fullstory_160004.html Mouse Study Offers Hope for Vaccine Against Chlamydia Bacteria's ... 2016 (HealthDay News) -- A new Canadian study with mice suggests there is hope for a vaccine to ...

  3. Cost-effectiveness of Chlamydia Vaccination Programs for Young Women

    Centers for Disease Control (CDC) Podcasts

    2015-06-19

    Dr. Kwame Owusu-Edusei discusses the importance of chlamydia vaccine development.  Created: 6/19/2015 by National Center for Emerging and Zoonotic Infectious Diseases (NCEZID).   Date Released: 6/22/2015.

  4. 原料血浆和凝血因子类产品中人细小病毒B19污染情况调查

    Institute of Scientific and Technical Information of China (English)

    贾俊婷; 马玉媛; 郭逸; 赵雄; 赵福广; 章金刚

    2015-01-01

    目的 检测混合原料血浆和凝血因子类产品中人细小病毒B19(human parvovirus B19,B19病毒)核酸,分析我国原料血浆及凝血因子类产品中B19病毒的污染情况。方法 针对B19病毒的保守区域NS1区合成引物及探针,采用Taq Man实时定量PCR法检测混合原料血浆和4类凝血因子类产品中B19病毒核酸。结果 混合原料血浆的B19病毒核酸的阳性率为59.49%(116/195),最高浓度可达1.35×1010拷贝/ml。因子Ⅷ、凝血酶、纤维蛋白原以及凝血酶原复合物的阳性率分别为93.55%(29/31)、100%(10/10)、85.71%(6/7)和88.89%(8/9)。结论 我国混合原料血浆与凝血因子类产品中B19病毒的污染率较高,有必要进行原料血浆的B19病毒筛查,对于保障血液制品的病毒安全性具有重要意义。

  5. The Relationship between maternal infection with human parvovirus B19 and fetal death and congenital malformation%妊娠期妇女人细小病毒B19感染与死胎及胎儿畸形关系的研究

    Institute of Scientific and Technical Information of China (English)

    李冰琳; 王淑莉; 郭静; 屈新中

    2001-01-01

    目的 了解妊娠期妇女人细小病毒B19(human parvovirus B19,简称B19)感染与死胎及胎儿畸形的关系。方法 采用前瞻性的研究方法,应用聚合酶链反应(PCR)技术对335例孕妇血清进行B19 DNA检测,并随访其妊娠结局。结果 在335例孕妇中,血清B19 DNA阳性67例,B19 DNA阴性268例。其中在67例B19 DNA阳性者中,发生4例死胎和1例无脑儿,在268例B19 DNA阴性者中,无一例发生死胎和胎儿畸形,阳性与阴性者间比较,差异有显著性(P<0.05)。两者正常分娩的新生儿外观均无异常。结论 妊娠期妇女感染B19可导致死胎和胎儿畸形发生。%Objective To study the relationship between matanal infection with human parvovirus B19 and fetal death and congenital malformation. Methed B19-DNA was detected by Polymerase Chain Reaction (PCR) in blood samples from 335 pregnant women. The pregnant outcomes were followed. Results  In 335 pregnant women, 67 cases were B19-DNA positive and 268 cases were B19-DNA regative. There were four fetal deaths and one anencephalus in B19-DNA positive group. There was no fetal deaths or congenital malformation in B19-DNA negative group. The difference is significant (P<0.05). Conclusions  Maternal infection with human parvovirus B19 may contribute to fetal death and congenital malformation.

  6. Study on Drug Resistance and Relative Mechanisms of Chlamydia Trachomatis

    Institute of Scientific and Technical Information of China (English)

    侯淑萍; 刘全忠

    2004-01-01

    Abstract: Chlamydia Trachomatis (C.T.) is one of the most common pathogens of human sexually transmitted diseases. Treatment of C.T. infection primarily depends on Tetracyclines, Macrolides and Quinolones, but with the wide use of antibiotics an increasing number of drug-resistant Chlamydia trachomatis cases have been reported. This review summarizes the resistant conditions and the possible resistance mechanisms of C.T..

  7. Ivermectin inhibits growth of Chlamydia trachomatis in epithelial cells.

    Directory of Open Access Journals (Sweden)

    Matthew A Pettengill

    Full Text Available Ivermectin is currently approved for treatment of both clinical and veterinary infections by nematodes, including Onchocerca cervicalis in horses and Onchocerca volvulus in humans. However, ivermectin has never been shown to be effective against bacterial pathogens. Here we show that ivermectin also inhibits infection of epithelial cells by the bacterial pathogen, Chlamydia trachomatis, at doses that could be envisioned clinically for sexually-transmitted or ocular infections by Chlamydia.

  8. Ivermectin inhibits growth of Chlamydia trachomatis in epithelial cells.

    Science.gov (United States)

    Pettengill, Matthew A; Lam, Verissa W; Ollawa, Ikechukwu; Marques-da-Silva, Camila; Ojcius, David M

    2012-01-01

    Ivermectin is currently approved for treatment of both clinical and veterinary infections by nematodes, including Onchocerca cervicalis in horses and Onchocerca volvulus in humans. However, ivermectin has never been shown to be effective against bacterial pathogens. Here we show that ivermectin also inhibits infection of epithelial cells by the bacterial pathogen, Chlamydia trachomatis, at doses that could be envisioned clinically for sexually-transmitted or ocular infections by Chlamydia. PMID:23119027

  9. Hospital-acquired pneumonia

    Science.gov (United States)

    ... tends to be more serious than other lung infections because: People in the hospital are often very sick and cannot fight off ... prevent pneumonia. Most hospitals have programs to prevent hospital-acquired infections.

  10. Pneumonia (For Parents)

    Science.gov (United States)

    ... a medicine to treat your child's cough because cough suppressants stop the lungs from clearing mucus, which isn't helpful in some types of pneumonia. Over-the-counter cough and cold medications are not recommended for any ...

  11. Pneumonia in adults - discharge

    Science.gov (United States)

    ... In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious ... ed. Philadelphia, PA: Elsevier Saunders; 2015:chap 69. Mandell LA. Streptococcus pneumoniae infections. In: Goldman L, Schafer ...

  12. Pneumonia - adults (community acquired)

    Science.gov (United States)

    ... going to the bathroom After changing a baby's diaper After coming in contact with people who are ... pneumoniae. Vaccines are even more important for older adults and people with diabetes, asthma, emphysema, HIV, cancer, ...

  13. Bronchoscopy in lipoid pneumonia.

    OpenAIRE

    Kameswaran, M.; Annobil, S H; Benjamin, B.; Salim, M.

    1992-01-01

    Forcible administration of rendered animal fat to infants is a tradition in south western Saudi Arabia. Accidental inhalation may result in a resistant form of lipoid pneumonia. A series of 24 cases of lipoid pneumonia, 22 of which were diagnosed by bronchoscopy with bronchial lavage and microscopic examination of the aspirate, are reported. The technique is described briefly and the results analysed. A high index of suspicion together with bronchoscopy and bronchial lavage of all cases of re...

  14. Novel overlapping coding sequences in Chlamydia trachomatis

    DEFF Research Database (Denmark)

    Jensen, Klaus Thorleif; Petersen, Lise; Falk, Søren;

    2006-01-01

    Chlamydia trachomatis is the aetiological agent of trachoma and sexually transmitted infections. The C. trachomatis genome sequence revealed an organism adapted to the intracellular habitat with a high coding ratio and a small genome consisting of 1.042-kilobase (kb) with 895 annotated protein...... coding genes. Here, we repredict the protein-coding genes of the C. trachomatis genome using the gene-finder EasyGene that was trained specifically for C. trachomatis, and compare it with the primary C. trachomatis annotation. Our work predicts 15 genes not listed in the primary annotation and 853...... that are in agreement with the primary annotation. Forty two genes from the primary annotation are not predicted by EasyGene. The majority of these genes are listed as hypothetical in the primary annotation. The 15 novel predicted genes all overlap with genes on the complementary strand. We find homologues of several...

  15. [Current aspects of Chlamydia trachomatis infection].

    Science.gov (United States)

    de Barbeyrac, Bertille

    2013-04-01

    The number of detection and diagnosis of urogenital infections with Chlamydia trachomatis is increasing among both men and women. Three-quarters involve young people between 15 and 24 years. Infection, often asymptomatic, is more common in women. It is necessary to identify it to avoid complications.The number of rectal lymphogranuloma venereum (LGV) is also growing. The affected patients are homo/bisexuel men frequently co-infected with HIV. Nucleic acid amplification tests (NAATs) are the tests of choice to the diagnosis of C. trachomatis infection regardless of the clinical situation. Most of tests simultaneously detect C. trachomatis and Neisseria gonorrhoeae. The recommended treatment regimens for a non-complicated infection to C. trachomatis is azithromycin 1g orally in a single dose or doxycyline 100 mg orally twice a day for 7 days. Doxycyclin for 21 days remains the treatment of choice for LGV. Patients should be instructed to refer their sex partners for treatment. PMID:23419460

  16. The humoral immune response to Chlamydia trachomatis in patients with acute reactive arthritis

    DEFF Research Database (Denmark)

    Larsen, B; Birkelund, Svend; Mordhorst, CH;

    1994-01-01

    Sera from 25 patients with clinical signs of reactive arthritis were analysed for antibodies against Chlamydia trachomatis by immunoblotting. Purified elementary bodies, purified Chlamydia outer membrane complexes, and purified recombinant subcomponents were used as antigens. Antibodies against C...

  17. Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care

    Directory of Open Access Journals (Sweden)

    van Rijckevorsel Gini

    2012-06-01

    Full Text Available Abstract Background Primary maternal infection with cytomegalovirus (CMV, parvovirus B19 (B19V, and varicella-zoster virus (VZV may result in adverse pregnancy outcomes like congenital infection or foetal loss. Women working in child day care have an increased exposure to CMV, B19V, and VZV. By comparing the seroprevalence of IgG-class antibodies against CMV, VZV and B19V in female day care workers (DCW with the seroprevalence in women not working in day care this study aimed to assess the association between occupation and infection. Methods A cross-sectional design was used. Out of a random sample of 266 day care centres, demographic data, data on work history, and blood samples were collected from 285 women from 38 centres. In addition, blood samples and basic demographics from women who participated in a cross-sectional survey of the Amsterdam population (2004 were used. All blood samples were tested for IgG-class antibodies against CMV, B19V, and VZV. Results Twenty-seven percent of the DCW were still susceptible to B19V or CMV. Working in day care was independently associated with B19V infection in all DCW (prevalence ratio [PR] 1.2; 95 % CI 1.1–1.3, and with CMV infection in DCW of European origin only (PR 1.7; 95 % CI 1.3–2.3. Almost all women born outside Europe tested seropositive for CMV (96 %. All DCW tested seropositive for VZV, compared to only 94 % of the women not working in day care. Conclusion This study confirms the clear association between employment in child day care centres and infection with CMV and B19V. Intervention policies, like screening of new employees and awareness campaigns emphasizing hygienic measures among DCW, should be implemented urgently to improve the maternal health of these women and the health of their offspring.

  18. QnrB19 gene bracketed by IS26 and 40 kb IncR plasmid from an Escherichia coli isolated from a veal calf

    OpenAIRE

    Hordijk, J.; Bosman, A.B.; Essen-Zandbergen, van, A.; Veldman, K.T.; Dierikx, C.M.; Wagenaar, J. A.; Mevius, D.J.

    2011-01-01

    qnrB19 genes have been reported in Escherichia coli, Escherichia hermannii, Salmonella enterica, and Klebsiella spp., located on IncN, IncL/M (human isolates), and ColE-like (both human and chicken isolates) plasmids (2, 6, 8, 9, 11, 13, 14, 16). This study describes the characterization of the genetic environment of a plasmid-mediated qnrB19 gene identified in E. coli isolated from a veal calf in the Netherlands.

  19. A Novel Murine Model of Parvovirus Associated Dilated Cardiomyopathy Induced by Immunization with VP1-Unique Region of Parvovirus B19

    Science.gov (United States)

    Šimoliūnas, Egidijus; Rinkūnaitė, Ieva; Smalinskaitė, Luka; Podkopajev, Andrej; Bironaitė, Daiva; Weis, Cleo-Aron; Marx, Alexander; Bukelskienė, Virginija; Gretz, Norbert; Grabauskienė, Virginija; Labeit, Dittmar; Labeit, Siegfried

    2016-01-01

    Background. Parvovirus B19 (B19V) is a common finding in endomyocardial biopsy specimens from myocarditis and dilated cardiomyopathy patients. However, current understanding of how B19V is contributing to cardiac damage is rather limited due to the lack of appropriate mice models. In this work we demonstrate that immunization of BALB/c mice with the major immunogenic determinant of B19V located in the unique sequence of capsid protein VP1 (VP1u) is an adequate model to study B19V associated heart damage. Methods and Results. We immunized mice in the experimental group with recombinant VP1u; immunization with cardiac myosin derived peptide served as a positive reference and phosphate buffered saline served as negative control. Cardiac function and dimensions were followed echocardiographically 69 days after immunization. Progressive dilatation of left ventricle and decline of ejection fraction were observed in VP1u- and myosin-immunized mice. Histologically, severe cardiac fibrosis and accumulation of heart failure cells in lungs were observed 69 days after immunization. Transcriptomic profiling revealed ongoing cardiac remodeling and immune process in VP1u- and myosin-immunized mice. Conclusions. Immunization of BALB/c mice with VP1u induces dilated cardiomyopathy in BALB/c mice and it could be used as a model to study clinically relevant B19V associated cardiac damage. PMID:27812527

  20. EPIDEMIOLOGICAL INVESTIGATION OF THE HUMAN PARVOVIRUS B19 AMONG PART BLOOD DONATORS IN LUXI REGION OF SHANDONG%山东鲁西地区部分献血员人细小病毒B19流行病学调查

    Institute of Scientific and Technical Information of China (English)

    张念华; 杜振兰; 赵英会

    2009-01-01

    [目的]为了解细小病毒B19在山东鲁西地区人群中的感染情况,以控制其传染. [方法]用实时荧光定量PCR方法检测人细小病毒B19感染,用卡方检验统计分析献血员感染率和孕妇感染率,检验其有无显著性差异.[结果]检测300名献血员,有19例人细小病毒B19感染阳性,阳性率为6.33%;献血员人细小病毒B19感染率和孕妇感染率比较差异不显著. [结论]山东鲁西地区献血员人细小病毒B19有一定感染率,所以有必要对献血员血液进行人细小病毒B19的筛查.献血员和孕妇人细小病毒B19感染率虽然无差异,但都有一定感染率,所以对孕妇人细小病毒B19感染亦应引起重视.

  1. [Chlamydia trachomatis infection in mother and child; the importance of a complete history and efficient interdisciplinary communication].

    Science.gov (United States)

    Naafs, Jolanda C; Kleinhout, Mirjam Y

    2016-01-01

    General practitioners and paediatricians are frequently confronted with coughing infants. The age of the infant, the history of both mother and child, as well as the current maternal condition may provide important diagnostic information. A 4-week-old male infant was referred to the paediatrician with a persistent cough. He was admitted to hospital with dyspnoea and need for supplemental oxygen. Meanwhile, his mother was admitted with unexplained abdominal pain and elevated laboratory inflammation markers. Her history revealed an ectopic pregnancy. The infant's condition, for which the initial differential diagnosis was viral bronchiolitis or whooping cough, deteriorated. His medical history revealed a purulent conjunctivitis. Chlamydia trachomatis PCR turned out to be positive in both mother and child. C. trachomatis pneumonia is a common, yet often overlooked cause of cough in infants. This clinical lesson emphasises the importance of a complete history and efficient communication between medical specialists.

  2. Pneumonia Can Be Prevented -- Vaccines Can Help

    Science.gov (United States)

    ... What's this? Submit Button Past Emails CDC Features Pneumonia Can Be Prevented—Vaccines Can Help Language: English ... of an adult patient with pneumonia. What Is Pneumonia? Pneumonia is an infection of the lungs that ...

  3. Exploring Chlamydia Positivity among Females on College Campuses, 2008-2010

    Science.gov (United States)

    Habel, Melissa A.; Leichliter, Jami S.; Torrone, Elizabeth

    2016-01-01

    Objective: Describe chlamydia positivity among young women tested at college health centers by student characteristics: age, race/ethnicity, and institution type. Participants: During 2008-2010, colleges participating in a national infertility prevention program provided chlamydia testing data from females aged 18-24. Methods: Chlamydia positivity…

  4. Pneumonia in the immunocompetent patient.

    Science.gov (United States)

    Reynolds, J H; McDonald, G; Alton, H; Gordon, S B

    2010-12-01

    Pneumonia is an acute inflammation of the lower respiratory tract. Lower respiratory tract infection is a major cause of mortality worldwide. Pneumonia is most common at the extremes of life. Predisposing factors in children include an under-developed immune system together with other factors, such as malnutrition and over-crowding. In adults, tobacco smoking is the single most important preventable risk factor. The commonest infecting organisms in children are respiratory viruses and Streptoccocus pneumoniae. In adults, pneumonia can be broadly classified, on the basis of chest radiographic appearance, into lobar pneumonia, bronchopneumonia and pneumonia producing an interstitial pattern. Lobar pneumonia is most commonly associated with community acquired pneumonia, bronchopneumonia with hospital acquired infection and an interstitial pattern with the so called atypical pneumonias, which can be caused by viruses or organisms such as Mycoplasma pneumoniae. Most cases of pneumonia can be managed with chest radiographs as the only form of imaging, but CT can detect pneumonia not visible on the chest radiograph and may be of value, particularly in the hospital setting. Complications of pneumonia include pleural effusion, empyema and lung abscess. The chest radiograph may initially indicate an effusion but ultrasound is more sensitive, allows characterisation in some cases and can guide catheter placement for drainage. CT can also be used to characterise and estimate the extent of pleural disease. Most lung abscesses respond to medical therapy, with surgery and image guided catheter drainage serving as options for those cases who do not respond. PMID:21088086

  5. NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.

    Directory of Open Access Journals (Sweden)

    Mathias Streitz

    Full Text Available BACKGROUND: Parvovirus B19 (B19V is the most commonly detected virus in endomyocardial biopsies (EMBs from patients with inflammatory cardiomyopathy (DCMi. Despite the importance of T-cells in antiviral defense, little is known about the role of B19V specific T-cells in this entity. METHODOLOGY AND PRINCIPAL FINDINGS: An exceptionally high B19V viral load in EMBs (115,091 viral copies/mug nucleic acids, peripheral blood mononuclear cells (PBMCs and serum was measured in a DCMi patient at initial presentation, suggesting B19V viremia. The B19V viral load in EMBs had decreased substantially 6 and 12 months afterwards, and was not traceable in PBMCs and the serum at these times. Using pools of overlapping peptides spanning the whole B19V proteome, strong CD8(+ T-cell responses were elicited to the 10-amino-acid peptides SALKLAIYKA (19.7% of all CD8(+ cells and QSALKLAIYK (10% and additional weaker responses to GLCPHCINVG (0.71% and LLHTDFEQVM (0.06%. Real-time RT-PCR of IFNgamma secretion-assay-enriched T-cells responding to the peptides, SALKLAIYKA and GLCPHCINVG, revealed a disproportionately high T-cell receptor Vbeta (TRBV 11 expression in this population. Furthermore, dominant expression of type-1 (IFNgamma, IL2, IL27 and T-bet and of cytotoxic T-cell markers (Perforin and Granzyme B was found, whereas gene expression indicating type-2 (IL4, GATA3 and regulatory T-cells (FoxP3 was low. CONCLUSIONS: Our results indicate that B19V Ag-specific CD8(+ T-cells with effector function are involved in B19V associated DCMi. In particular, a dominant role of TRBV11 and type-1/CTL effector cells in the T-cell mediated antiviral immune response is suggested. The persistence of B19V in the endomyocardium is a likely antigen source for the maintenance of CD8(+ T-cell responses to the identified epitopes.

  6. Entry of genital Chlamydia trachomatis into polarized human epithelial cells.

    Science.gov (United States)

    Wyrick, P B; Choong, J; Davis, C H; Knight, S T; Royal, M O; Maslow, A S; Bagnell, C R

    1989-01-01

    To study the initial invasion process(es) of genital chlamydiae, a model system consisting of hormonally maintained primary cultures of human endometrial gland epithelial cells (HEGEC), grown in a polarized orientation on collagen-coated filters, was utilized. After Chlamydia trachomatis inoculation of the apical surface of polarized HEGEC, chlamydiae were readily visualized, by transmission electron microscopy, in coated pits and coated vesicles. This was true for HEGEC maintained in physiologic concentrations of estrogen (proliferative phase) and of estrogen plus progesterone (secretory phase), despite the finding that association of chlamydiae with secretory-phase HEGEC is significantly reduced (P = 0.025; A.S. Maslow, C.H. Davis, J. Choong, and P.B. Wyrick, Am. J. Obstet. Gynecol. 159:1006-1014, 1988). In contrast, chlamydiae were rarely observed in the clathrin-associated structures if the HEGEC were cultured on plastic surfaces. The same pattern of coated pit versus noncoated pit entry was reproducible in HeLa cells. The quantity of coated pits associated with isolated membrane sheets derived from HeLa cells, grown on poly-L-lysine-coated cover slips in medium containing the female hormones, was not significantly different as monitored by radiolabeling studies and by laser scanning microscopy. These data suggest that culture conditions which mimic in vivo cellular organization may enhance entry into coated pits for some obligate intracellular pathogens. Images PMID:2744852

  7. A compendium for Mycoplasma pneumoniae

    Directory of Open Access Journals (Sweden)

    Gretchen Lynn Parrott

    2016-04-01

    Full Text Available Historically, atypical pneumonia was a term used to describe an unusual presentation of pneumonia. Currently, it is used to describe the multitude of symptoms juxtaposing the classic symptoms found in cases of pneumococcal pneumonia. Specifically, atypical pneumonia is a syndrome resulting from a relatively common group of pathogens including Chlamydophila sp., and Mycoplasma pneumoniae. The incidence of M. pneumoniae pneumonia in adults is less than the burden experienced by children. Transmission rates among families indicate children may act as a reservoir and maintain contagiousness over a long period of time ranging from months to years. In adults, M. pneumoniae typically produces a mild, walking pneumonia and is considered to be one of the causes of persistent cough in patients. M. pneumoniae has also been shown to trigger the exacerbation of other lung diseases. It has been repeatedly detected in patients with bronchitis, asthma, chronic obstructive pulmonary disorder and cystic fibrosis. Recent advances in technology allow for the rapid diagnosis of M. pneumoniae through the use of polymerase chain reaction (PCR or rapid antigen tests. With this, more effort has been afforded to identify the causative etiologic agent in all cases of pneumonia. However, previous practices, including the overprescribing of macrolide treatment in China and Japan, have created increased incidence of macrolide-resistant M. pneumoniae. Reports from these countries indicate that >85% of M. pneumoniae pneumonia pediatric cases are macrolide-resistant. Despite its extensively studied past, the smallest bacterial species still inspires some of the largest questions. The developments in microbiology, diagnostic features and techniques, epidemiology, treatment and vaccines, and upper respiratory conditions associated with M. pneumoniae in adult populations are included within this review.

  8. A Compendium for Mycoplasma pneumoniae.

    Science.gov (United States)

    Parrott, Gretchen L; Kinjo, Takeshi; Fujita, Jiro

    2016-01-01

    Historically, atypical pneumonia was a term used to describe an unusual presentation of pneumonia. Currently, it is used to describe the multitude of symptoms juxtaposing the classic symptoms found in cases of pneumococcal pneumonia. Specifically, atypical pneumonia is a syndrome resulting from a relatively common group of pathogens including Chlamydophila sp., and Mycoplasma pneumoniae. The incidence of M. pneumoniae pneumonia in adults is less than the burden experienced by children. Transmission rates among families indicate children may act as a reservoir and maintain contagiousness over a long period of time ranging from months to years. In adults, M. pneumoniae typically produces a mild, "walking" pneumonia and is considered to be one of the causes of persistent cough in patients. M. pneumoniae has also been shown to trigger the exacerbation of other lung diseases. It has been repeatedly detected in patients with bronchitis, asthma, chronic obstructive pulmonary disorder, and cystic fibrosis. Recent advances in technology allow for the rapid diagnosis of M. pneumoniae through the use of polymerase chain reaction or rapid antigen tests. With this, more effort has been afforded to identify the causative etiologic agent in all cases of pneumonia. However, previous practices, including the overprescribing of macrolide treatment in China and Japan, have created increased incidence of macrolide-resistant M. pneumoniae. Reports from these countries indicate that >85% of M. pneumoniae pneumonia pediatric cases are macrolide-resistant. Despite its extensively studied past, the smallest bacterial species still inspires some of the largest questions. The developments in microbiology, diagnostic features and techniques, epidemiology, treatment and vaccines, and upper respiratory conditions associated with M. pneumoniae in adult populations are included within this review. PMID:27148202

  9. Idiopathic interstitial pneumonia

    International Nuclear Information System (INIS)

    In order to identify and classify the basic CT appearance of interstitial pneumonia, radiologic-pathologic correlative study was performed using inflated and fixed lungs from autopsy and surgery. The patterns of the abnormalities on the CT images of interstitial pneumonia were classified into 7 categories. Important pathological changes which affected the CT images were alveolar collapse and airway dilatation. Based on the result of above study, we analyzed CT of 22 patients with IIP. The lesions which were classified into a hazy density, micronodular densities, confluence of various sized ring like shadows and subpleural bullous changes were frequently recognized together mostly in the periphery of the lung. (author)

  10. "Candidatus Mesochlamydia elodeae" (Chlamydiae: Parachlamydiaceae), a novel chlamydia parasite of free-living amoebae.

    Science.gov (United States)

    Corsaro, Daniele; Müller, Karl-Dieter; Wingender, Jost; Michel, Rolf

    2013-02-01

    Vannella sp. isolated from waterweed Elodea sp. was found infected by a chlamydia-like organism. This organism behaves like a parasite, causing the death through burst of its host. Once the vannellae degenerated, the parasite was successfully kept in laboratory within a Saccamoeba sp. isolated from the same waterweed sample, which revealed in fine through electron microscopy to harbor two bacterial endosymbionts: the chlamydial parasite we introduce and another endosymbiont initially and naturally present in the host. Herein, we provide molecular-based identification of both the amoeba host and its two endosymbionts, with special focus on the chlamydia parasite. High sequence similarity values of the 18S rDNA permitted to assign the amoeba to the species Saccamoeba lacustris (Amoebozoa, Tubulinea). The bacterial endosymbiont naturally harbored by the host belonged to Sphingomonas koreensis (Alpha-Proteobacteria). The chlamydial parasite showed a strict specificity for Saccamoeba spp., being unable to infect a variety of other amoebae, including Acanthamoeba, and it was itself infected by a bacteriophage. Sequence similarity values of the 16S rDNA and phylogenetic analysis indicated that this strain is a new member of the family Parachlamydiaceae, for which we propose the name "Candidatus Mesochlamydia elodeae."

  11. Marcadores inflamatórios e anticorpos anti-chlamydia em pacientes com síndrome metabólica Marcadores inflamatorios y anticuerpos anti-chlamydia en pacientes con síndrome metabólico Inflammatory markers and antichlamydial antibodies in patients with metabolic syndrome

    Directory of Open Access Journals (Sweden)

    Rosecler Riethmuller Franco

    2011-02-01

    Full Text Available FUNDAMENTO: A síndrome metabólica está associada ao aumento de risco de eventos cardiovasculares. Marcadores inflamatórios e anticorpos anti-Chlamydia têm sido relacionados ao desenvolvimento e à progressão da aterosclerose e dos eventos cardiovasculares. OBJETIVO: Avaliar os marcadores inflamatórios interleucina-6 (IL-6 e fator de necrose tumoral-alfa (TNF-α e os anticorpos anti-Chlamydia pneumoniae em pacientes com síndrome metabólica (SM, com e sem eventos cardiovasculares. MÉTODOS: Estudo transversal constituído por 147 indivíduos. Desses, 100 (68% com SM e sem eventos cardiovasculares; e 47 (32% com SM e com eventos cardiovasculares. Dos indivíduos que sofreram eventos cardiovasculares, 13 (6,11% apresentam infarto agudo do miocárdio (IAM, e dez (4,7%, acidente vascular cerebral (AVC. O diagnóstico da SM foi determinado pelos critérios do NCEP-ATPIII. RESULTADOS: A média de idade dos sujeitos com eventos cardiovasculares foi de 61,26 ± 8,5 e de 59,32 ± 9,9 nos indivíduos sem esses eventos (p=0,279, havendo predomínio do sexo feminino. O grupo com SM e sem evento apresentou maior peso, altura, IMC e circunferência abdominal. Para os indivíduos com eventos cardiovasculares (p=0,001, os marcadores inflamatórios IL-6 e TNF-α e a doença vascular periférica foram significativamente maiores. Obtiveram-se níveis elevados de anticorpos IgG para Chlamydia pneumoniae no grupo SM, sem eventos e de IgA no grupo com eventos quando comparados os dois grupos. Com relação ao IAM e ao AVC, os anticorpos anti-Chlamydia pneumoniae não demonstraram significância estatística, comparados ao grupo sem eventos cardiovasculares. Associação foi observada com o uso de estatinas, hipoglicemiantes orais, injetáveis e anti-inflamatórios não esteroidais no grupo com esses eventos. CONCLUSÃO: Marcadores inflamatórios encontram-se significativamente elevados em pacientes com SM, com IAM e AVC. Anticorpos anti-Chlamydia n

  12. 妊娠期人微小病毒B19感染对妊娠结局的影响及机制的研究

    Institute of Scientific and Technical Information of China (English)

    任育宏; 王秀华

    2002-01-01

    目的:探讨妊娠期人微小病毒B19(human parvovirus B19,以下简称B19病毒)感染与死胎、胎儿畸形的关系及病毒作用机制。方法:应用聚合酶链反应(PCR)技术对31例发生死胎或胎儿畸形的孕妇静脉血血清进行B19病毒DNA检测,并用免疫组织化学和原位杂交技术检测上述病例胎盘组织中凋亡相关基因(p53,p21,Caspase3)mRNA的蛋白表达情况,均设对照组。结果:不良妊娠组母血中B19病毒阳性率为32.26%,对照组阳性率仅为6.67%,P<0.05,两组有显著性差异。经PCR证实有B19病毒感染的胎盘中,检测到p53,p21蛋白的表达和p53,Caspase3 mRNA的表达,平均灰度值分别为215.2471和208.2158,与B19病毒(DNA(一)组和正常对照组相比,二者有显著性差异(P<0.05)。结论:妊娠期人微小病毒B19感染与死胎、胎儿畸形的发生存在相关性;B19病毒引起感染的机制可能影响细胞凋亡。

  13. Prevalence of Chlamydia trachomatis Infection among Low- and High-Risk Filipino Women and Performance of Chlamydia Rapid Tests in Resource-Limited Settings▿

    OpenAIRE

    Saison, Francis; Mahilum-Tapay, Lourdes; Michel, Claude-Edouard E.; Buttress, Nigel D.; Nadala, Elpidio Cesar B.; Magbanua, Jose Paolo V; Emma M Harding-Esch; Villaruel, M. Odeta; Canong, Lorna; Celis, Rey L.; Lee, Helen H.

    2007-01-01

    The prevalence of urogenital Chlamydia trachomatis infection was determined with a PCR-based test of women from low- and high-risk populations in Iloilo City, Philippines, between August 2002 and March 2006. Two rapid tests for C. trachomatis, Clearview Chlamydia MF and the Chlamydia Rapid Test (CRT), were also evaluated in these resource-limited settings. Specimens were obtained from female sex workers (FSWs; n = 1,484) attending a social hygiene clinic (SHC) and from women (n = 838) attendi...

  14. Burden of Severe Pneumonia, Pneumococcal Pneumonia and Pneumonia Deaths in Indian States: Modelling Based Estimates

    OpenAIRE

    Farooqui, H; Jit, M.; Heymann, DL; Zodpey, S.

    2015-01-01

    The burden of severe pneumonia in terms of morbidity and mortality is unknown in India especially at sub-national level. In this context, we aimed to estimate the number of severe pneumonia episodes, pneumococcal pneumonia episodes and pneumonia deaths in children younger than 5 years in 2010. We adapted and parameterized a mathematical model based on the epidemiological concept of potential impact fraction developed CHERG for this analysis. The key parameters that determine the distribution ...

  15. Diagnostic Procedures to Detect Chlamydia trachomatis Infections.

    Science.gov (United States)

    Meyer, Thomas

    2016-08-05

    The intracellular life style of chlamydia and the ability to cause persistent infections with low-grade replication requires tests with high analytical sensitivity to directly detect C. trachomatis (CT) in medical samples. Nucleic acid amplification tests (NAATs) are the most sensitive assays with a specificity similar to cell culture and are considered the method of choice for CT detection. In addition, NAATs can be performed on various clinical specimens that do not depend on specific transport and storage conditions, since NAATs do not require infectious bacteria. In the case of lower genital tract infections, first void urine and vaginal swabs are the recommended specimens for testing males and females, respectively. Infections of anorectal, oropharyngeal and ocular epithelia should also be tested by NAAT analysis of corresponding mucosal swabs. In particular, anorectal infections of men who have sex with men (MSM) should include evaluation of lymphogranuloma venereum (LGV) by identification of genotypes L1, L2 or L3. Detection of CT antigens by enzyme immunoassay (EIAs) or rapid diagnostic tests (RDTs) are unsuitable due to insufficient sensitivity and specificity. Recent PCR-based RDTs, however, are non-inferior to standard NAATs, and might be used at the point-of-care. Serology finds application in the diagnostic work-up of suspected chronic CT infection but is inappropriate to diagnose acute infections.

  16. Cost-effectiveness of Chlamydia Vaccination Programs for Young Women

    OpenAIRE

    Owusu-Edusei, Kwame; Harrell W Chesson; Gift, Thomas L.; Brunham, Robert C.; Bolan, Gail

    2015-01-01

    We explored potential cost-effectiveness of a chlamydia vaccine for young women in the United States by using a compartmental heterosexual transmission model. We tracked health outcomes (acute infections and sequelae measured in quality-adjusted life-years [QALYs]) and determined incremental cost-effectiveness ratios (ICERs) over a 50-year analytic horizon. We assessed vaccination of 14-year-old girls and catch-up vaccination for 15–24-year-old women in the context of an existing chlamydia sc...

  17. Exogenous lipid pneumonia

    International Nuclear Information System (INIS)

    Exogenous lipid pneumonia (ELP) is caused by the aspiration of animal, vegetal or, more often, mineral oils. Even though it may also be acute, ELP is most frequently a chronic disease, affecting people with predisposing factors, such as neuromuscular disorders, structural abnormalities and so on; very often exogenous lipid pneumonia is found in tracheotomized patients. The pathology of lipid pneumonia is a chronic inflammatory process evolving in foreign-body-like reaction, and eventually in ''end-stage lung'' condition. Clinically, most patients are asymptomatic; few cases only present with cough, dyspnea and chest pain. Eight cases of ELP, studied over the past 3 years, are described in this paper. All the patients were examined by chest radiographs and standard tomograms; 3 patients underwent CT. X-ray features were mono/bilateral consolidation of the lower zones, with air bronchogram and variable reduction in volume. CT density was not specific for fat tissue. In all cases the diagnosis was confirmed at biopsy. In 5 patients, followed for at least one year, clinical-radiological features showed no change. Thus, complications of ELP (especially malignant evolution) could be excluded. The authors conclude that lipid pneumonia must be considered in differential diagnosis of patients with history of usage of oils and compatible X-ray findings. The usefulness of an accurate follow-up is stressed

  18. Lipoid pneumonia: an overview.

    Science.gov (United States)

    Hadda, Vijay; Khilnani, Gopi C

    2010-12-01

    Lipoid pneumonia is an uncommon disease caused by the presence of lipid in the alveoli. It is classified into two major groups, depending on whether the lipid/oil in the respiratory tract is from an exogenous (exogenous lipoid pneumonia) or endogenous/idiopathic (endogenous lipoid pneumonia) source. The usual presentation occurs with insidious onset and nonspecific respiratory symptoms such as dyspnea and/or cough. The main radiological findings include airspace consolidations, ground-glass attenuation, airspace nodules and 'crazy-paving' pattern. However, the radiological appearance of the disorder can mimic many other lung diseases, including carcinoma. Owing to the nonspecific clinical presentation and radiological features, the diagnosis is often missed or delayed. Pathologically, lipoid pneumonia is a chronic foreign body reaction to fat, characterized by lipid-laden macrophages. Diagnosis of this disease requires a high index of suspicion and can be confirmed by demonstration of lipid-laden macrophages in respiratory samples such as sputum, bronchoalveolar lavage fluid or fine-needle aspiration cytology/biopsy from lung lesions. Treatment protocols for this illness are poorly defined. PMID:21128754

  19. Hypervirulent Klebsiella pneumoniae

    OpenAIRE

    Patel, Payal K.; Russo, Thomas A.; Karchmer, Adolf W.

    2014-01-01

    Hypervirulent strains of Klebsiella pneumoniae are associated with abscess formation, commonly hepatic, and metastatic spread, even in healthy patients. We describe a case of this clinical syndrome, genotypic and phenotypic features of the isolate, and briefly review epidemiology, clinical manifestations, and pathogenesis of this underappreciated syndrome.

  20. 血液病和风湿性疾病患者微小病毒B19感染检测

    Institute of Scientific and Technical Information of China (English)

    陈莹; 刘复强; 翟艳玲

    2004-01-01

    人微小病毒B19(Human parvovirus B19,HPV B19)是微小病毒族中唯一与人类疾病有密切关系的病毒。有研究表明,HPVB19与传染性红斑、一过性再障危象、慢性贫血、关节炎及先天性肠闭锁密切相关。我们对血液病和风湿性疾病患者进行了HPVB19感染的血清学调查,现报告如下。